country,term,count
AL,ACUTE MYOCARDIAL INFARCTION,2
DZ,FACIAL BONES FRACTURE,1
DZ,FALL,1
DZ,HYPOTENSION,1
DZ,MALAISE,1
DZ,ORTHOSTATIC HYPOTENSION,1
DZ,RENAL ATROPHY,1
DZ,SHOCK,1
DZ,URTICARIA,1
AG,INJURY,1
AG,SUBARACHNOID HAEMATOMA,1
AG,SUBDURAL HAEMATOMA,1
AG,URINARY RETENTION,1
AR,ATRIAL FIBRILLATION,2
AR,ATRIOVENTRICULAR BLOCK FIRST DEGREE,2
AR,BRADYCARDIA,2
AR,DYSPNOEA,2
AR,ELECTROCARDIOGRAM QT PROLONGED,2
AR,HOT FLUSH,2
AR,LETHARGY,2
AR,SUPRAVENTRICULAR EXTRASYSTOLES,2
AR,THROMBOCYTOPENIA,2
AR,ABDOMINAL DISTENSION,1
AR,ABDOMINAL PAIN,1
AR,ASTHMA,1
AR,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
AR,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
AR,CARDIAC FAILURE,1
AR,COLITIS,1
AR,DIARRHOEA HAEMORRHAGIC,1
AR,DRUG INTOLERANCE,1
AR,GASTROINTESTINAL HAEMORRHAGE,1
AR,HYPERSENSITIVITY,1
AR,LARGE INTESTINAL HAEMORRHAGE,1
AW,BLOOD COUNT ABNORMAL,1
AW,DIARRHOEA,1
AW,GENERAL PHYSICAL HEALTH DETERIORATION,1
AW,LIVER FUNCTION TEST ABNORMAL,1
AW,PLATELET COUNT INCREASED,1
AW,VENTRICULAR TACHYCARDIA,1
AU,HYPOTENSION,48
AU,ATRIAL FIBRILLATION,42
AU,ACUTE KIDNEY INJURY,41
AU,DYSPNOEA,40
AU,DIZZINESS,26
AU,DRUG-INDUCED LIVER INJURY,26
AU,NAUSEA,25
AU,PYREXIA,25
AU,MYOCARDIAL INFARCTION,24
AU,RENAL IMPAIRMENT,24
AU,CHEST PAIN,23
AU,DIARRHOEA,23
AU,BRADYCARDIA,22
AU,FALL,22
AU,MALAISE,22
AU,SYNCOPE,21
AU,FATIGUE,19
AU,TACHYCARDIA,19
AU,COAGULOPATHY,18
AU,RHABDOMYOLYSIS,17
AU,SEPSIS,16
AU,ACUTE MYOCARDIAL INFARCTION,15
AU,CARDIAC FAILURE,15
AU,CONFUSIONAL STATE,15
AU,HYPERTENSION,15
AU,OEDEMA PERIPHERAL,15
AU,HAEMOGLOBIN DECREASED,14
AU,LETHARGY,14
AU,LOWER RESPIRATORY TRACT INFECTION,14
AU,PULMONARY EMBOLISM,14
AU,VENTRICULAR HYPOKINESIA,14
AU,ANAEMIA,13
AU,COUGH,13
AU,NEUTROPHIL COUNT INCREASED,13
AU,OVERDOSE,13
AU,PNEUMONIA,13
AU,BLOOD CREATININE INCREASED,12
AU,BLOOD GLUCOSE INCREASED,12
AU,DEHYDRATION,12
AU,GENERAL PHYSICAL HEALTH DETERIORATION,12
AU,HYPERKALAEMIA,12
AU,PLEURAL EFFUSION,12
AU,WHITE BLOOD CELL COUNT INCREASED,12
AU,ABDOMINAL PAIN,11
AU,CORONARY ARTERY DISEASE,11
AU,DEATH,11
AU,PAIN IN EXTREMITY,11
AU,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,11
AU,PROTEIN TOTAL DECREASED,11
AU,VOMITING,11
AU,ASTHENIA,10
AU,BLOOD LACTATE DEHYDROGENASE INCREASED,10
AU,CEREBROVASCULAR ACCIDENT,10
AU,CHEST DISCOMFORT,10
AU,CHILLS,10
AU,DECREASED APPETITE,10
AU,DILATATION ATRIAL,10
AU,HEADACHE,10
AU,NEUTROPHILIA,10
AU,TOXICITY TO VARIOUS AGENTS,10
AU,ALANINE AMINOTRANSFERASE INCREASED,9
AU,BACK PAIN,9
AU,BLOOD CHLORIDE INCREASED,9
AU,DRUG INEFFECTIVE,9
AU,EJECTION FRACTION DECREASED,9
AU,FEBRILE NEUTROPENIA,9
AU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,9
AU,INCORRECT DOSE ADMINISTERED,9
AU,ISCHAEMIC HEPATITIS,9
AU,LOSS OF CONSCIOUSNESS,9
AU,MULTIPLE ORGAN DYSFUNCTION SYNDROME,9
AU,RENAL FAILURE ACUTE,9
AU,TACHYPNOEA,9
AU,URINARY TRACT INFECTION,9
AU,BLOOD ALKALINE PHOSPHATASE INCREASED,8
AU,BLOOD CREATINE PHOSPHOKINASE INCREASED,8
AU,BLOOD PRESSURE INCREASED,8
AU,CARDIOGENIC SHOCK,8
AU,CONDITION AGGRAVATED,8
AU,DELIRIUM,8
AU,EOSINOPHILIA,8
AU,GLOMERULAR FILTRATION RATE DECREASED,8
AU,PAIN,8
AU,PNEUMONIA HAEMOPHILUS,8
AU,SOMNOLENCE,8
AU,ACUTE CORONARY SYNDROME,7
AU,CHRONIC KIDNEY DISEASE,7
AU,DELUSION,7
AU,HEART RATE INCREASED,7
AU,METABOLIC ACIDOSIS,7
AU,MITRAL VALVE SCLEROSIS,7
AU,MUSCULAR WEAKNESS,7
AU,MYALGIA,7
AU,PANCYTOPENIA,7
AU,PRURITUS,7
AU,THROMBOCYTOPENIA,7
AU,TRICUSPID VALVE SCLEROSIS,7
AU,ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS,6
AU,ASPARTATE AMINOTRANSFERASE INCREASED,6
AU,BLOOD CALCIUM DECREASED,6
AU,CARDIAC ARREST,6
AU,CONTUSION,6
AU,CYANOSIS,6
AU,ELECTROCARDIOGRAM ABNORMAL,6
AU,HAEMATOCRIT DECREASED,6
AU,HAEMORRHAGE INTRACRANIAL,6
AU,HYPERHIDROSIS,6
AU,HYPOAESTHESIA,6
AU,HYPOPHAGIA,6
AU,INSOMNIA,6
AU,LYMPHOCYTE COUNT DECREASED,6
AU,NEUTROPENIA,6
AU,OSTEOPOROSIS,6
AU,PALPITATIONS,6
AU,PANCREATIC CARCINOMA,6
AU,PULMONARY OEDEMA,6
AU,RASH,6
AU,RECTAL HAEMORRHAGE,6
AU,RESPIRATORY FAILURE,6
AU,SYSTOLIC DYSFUNCTION,6
AU,TRANSIENT ISCHAEMIC ATTACK,6
AU,WEIGHT DECREASED,6
AU,ANGINA PECTORIS,5
AU,BASAL CELL CARCINOMA,5
AU,BLOOD IRON DECREASED,5
AU,BLOOD SODIUM DECREASED,5
AU,CHROMATURIA,5
AU,COGNITIVE DISORDER,5
AU,CORONARY ARTERY STENOSIS,5
AU,DEPRESSION,5
AU,DRUG EFFECT INCOMPLETE,5
AU,FEMUR FRACTURE,5
AU,HAEMATURIA,5
AU,HYPOCALCAEMIA,5
AU,INTENTIONAL OVERDOSE,5
AU,LEUKOCYTOSIS,5
AU,LIMB DISCOMFORT,5
AU,LIVER FUNCTION TEST ABNORMAL,5
AU,MITRAL VALVE INCOMPETENCE,5
AU,MYOCARDIAL ISCHAEMIA,5
AU,MYOCARDITIS,5
AU,MYOCLONUS,5
AU,OSTEOARTHRITIS,5
AU,OXYGEN SATURATION DECREASED,5
AU,PERICARDIAL HAEMORRHAGE,5
AU,PNEUMONIA ASPIRATION,5
AU,RASH MACULO-PAPULAR,5
AU,RED BLOOD CELL COUNT DECREASED,5
AU,SKIN LESION,5
AU,SQUAMOUS CELL CARCINOMA OF SKIN,5
AU,SUICIDE ATTEMPT,5
AU,WEIGHT INCREASED,5
AU,ABDOMINAL PAIN UPPER,4
AU,ANGIOEDEMA,4
AU,ARTHRALGIA,4
AU,BLOOD PHOSPHORUS DECREASED,4
AU,BLOOD PRESSURE DECREASED,4
AU,BLOOD PRESSURE SYSTOLIC INCREASED,4
AU,BLOOD UREA INCREASED,4
AU,C-REACTIVE PROTEIN INCREASED,4
AU,CARDIAC FAILURE CONGESTIVE,4
AU,CEREBRAL HYPERPERFUSION SYNDROME,4
AU,CIRCULATORY COLLAPSE,4
AU,CONSTIPATION,4
AU,DEEP VEIN THROMBOSIS,4
AU,DYSPHAGIA,4
AU,DYSPHONIA,4
AU,DYSPNOEA EXERTIONAL,4
AU,ELECTROCARDIOGRAM QT PROLONGED,4
AU,FEELING ABNORMAL,4
AU,GAIT DISTURBANCE,4
AU,HAEMORRHAGE,4
AU,HALLUCINATION_ VISUAL,4
AU,HEPATIC FAILURE,4
AU,HEPATOTOXICITY,4
AU,HYPOMAGNESAEMIA,4
AU,HYPONATRAEMIA,4
AU,INFECTION,4
AU,LACERATION,4
AU,MUSCLE SPASMS,4
AU,PERICARDIAL EFFUSION,4
AU,PERIPHERAL SWELLING,4
AU,POLYCHROMASIA,4
AU,SCHIZOPHRENIA,4
AU,SEIZURE,4
AU,SEPTIC SHOCK,4
AU,SKIN CANCER,4
AU,SKIN DISCOLOURATION,4
AU,SUICIDAL IDEATION,4
AU,TREMOR,4
AU,TROPONIN INCREASED,4
AU,TYPE 2 DIABETES MELLITUS,4
AU,UNRESPONSIVE TO STIMULI,4
AU,VISION BLURRED,4
AU,ABNORMAL BEHAVIOUR,3
AU,ACUTE PHASE REACTION,3
AU,AGRANULOCYTOSIS,3
AU,ANAPHYLACTIC REACTION,3
AU,ANXIETY,3
AU,ATAXIA,3
AU,ATELECTASIS,3
AU,ATRIAL FLUTTER,3
AU,BLOOD ALBUMIN DECREASED,3
AU,BLOOD BICARBONATE DECREASED,3
AU,BLOOD CREATINE PHOSPHOKINASE ABNORMAL,3
AU,BLOOD URIC ACID INCREASED,3
AU,BONE PAIN,3
AU,CARDIAC MURMUR,3
AU,CHRONIC LYMPHOCYTIC LEUKAEMIA,3
AU,CYANOSIS CENTRAL,3
AU,DELIRIUM FEBRILE,3
AU,DEVICE BATTERY ISSUE,3
AU,DIASTOLIC DYSFUNCTION,3
AU,DILATATION VENTRICULAR,3
AU,DISEASE PROGRESSION,3
AU,DISSEMINATED INTRAVASCULAR COAGULATION,3
AU,DIVERTICULITIS,3
AU,DYSURIA,3
AU,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,3
AU,EYE PAIN,3
AU,GASTRIC HAEMORRHAGE,3
AU,GASTROENTERITIS,3
AU,GASTROINTESTINAL HAEMORRHAGE,3
AU,GASTROOESOPHAGEAL REFLUX DISEASE,3
AU,HAEMODYNAMIC INSTABILITY,3
AU,HEAD INJURY,3
AU,HEMIPLEGIA,3
AU,HEPATIC ENZYME INCREASED,3
AU,HERPES ZOSTER,3
AU,HYPERCHOLESTEROLAEMIA,3
AU,HYPERTONIA,3
AU,HYPOKALAEMIA,3
AU,HYPOKINESIA,3
AU,INCONTINENCE,3
AU,INFLUENZA LIKE ILLNESS,3
AU,INTERNATIONAL NORMALISED RATIO INCREASED,3
AU,KIDNEY INFECTION,3
AU,LACTIC ACIDOSIS,3
AU,LEFT VENTRICULAR DYSFUNCTION,3
AU,LYMPHOCYTE COUNT INCREASED,3
AU,MELAENA,3
AU,METASTASES TO LIVER,3
AU,MONOCYTE COUNT INCREASED,3
AU,MOUTH ULCERATION,3
AU,MULTI-ORGAN FAILURE,3
AU,MUSCULOSKELETAL CHEST PAIN,3
AU,NASOPHARYNGITIS,3
AU,NEPHRITIC SYNDROME,3
AU,NON-HODGKIN^S LYMPHOMA,3
AU,OEDEMA,3
AU,PANCREATITIS ACUTE,3
AU,PARAESTHESIA,3
AU,PLASMA CELL MYELOMA,3
AU,PLATELET COUNT DECREASED,3
AU,POLLAKIURIA,3
AU,POST PROCEDURAL HAEMORRHAGE,3
AU,PRODUCT USE IN UNAPPROVED INDICATION,3
AU,PSYCHIATRIC DECOMPENSATION,3
AU,RED CELL DISTRIBUTION WIDTH INCREASED,3
AU,RENAL VASCULITIS,3
AU,RESPIRATORY DISTRESS,3
AU,SECOND PRIMARY MALIGNANCY,3
AU,SEDATION,3
AU,SINUS TACHYCARDIA,3
AU,SKIN ULCER,3
AU,SLEEP APNOEA SYNDROME,3
AU,SNORING,3
AU,SPEECH DISORDER,3
AU,TENDERNESS,3
AU,THROAT TIGHTNESS,3
AU,THROMBOTIC THROMBOCYTOPENIC PURPURA,3
AU,TRANSFERRIN DECREASED,3
AU,TRICUSPID VALVE INCOMPETENCE,3
AU,TROPONIN T INCREASED,3
AU,URINARY RETENTION,3
AU,URINE ODOUR ABNORMAL,3
AU,URINE OUTPUT DECREASED,3
AU,VITAMIN D DEFICIENCY,3
AU,WHEEZING,3
AU,ABDOMINAL DISCOMFORT,2
AU,ABDOMINAL TENDERNESS,2
AU,ACTINIC KERATOSIS,2
AU,ADVERSE DRUG REACTION,2
AU,AMNESIA,2
AU,ANGER,2
AU,ANION GAP DECREASED,2
AU,AORTIC VALVE INCOMPETENCE,2
AU,APHASIA,2
AU,ATRIAL TACHYCARDIA,2
AU,BLOOD BILIRUBIN INCREASED,2
AU,BLOOD CHLORIDE DECREASED,2
AU,BLOOD CHOLESTEROL INCREASED,2
AU,BLOOD CREATINE INCREASED,2
AU,BLOOD CREATININE DECREASED,2
AU,BLOOD POTASSIUM DECREASED,2
AU,BLOOD PRESSURE SYSTOLIC,2
AU,BLOOD PRESSURE SYSTOLIC DECREASED,2
AU,BLOOD PROLACTIN INCREASED,2
AU,BODY MASS INDEX INCREASED,2
AU,BODY TEMPERATURE INCREASED,2
AU,BRAIN INJURY,2
AU,BRAIN NEOPLASM,2
AU,BREAST CANCER,2
AU,BRONCHITIS,2
AU,BURNING SENSATION,2
AU,CACHEXIA,2
AU,CARDIAC DISORDER,2
AU,CARDIAC FAILURE ACUTE,2
AU,CARDIAC TAMPONADE,2
AU,CARDIOVASCULAR DISORDER,2
AU,CELLULITIS,2
AU,CEREBRAL HAEMORRHAGE,2
AU,CEREBRAL ISCHAEMIA,2
AU,CHOLANGITIS,2
AU,CHOLECYSTITIS,2
AU,CHOLELITHIASIS,2
AU,COLITIS,2
AU,COLON CANCER,2
AU,COMA SCALE ABNORMAL,2
AU,COMMUNICATION DISORDER,2
AU,CONCOMITANT DISEASE AGGRAVATED,2
AU,CONGESTIVE CARDIOMYOPATHY,2
AU,CONVULSION,2
AU,CORONARY ARTERY OCCLUSION,2
AU,CREPITATIONS,2
AU,CRYPTOCOCCOSIS,2
AU,DEAFNESS NEUROSENSORY,2
AU,DEPRESSED LEVEL OF CONSCIOUSNESS,2
AU,DIZZINESS POSTURAL,2
AU,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
AU,DRUG TOLERANCE DECREASED,2
AU,ECZEMA,2
AU,ELECTROCARDIOGRAM T WAVE ABNORMAL,2
AU,EMPHYSEMA,2
AU,ENCEPHALOPATHY,2
AU,ENDOCARDITIS,2
AU,ERYTHEMA,2
AU,ESCHERICHIA URINARY TRACT INFECTION,2
AU,FAECES DISCOLOURED,2
AU,FLUID OVERLOAD,2
AU,FLUSHING,2
AU,FOETAL EXPOSURE DURING PREGNANCY,2
AU,GANGRENE,2
AU,GASTRIC ULCER,2
AU,GASTRITIS,2
AU,GLAUCOMA,2
AU,GOUT,2
AU,GRIEF REACTION,2
AU,HAEMOLYTIC ANAEMIA,2
AU,HALLUCINATION,2
AU,HEART RATE DECREASED,2
AU,HEART RATE IRREGULAR,2
AU,HEPATIC FUNCTION ABNORMAL,2
AU,HEPATIC STEATOSIS,2
AU,HEPATITIS C,2
AU,HIATUS HERNIA,2
AU,HYDRONEPHROSIS,2
AU,HYPERTHYROIDISM,2
AU,HYPOALBUMINAEMIA,2
AU,HYPOPHOSPHATAEMIA,2
AU,HYPOTHERMIA,2
AU,HYPOXIA,2
AU,IMMUNOGLOBULINS DECREASED,2
AU,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
AU,INFUSION RELATED REACTION,2
AU,INTESTINAL HAEMORRHAGE,2
AU,INTESTINAL OBSTRUCTION,2
AU,INTRAVENTRICULAR HAEMORRHAGE,2
AU,JAUNDICE,2
AU,JOINT SWELLING,2
AU,KERATOACANTHOMA,2
AU,LARGE INTESTINE POLYP,2
AU,LEFT ATRIAL DILATATION,2
AU,LIVER FUNCTION TEST INCREASED,2
AU,LOCALISED INFECTION,2
AU,MALIGNANT NEOPLASM PROGRESSION,2
AU,MEAN CELL HAEMOGLOBIN DECREASED,2
AU,MEDICAL DEVICE PAIN,2
AU,MEMORY IMPAIRMENT,2
AU,MENTAL DISORDER,2
AU,METASTASES TO LUNG,2
AU,MOBILITY DECREASED,2
AU,MUSCULOSKELETAL PAIN,2
AU,MYELODYSPLASTIC SYNDROME,2
AU,MYOPATHY,2
AU,MYOSITIS,2
AU,NEUTROPENIC SEPSIS,2
AU,NIGHT SWEATS,2
AU,OLIGURIA,2
AU,ORTHOPNOEA,2
AU,ORTHOSTATIC HYPOTENSION,2
AU,OXYGEN SATURATION,2
AU,PARKINSON^S DISEASE,2
AU,PARTIAL SEIZURES,2
AU,PERICARDITIS,2
AU,PNEUMONITIS,2
AU,PNEUMOTHORAX,2
AU,POLYARTHRITIS,2
AU,PRODUCT QUALITY ISSUE,2
AU,PROTEINURIA,2
AU,PSYCHIATRIC SYMPTOM,2
AU,PSYCHOTIC DISORDER,2
AU,PULMONARY ARTERIAL HYPERTENSION,2
AU,PULMONARY FIBROSIS,2
AU,PULSE ABSENT,2
AU,REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA,2
AU,RENAL CYST,2
AU,RENAL FAILURE,2
AU,RENAL FAILURE CHRONIC,2
AU,RENAL TUBULAR NECROSIS,2
AU,SERUM FERRITIN DECREASED,2
AU,SLEEP DISORDER,2
AU,SPINAL COMPRESSION FRACTURE,2
AU,SPLENOMEGALY,2
AU,SPUTUM DISCOLOURED,2
AU,SQUAMOUS CELL CARCINOMA,2
AU,STAPHYLOCOCCAL INFECTION,2
AU,STAPHYLOCOCCAL SEPSIS,2
AU,SUBDURAL HAEMORRHAGE,2
AU,SUDDEN DEATH,2
AU,SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT,2
AU,THROMBOSIS,2
AU,THROMBOTIC MICROANGIOPATHY,2
AU,THYROIDITIS,2
AU,TRANSAMINASES INCREASED,2
AU,TRANSPLANT REJECTION,2
AU,TROPONIN I INCREASED,2
AU,UNDERDOSE,2
AU,URINARY INCONTINENCE,2
AU,UROSEPSIS,2
AU,VASCULAR DEMENTIA,2
AU,VENTRICULAR EXTRASYSTOLES,2
AU,VERTIGO,2
AU,VISUAL IMPAIRMENT,2
AU,WHITE BLOOD CELL ANALYSIS ABNORMAL,2
AU,WITHDRAWAL SYNDROME,2
AU,WRIST FRACTURE,2
AU,ABASIA,1
AU,ABDOMINAL DISTENSION,1
AU,ABDOMINAL WALL HAEMATOMA,1
AU,ABNORMAL DREAMS,1
AU,ABORTION INCOMPLETE,1
AU,ABSCESS NECK,1
AU,ACCIDENTAL EXPOSURE TO PRODUCT,1
AU,ACCIDENTAL OVERDOSE,1
AU,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
AU,ACUTE HEPATIC FAILURE,1
AU,ACUTE MYELOID LEUKAEMIA,1
AU,ACUTE PULMONARY OEDEMA,1
AU,ACUTE RESPIRATORY DISTRESS SYNDROME,1
AU,ACUTE RESPIRATORY FAILURE,1
AU,AGEUSIA,1
AU,AGGRESSION,1
AU,AGITATION,1
AU,AIRWAY COMPLICATION OF ANAESTHESIA,1
AU,ALBUMIN URINE PRESENT,1
AU,ALTERED STATE OF CONSCIOUSNESS,1
AU,ANAESTHETIC COMPLICATION PULMONARY,1
AU,ANAL INCONTINENCE,1
AU,ANASTOMOTIC LEAK,1
AU,ANGIOMYOLIPOMA,1
AU,ANION GAP INCREASED,1
AU,ANOSMIA,1
AU,ANOXIA,1
AU,ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC,1
AU,ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC,1
AU,ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC,1
AU,ANTIPSYCHOTIC DRUG LEVEL DECREASED,1
AU,AORTIC ANEURYSM,1
AU,AORTIC DILATATION,1
AU,AORTIC DISSECTION,1
AU,AORTIC DISSECTION RUPTURE,1
AU,AORTIC STENOSIS,1
AU,APLASIA PURE RED CELL,1
AU,APPLICATION SITE PAIN,1
AU,ARRHYTHMIA,1
AU,ARTERIAL DISORDER,1
AU,ARTERIAL STENOSIS,1
AU,ARTERIOSCLEROSIS,1
AU,ARTERIOSCLEROSIS CORONARY ARTERY,1
AU,ARTHRITIS,1
AU,ARTHRITIS BACTERIAL,1
AU,ARTHRODESIS,1
AU,ARTHROPATHY,1
AU,ASCITES,1
AU,ASTHMA,1
AU,ATRIOVENTRICULAR BLOCK,1
AU,AUTOIMMUNE HEPATITIS,1
AU,AZOTAEMIA,1
AU,BACK DISORDER,1
AU,BACTERIAL INFECTION,1
AU,BALANCE DISORDER,1
AU,BALANOPOSTHITIS,1
AU,BLADDER ADENOCARCINOMA STAGE III,1
AU,BLINDNESS,1
AU,BLINDNESS TRANSIENT,1
AU,BLINDNESS UNILATERAL,1
AU,BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED,1
AU,BLOOD BICARBONATE INCREASED,1
AU,BLOOD CALCIUM INCREASED,1
AU,BLOOD CREATINE PHOSPHOKINASE DECREASED,1
AU,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,1
AU,BLOOD DISORDER,1
AU,BLOOD INSULIN INCREASED,1
AU,BLOOD LACTATE DEHYDROGENASE DECREASED,1
AU,BLOOD MAGNESIUM DECREASED,1
AU,BLOOD OSMOLARITY DECREASED,1
AU,BLOOD PARATHYROID HORMONE INCREASED,1
AU,BLOOD POTASSIUM INCREASED,1
AU,BLOOD TRIGLYCERIDES INCREASED,1
AU,BLOOD UREA DECREASED,1
AU,BONE DENSITY DECREASED,1
AU,BONE MARROW FAILURE,1
AU,BOWEL PREPARATION,1
AU,BOWEN^S DISEASE,1
AU,BRAIN SCAN ABNORMAL,1
AU,BREAST CANCER METASTATIC,1
AU,BRONCHOSPASM,1
AU,BURSITIS,1
AU,CALCIUM IONISED INCREASED,1
AU,CAMPYLOBACTER INFECTION,1
AU,CARBON MONOXIDE DIFFUSING CAPACITY DECREASED,1
AU,CARDIAC ENZYMES INCREASED,1
AU,CARDIAC FUNCTION TEST ABNORMAL,1
AU,CARDIAC HYPERTROPHY,1
AU,CARDIAC PACEMAKER INSERTION,1
AU,CARDIAC SEPTAL DEFECT,1
AU,CARDIO-RESPIRATORY ARREST,1
AU,CARDIOMYOPATHY,1
AU,CAROTID ARTERIOSCLEROSIS,1
AU,CATARACT,1
AU,CATARACT OPERATION,1
AU,CATHETER SITE HAEMORRHAGE,1
AU,CHOLANGITIS ACUTE,1
AU,CHOLECYSTECTOMY,1
AU,CHRONIC MYELOID LEUKAEMIA (IN REMISSION),1
AU,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
AU,CLAUSTROPHOBIA,1
AU,COAGULATION FACTOR DECREASED,1
AU,COAGULATION TEST ABNORMAL,1
AU,COAGULATION TIME PROLONGED,1
AU,COELIAC DISEASE,1
AU,COGWHEEL RIGIDITY,1
AU,COLITIS ULCERATIVE,1
AU,COLON CANCER METASTATIC,1
AU,COMA,1
AU,CONCOMITANT DISEASE PROGRESSION,1
AU,CONDUCTION DISORDER,1
AU,CONJUNCTIVAL HAEMORRHAGE,1
AU,CORONARY ARTERY BYPASS,1
AU,CORONARY ARTERY DISSECTION,1
AU,CREATININE RENAL CLEARANCE ABNORMAL,1
AU,CUSHING^S SYNDROME,1
AU,CYSTITIS,1
AU,CYTOMEGALOVIRUS COLITIS,1
AU,DEPERSONALISATION,1
AU,DERMATITIS ATOPIC,1
AU,DERMATITIS CONTACT,1
AU,DEVICE BREAKAGE,1
AU,DEVICE MALFUNCTION,1
AU,DIABETES MELLITUS,1
AU,DIABETES MELLITUS INADEQUATE CONTROL,1
AU,DIALYSIS,1
AU,DISEASE RECURRENCE,1
AU,DISORIENTATION,1
AU,DISSOCIATION,1
AU,DIVERTICULAR PERFORATION,1
AU,DIVERTICULUM,1
AU,DIVERTICULUM INTESTINAL HAEMORRHAGIC,1
AU,DRUG ADMINISTRATION ERROR,1
AU,DRUG CLEARANCE DECREASED,1
AU,DRUG ERUPTION,1
AU,DRUG LEVEL INCREASED,1
AU,DRUG RESISTANCE,1
AU,DRUG SPECIFIC ANTIBODY PRESENT,1
AU,DRY SKIN,1
AU,DUODENAL OBSTRUCTION,1
AU,DUODENITIS,1
AU,DYSARTHRIA,1
AU,DYSGEUSIA,1
AU,DYSKINESIA,1
AU,DYSPEPSIA,1
AU,DYSSTASIA,1
AU,EAR PAIN,1
AU,ECZEMA NUMMULAR,1
AU,ELDERLY,1
AU,ELECTROCARDIOGRAM CHANGE,1
AU,ELECTROCARDIOGRAM PR PROLONGATION,1
AU,ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL,1
AU,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,1
AU,ELECTROCARDIOGRAM ST SEGMENT ABNORMAL,1
AU,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
AU,ELECTROCARDIOGRAM T WAVE INVERSION,1
AU,ELECTROLYTE IMBALANCE,1
AU,EMBOLIC STROKE,1
AU,EMOTIONAL DISTRESS,1
AU,ENCEPHALITIS,1
AU,ENCEPHALITIS VIRAL,1
AU,ENDOTRACHEAL INTUBATION COMPLICATION,1
AU,ENTEROCOLITIS BACTERIAL,1
AU,ENTEROCOLITIS FUNGAL,1
AU,EOSINOPHIL COUNT DECREASED,1
AU,EPIGLOTTITIS,1
AU,EPISTAXIS,1
AU,ERECTILE DYSFUNCTION,1
AU,ERUCTATION,1
AU,ESCHERICHIA BACTERAEMIA,1
AU,ESCHERICHIA INFECTION,1
AU,ESCHERICHIA SEPSIS,1
AU,ESCHERICHIA TEST POSITIVE,1
AU,EXERCISE TOLERANCE DECREASED,1
AU,EYELID OEDEMA,1
AU,FACIAL PAIN,1
AU,FACTOR VIII INHIBITION,1
AU,FEAR,1
AU,FEMALE GENITAL TRACT FISTULA,1
AU,FEMORAL NECK FRACTURE,1
AU,FLANK PAIN,1
AU,FLUID RETENTION,1
AU,FOAMING AT MOUTH,1
AU,FOLLICULITIS,1
AU,FOOD INTOLERANCE,1
AU,FOREIGN BODY,1
AU,GASTRIC DISORDER,1
AU,GASTRIC MUCOSAL HYPERTROPHY,1
AU,GASTROINTESTINAL CANCER METASTATIC,1
AU,GENERAL PHYSICAL CONDITION ABNORMAL,1
AU,GIARDIASIS,1
AU,GLOMERULONEPHRITIS,1
AU,GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE,1
AU,GLUCOSE TOLERANCE IMPAIRED,1
AU,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
AU,GRANULOCYTOPENIA,1
AU,GRIP STRENGTH DECREASED,1
AU,HAEMATEMESIS,1
AU,HAEMATOCHEZIA,1
AU,HAEMATOMA,1
AU,HAEMOLYTIC URAEMIC SYNDROME,1
AU,HAEMOPTYSIS,1
AU,HAEMORRHAGE URINARY TRACT,1
AU,HAEMORRHAGIC INFARCTION,1
AU,HAEMORRHAGIC STROKE,1
AU,HAEMORRHOIDS,1
AU,HEARING IMPAIRED,1
AU,HEMIPARESIS,1
AU,HEPATIC CIRRHOSIS,1
AU,HEPATIC CYST,1
AU,HEPATIC ENCEPHALOPATHY,1
AU,HEPATIC MASS,1
AU,HEPATIC NEOPLASM,1
AU,HEPATITIS B CORE ANTIBODY POSITIVE,1
AU,HEPATITIS B SURFACE ANTIBODY POSITIVE,1
AU,HEPATOSPLENOMEGALY,1
AU,HIP FRACTURE,1
AU,HOMICIDE,1
AU,HOSPITALISATION,1
AU,HOT FLUSH,1
AU,HYDROURETER,1
AU,HYPERCALCAEMIA,1
AU,HYPERDYNAMIC LEFT VENTRICLE,1
AU,HYPERGLYCAEMIA,1
AU,HYPERPARATHYROIDISM SECONDARY,1
AU,HYPERSENSITIVITY,1
AU,HYPERTENSIVE CRISIS,1
AU,HYPOACUSIS,1
AU,HYPOPERFUSION,1
AU,HYPOPHYSITIS,1
AU,HYPOTHYROIDISM,1
AU,HYPOVOLAEMIC SHOCK,1
AU,ILEAL STENOSIS,1
AU,IMMEDIATE POST-INJECTION REACTION,1
AU,IMMUNE THROMBOCYTOPENIC PURPURA,1
AU,IMPAIRED HEALING,1
AU,IMPAIRED SELF-CARE,1
AU,INFECTED SKIN ULCER,1
AU,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
AU,INFLAMMATION,1
AU,INFLAMMATORY BOWEL DISEASE,1
AU,INHIBITORY DRUG INTERACTION,1
AU,INJECTION SITE PAIN,1
AU,INJURY,1
AU,INTERMITTENT CLAUDICATION,1
AU,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
AU,INTERNATIONAL NORMALISED RATIO DECREASED,1
AU,INTESTINAL ISCHAEMIA,1
AU,INTRACARDIAC THROMBUS,1
AU,IRON DEFICIENCY ANAEMIA,1
AU,ISCHAEMIA,1
AU,ISCHAEMIC STROKE,1
AU,JAUNDICE CHOLESTATIC,1
AU,JOINT STIFFNESS,1
AU,KAPOSI^S SARCOMA,1
AU,KETOSIS,1
AU,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
AU,LABOUR COMPLICATION,1
AU,LACUNAR INFARCTION,1
AU,LARYNGOSPASM,1
AU,LEUKOPENIA,1
AU,LICHENIFICATION,1
AU,LINEAR IGA DISEASE,1
AU,LIPASE INCREASED,1
AU,LIVER DISORDER,1
AU,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
AU,LOW BIRTH WEIGHT BABY,1
AU,LOW DENSITY LIPOPROTEIN INCREASED,1
AU,LOWER RESPIRATORY TRACT INFECTION VIRAL,1
AU,LUNG ABSCESS,1
AU,LUNG CONSOLIDATION,1
AU,LYMPHOCYTE PERCENTAGE DECREASED,1
AU,LYMPHOCYTIC INFILTRATION,1
AU,LYMPHOPENIA,1
AU,MACROCYTOSIS,1
AU,MACULAR FIBROSIS,1
AU,MALLORY-WEISS SYNDROME,1
AU,MALNUTRITION,1
AU,MAST CELL ACTIVATION SYNDROME,1
AU,MATERNAL EXPOSURE DURING PREGNANCY,1
AU,MEAN CELL VOLUME ABNORMAL,1
AU,MEAN CELL VOLUME DECREASED,1
AU,MEAN PLATELET VOLUME DECREASED,1
AU,MENIERE^S DISEASE,1
AU,MENINGIOMA,1
AU,METASTASES TO OVARY,1
AU,METASTASES TO SPINE,1
AU,METASTATIC GASTRIC CANCER,1
AU,MIGRAINE,1
AU,MINERAL SUPPLEMENTATION,1
AU,MITRAL VALVE DISEASE,1
AU,MONOCYTE COUNT DECREASED,1
AU,MOOD ALTERED,1
AU,MOOD SWINGS,1
AU,MUCOUS STOOLS,1
AU,MUSCLE CONTRACTIONS INVOLUNTARY,1
AU,MUSCLE TWITCHING,1
AU,MYELOCYTE COUNT INCREASED,1
AU,MYELOFIBROSIS,1
AU,MYOCARDIAL NECROSIS MARKER INCREASED,1
AU,MYOCARDIAL STRAIN,1
AU,MYOGLOBIN URINE,1
AU,NAIL BED BLEEDING,1
AU,NECK PAIN,1
AU,NEOPLASM MALIGNANT,1
AU,NEUROLEPTIC MALIGNANT SYNDROME,1
AU,NEUROLOGICAL DECOMPENSATION,1
AU,NEUROPATHY PERIPHERAL,1
AU,NEUTROPHIL PERCENTAGE INCREASED,1
AU,NEUTROPHIL TOXIC GRANULATION PRESENT,1
AU,NITRITE URINE PRESENT,1
AU,NO THERAPEUTIC RESPONSE,1
AU,NON-CARDIAC CHEST PAIN,1
AU,NONINFECTIVE SIALOADENITIS,1
AU,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
AU,NORMOCYTIC ANAEMIA,1
AU,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,1
AU,OBSESSIVE-COMPULSIVE DISORDER,1
AU,OBSTRUCTIVE AIRWAYS DISORDER,1
AU,OCCULT BLOOD POSITIVE,1
AU,ODYNOPHAGIA,1
AU,OESOPHAGEAL CANDIDIASIS,1
AU,OESOPHAGITIS,1
AU,OLIGODENDROGLIOMA,1
AU,ONYCHOMADESIS,1
AU,ORAL CANDIDIASIS,1
AU,OROPHARYNGEAL PAIN,1
AU,OSTEONECROSIS OF JAW,1
AU,OSTEOPOROTIC FRACTURE,1
AU,OVARIAN CYST,1
AU,OVERWEIGHT,1
AU,PAIN IN JAW,1
AU,PALLOR,1
AU,PANCREATIC CARCINOMA METASTATIC,1
AU,PANCREATITIS,1
AU,PAPULE,1
AU,PARAESTHESIA ORAL,1
AU,PARAINFLUENZAE VIRUS INFECTION,1
AU,PARAPLEGIA,1
AU,PELVIC FRACTURE,1
AU,PENILE BLISTER,1
AU,PERICARDIAL DRAINAGE,1
AU,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
AU,PERIPHERAL SENSORY NEUROPATHY,1
AU,PERITONEAL HAEMORRHAGE,1
AU,PERSECUTORY DELUSION,1
AU,PHARYNGEAL OEDEMA,1
AU,PHARYNGEAL PARAESTHESIA,1
AU,PLASMACYTOMA,1
AU,PLATELET COUNT INCREASED,1
AU,PLEURITIC PAIN,1
AU,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
AU,PNEUMONIA PNEUMOCOCCAL,1
AU,PNEUMOPERITONEUM,1
AU,PO2 INCREASED,1
AU,POST HERPETIC NEURALGIA,1
AU,POST STREPTOCOCCAL GLOMERULONEPHRITIS,1
AU,PREMATURE BABY,1
AU,PRESYNCOPE,1
AU,PRODUCT USE ISSUE,1
AU,PRODUCTIVE COUGH,1
AU,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
AU,PROSTATE CANCER,1
AU,PROSTATIC DISORDER,1
AU,PROSTATOMEGALY,1
AU,PROTHROMBIN TIME PROLONGED,1
AU,PSYCHOTIC SYMPTOM,1
AU,PULMONARY HAEMORRHAGE,1
AU,PULMONARY HYPERTENSION,1
AU,PULMONARY INFARCTION,1
AU,PULMONARY VALVE INCOMPETENCE,1
AU,PURULENT PERICARDITIS,1
AU,PYELONEPHRITIS,1
AU,QUALITY OF LIFE DECREASED,1
AU,RADIATION INJURY,1
AU,RADIATION NECROSIS,1
AU,RADIUS FRACTURE,1
AU,RASH PAPULAR,1
AU,RASH PRURITIC,1
AU,REBOUND EFFECT,1
AU,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
AU,REFUSAL OF EXAMINATION,1
AU,RENAL CYST INFECTION,1
AU,RENAL FUNCTION TEST ABNORMAL,1
AU,RENAL PAIN,1
AU,RENAL TRANSPLANT FAILURE,1
AU,RESPIRATORY DEPRESSION,1
AU,RESPIRATORY TRACT CONGESTION,1
AU,RESPIRATORY TRACT INFECTION,1
AU,RESTLESS LEGS SYNDROME,1
AU,RETINAL ARTERY EMBOLISM,1
AU,RETROPERITONEAL LYMPHADENOPATHY,1
AU,RETROPERITONEAL MASS,1
AU,RHEUMATOID ARTHRITIS,1
AU,RIB FRACTURE,1
AU,SEASONAL ALLERGY,1
AU,SENSATION OF FOREIGN BODY,1
AU,SENSORY LOSS,1
AU,SEROTONIN SYNDROME,1
AU,SERUM FERRITIN INCREASED,1
AU,SHOCK,1
AU,SIALOADENITIS,1
AU,SICK SINUS SYNDROME,1
AU,SINUSITIS,1
AU,SJOGREN^S SYNDROME,1
AU,SKIN INFECTION,1
AU,SKIN PAPILLOMA,1
AU,SNEEZING,1
AU,SOMATIC DELUSION,1
AU,SPINAL CORD COMPRESSION,1
AU,SPINAL CORD HAEMORRHAGE,1
AU,SPINAL OSTEOARTHRITIS,1
AU,SPLENIC CYST,1
AU,SPLENIC HAEMORRHAGE,1
AU,SPLENIC RUPTURE,1
AU,SPLENIC VARICES,1
AU,SPLENIC VEIN THROMBOSIS,1
AU,SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY,1
AU,STAPHYLOCOCCUS TEST POSITIVE,1
AU,STENOSIS,1
AU,STREPTOCOCCAL BACTERAEMIA,1
AU,STRESS CARDIOMYOPATHY,1
AU,SUBDURAL HAEMATOMA,1
AU,SUNBURN,1
AU,SUPRAVENTRICULAR EXTRASYSTOLES,1
AU,SUSPECTED COUNTERFEIT PRODUCT,1
AU,SYNOVITIS,1
AU,SYSTEMIC CANDIDA,1
AU,SYSTEMIC MASTOCYTOSIS,1
AU,TEMPERATURE INTOLERANCE,1
AU,THERAPEUTIC RESPONSE DECREASED,1
AU,THERAPEUTIC RESPONSE UNEXPECTED,1
AU,THERAPY CHANGE,1
AU,THERMAL BURN,1
AU,THINKING ABNORMAL,1
AU,THORACIC VERTEBRAL FRACTURE,1
AU,THROMBIN TIME ABNORMAL,1
AU,THROMBOCYTOPENIC PURPURA,1
AU,THROMBOSIS IN DEVICE,1
AU,THROMBOTIC CEREBRAL INFARCTION,1
AU,THYROID DISORDER,1
AU,TONSIL CANCER METASTATIC,1
AU,TOOTH EROSION,1
AU,TOOTH SOCKET HAEMORRHAGE,1
AU,TRANSFERRIN SATURATION DECREASED,1
AU,TRANSFERRIN SATURATION INCREASED,1
AU,TRANSITIONAL CELL CARCINOMA,1
AU,TUMOUR LYSIS SYNDROME,1
AU,ULNA FRACTURE,1
AU,URINARY BLADDER HAEMORRHAGE,1
AU,URINE CALCIUM DECREASED,1
AU,URINE SODIUM INCREASED,1
AU,UTERINE POLYP,1
AU,VAGINAL HAEMORRHAGE,1
AU,VAGINAL INFLAMMATION,1
AU,VARICOSE VEIN,1
AU,VASCULAR CALCIFICATION,1
AU,VASCULAR PSEUDOANEURYSM,1
AU,VASCULITIS,1
AU,VENOUS OXYGEN SATURATION INCREASED,1
AU,VENTRICULAR HYPERTROPHY,1
AU,VENTRICULAR INTERNAL DIAMETER ABNORMAL,1
AU,VENTRICULAR TACHYCARDIA,1
AU,VESSEL PERFORATION,1
AU,VIRAL INFECTION,1
AU,VITAMIN D DECREASED,1
AU,VULVOVAGINAL CANDIDIASIS,1
AU,VULVOVAGINAL INJURY,1
AU,WHITE BLOOD CELL COUNT DECREASED,1
AU,WOUND INFECTION,1
AU,WRONG DRUG ADMINISTERED,1
AU,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
AU,XANTHELASMA,1
AT,DELIRIUM,8
AT,PNEUMONIA,5
AT,HALLUCINATIONS_ MIXED,4
AT,ANAEMIA,3
AT,ATRIAL FIBRILLATION,3
AT,BACK PAIN,3
AT,BETA 2 MICROGLOBULIN INCREASED,3
AT,CONFUSIONAL STATE,3
AT,DIARRHOEA,3
AT,FOETAL EXPOSURE DURING PREGNANCY,3
AT,FOETAL GROWTH RESTRICTION,3
AT,HEMIPARESIS,3
AT,LYMPHOCYTE COUNT INCREASED,3
AT,NAUSEA,3
AT,PSYCHOMOTOR HYPERACTIVITY,3
AT,WHITE BLOOD CELL COUNT INCREASED,3
AT,ABDOMINAL PAIN,2
AT,CARDIAC FAILURE,2
AT,CEREBRAL HAEMORRHAGE,2
AT,CONGENITAL CYSTIC KIDNEY DISEASE,2
AT,CONTUSION,2
AT,DEHYDRATION,2
AT,DYSPNOEA,2
AT,GLOMERULAR FILTRATION RATE DECREASED,2
AT,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
AT,LOW BIRTH WEIGHT BABY,2
AT,PREMATURE BABY,2
AT,VOMITING,2
AT,ABDOMINAL DISCOMFORT,1
AT,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
AT,ACUTE KIDNEY INJURY,1
AT,ADJUSTMENT DISORDER,1
AT,ADRENAL ADENOMA,1
AT,ASPARTATE AMINOTRANSFERASE DECREASED,1
AT,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
AT,BASAL CELL CARCINOMA,1
AT,BENIGN PROSTATIC HYPERPLASIA,1
AT,BILE DUCT STONE,1
AT,BLOOD CREATININE INCREASED,1
AT,BLOOD PRESSURE INCREASED,1
AT,BLOOD PRESSURE SYSTOLIC INCREASED,1
AT,BLOOD TRIGLYCERIDES INCREASED,1
AT,BLOOD UREA INCREASED,1
AT,BLOOD URIC ACID INCREASED,1
AT,CEREBRAL HAEMATOMA,1
AT,CHOLANGITIS INFECTIVE,1
AT,CHOLELITHIASIS,1
AT,COLITIS MICROSCOPIC,1
AT,CONSTIPATION,1
AT,COUGH,1
AT,CYTOMEGALOVIRUS INFECTION,1
AT,DEATH,1
AT,DIABETES MELLITUS,1
AT,DIZZINESS,1
AT,DRUG INTOLERANCE,1
AT,DUODENAL ULCER HAEMORRHAGE,1
AT,EAR HAEMORRHAGE,1
AT,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,1
AT,EOSINOPHIL COUNT INCREASED,1
AT,EPISTAXIS,1
AT,EXPOSURE DURING PREGNANCY,1
AT,FACIAL PARALYSIS,1
AT,FALL,1
AT,FEMUR FRACTURE,1
AT,FLATULENCE,1
AT,FLUID RETENTION,1
AT,GAIT DISTURBANCE,1
AT,GASTROENTERITIS,1
AT,GASTROINTESTINAL PERFORATION,1
AT,GASTROINTESTINAL SOUNDS ABNORMAL,1
AT,GENERAL PHYSICAL HEALTH DETERIORATION,1
AT,HAEMATURIA,1
AT,HAEMORRHAGE,1
AT,HEADACHE,1
AT,HEART RATE INCREASED,1
AT,HYPERKALAEMIA,1
AT,HYPERSENSITIVITY,1
AT,HYPERTENSION,1
AT,HYPOKALAEMIA,1
AT,HYPONATRAEMIA,1
AT,HYPOPHYSITIS,1
AT,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
AT,IMPAIRED HEALING,1
AT,INFECTION,1
AT,INSOMNIA,1
AT,INTENTIONAL PRODUCT MISUSE,1
AT,INTERVERTEBRAL DISC DEGENERATION,1
AT,KIDNEY TRANSPLANT REJECTION,1
AT,KNEE ARTHROPLASTY,1
AT,LIPOMATOSIS,1
AT,MALIGNANT NEOPLASM PROGRESSION,1
AT,MEASLES,1
AT,MELAENA,1
AT,MICROCEPHALY,1
AT,MOBILITY DECREASED,1
AT,MONOPARESIS,1
AT,MUSCLE SPASMS,1
AT,MUSCULOSKELETAL DISORDER,1
AT,MYOCARDIAL INFARCTION,1
AT,NEPHROLITHIASIS,1
AT,NEUTROPENIA,1
AT,NOCTURNAL DYSPNOEA,1
AT,OROPHARYNGEAL CANCER,1
AT,OSTEOCHONDROSIS,1
AT,PAIN,1
AT,PALLOR,1
AT,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
AT,PANCREATIC ATROPHY,1
AT,PHARYNGEAL HAEMORRHAGE,1
AT,PNEUMOPERITONEUM,1
AT,PRE-ECLAMPSIA,1
AT,PREMATURE LABOUR,1
AT,PROTEIN URINE PRESENT,1
AT,PULMONARY OEDEMA,1
AT,RENAL CELL CARCINOMA,1
AT,RENAL FAILURE ACUTE,1
AT,RENAL IMPAIRMENT,1
AT,SCAR,1
AT,SCOLIOSIS,1
AT,SECOND PRIMARY MALIGNANCY,1
AT,SEPSIS,1
AT,SKIN CANCER,1
AT,SKIN LESION,1
AT,SKIN TURGOR DECREASED,1
AT,SQUAMOUS CELL CARCINOMA,1
AT,SYNCOPE,1
AT,TACHYCARDIA,1
AT,TOOTH DISORDER,1
AT,TRANSAMINASES INCREASED,1
AT,TRANSFUSION,1
AT,URINARY RETENTION,1
AT,URINARY TRACT INFECTION,1
AT,VENTRICULAR ARRHYTHMIA,1
AT,WHITE BLOOD CELL COUNT DECREASED,1
BY,NEPHROPATHY,8
BY,CARDIAC TAMPONADE,1
BY,ISCHAEMIC STROKE,1
BY,THERAPY NON-RESPONDER,1
BE,DRUG RESISTANCE,2
BE,PYREXIA,2
BE,RENAL FAILURE,2
BE,ACCIDENTAL EXPOSURE TO PRODUCT,1
BE,ACUTE MYELOID LEUKAEMIA,1
BE,ACUTE MYOCARDIAL INFARCTION,1
BE,ANAEMIA,1
BE,ARRHYTHMIA,1
BE,ATRIAL FIBRILLATION,1
BE,BLEPHARITIS,1
BE,BLINDNESS UNILATERAL,1
BE,BRADYCARDIA,1
BE,CARDIAC FAILURE,1
BE,CEREBROVASCULAR ACCIDENT,1
BE,CHOLANGIOCARCINOMA,1
BE,CONDITION AGGRAVATED,1
BE,CONSTIPATION,1
BE,DERMATITIS CONTACT,1
BE,DIVERTICULITIS,1
BE,DRUG HYPERSENSITIVITY,1
BE,DYSPNOEA,1
BE,EJECTION FRACTION DECREASED,1
BE,ERYTHEMA,1
BE,ESCHERICHIA URINARY TRACT INFECTION,1
BE,GASTRIC CANCER RECURRENT,1
BE,GASTROINTESTINAL HAEMORRHAGE,1
BE,GASTROOESOPHAGEAL REFLUX DISEASE,1
BE,HEMIPARESIS,1
BE,HEPATIC CANCER,1
BE,HEPATIC FAILURE,1
BE,HYPERTHERMIA,1
BE,HYPOKALAEMIA,1
BE,HYPONATRAEMIA,1
BE,LOCALISED OEDEMA,1
BE,MALIGNANT NEOPLASM PROGRESSION,1
BE,MATERNAL EXPOSURE DURING PREGNANCY,1
BE,MYELODYSPLASTIC SYNDROME,1
BE,NAUSEA,1
BE,NERVOUS SYSTEM DISORDER,1
BE,NEUTROPENIA,1
BE,NORMAL NEWBORN,1
BE,OCCUPATIONAL EXPOSURE TO PRODUCT,1
BE,OEDEMA PERIPHERAL,1
BE,OPTIC NEURITIS,1
BE,PARAESTHESIA,1
BE,PERICARDITIS INFECTIVE,1
BE,PRURITUS,1
BE,SHOCK,1
BE,SINUS NODE DYSFUNCTION,1
BE,SKIN EXFOLIATION,1
BE,TRANSIENT ISCHAEMIC ATTACK,1
BE,TREMOR,1
BE,URINARY TRACT INFECTION,1
BR,WEIGHT DECREASED,11
BR,DRUG INEFFECTIVE,9
BR,MALAISE,9
BR,BLOOD PRESSURE INCREASED,8
BR,ANXIETY,7
BR,DIZZINESS,7
BR,ATRIAL FIBRILLATION,6
BR,CORONARY ARTERY OCCLUSION,6
BR,INFARCTION,6
BR,PAIN IN EXTREMITY,6
BR,PYREXIA,6
BR,ARTHRALGIA,5
BR,BACK PAIN,5
BR,BLOOD PRESSURE FLUCTUATION,5
BR,CARDIAC ARREST,5
BR,HEADACHE,5
BR,HYPERTENSION,5
BR,HYPOTENSION,5
BR,PAIN,5
BR,ASTHENIA,4
BR,BLOOD CHOLESTEROL INCREASED,4
BR,BLOOD GLUCOSE INCREASED,4
BR,CHEST PAIN,4
BR,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,4
BR,DEPRESSION,4
BR,FALL,4
BR,HEART RATE INCREASED,4
BR,HYPERGLYCAEMIA,4
BR,HYPOGLYCAEMIA,4
BR,INFECTION,4
BR,MEMORY IMPAIRMENT,4
BR,NERVOUSNESS,4
BR,OSTEOARTHRITIS,4
BR,PLEURAL EFFUSION,4
BR,TREMOR,4
BR,URINARY TRACT INFECTION,4
BR,VISUAL ACUITY REDUCED,4
BR,VISUAL IMPAIRMENT,4
BR,ABDOMINAL PAIN,3
BR,ANAEMIA,3
BR,ARTERIAL OCCLUSIVE DISEASE,3
BR,BLOOD PRESSURE INADEQUATELY CONTROLLED,3
BR,CARDIAC DISORDER,3
BR,CARDIAC FAILURE CONGESTIVE,3
BR,CATARACT,3
BR,CEREBROVASCULAR ACCIDENT,3
BR,DIABETES MELLITUS,3
BR,DIARRHOEA,3
BR,DRUG DOSE OMISSION,3
BR,DYSPHONIA,3
BR,ELECTROCARDIOGRAM QT PROLONGED,3
BR,ERYTHEMA,3
BR,FEELING ABNORMAL,3
BR,HEPATITIS,3
BR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
BR,INFLUENZA,3
BR,INSOMNIA,3
BR,INTENTIONAL PRODUCT MISUSE,3
BR,MOBILITY DECREASED,3
BR,NAUSEA,3
BR,PERIPHERAL SWELLING,3
BR,SEPSIS,3
BR,SOMNOLENCE,3
BR,SPEECH DISORDER,3
BR,TACHYCARDIA,3
BR,TOOTH DISORDER,3
BR,VISION BLURRED,3
BR,ABDOMINAL PAIN UPPER,2
BR,ACUTE CORONARY SYNDROME,2
BR,ACUTE KIDNEY INJURY,2
BR,ARRHYTHMIA,2
BR,ARTERIAL CATHETERISATION,2
BR,ARTHRITIS,2
BR,ARTHROPATHY,2
BR,BLISTER,2
BR,BLOOD PRESSURE DECREASED,2
BR,BREAST MASS,2
BR,CARDIAC ASSISTANCE DEVICE USER,2
BR,CARDIAC FAILURE,2
BR,CARDIO-RESPIRATORY ARREST,2
BR,CHILLS,2
BR,CHOLECYSTECTOMY,2
BR,CHOLECYSTITIS ACUTE,2
BR,CONJUNCTIVITIS,2
BR,CORONARY ARTERY STENOSIS,2
BR,COUGH,2
BR,DYSPNOEA,2
BR,EYE IRRITATION,2
BR,EYE PAIN,2
BR,FATIGUE,2
BR,FEEDING DISORDER,2
BR,FEELING HOT,2
BR,FEMUR FRACTURE,2
BR,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
BR,HAEMORRHAGE,2
BR,HEAD INJURY,2
BR,HORDEOLUM,2
BR,HYPERSENSITIVITY,2
BR,INTRACRANIAL PRESSURE INCREASED,2
BR,LEFT ATRIAL DILATATION,2
BR,LIVER DISORDER,2
BR,MACULE,2
BR,MYOCARDIAL INFARCTION,2
BR,OCULAR HYPERAEMIA,2
BR,PNEUMONIA,2
BR,POSTOPERATIVE DELIRIUM,2
BR,PRODUCT USE ISSUE,2
BR,PRURITUS,2
BR,PSORIASIS,2
BR,PSYCHOTIC DISORDER,2
BR,RENAL FAILURE,2
BR,RENAL IMPAIRMENT,2
BR,RESPIRATORY FAILURE,2
BR,RESPIRATORY TRACT INFECTION,2
BR,SINOBRONCHITIS,2
BR,SKIN DISCOLOURATION,2
BR,STENT PLACEMENT,2
BR,SWELLING,2
BR,TOTAL LUNG CAPACITY DECREASED,2
BR,VASCULAR STENT THROMBOSIS,2
BR,VEIN DISORDER,2
BR,VITAMIN D DECREASED,2
BR,VOMITING,2
BR,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
BR,ACTIVITIES OF DAILY LIVING IMPAIRED,1
BR,ACUTE ABDOMEN,1
BR,ACUTE MYOCARDIAL INFARCTION,1
BR,AGITATION,1
BR,ALLERGY TO ARTHROPOD STING,1
BR,AMNESIA,1
BR,ANGINA PECTORIS,1
BR,ANGINA UNSTABLE,1
BR,ANGIOPLASTY,1
BR,AORTIC ARTERIOSCLEROSIS,1
BR,ARTHROPOD BITE,1
BR,ATRIAL THROMBOSIS,1
BR,ATYPICAL PNEUMONIA,1
BR,AURA,1
BR,BACK DISORDER,1
BR,BENIGN PROSTATIC HYPERPLASIA,1
BR,BLADDER PAIN,1
BR,BLINDNESS,1
BR,BLOOD GLUCOSE ABNORMAL,1
BR,BLOOD POTASSIUM DECREASED,1
BR,BLOOD PRESSURE SYSTOLIC INCREASED,1
BR,BODY HEIGHT DECREASED,1
BR,BONE EROSION,1
BR,BONE MARROW TOXICITY,1
BR,BREAST CANCER FEMALE,1
BR,BRONCHIAL DISORDER,1
BR,CALCIUM DEFICIENCY,1
BR,CALCULUS URETHRAL,1
BR,CARDIAC PACEMAKER INSERTION,1
BR,CARDIOGENIC SHOCK,1
BR,CAROTID ARTERY DISEASE,1
BR,CATARACT OPERATION,1
BR,CATHETERISATION CARDIAC,1
BR,CEREBRAL HAEMATOMA,1
BR,CEREBRAL THROMBOSIS,1
BR,CHONDROPATHY,1
BR,CHROMATURIA,1
BR,CHRONIC KIDNEY DISEASE,1
BR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
BR,CLOT RETRACTION ABNORMAL,1
BR,COMA,1
BR,CONDITION AGGRAVATED,1
BR,CONFUSIONAL STATE,1
BR,CREATININE RENAL CLEARANCE ABNORMAL,1
BR,DEAFNESS,1
BR,DECREASED APPETITE,1
BR,DECREASED IMMUNE RESPONSIVENESS,1
BR,DEMYELINATING POLYNEUROPATHY,1
BR,DEPRESSED MOOD,1
BR,DIABETES MELLITUS INADEQUATE CONTROL,1
BR,DIPLOPIA,1
BR,DISCOMFORT,1
BR,DISSOCIATION,1
BR,DIVERTICULITIS,1
BR,DRUG DISPENSING ERROR,1
BR,DRUG EFFECT DECREASED,1
BR,DRUG EFFECT INCOMPLETE,1
BR,DRUG HYPERSENSITIVITY,1
BR,DRUG INTOLERANCE,1
BR,DRUG PRESCRIBING ERROR,1
BR,DRUG-INDUCED LIVER INJURY,1
BR,DRY SKIN,1
BR,DYSPEPSIA,1
BR,DYSURIA,1
BR,EAR INFECTION,1
BR,EMOTIONAL DISTRESS,1
BR,ERYSIPELAS,1
BR,EUPHORIC MOOD,1
BR,EXCESSIVE CERUMEN PRODUCTION,1
BR,EXPOSURE DURING PREGNANCY,1
BR,EYE HAEMORRHAGE,1
BR,EYE MOVEMENT DISORDER,1
BR,FACE INJURY,1
BR,FACIAL PARALYSIS,1
BR,FIBROMYALGIA,1
BR,FINGER AMPUTATION,1
BR,FISTULA,1
BR,FOOT DEFORMITY,1
BR,GAIT DISTURBANCE,1
BR,GALLBLADDER ENLARGEMENT,1
BR,GASTROINTESTINAL CARCINOMA,1
BR,GASTROINTESTINAL HAEMORRHAGE,1
BR,GASTROINTESTINAL INFLAMMATION,1
BR,GENERALISED OEDEMA,1
BR,GLOMERULONEPHRITIS MEMBRANOUS,1
BR,HAEMATOCHEZIA,1
BR,HAEMATOMA,1
BR,HAEMOGLOBIN DECREASED,1
BR,HAEMORRHAGIC ANAEMIA,1
BR,HAEMORRHOIDS,1
BR,HEPATIC CANCER,1
BR,HEPATIC FAILURE,1
BR,HEPATIC STEATOSIS,1
BR,HEPATOMEGALY,1
BR,HERPES VIRUS INFECTION,1
BR,HIGH DENSITY LIPOPROTEIN DECREASED,1
BR,HOSPITALISATION,1
BR,HOT FLUSH,1
BR,HYDROCEPHALUS,1
BR,HYPERHIDROSIS,1
BR,HYPERSOMNIA,1
BR,HYPERTENSIVE CRISIS,1
BR,IMMUNODEFICIENCY,1
BR,IMPAIRED FASTING GLUCOSE,1
BR,INCORRECT DOSE ADMINISTERED,1
BR,INCREASED BRONCHIAL SECRETION,1
BR,INFLAMMATION,1
BR,INJECTION SITE ERYTHEMA,1
BR,INJECTION SITE PRURITUS,1
BR,INJURY,1
BR,INTERNATIONAL NORMALISED RATIO INCREASED,1
BR,INTESTINAL HAEMORRHAGE,1
BR,INTESTINAL STENOSIS,1
BR,IRRITABILITY,1
BR,ISCHAEMIC HEPATITIS,1
BR,ISCHAEMIC STROKE,1
BR,JAUNDICE,1
BR,JOINT EFFUSION,1
BR,KIDNEY INFECTION,1
BR,KNEE ARTHROPLASTY,1
BR,LEFT ATRIAL HYPERTROPHY,1
BR,LEFT VENTRICULAR DYSFUNCTION,1
BR,LEUKAEMIA,1
BR,LEUKOCYTOSIS,1
BR,LOCALISED INFECTION,1
BR,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
BR,LOWER LIMB FRACTURE,1
BR,LUMBAR VERTEBRAL FRACTURE,1
BR,LUNG INFECTION,1
BR,LYMPH NODE PAIN,1
BR,MACROCYTOSIS,1
BR,MELAENA,1
BR,MENTAL DISORDER,1
BR,METABOLIC SYNDROME,1
BR,METASTASES TO LIVER,1
BR,METASTASES TO SPINE,1
BR,MICROALBUMINURIA,1
BR,MONOPLEGIA,1
BR,MOOD ALTERED,1
BR,MOVEMENT DISORDER,1
BR,MULTI-ORGAN FAILURE,1
BR,MUSCLE DISORDER,1
BR,MUSCLE RIGIDITY,1
BR,MUSCLE SPASMS,1
BR,MUSCULAR DYSTROPHY,1
BR,MUSCULAR WEAKNESS,1
BR,MYALGIA,1
BR,NASAL SEPTUM ULCERATION,1
BR,NECROSIS,1
BR,NEOPLASM MALIGNANT,1
BR,NEPHROLITHIASIS,1
BR,OBSTRUCTIVE AIRWAYS DISORDER,1
BR,OEDEMA PERIPHERAL,1
BR,OPTIC NEURITIS,1
BR,ORAL CANDIDIASIS,1
BR,OVERDOSE,1
BR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
BR,PALPITATIONS,1
BR,PANIC DISORDER,1
BR,PELVIC FRACTURE,1
BR,PERITONITIS,1
BR,PLATELET COUNT DECREASED,1
BR,POLYGLANDULAR DISORDER,1
BR,POOR QUALITY SLEEP,1
BR,POST PROCEDURAL HAEMORRHAGE,1
BR,POSTOPERATIVE WOUND INFECTION,1
BR,PRE-EXISTING CONDITION IMPROVED,1
BR,PRODUCT AVAILABILITY ISSUE,1
BR,PRODUCT QUALITY ISSUE,1
BR,PRODUCT SUPPLY ISSUE,1
BR,PRODUCT USE IN UNAPPROVED INDICATION,1
BR,PRODUCTIVE COUGH,1
BR,PROLONGED EXPIRATION,1
BR,PROTHROMBIN TIME PROLONGED,1
BR,PULMONARY EMBOLISM,1
BR,PULMONARY OEDEMA,1
BR,PYOMYOSITIS,1
BR,RED BLOOD CELLS URINE,1
BR,RENAL DISORDER,1
BR,RENAL HAEMATOMA,1
BR,RENAL PAIN,1
BR,RETINAL HAEMORRHAGE,1
BR,RETINAL VEIN THROMBOSIS,1
BR,RHEUMATIC DISORDER,1
BR,RHEUMATOID LUNG,1
BR,RIGHT ATRIAL DILATATION,1
BR,SCIATICA,1
BR,SCOLIOSIS,1
BR,SEIZURE,1
BR,SENSORY DISTURBANCE,1
BR,SEPTIC SHOCK,1
BR,SINUSITIS,1
BR,SKIN DISORDER,1
BR,SKIN EXFOLIATION,1
BR,SKIN LESION,1
BR,SKIN REACTION,1
BR,SOCIAL AVOIDANT BEHAVIOUR,1
BR,SPINAL CORD COMPRESSION,1
BR,STAPHYLOCOCCAL INFECTION,1
BR,STRABISMUS,1
BR,SUICIDAL IDEATION,1
BR,SURGERY,1
BR,SYNCOPE,1
BR,SYSTEMIC LUPUS ERYTHEMATOSUS,1
BR,THERAPEUTIC RESPONSE UNEXPECTED,1
BR,THINKING ABNORMAL,1
BR,THORACIC CAVITY DRAINAGE,1
BR,THROMBOSIS,1
BR,THROMBOTIC MICROANGIOPATHY,1
BR,TREATMENT NONCOMPLIANCE,1
BR,TUBERCULOSIS,1
BR,TYPE 2 DIABETES MELLITUS,1
BR,UNDERDOSE,1
BR,UNEVALUABLE EVENT,1
BR,UPPER LIMB FRACTURE,1
BR,UPPER RESPIRATORY TRACT INFECTION,1
BR,URINARY RETENTION,1
BR,URINE CALCIUM DECREASED,1
BR,VASCULITIS,1
BR,VENOUS OCCLUSION,1
BR,VENTRICULAR ARRHYTHMIA,1
BR,VENTRICULAR EXTRASYSTOLES,1
BR,VERTEBRAL COLUMN MASS,1
BR,VITREOUS DETACHMENT,1
BR,WEIGHT FLUCTUATION,1
BR,WEIGHT INCREASED,1
BR,WHEEZING,1
BR,WHITE BLOOD CELL COUNT DECREASED,1
BR,WRONG DRUG ADMINISTERED,1
BR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
BG,ATRIAL FIBRILLATION,3
BG,ANGINA PECTORIS,1
BG,ANGINA UNSTABLE,1
BG,APHTHOUS ULCER,1
BG,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
BG,BACK PAIN,1
BG,BLINDNESS,1
BG,BLOOD URIC ACID INCREASED,1
BG,CHRONIC GASTRITIS,1
BG,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
BG,DISCOMFORT,1
BG,DYSPNOEA,1
BG,ELECTROCARDIOGRAM QT PROLONGED,1
BG,ENDOMETRIAL CANCER,1
BG,GENERAL PHYSICAL HEALTH DETERIORATION,1
BG,GRANULOCYTOPENIA,1
BG,HAEMOGLOBIN ABNORMAL,1
BG,HAEMORRHAGIC DIATHESIS,1
BG,HYPOACUSIS,1
BG,HYPOTENSION,1
BG,INTENTIONAL PRODUCT USE ISSUE,1
BG,LACTIC ACIDOSIS,1
BG,LIVER FUNCTION TEST ABNORMAL,1
BG,MELAENA,1
BG,METABOLIC ENCEPHALOPATHY,1
BG,PAIN,1
BG,PALPITATIONS,1
BG,PYODERMA,1
BG,RECTAL HAEMORRHAGE,1
BG,THROMBOCYTOPENIA,1
CA,FATIGUE,268
CA,DYSPNOEA,244
CA,DIARRHOEA,217
CA,FALL,198
CA,ASTHENIA,197
CA,MALAISE,197
CA,NAUSEA,175
CA,DIZZINESS,168
CA,PAIN,165
CA,BLOOD PRESSURE INCREASED,163
CA,DRUG INEFFECTIVE,153
CA,MYOCARDIAL INFARCTION,151
CA,DEATH,146
CA,PNEUMONIA,141
CA,ARTHRALGIA,140
CA,HYPOTENSION,136
CA,VOMITING,131
CA,BLOOD PRESSURE SYSTOLIC INCREASED,129
CA,PAIN IN EXTREMITY,129
CA,COUGH,128
CA,WEIGHT DECREASED,128
CA,HEADACHE,120
CA,HAEMOGLOBIN DECREASED,109
CA,PERIPHERAL SWELLING,108
CA,ABDOMINAL PAIN,105
CA,CHEST PAIN,101
CA,BACK PAIN,100
CA,DECREASED APPETITE,93
CA,HYPERTENSION,87
CA,PYREXIA,87
CA,ABDOMINAL DISCOMFORT,86
CA,NASOPHARYNGITIS,84
CA,ATRIAL FIBRILLATION,83
CA,HEART RATE DECREASED,81
CA,MALIGNANT NEOPLASM PROGRESSION,77
CA,ANAEMIA,75
CA,CONTUSION,75
CA,ABDOMINAL PAIN UPPER,71
CA,DEHYDRATION,71
CA,INJECTION SITE PAIN,69
CA,OEDEMA PERIPHERAL,69
CA,URINARY TRACT INFECTION,69
CA,CONSTIPATION,66
CA,HEART RATE INCREASED,66
CA,BODY TEMPERATURE DECREASED,64
CA,CONFUSIONAL STATE,64
CA,PRURITUS,63
CA,JOINT SWELLING,62
CA,BLOOD CREATININE INCREASED,59
CA,CARDIAC FAILURE CONGESTIVE,58
CA,GAIT DISTURBANCE,58
CA,WEIGHT INCREASED,58
CA,CEREBROVASCULAR ACCIDENT,56
CA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,56
CA,MUSCLE SPASMS,55
CA,HYPERHIDROSIS,54
CA,RASH,54
CA,CARDIAC DISORDER,53
CA,FEELING ABNORMAL,53
CA,CHEST DISCOMFORT,51
CA,CONDITION AGGRAVATED,51
CA,INFLUENZA,51
CA,BLOOD PRESSURE DECREASED,50
CA,HYPOGLYCAEMIA,50
CA,BLOOD PRESSURE DIASTOLIC DECREASED,49
CA,MYALGIA,49
CA,BALANCE DISORDER,47
CA,ERYTHEMA,47
CA,INSOMNIA,47
CA,THROMBOSIS,47
CA,ACUTE KIDNEY INJURY,46
CA,INFUSION RELATED REACTION,46
CA,RENAL IMPAIRMENT,46
CA,PALPITATIONS,45
CA,HEART RATE IRREGULAR,44
CA,PRODUCTIVE COUGH,44
CA,CHILLS,43
CA,INFECTION,43
CA,RHINORRHOEA,43
CA,PLEURAL EFFUSION,42
CA,PULMONARY OEDEMA,42
CA,RHEUMATOID ARTHRITIS,42
CA,HYPOAESTHESIA,41
CA,MUSCULOSKELETAL PAIN,41
CA,MUSCULOSKELETAL STIFFNESS,40
CA,SOMNOLENCE,40
CA,SYNCOPE,40
CA,CATARACT,39
CA,OROPHARYNGEAL PAIN,38
CA,SEPSIS,38
CA,ANGINA PECTORIS,37
CA,INTERNATIONAL NORMALISED RATIO INCREASED,37
CA,ARTHRITIS,36
CA,BRADYCARDIA,36
CA,URTICARIA,36
CA,ACUTE MYOCARDIAL INFARCTION,35
CA,BRONCHITIS,35
CA,CARDIAC FAILURE,35
CA,DYSPEPSIA,35
CA,LOSS OF CONSCIOUSNESS,35
CA,MUSCULAR WEAKNESS,35
CA,PRODUCT USE ISSUE,35
CA,VISUAL IMPAIRMENT,35
CA,PLATELET COUNT DECREASED,34
CA,RENAL FAILURE,34
CA,BLOOD GLUCOSE INCREASED,33
CA,BLOOD PRESSURE FLUCTUATION,33
CA,ABDOMINAL DISTENSION,32
CA,ALANINE AMINOTRANSFERASE INCREASED,32
CA,DEPRESSION,32
CA,FLUSHING,32
CA,HOT FLUSH,32
CA,MOBILITY DECREASED,32
CA,OXYGEN SATURATION DECREASED,32
CA,CORONARY ARTERY DISEASE,31
CA,SINUSITIS,31
CA,TACHYCARDIA,31
CA,CYSTITIS,30
CA,FEELING HOT,30
CA,GASTROINTESTINAL HAEMORRHAGE,30
CA,HAEMORRHAGE,30
CA,VISION BLURRED,30
CA,ANXIETY,29
CA,EPISTAXIS,29
CA,OEDEMA,29
CA,BACK DISORDER,28
CA,FLATULENCE,28
CA,FREQUENT BOWEL MOVEMENTS,28
CA,GASTROINTESTINAL DISORDER,28
CA,GENERAL PHYSICAL HEALTH DETERIORATION,28
CA,INJECTION SITE MASS,28
CA,OSTEOARTHRITIS,28
CA,PALLOR,28
CA,DYSPNOEA EXERTIONAL,27
CA,EATING DISORDER,27
CA,HYPERSENSITIVITY,27
CA,PARAESTHESIA,27
CA,SWELLING,27
CA,FLUID RETENTION,26
CA,METASTASES TO LIVER,26
CA,NASAL CONGESTION,26
CA,PRESYNCOPE,26
CA,TREMOR,26
CA,HAEMATOCHEZIA,25
CA,LOWER RESPIRATORY TRACT INFECTION,25
CA,MEMORY IMPAIRMENT,25
CA,METABOLIC ACIDOSIS,25
CA,NECK PAIN,25
CA,NEEDLE ISSUE,25
CA,STRESS,25
CA,ASPARTATE AMINOTRANSFERASE INCREASED,24
CA,CARDIAC ARREST,24
CA,DRUG EFFECT DECREASED,24
CA,NEPHROLITHIASIS,24
CA,WHITE BLOOD CELL COUNT INCREASED,24
CA,DRUG INTOLERANCE,23
CA,HYPOKALAEMIA,23
CA,INTESTINAL OBSTRUCTION,23
CA,PSORIASIS,23
CA,RECTAL HAEMORRHAGE,23
CA,RENAL FAILURE ACUTE,23
CA,BLOOD POTASSIUM DECREASED,22
CA,CELLULITIS,22
CA,CHOLELITHIASIS,22
CA,DIVERTICULITIS,22
CA,JAUNDICE,22
CA,LACERATION,22
CA,LYMPHADENOPATHY,22
CA,BLOOD IRON DECREASED,21
CA,CROHN^S DISEASE,21
CA,GOUT,21
CA,HERPES ZOSTER,21
CA,IMPAIRED HEALING,21
CA,POLLAKIURIA,21
CA,PULMONARY EMBOLISM,21
CA,SKIN ULCER,21
CA,TREATMENT FAILURE,21
CA,ACUTE CORONARY SYNDROME,20
CA,ARTHROPATHY,20
CA,BLOOD PRESSURE DIASTOLIC INCREASED,20
CA,DIABETES MELLITUS,20
CA,DRUG DOSE OMISSION,20
CA,DYSPHAGIA,20
CA,HYPONATRAEMIA,20
CA,LETHARGY,20
CA,LIMB INJURY,20
CA,ORTHOSTATIC HYPOTENSION,20
CA,SKIN EXFOLIATION,20
CA,WHEEZING,20
CA,ABASIA,19
CA,GASTROOESOPHAGEAL REFLUX DISEASE,19
CA,NECK MASS,19
CA,ROAD TRAFFIC ACCIDENT,19
CA,SEIZURE,19
CA,SLEEP DISORDER,19
CA,WOUND,19
CA,AMNESIA,18
CA,BLISTER,18
CA,BLOOD ALBUMIN DECREASED,18
CA,BODY TEMPERATURE INCREASED,18
CA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,18
CA,INCORRECT DOSE ADMINISTERED,18
CA,INFLUENZA LIKE ILLNESS,18
CA,LUNG DISORDER,18
CA,ALOPECIA,17
CA,BLOOD TEST ABNORMAL,17
CA,C-REACTIVE PROTEIN INCREASED,17
CA,DRUG HYPERSENSITIVITY,17
CA,DYSGEUSIA,17
CA,DYSURIA,17
CA,HEAD INJURY,17
CA,MUSCLE STRAIN,17
CA,NEOPLASM PROGRESSION,17
CA,OVERDOSE,17
CA,PRODUCT SUBSTITUTION ISSUE,17
CA,TRANSIENT ISCHAEMIC ATTACK,17
CA,ARRHYTHMIA,16
CA,ASTHMA,16
CA,BLOOD ALKALINE PHOSPHATASE INCREASED,16
CA,BONE PAIN,16
CA,BURNING SENSATION,16
CA,DELIRIUM,16
CA,HOSPITALISATION,16
CA,VOMITING PROJECTILE,16
CA,WHITE BLOOD CELL COUNT DECREASED,16
CA,ACNE,15
CA,CARDIAC FLUTTER,15
CA,DISEASE PROGRESSION,15
CA,DYSPHONIA,15
CA,EYE DISORDER,15
CA,HAEMATURIA,15
CA,HYPOCALCAEMIA,15
CA,HYPOMAGNESAEMIA,15
CA,INJECTION SITE ERYTHEMA,15
CA,LUNG INFECTION,15
CA,NIGHT SWEATS,15
CA,POOR QUALITY SLEEP,15
CA,RENAL DISORDER,15
CA,SCIATICA,15
CA,THROMBOCYTOSIS,15
CA,UNRESPONSIVE TO STIMULI,15
CA,UPPER RESPIRATORY TRACT INFECTION,15
CA,URINE ODOUR ABNORMAL,15
CA,VIRAL UPPER RESPIRATORY TRACT INFECTION,15
CA,CONVULSION,14
CA,CORONARY ARTERY OCCLUSION,14
CA,DEPRESSED MOOD,14
CA,DISORIENTATION,14
CA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,14
CA,HALLUCINATION,14
CA,HIP FRACTURE,14
CA,INFLAMMATION,14
CA,INJECTION SITE REACTION,14
CA,JOINT RANGE OF MOTION DECREASED,14
CA,LIMB DISCOMFORT,14
CA,MASS,14
CA,PULMONARY CONGESTION,14
CA,RASH ERYTHEMATOUS,14
CA,RESPIRATORY FAILURE,14
CA,SECOND PRIMARY MALIGNANCY,14
CA,SINUS BRADYCARDIA,14
CA,SURGERY,14
CA,CHROMATURIA,13
CA,DIABETIC KETOACIDOSIS,13
CA,HYPERGLYCAEMIA,13
CA,HYPOPHAGIA,13
CA,MUSCULOSKELETAL DISCOMFORT,13
CA,NERVOUSNESS,13
CA,SKIN DISCOLOURATION,13
CA,SPEECH DISORDER,13
CA,SPUTUM DISCOLOURED,13
CA,TOOTH DISORDER,13
CA,UNDERDOSE,13
CA,ABDOMINAL PAIN LOWER,12
CA,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,12
CA,AGITATION,12
CA,ANGIOEDEMA,12
CA,BLOOD GLUCOSE DECREASED,12
CA,CARDIAC VALVE DISEASE,12
CA,CHRONIC KIDNEY DISEASE,12
CA,DISCOMFORT,12
CA,GASTRIC DISORDER,12
CA,GENERALISED OEDEMA,12
CA,INJECTION SITE BRUISING,12
CA,JOINT STIFFNESS,12
CA,LIGAMENT SPRAIN,12
CA,LIVER DISORDER,12
CA,LUNG NEOPLASM MALIGNANT,12
CA,NEOPLASM,12
CA,NEURALGIA,12
CA,OSTEOPOROSIS,12
CA,POST PROCEDURAL INFECTION,12
CA,PROSTATE CANCER METASTATIC,12
CA,RENAL PAIN,12
CA,RESPIRATORY TRACT INFECTION,12
CA,RIB FRACTURE,12
CA,SWELLING FACE,12
CA,SWOLLEN TONGUE,12
CA,THROMBOCYTOPENIA,12
CA,VERTIGO,12
CA,ACTIVITIES OF DAILY LIVING IMPAIRED,11
CA,ASCITES,11
CA,BLOOD LACTATE DEHYDROGENASE INCREASED,11
CA,BONE DISORDER,11
CA,CLOSTRIDIUM DIFFICILE INFECTION,11
CA,CREATININE RENAL CLEARANCE DECREASED,11
CA,DEVICE RELATED INFECTION,11
CA,DRY SKIN,11
CA,DYSSTASIA,11
CA,ECZEMA,11
CA,EYE HAEMORRHAGE,11
CA,EYE PAIN,11
CA,FEBRILE NEUTROPENIA,11
CA,FEELING COLD,11
CA,FLANK PAIN,11
CA,HAEMATOMA,11
CA,HAEMORRHAGE INTRACRANIAL,11
CA,HAND DEFORMITY,11
CA,HEPATIC ENZYME INCREASED,11
CA,HYPERSOMNIA,11
CA,INJECTION SITE HAEMORRHAGE,11
CA,INJECTION SITE SWELLING,11
CA,INJURY,11
CA,INTERVERTEBRAL DISC DEGENERATION,11
CA,JOINT INJURY,11
CA,LOCALISED INFECTION,11
CA,NEOPLASM MALIGNANT,11
CA,OCULAR HYPERAEMIA,11
CA,PULMONARY HYPERTENSION,11
CA,RESTLESSNESS,11
CA,SPINAL FRACTURE,11
CA,STOMATITIS,11
CA,THERAPEUTIC RESPONSE DECREASED,11
CA,THROAT IRRITATION,11
CA,TOXICITY TO VARIOUS AGENTS,11
CA,URINARY RETENTION,11
CA,VISUAL ACUITY REDUCED,11
CA,ABSCESS,10
CA,APHONIA,10
CA,BASAL CELL CARCINOMA,10
CA,BLOOD CREATININE ABNORMAL,10
CA,BLOOD MAGNESIUM DECREASED,10
CA,BLOOD POTASSIUM INCREASED,10
CA,BREAST CANCER,10
CA,CARDIAC OUTPUT DECREASED,10
CA,CEREBRAL HAEMORRHAGE,10
CA,DRUG EFFECT INCOMPLETE,10
CA,DRY MOUTH,10
CA,EYE SWELLING,10
CA,FIBROMYALGIA,10
CA,FOETAL EXPOSURE DURING PREGNANCY,10
CA,FUNGAL INFECTION,10
CA,GASTROENTERITIS VIRAL,10
CA,GLOMERULAR FILTRATION RATE DECREASED,10
CA,GROIN PAIN,10
CA,HAEMATEMESIS,10
CA,HYPOXIA,10
CA,KIDNEY INFECTION,10
CA,MELAENA,10
CA,PARALYSIS,10
CA,PERIPHERAL COLDNESS,10
CA,PROSTATE CANCER,10
CA,PSORIATIC ARTHROPATHY,10
CA,RESPIRATORY RATE INCREASED,10
CA,ULCER,10
CA,URINE OUTPUT DECREASED,10
CA,ANAPHYLACTIC REACTION,9
CA,ARTERIOVENOUS FISTULA OCCLUSION,9
CA,BLINDNESS,9
CA,BLOOD BILIRUBIN INCREASED,9
CA,BLOOD CHOLESTEROL INCREASED,9
CA,BLOOD URINE PRESENT,9
CA,COGNITIVE DISORDER,9
CA,DEEP VEIN THROMBOSIS,9
CA,DEMENTIA,9
CA,DIABETES MELLITUS INADEQUATE CONTROL,9
CA,DYSARTHRIA,9
CA,EAR PAIN,9
CA,ECCHYMOSIS,9
CA,ELECTROCARDIOGRAM QT PROLONGED,9
CA,ERUCTATION,9
CA,EXOSTOSIS,9
CA,EXTRASYSTOLES,9
CA,FAECES DISCOLOURED,9
CA,HAEMOPTYSIS,9
CA,HEPATIC NEOPLASM,9
CA,HYPOTHYROIDISM,9
CA,KNEE ARTHROPLASTY,9
CA,LOCAL SWELLING,9
CA,METASTASES TO BONE,9
CA,MIDDLE INSOMNIA,9
CA,MYOCARDIAL ISCHAEMIA,9
CA,NEUTROPENIA,9
CA,OSTEONECROSIS,9
CA,PANCREATITIS,9
CA,POLYP,9
CA,POOR VENOUS ACCESS,9
CA,PRODUCT USE IN UNAPPROVED INDICATION,9
CA,PULMONARY FIBROSIS,9
CA,RALES,9
CA,SINUS CONGESTION,9
CA,SINUS TACHYCARDIA,9
CA,SKIN CANCER,9
CA,SKIN LESION,9
CA,SYRINGE ISSUE,9
CA,TROPONIN INCREASED,9
CA,VIRAL INFECTION,9
CA,AGGRESSION,8
CA,ATRIAL FLUTTER,8
CA,BACTERIAL INFECTION,8
CA,BLOOD PRESSURE ABNORMAL,8
CA,CANDIDA INFECTION,8
CA,CARDIAC OPERATION,8
CA,CARDIOMEGALY,8
CA,CARPAL TUNNEL SYNDROME,8
CA,COLITIS ULCERATIVE,8
CA,COLON CANCER,8
CA,CORONARY ARTERY BYPASS,8
CA,DIZZINESS POSTURAL,8
CA,DRUG LEVEL INCREASED,8
CA,EYE PRURITUS,8
CA,GASTROINTESTINAL INFLAMMATION,8
CA,GINGIVAL BLEEDING,8
CA,GLAUCOMA,8
CA,HYPERKALAEMIA,8
CA,HYPOACUSIS,8
CA,INJECTION SITE EXTRAVASATION,8
CA,INTERVERTEBRAL DISC PROTRUSION,8
CA,IRRITABILITY,8
CA,LACRIMATION INCREASED,8
CA,METASTASES TO LUNG,8
CA,OSTEOMYELITIS,8
CA,PANCYTOPENIA,8
CA,PERICARDIAL EFFUSION,8
CA,PHOTOPSIA,8
CA,PNEUMOTHORAX,8
CA,PULMONARY THROMBOSIS,8
CA,RASH GENERALISED,8
CA,RESPIRATORY DISORDER,8
CA,RESPIRATORY TRACT CONGESTION,8
CA,SLEEP APNOEA SYNDROME,8
CA,SUICIDAL IDEATION,8
CA,TERMINAL STATE,8
CA,THERAPY NON-RESPONDER,8
CA,TINNITUS,8
CA,TOOTH INFECTION,8
CA,TORSADE DE POINTES,8
CA,UPPER LIMB FRACTURE,8
CA,VISUAL FIELD DEFECT,8
CA,ACCIDENT,7
CA,ACUTE PULMONARY OEDEMA,7
CA,ADVERSE EVENT,7
CA,ANGINA UNSTABLE,7
CA,ARTERIAL OCCLUSIVE DISEASE,7
CA,ATRIOVENTRICULAR BLOCK,7
CA,ATRIOVENTRICULAR BLOCK COMPLETE,7
CA,BACK INJURY,7
CA,BLOOD CALCIUM DECREASED,7
CA,BLOOD UREA INCREASED,7
CA,BLUE TOE SYNDROME,7
CA,BONE MARROW FAILURE,7
CA,BOWEL MOVEMENT IRREGULARITY,7
CA,BRONCHOSPASM,7
CA,CATHETERISATION CARDIAC,7
CA,CORONARY ARTERIAL STENT INSERTION,7
CA,CYST,7
CA,DEPRESSED LEVEL OF CONSCIOUSNESS,7
CA,DIARRHOEA HAEMORRHAGIC,7
CA,DIVERTICULUM,7
CA,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,7
CA,FOOT FRACTURE,7
CA,GALLBLADDER DISORDER,7
CA,GASTRITIS,7
CA,HAEMATOCRIT DECREASED,7
CA,HEPATIC CIRRHOSIS,7
CA,HEPATIC PAIN,7
CA,INCREASED APPETITE,7
CA,JOINT DISLOCATION,7
CA,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,7
CA,MACULAR DEGENERATION,7
CA,MIGRAINE,7
CA,NERVOUS SYSTEM DISORDER,7
CA,PARKINSON^S DISEASE,7
CA,PERICARDITIS,7
CA,PREMATURE BABY,7
CA,PROCEDURAL PAIN,7
CA,PRODUCT QUALITY ISSUE,7
CA,PULMONARY FUNCTION TEST ABNORMAL,7
CA,PULMONARY FUNCTION TEST DECREASED,7
CA,REGURGITATION,7
CA,RESTLESS LEGS SYNDROME,7
CA,SCAB,7
CA,SCAR,7
CA,SEPTIC SHOCK,7
CA,SMALL INTESTINAL OBSTRUCTION,7
CA,SPINAL COLUMN STENOSIS,7
CA,SPINAL DISORDER,7
CA,SPINAL PAIN,7
CA,STAPHYLOCOCCAL INFECTION,7
CA,THROAT TIGHTNESS,7
CA,TOOTHACHE,7
CA,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,7
CA,ABDOMINAL MASS,6
CA,ADVERSE DRUG REACTION,6
CA,ADVERSE REACTION,6
CA,ANGLE CLOSURE GLAUCOMA,6
CA,AORTIC STENOSIS,6
CA,APLASIA PURE RED CELL,6
CA,ATELECTASIS,6
CA,BLOOD SODIUM DECREASED,6
CA,BONE CANCER,6
CA,CHVOSTEK^S SIGN,6
CA,COLITIS,6
CA,CONCOMITANT DISEASE AGGRAVATED,6
CA,DENTAL CARIES,6
CA,DIVERTICULAR PERFORATION,6
CA,DRY EYE,6
CA,DYSKINESIA,6
CA,DYSLIPIDAEMIA,6
CA,EAR DISCOMFORT,6
CA,FEEDING DISORDER,6
CA,FEMUR FRACTURE,6
CA,FISTULA,6
CA,FLUID OVERLOAD,6
CA,FULL BLOOD COUNT DECREASED,6
CA,GASTRIC ULCER,6
CA,HAEMORRHAGIC STROKE,6
CA,HEMIPARESIS,6
CA,HEPATIC LESION,6
CA,HEPATIC STEATOSIS,6
CA,HERNIA,6
CA,HYPOVOLAEMIA,6
CA,INFECTED SKIN ULCER,6
CA,INTESTINAL RESECTION,6
CA,LIP SWELLING,6
CA,LIVER ABSCESS,6
CA,LIVER FUNCTION TEST INCREASED,6
CA,LOW BIRTH WEIGHT BABY,6
CA,LUMBAR VERTEBRAL FRACTURE,6
CA,MALLORY-WEISS SYNDROME,6
CA,MATERNAL EXPOSURE DURING PREGNANCY,6
CA,METASTASES TO SPINE,6
CA,MICTURITION URGENCY,6
CA,MUSCLE RUPTURE,6
CA,MUSCLE TIGHTNESS,6
CA,MUSCULOSKELETAL CHEST PAIN,6
CA,NEUROLEPTIC MALIGNANT SYNDROME,6
CA,NEUROPATHY PERIPHERAL,6
CA,NEUTROPHIL COUNT INCREASED,6
CA,NIGHTMARE,6
CA,OBSTRUCTIVE AIRWAYS DISORDER,6
CA,OSTEONECROSIS OF JAW,6
CA,PAIN OF SKIN,6
CA,PANIC ATTACK,6
CA,PELVIC FRACTURE,6
CA,PLASMA CELL MYELOMA,6
CA,POST PROCEDURAL COMPLICATION,6
CA,PROSTATIC DISORDER,6
CA,PULMONARY MASS,6
CA,PURULENT DISCHARGE,6
CA,RECTAL ADENOCARCINOMA,6
CA,RED BLOOD CELL COUNT DECREASED,6
CA,RENAL CYST,6
CA,RESPIRATORY DISTRESS,6
CA,RETCHING,6
CA,SKIN DISORDER,6
CA,SPINAL OPERATION,6
CA,SQUAMOUS CELL CARCINOMA,6
CA,SUICIDE ATTEMPT,6
CA,SUNBURN,6
CA,TEMPERATURE INTOLERANCE,6
CA,TENDERNESS,6
CA,TENDONITIS,6
CA,TRAUMATIC HAEMORRHAGE,6
CA,UPPER GASTROINTESTINAL HAEMORRHAGE,6
CA,URINARY TRACT INFECTION BACTERIAL,6
CA,UROSEPSIS,6
CA,VASCULAR GRAFT,6
CA,VENTRICULAR FIBRILLATION,6
CA,VENTRICULAR TACHYCARDIA,6
CA,WOUND SECRETION,6
CA,WRIST FRACTURE,6
CA,YELLOW SKIN,6
CA,ABDOMINAL TENDERNESS,5
CA,ACIDOSIS,5
CA,ADDISON^S DISEASE,5
CA,AGEUSIA,5
CA,AORTIC VALVE REPLACEMENT,5
CA,APPENDICITIS,5
CA,ARTERIOSCLEROSIS CORONARY ARTERY,5
CA,ARTHRITIS INFECTIVE,5
CA,ATYPICAL FEMUR FRACTURE,5
CA,BLADDER CANCER,5
CA,BLOOD CREATINE PHOSPHOKINASE INCREASED,5
CA,BLOOD ELECTROLYTES DECREASED,5
CA,BLOOD GLUCOSE FLUCTUATION,5
CA,BLOOD IRON INCREASED,5
CA,BLOOD PRESSURE SYSTOLIC DECREASED,5
CA,BRAIN HERNIATION,5
CA,CARDIOGENIC SHOCK,5
CA,CARDIOVERSION,5
CA,CHRONIC SINUSITIS,5
CA,CIRCULATORY COLLAPSE,5
CA,CONCUSSION,5
CA,CONTRAINDICATED PRODUCT ADMINISTERED,5
CA,CREPITATIONS,5
CA,DECUBITUS ULCER,5
CA,DIPLOPIA,5
CA,DISTURBANCE IN ATTENTION,5
CA,EAR INFECTION,5
CA,EMBOLIC STROKE,5
CA,ENCEPHALOPATHY,5
CA,EPIGASTRIC DISCOMFORT,5
CA,EXTRAPYRAMIDAL DISORDER,5
CA,FAECES SOFT,5
CA,FLUID INTAKE REDUCED,5
CA,GASTROENTERITIS,5
CA,GASTROINTESTINAL INFECTION,5
CA,GASTROINTESTINAL PAIN,5
CA,GLYCOSYLATED HAEMOGLOBIN INCREASED,5
CA,HAEMOGLOBIN ABNORMAL,5
CA,HAEMORRHOIDS,5
CA,HEPATIC CANCER,5
CA,HEPATIC CYST,5
CA,HUMERUS FRACTURE,5
CA,HYPERCALCAEMIA,5
CA,HYPOAESTHESIA ORAL,5
CA,ILL-DEFINED DISORDER,5
CA,INCREASED TENDENCY TO BRUISE,5
CA,INCREASED VISCOSITY OF BRONCHIAL SECRETION,5
CA,INTESTINAL PERFORATION,5
CA,INTESTINAL STENOSIS,5
CA,LABORATORY TEST ABNORMAL,5
CA,LEFT VENTRICULAR DYSFUNCTION,5
CA,LIPASE INCREASED,5
CA,LOSS OF CONTROL OF LEGS,5
CA,LOWER LIMB FRACTURE,5
CA,LYMPHOMA,5
CA,MALIGNANT MELANOMA,5
CA,MECHANICAL URTICARIA,5
CA,MELANOCYTIC NAEVUS,5
CA,MOVEMENT DISORDER,5
CA,MULTI-ORGAN FAILURE,5
CA,MUSCULOSKELETAL DISORDER,5
CA,NO THERAPEUTIC RESPONSE,5
CA,ORAL HERPES,5
CA,ORAL PAIN,5
CA,OSTEOPENIA,5
CA,PAIN IN JAW,5
CA,PHARYNGITIS,5
CA,PNEUMONITIS,5
CA,POSTOPERATIVE WOUND INFECTION,5
CA,PROTEINURIA,5
CA,PRURITUS GENERALISED,5
CA,PYELONEPHRITIS,5
CA,RASH PRURITIC,5
CA,RENAL CANCER,5
CA,RESPIRATORY ARREST,5
CA,RHABDOMYOLYSIS,5
CA,SEASONAL ALLERGY,5
CA,SERUM FERRITIN INCREASED,5
CA,SHOCK,5
CA,SKIN ABRASION,5
CA,SPINAL OSTEOARTHRITIS,5
CA,TOOTH ABSCESS,5
CA,TOOTH FRACTURE,5
CA,TRANSFUSION,5
CA,TYPE 2 DIABETES MELLITUS,5
CA,UNEVALUABLE EVENT,5
CA,VITAMIN B12 DEFICIENCY,5
CA,VITAMIN D DEFICIENCY,5
CA,WOUND INFECTION,5
CA,ABNORMAL FAECES,4
CA,ACUTE MYELOID LEUKAEMIA,4
CA,ADRENAL INSUFFICIENCY,4
CA,ANORECTAL DISCOMFORT,4
CA,APNOEA,4
CA,APPETITE DISORDER,4
CA,ASPERGILLUS INFECTION,4
CA,BACTERIAL SEPSIS,4
CA,BILE DUCT OBSTRUCTION,4
CA,BLOOD DISORDER,4
CA,BLOOD GLUCOSE ABNORMAL,4
CA,BLOOD PARATHYROID HORMONE INCREASED,4
CA,BONE LESION,4
CA,BRAIN NEOPLASM,4
CA,BRAIN OEDEMA,4
CA,BURSITIS,4
CA,CARDIAC MURMUR,4
CA,CARDIAC PACEMAKER INSERTION,4
CA,CARDIO-RESPIRATORY ARREST,4
CA,CATARACT OPERATION,4
CA,CHOLECYSTITIS,4
CA,CLOSTRIDIUM DIFFICILE COLITIS,4
CA,COAGULOPATHY,4
CA,COLD SWEAT,4
CA,COLITIS MICROSCOPIC,4
CA,CYANOSIS,4
CA,DERMATITIS,4
CA,DEVICE OCCLUSION,4
CA,DIVERTICULUM INTESTINAL HAEMORRHAGIC,4
CA,DRUG ADMINISTRATION ERROR,4
CA,EJECTION FRACTION DECREASED,4
CA,ELECTROCARDIOGRAM ABNORMAL,4
CA,ELECTROLYTE IMBALANCE,4
CA,EMOTIONAL DISTRESS,4
CA,FACIAL PARALYSIS,4
CA,FAECALOMA,4
CA,FAECES HARD,4
CA,FORCED EXPIRATORY VOLUME DECREASED,4
CA,GASTRIC CANCER,4
CA,GASTRIC INFECTION,4
CA,GASTROINTESTINAL CARCINOMA,4
CA,GASTROINTESTINAL MOTILITY DISORDER,4
CA,GASTROINTESTINAL NECROSIS,4
CA,GASTROINTESTINAL SOUNDS ABNORMAL,4
CA,GENERAL PHYSICAL CONDITION ABNORMAL,4
CA,GLUCOSE TOLERANCE IMPAIRED,4
CA,HAEMORRHOIDAL HAEMORRHAGE,4
CA,HAEMOTHORAX,4
CA,HEPATITIS ACUTE,4
CA,HIATUS HERNIA,4
CA,HYPERVENTILATION,4
CA,HYPOVENTILATION,4
CA,INJECTION SITE INDURATION,4
CA,INJECTION SITE WARMTH,4
CA,INTENTIONAL PRODUCT MISUSE,4
CA,INTERNATIONAL NORMALISED RATIO ABNORMAL,4
CA,INTERNATIONAL NORMALISED RATIO DECREASED,4
CA,IRON DEFICIENCY ANAEMIA,4
CA,ISCHAEMIC CEREBRAL INFARCTION,4
CA,LACTIC ACIDOSIS,4
CA,LARGE INTESTINE POLYP,4
CA,LEFT VENTRICULAR HYPERTROPHY,4
CA,LEUKOPENIA,4
CA,LIVER FUNCTION TEST ABNORMAL,4
CA,LOWER GASTROINTESTINAL HAEMORRHAGE,4
CA,LUNG ABSCESS,4
CA,LUNG INFILTRATION,4
CA,LYMPHOCYTE COUNT DECREASED,4
CA,MALABSORPTION,4
CA,MENTAL DISORDER,4
CA,MENTAL IMPAIRMENT,4
CA,MUSCLE RIGIDITY,4
CA,MUSCLE TWITCHING,4
CA,MYOCLONUS,4
CA,NASAL DISCHARGE DISCOLOURATION,4
CA,OCULAR ICTERUS,4
CA,OESOPHAGEAL ULCER,4
CA,OVARIAN CYST RUPTURED,4
CA,PANCREATIC CARCINOMA,4
CA,PHOTOPHOBIA,4
CA,PHOTOSENSITIVITY REACTION,4
CA,PNEUMONIA VIRAL,4
CA,POLYPECTOMY,4
CA,POOR PERIPHERAL CIRCULATION,4
CA,PROCTALGIA,4
CA,PROSTATIC SPECIFIC ANTIGEN INCREASED,4
CA,PROSTATOMEGALY,4
CA,PSYCHOTIC DISORDER,4
CA,PULMONARY TOXICITY,4
CA,RASH PUSTULAR,4
CA,RENAL TUBULAR NECROSIS,4
CA,RHINITIS,4
CA,ROTATOR CUFF SYNDROME,4
CA,SENSITIVITY TO WEATHER CHANGE,4
CA,SEROTONIN SYNDROME,4
CA,SKIN INFECTION,4
CA,SKIN IRRITATION,4
CA,SKIN MASS,4
CA,SPINAL COMPRESSION FRACTURE,4
CA,SQUAMOUS CELL CARCINOMA OF SKIN,4
CA,STEVENS-JOHNSON SYNDROME,4
CA,SUPRAVENTRICULAR TACHYCARDIA,4
CA,URINARY INCONTINENCE,4
CA,UTERINE CANCER,4
CA,VACCINATION SITE PAIN,4
CA,VASCULITIS,4
CA,WALKING AID USER,4
CA,WALKING DISABILITY,4
CA,WRONG TECHNIQUE IN DRUG USAGE PROCESS,4
CA,ABDOMINAL HERNIA,3
CA,ABDOMINAL WALL HAEMATOMA,3
CA,ABNORMAL BEHAVIOUR,3
CA,ACCIDENTAL OVERDOSE,3
CA,ADHESION,3
CA,ALTERED STATE OF CONSCIOUSNESS,3
CA,ANAL ABSCESS,3
CA,ANGER,3
CA,ANGIOPLASTY,3
CA,ANKYLOSING SPONDYLITIS,3
CA,AORTIC ARTERIOSCLEROSIS,3
CA,AORTIC VALVE INCOMPETENCE,3
CA,APHASIA,3
CA,APPARENT DEATH,3
CA,ARTERIOSCLEROSIS,3
CA,ATAXIA,3
CA,ATRIAL THROMBOSIS,3
CA,AUTOIMMUNE HEPATITIS,3
CA,BEDRIDDEN,3
CA,BETA HAEMOLYTIC STREPTOCOCCAL INFECTION,3
CA,BILIRUBIN CONJUGATED INCREASED,3
CA,BLADDER NECK OBSTRUCTION,3
CA,BLADDER NEOPLASM,3
CA,BLADDER TRANSITIONAL CELL CARCINOMA,3
CA,BLOOD BILIRUBIN UNCONJUGATED INCREASED,3
CA,CACHEXIA,3
CA,CARCINOID CRISIS,3
CA,CARDIAC HYPERTROPHY,3
CA,CATHETER SITE ERYTHEMA,3
CA,CEREBRAL INFARCTION,3
CA,CHOKING,3
CA,CHOKING SENSATION,3
CA,CHOROIDAL EFFUSION,3
CA,COLON DYSPLASIA,3
CA,COMPRESSION FRACTURE,3
CA,CORONARY ARTERY STENOSIS,3
CA,DECREASED ACTIVITY,3
CA,DEVICE ISSUE,3
CA,DRUG RESISTANCE,3
CA,EAR DISORDER,3
CA,EMPHYSEMA,3
CA,ENDOCARDITIS,3
CA,EOSINOPHIL COUNT INCREASED,3
CA,EPIDURAL HAEMORRHAGE,3
CA,EPSTEIN-BARR VIRUS INFECTION,3
CA,EYE INFECTION,3
CA,EYE INFLAMMATION,3
CA,EYE OPERATION,3
CA,FACE OEDEMA,3
CA,FACIAL BONES FRACTURE,3
CA,FACIAL PAIN,3
CA,FAILURE TO THRIVE,3
CA,FEAR,3
CA,FEELING OF BODY TEMPERATURE CHANGE,3
CA,FIBROSIS,3
CA,FOOT DEFORMITY,3
CA,FORCED VITAL CAPACITY DECREASED,3
CA,GASTRIC HAEMORRHAGE,3
CA,GASTROINTESTINAL ULCER,3
CA,GENERALISED TONIC-CLONIC SEIZURE,3
CA,HAEMOGLOBINURIA,3
CA,HAEMOLYSIS,3
CA,HEART VALVE INCOMPETENCE,3
CA,HEMIANOPIA HETERONYMOUS,3
CA,HEPATOTOXICITY,3
CA,HERPES VIRUS INFECTION,3
CA,HIP ARTHROPLASTY,3
CA,HUNGER,3
CA,HYDRONEPHROSIS,3
CA,HYPERTHYROIDISM,3
CA,HYPERTRICHOSIS,3
CA,HYPOKINESIA,3
CA,HYPOPNOEA,3
CA,HYPOTHERMIA,3
CA,HYSTERECTOMY,3
CA,IMPLANTABLE DEFIBRILLATOR INSERTION,3
CA,INCOHERENT,3
CA,INCONTINENCE,3
CA,INCREASED BRONCHIAL SECRETION,3
CA,INCREASED UPPER AIRWAY SECRETION,3
CA,INFARCTION,3
CA,INFREQUENT BOWEL MOVEMENTS,3
CA,INFUSION SITE DISCHARGE,3
CA,INFUSION SITE ERYTHEMA,3
CA,INGUINAL HERNIA,3
CA,INJECTION SITE DISCOMFORT,3
CA,INJECTION SITE PRURITUS,3
CA,INJECTION SITE RASH,3
CA,INJECTION SITE SCAR,3
CA,INSULIN-LIKE GROWTH FACTOR INCREASED,3
CA,INTERNAL HAEMORRHAGE,3
CA,INTESTINAL HAEMORRHAGE,3
CA,INTESTINAL POLYP,3
CA,INTRA-ABDOMINAL FLUID COLLECTION,3
CA,JAW DISORDER,3
CA,JOINT EFFUSION,3
CA,KNEE OPERATION,3
CA,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,3
CA,LARGE INTESTINAL ULCER,3
CA,LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION,3
CA,LOWER RESPIRATORY TRACT CONGESTION,3
CA,LUNG NEOPLASM,3
CA,MEDICATION ERROR,3
CA,METASTASES TO CENTRAL NERVOUS SYSTEM,3
CA,MOOD ALTERED,3
CA,MOUTH ULCERATION,3
CA,MULTIPLE SCLEROSIS,3
CA,MUSCLE DISORDER,3
CA,MYELODYSPLASTIC SYNDROME,3
CA,NERVE INJURY,3
CA,NEUTROPHIL COUNT DECREASED,3
CA,NOCTURIA,3
CA,NON-CARDIAC CHEST PAIN,3
CA,OESOPHAGEAL CARCINOMA,3
CA,ORAL CANDIDIASIS,3
CA,ORAL DISCOMFORT,3
CA,ORAL INFECTION,3
CA,PANCREATITIS ACUTE,3
CA,PATHOLOGICAL FRACTURE,3
CA,PERIPHERAL ARTERY OCCLUSION,3
CA,PERIPHERAL VENOUS DISEASE,3
CA,PERITONITIS BACTERIAL,3
CA,PERSONALITY CHANGE,3
CA,PETECHIAE,3
CA,PHARYNGEAL OEDEMA,3
CA,PLATELET COUNT INCREASED,3
CA,POLYDIPSIA,3
CA,POST PROCEDURAL HAEMORRHAGE,3
CA,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,3
CA,POSTOPERATIVE ABSCESS,3
CA,PREMATURE DELIVERY,3
CA,PRODUCT STORAGE ERROR,3
CA,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,3
CA,PULMONARY HAEMORRHAGE,3
CA,PULSE ABSENT,3
CA,PULSELESS ELECTRICAL ACTIVITY,3
CA,PURPURA,3
CA,RASH MACULAR,3
CA,RASH PAPULAR,3
CA,RED BLOOD CELL COUNT INCREASED,3
CA,REFLUX GASTRITIS,3
CA,RENAL CANCER METASTATIC,3
CA,RENAL CELL CARCINOMA,3
CA,RETINAL HAEMORRHAGE,3
CA,SENSATION OF HEAVINESS,3
CA,SENSITIVITY OF TEETH,3
CA,SINUS NODE DYSFUNCTION,3
CA,SLUGGISHNESS,3
CA,SOFT TISSUE INJURY,3
CA,SPINAL CORD INFARCTION,3
CA,STAPHYLOCOCCAL BACTERAEMIA,3
CA,SYNOVIAL CYST,3
CA,SYSTEMIC LUPUS ERYTHEMATOSUS,3
CA,TACHYPNOEA,3
CA,THERAPY CESSATION,3
CA,THINKING ABNORMAL,3
CA,THYROID CANCER,3
CA,THYROID MASS,3
CA,TOOTH EXTRACTION,3
CA,TOXIC ENCEPHALOPATHY,3
CA,TOXIC EPIDERMAL NECROLYSIS,3
CA,TREATMENT NONCOMPLIANCE,3
CA,TRICUSPID VALVE INCOMPETENCE,3
CA,TUMOUR INVASION,3
CA,UPPER-AIRWAY COUGH SYNDROME,3
CA,URETHRAL STENOSIS,3
CA,URINE ABNORMALITY,3
CA,UTERINE LEIOMYOMA,3
CA,VARICOSE VEIN,3
CA,VEIN DISORDER,3
CA,VENOUS OCCLUSION,3
CA,VENTRICULAR EXTRASYSTOLES,3
CA,VULVOVAGINAL MYCOTIC INFECTION,3
CA,WEIGHT FLUCTUATION,3
CA,5-HYDROXYINDOLACETIC ACID IN URINE INCREASED,2
CA,ABDOMINAL ABSCESS,2
CA,ABNORMAL DREAMS,2
CA,ABNORMAL SENSATION IN EYE,2
CA,ABSCESS INTESTINAL,2
CA,ACCIDENT AT WORK,2
CA,ACCIDENTAL EXPOSURE TO PRODUCT,2
CA,ACTINIC KERATOSIS,2
CA,ACUTE HEPATIC FAILURE,2
CA,ACUTE PSYCHOSIS,2
CA,ACUTE RESPIRATORY DISTRESS SYNDROME,2
CA,ADENOCARCINOMA OF COLON,2
CA,ALVEOLITIS,2
CA,ANAEMIA MACROCYTIC,2
CA,ANAL INCONTINENCE,2
CA,ANAPHYLACTIC SHOCK,2
CA,ANEURYSM,2
CA,ANGIOGRAM,2
CA,ANTI-ERYTHROPOIETIN ANTIBODY NEGATIVE,2
CA,ANTICONVULSANT DRUG LEVEL INCREASED,2
CA,AORTIC VALVE SCLEROSIS,2
CA,APHAGIA,2
CA,ASTHENOPIA,2
CA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,2
CA,AUTONOMIC NERVOUS SYSTEM IMBALANCE,2
CA,B-CELL LYMPHOMA,2
CA,BACTERIAL TEST POSITIVE,2
CA,BACTERIURIA,2
CA,BENIGN BREAST NEOPLASM,2
CA,BENIGN PANCREATIC NEOPLASM,2
CA,BENIGN PROSTATIC HYPERPLASIA,2
CA,BILE DUCT STONE,2
CA,BILE OUTPUT INCREASED,2
CA,BLADDER DISORDER,2
CA,BLEEDING TIME PROLONGED,2
CA,BLEEDING VARICOSE VEIN,2
CA,BLOOD CALCIUM INCREASED,2
CA,BLOOD CHOLESTEROL ABNORMAL,2
CA,BLOOD CHROMOGRANIN A INCREASED,2
CA,BLOOD COUNT ABNORMAL,2
CA,BLOOD GROWTH HORMONE INCREASED,2
CA,BLOOD IMMUNOGLOBULIN E INCREASED,2
CA,BLOOD PRESSURE DIASTOLIC ABNORMAL,2
KY,DEATH,1
CL,CARDIOMEGALY,1
CL,EJECTION FRACTION DECREASED,1
CL,EXTRASYSTOLES,1
CN,HAEMOGLOBIN DECREASED,26
CN,LYMPHOCYTE COUNT DECREASED,23
CN,BLOOD GLUCOSE INCREASED,17
CN,CARDIAC FAILURE,16
CN,PYREXIA,16
CN,BLOOD UREA INCREASED,15
CN,CHEST DISCOMFORT,15
CN,DIZZINESS,15
CN,LUNG INFECTION,15
CN,NEUTROPHIL COUNT INCREASED,14
CN,WHITE BLOOD CELL COUNT INCREASED,14
CN,BLOOD CREATININE INCREASED,13
CN,CHEST PAIN,13
CN,CORONARY ARTERY DISEASE,13
CN,LACTIC ACIDOSIS,13
CN,ARRHYTHMIA,12
CN,HYPERTENSION,12
CN,INCISION SITE PAIN,12
CN,NAUSEA,12
CN,UPPER GASTROINTESTINAL HAEMORRHAGE,12
CN,VOMITING,12
CN,ALANINE AMINOTRANSFERASE INCREASED,11
CN,ASPARTATE AMINOTRANSFERASE INCREASED,11
CN,PALPITATIONS,11
CN,DYSPNOEA,10
CN,RED BLOOD CELLS URINE POSITIVE,10
CN,URINARY TRACT INFECTION,10
CN,ACUTE MYOCARDIAL INFARCTION,9
CN,BLOOD PRESSURE INCREASED,9
CN,CARDIOMYOPATHY,9
CN,DIARRHOEA,9
CN,FATIGUE,9
CN,OVERDOSE,9
CN,PLATELET COUNT DECREASED,9
CN,PROTEIN URINE PRESENT,9
CN,ABDOMINAL DISTENSION,8
CN,ASTHENIA,8
CN,CONDITION AGGRAVATED,8
CN,DRUG-INDUCED LIVER INJURY,8
CN,ECCHYMOSIS,8
CN,ANGINA UNSTABLE,7
CN,C-REACTIVE PROTEIN INCREASED,7
CN,COUGH,7
CN,DRUG INEFFECTIVE,7
CN,HAEMATURIA,7
CN,INTERNATIONAL NORMALISED RATIO INCREASED,7
CN,SUPRAVENTRICULAR TACHYCARDIA,7
CN,ARTERIOSCLEROSIS CORONARY ARTERY,6
CN,BACK PAIN,6
CN,BLOOD ALBUMIN DECREASED,6
CN,DYSURIA,6
CN,HAEMOPTYSIS,6
CN,HEART RATE INCREASED,6
CN,HYPERHIDROSIS,6
CN,MYOCARDIAL INFARCTION,6
CN,OEDEMA PERIPHERAL,6
CN,RENAL IMPAIRMENT,6
CN,THROMBOCYTOPENIA,6
CN,BLOOD TRIGLYCERIDES INCREASED,5
CN,CARDIAC FAILURE CHRONIC,5
CN,CEREBRAL INFARCTION,5
CN,CONSTIPATION,5
CN,DECREASED APPETITE,5
CN,DIABETES MELLITUS,5
CN,ELECTROCARDIOGRAM QT PROLONGED,5
CN,HYPERURICAEMIA,5
CN,LEUKOPENIA,5
CN,MYOPATHY,5
CN,NASOPHARYNGITIS,5
CN,RENAL FAILURE,5
CN,RESPIRATORY FAILURE,5
CN,RHABDOMYOLYSIS,5
CN,SINUS BRADYCARDIA,5
CN,STRESS CARDIOMYOPATHY,5
CN,VENTRICULAR TACHYCARDIA,5
CN,WHITE BLOOD CELL COUNT DECREASED,5
CN,ABDOMINAL PAIN,4
CN,ANAEMIA,4
CN,APLASIA PURE RED CELL,4
CN,ATRIAL FIBRILLATION,4
CN,CEREBRAL HAEMORRHAGE,4
CN,COMPLICATIONS OF TRANSPLANTED KIDNEY,4
CN,DERMATITIS EXFOLIATIVE,4
CN,HAEMORRHAGE,4
CN,HYPOKALAEMIA,4
CN,LIVER INJURY,4
CN,METABOLIC ACIDOSIS,4
CN,OEDEMA,4
CN,PNEUMONIA,4
CN,PROCEDURAL PAIN,4
CN,PRODUCT USE ISSUE,4
CN,PRODUCTIVE COUGH,4
CN,RASH,4
CN,SYNCOPE,4
CN,TORSADE DE POINTES,4
CN,UPPER RESPIRATORY TRACT INFECTION,4
CN,VASCULAR STENT THROMBOSIS,4
CN,WHEEZING,4
CN,WITHDRAWAL SYNDROME,4
CN,ABDOMINAL DISCOMFORT,3
CN,ABDOMINAL PAIN UPPER,3
CN,ANGINA PECTORIS,3
CN,ARTERIOSCLEROSIS,3
CN,BILIRUBIN CONJUGATED INCREASED,3
CN,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
CN,BLOOD POTASSIUM DECREASED,3
CN,BLOOD PRESSURE INADEQUATELY CONTROLLED,3
CN,BLOOD URIC ACID INCREASED,3
CN,BLOOD URINE PRESENT,3
CN,BONE MARROW FAILURE,3
CN,BONE PAIN,3
CN,BRADYCARDIA,3
CN,CARDIAC DISORDER,3
CN,CARDIOGENIC SHOCK,3
CN,CARDIOMEGALY,3
CN,CIRCULATORY COLLAPSE,3
CN,CONCOMITANT DISEASE PROGRESSION,3
CN,CONFUSIONAL STATE,3
CN,CORONARY ARTERY STENOSIS,3
CN,CYTOMEGALOVIRUS INFECTION,3
CN,DEATH,3
CN,DEGENERATIVE AORTIC VALVE DISEASE,3
CN,DRUG LEVEL INCREASED,3
CN,DRUG RESISTANCE,3
CN,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,3
CN,GASTROINTESTINAL HAEMORRHAGE,3
CN,GRAND MAL CONVULSION,3
CN,HEADACHE,3
CN,HYDRONEPHROSIS,3
CN,HYPOAESTHESIA,3
CN,HYPOCALCAEMIA,3
CN,KIDNEY TRANSPLANT REJECTION,3
CN,LACUNAR INFARCTION,3
CN,MITRAL VALVE INCOMPETENCE,3
CN,MULTI-ORGAN FAILURE,3
CN,MUSCULAR WEAKNESS,3
CN,NEPHROPATHY TOXIC,3
CN,POLLAKIURIA,3
CN,TREMOR,3
CN,TRICUSPID VALVE INCOMPETENCE,3
CN,VENTRICULAR EXTRASYSTOLES,3
CN,VENTRICULAR FIBRILLATION,3
CN,ANAPHYLACTIC SHOCK,2
CN,AORTIC VALVE THICKENING,2
CN,ARTHRALGIA,2
CN,ATRIAL FLUTTER,2
CN,ATRIOVENTRICULAR BLOCK,2
CN,ATRIOVENTRICULAR BLOCK FIRST DEGREE,2
CN,BLOOD BILIRUBIN INCREASED,2
CN,BLOOD CHOLESTEROL INCREASED,2
CN,BLOOD LACTATE DEHYDROGENASE INCREASED,2
CN,BLOOD SODIUM DECREASED,2
CN,CARDIAC VALVE DISEASE,2
CN,CHOLELITHIASIS,2
CN,CHRONIC KIDNEY DISEASE,2
CN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
CN,COAGULOPATHY,2
CN,COMA,2
CN,CONVULSION,2
CN,CORONARY ARTERY RESTENOSIS,2
CN,CUSHING^S SYNDROME,2
CN,DELAYED GRAFT FUNCTION,2
CN,DIABETIC NEPHROPATHY,2
CN,DISEASE PROGRESSION,2
CN,DRUG DEPENDENCE,2
CN,DRUG HYPERSENSITIVITY,2
CN,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
CN,DYSGEUSIA,2
CN,EJECTION FRACTION DECREASED,2
CN,ELECTROCARDIOGRAM ABNORMAL,2
CN,ELECTROLYTE IMBALANCE,2
CN,ENTERITIS,2
CN,FACE OEDEMA,2
CN,FLATULENCE,2
CN,GASTRIC ULCER,2
CN,GENERALISED OEDEMA,2
CN,GINGIVAL BLEEDING,2
CN,GLOMERULAR FILTRATION RATE DECREASED,2
CN,HAEMATEMESIS,2
CN,HEPATIC FUNCTION ABNORMAL,2
CN,HYPERKALAEMIA,2
CN,HYPERLIPIDAEMIA,2
CN,HYPOAESTHESIA ORAL,2
CN,HYPOTENSION,2
CN,INFLUENZA LIKE ILLNESS,2
CN,INGUINAL HERNIA,2
CN,INTENTIONAL PRODUCT MISUSE,2
CN,ISCHAEMIC CARDIOMYOPATHY,2
CN,LEFT VENTRICULAR DYSFUNCTION,2
CN,LEFT VENTRICULAR ENLARGEMENT,2
CN,LEFT VENTRICULAR FAILURE,2
CN,LEFT VENTRICULAR HYPERTROPHY,2
CN,LOSS OF CONSCIOUSNESS,2
CN,LOW DENSITY LIPOPROTEIN INCREASED,2
CN,LUNG DISORDER,2
CN,MANIA,2
CN,MELAENA,2
CN,MUSCULOSKELETAL PAIN,2
CN,MYALGIA,2
CN,MYOCARDIAL ISCHAEMIA,2
CN,NEPHROLITHIASIS,2
CN,NEUTROPHIL COUNT DECREASED,2
CN,OSTEOPOROSIS,2
CN,PALLOR,2
CN,PAPULE,2
CN,PERIPHERAL COLDNESS,2
CN,PERIPHERAL SWELLING,2
CN,PNEUMOCYSTIS JIROVECII PNEUMONIA,2
CN,PROTEINURIA,2
CN,PRURITUS,2
CN,PULMONARY HYPERTENSION,2
CN,RALES,2
CN,RED BLOOD CELL COUNT DECREASED,2
CN,RENAL ARTERY STENOSIS,2
CN,RENAL CYST,2
CN,RENAL TUBULAR ACIDOSIS,2
CN,SOMNAMBULISM,2
CN,STEVENS-JOHNSON SYNDROME,2
CN,SUPRAVENTRICULAR EXTRASYSTOLES,2
CN,TENDERNESS,2
CN,TOXIC EPIDERMAL NECROLYSIS,2
CN,TYPE 2 DIABETES MELLITUS,2
CN,URINARY RETENTION,2
CN,URINE OUTPUT DECREASED,2
CN,VISION BLURRED,2
CN,WEIGHT DECREASED,2
CN,ABDOMINAL PAIN LOWER,1
CN,ABORTION,1
CN,ACUTE CORONARY SYNDROME,1
CN,ACUTE KIDNEY INJURY,1
CN,ACUTE PULMONARY OEDEMA,1
CN,AGITATION,1
CN,ALPHA HYDROXYBUTYRATE DEHYDROGENASE INCREASED,1
CN,ALTERED STATE OF CONSCIOUSNESS,1
CN,AMAUROSIS,1
CN,ANAL ABSCESS,1
CN,ANAL FISSURE,1
CN,ANGIOEDEMA,1
CN,ANGLE CLOSURE GLAUCOMA,1
CN,ANION GAP INCREASED,1
CN,ANURIA,1
CN,ANXIETY,1
CN,AORTIC ANEURYSM,1
CN,AORTIC ARTERIOSCLEROSIS,1
CN,AORTIC CALCIFICATION,1
CN,AORTIC DILATATION,1
CN,AORTIC VALVE INCOMPETENCE,1
CN,APHTHOUS ULCER,1
CN,ARRHYTHMIA SUPRAVENTRICULAR,1
CN,ARTERIAL STENOSIS,1
CN,ARTERIOVENOUS FISTULA THROMBOSIS,1
CN,ASTHMA,1
CN,ATRIOVENTRICULAR BLOCK COMPLETE,1
CN,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
CN,BASE EXCESS NEGATIVE,1
CN,BILE DUCT CANCER,1
CN,BK VIRUS INFECTION,1
CN,BLOOD ALKALINE PHOSPHATASE INCREASED,1
CN,BLOOD BICARBONATE DECREASED,1
CN,BLOOD CALCIUM DECREASED,1
CN,BLOOD CHLORIDE DECREASED,1
CN,BLOOD CREATININE ABNORMAL,1
CN,BLOOD LACTIC ACID INCREASED,1
CN,BLOOD PH DECREASED,1
CN,BLOOD PRESSURE DECREASED,1
CN,BLOOD PRESSURE FLUCTUATION,1
CN,BLOOD PRESSURE SYSTOLIC INCREASED,1
CN,BODY TEMPERATURE INCREASED,1
CN,BONE DENSITY ABNORMAL,1
CN,BRADYARRHYTHMIA,1
CN,BRAIN STEM HAEMORRHAGE,1
CN,BRAIN STEM SYNDROME,1
CN,BREATH SOUNDS ABNORMAL,1
CN,BRONCHITIS,1
CN,BUNDLE BRANCH BLOCK LEFT,1
CN,BUNDLE BRANCH BLOCK RIGHT,1
CN,CARDIAC ARREST,1
CN,CARDIAC ENZYMES INCREASED,1
CN,CEREBRAL ARTERY THROMBOSIS,1
CN,CHILLS,1
CN,CHOLECYSTITIS ACUTE,1
CN,CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER,1
CN,COAGULATION TIME PROLONGED,1
CN,COLON CANCER STAGE 0,1
CN,COMPLICATIONS OF TRANSPLANT SURGERY,1
CN,CONGESTIVE CARDIOMYOPATHY,1
CN,CONJUNCTIVAL HAEMORRHAGE,1
CN,CONJUNCTIVAL PALLOR,1
CN,CONTRAINDICATED PRODUCT ADMINISTERED,1
CN,CONTRAST MEDIA REACTION,1
CN,COR PULMONALE CHRONIC,1
CN,CORONARY ARTERY INSUFFICIENCY,1
CN,CRYSTALLURIA,1
CN,CYANOSIS,1
CN,CYTOMEGALOVIRUS COLITIS,1
CN,DEAFNESS,1
CN,DEEP VEIN THROMBOSIS,1
CN,DEGENERATIVE MITRAL VALVE DISEASE,1
CN,DELIRIUM,1
CN,DENTAL CARIES,1
CN,DEPRESSED LEVEL OF CONSCIOUSNESS,1
CN,DERMATITIS,1
CN,DERMATITIS ALLERGIC,1
CN,DERMATITIS BULLOUS,1
CN,DIABETES MELLITUS INADEQUATE CONTROL,1
CN,DIASTOLIC DYSFUNCTION,1
CN,DILATATION VENTRICULAR,1
CN,DISCOMFORT,1
CN,DISORIENTATION,1
CN,DISTRACTIBILITY,1
CN,DISTURBANCE IN ATTENTION,1
CN,DRUG ADMINISTRATION ERROR,1
CN,DRUG CLEARANCE DECREASED,1
CN,DRUG PRESCRIBING ERROR,1
CN,DRUG WITHDRAWAL SYNDROME,1
CN,DRY MOUTH,1
CN,DYSARTHRIA,1
CN,DYSLIPIDAEMIA,1
CN,DYSPEPSIA,1
CN,DYSPHORIA,1
CN,DYSPNOEA EXERTIONAL,1
CN,EAR SWELLING,1
CN,ECHOCARDIOGRAM ABNORMAL,1
CN,ELECTROCARDIOGRAM RR INTERVAL PROLONGED,1
CN,ELECTROCARDIOGRAM ST-T CHANGE,1
CN,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,1
CN,ENDOMETRIAL CANCER,1
CN,EPILEPSY,1
CN,EPISTAXIS,1
CN,ERUCTATION,1
CN,EXPOSED BONE IN JAW,1
CN,EXPOSURE DURING PREGNANCY,1
CN,EXTRASYSTOLES,1
CN,FACIAL SPASM,1
CN,FALL,1
CN,FANCONI SYNDROME ACQUIRED,1
CN,FEAR,1
CN,FEBRILE NEUTROPENIA,1
CN,FEELING HOT,1
CN,FIBRIN D DIMER INCREASED,1
CN,FISTULA,1
CN,FLANK PAIN,1
CN,FOREIGN BODY,1
CN,FRACTURE,1
CN,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
CN,GASTRIC ULCER HAEMORRHAGE,1
CN,GASTROENTERITIS,1
CN,GASTROINTESTINAL DISORDER,1
CN,GASTROOESOPHAGEAL REFLUX DISEASE,1
CN,GENERALISED ANXIETY DISORDER,1
CN,GLIOMA,1
CN,GLUCOSE TOLERANCE IMPAIRED,1
CN,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
CN,GROIN PAIN,1
CN,HAEMATOCHEZIA,1
CN,HAEMATOMA,1
CN,HAEMORRHAGE INTRACRANIAL,1
CN,HAEMORRHAGIC DIATHESIS,1
CN,HALLUCINATION_ AUDITORY,1
CN,HEAD DISCOMFORT,1
CN,HEART SOUNDS ABNORMAL,1
CN,HELMINTHIC INFECTION,1
CN,HEPATIC CYST,1
CN,HEPATIC ENZYME INCREASED,1
CN,HEPATIC STEATOSIS,1
CN,HEPATITIS ACUTE,1
CN,HEPATITIS B CORE ANTIBODY POSITIVE,1
CN,HEPATITIS B SURFACE ANTIBODY POSITIVE,1
CN,HERPES ZOSTER,1
CN,HICCUPS,1
CN,HIGH DENSITY LIPOPROTEIN DECREASED,1
CN,HOSPITALISATION,1
CN,HYPERALDOSTERONISM,1
CN,HYPERBILIRUBINAEMIA,1
CN,HYPERCALCAEMIA,1
CN,HYPERCHLORAEMIA,1
CN,HYPERSENSITIVITY,1
CN,HYPERTENSIVE HEART DISEASE,1
CN,HYPERTROPHIC CARDIOMYOPATHY,1
CN,HYPOALBUMINAEMIA,1
CN,HYPOGLYCAEMIC COMA,1
CN,HYPOPHOSPHATAEMIA,1
CN,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
CN,IMPAIRED WORK ABILITY,1
CN,INADEQUATE ANALGESIA,1
CN,INCOHERENT,1
CN,INFECTION,1
CN,INFLUENZA,1
CN,INFUSION RELATED REACTION,1
CN,INSOMNIA,1
CN,INTENTIONAL PRODUCT USE ISSUE,1
CN,INTERSTITIAL LUNG DISEASE,1
CN,INTESTINAL OBSTRUCTION,1
CN,INTRAVENTRICULAR HAEMORRHAGE,1
CN,ISCHAEMIC STROKE,1
CN,KIDNEY ENLARGEMENT,1
CN,KIDNEY INFECTION,1
CN,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
CN,LABOUR INDUCTION,1
CN,LACRIMATION INCREASED,1
CN,LATENT SYPHILIS,1
CN,LDL/HDL RATIO INCREASED,1
CN,LEFT ATRIAL DILATATION,1
CN,LEFT ATRIAL ENLARGEMENT,1
CN,LIGAMENT SPRAIN,1
CN,LIP SWELLING,1
CN,LIPIDS ABNORMAL,1
CN,LIVER DISORDER,1
CN,LOWER RESPIRATORY TRACT INFECTION,1
CN,LUNG NEOPLASM MALIGNANT,1
CN,MALAISE,1
CN,MALIGNANT NEOPLASM PROGRESSION,1
CN,MATERNAL EXPOSURE DURING PREGNANCY,1
CN,MEDIASTINAL HAEMATOMA,1
CN,MEMORY IMPAIRMENT,1
CN,MENTAL DISORDER,1
CN,METASTATIC GASTRIC CANCER,1
CN,MIOSIS,1
CN,MOUTH SWELLING,1
CN,MUSCLE TIGHTNESS,1
CN,MUSCLE TWITCHING,1
CN,MUSCULOSKELETAL DISCOMFORT,1
CN,MUSCULOSKELETAL STIFFNESS,1
CN,MYOCARDIAL BRIDGING,1
CN,NEOPLASM PROGRESSION,1
CN,NEPHROPATHY,1
CN,NEUROPATHY PERIPHERAL,1
CN,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
CN,NUCHAL RIGIDITY,1
CN,OCULAR HYPERAEMIA,1
CN,OEDEMATOUS KIDNEY,1
CN,OESOPHAGEAL HAEMORRHAGE,1
CN,OLIGURIA,1
CN,OPISTHOTONUS,1
CN,ORAL PAIN,1
CN,OROPHARYNGEAL PAIN,1
CN,OSTEOARTHRITIS,1
CN,OSTEOMALACIA,1
CN,OSTEONECROSIS OF JAW,1
CN,PAIN,1
CN,PAIN IN EXTREMITY,1
CN,PANCREATITIS ACUTE,1
CN,PANIC ATTACK,1
CN,PANIC DISORDER,1
CN,PARAESTHESIA,1
CN,PARKINSON^S DISEASE,1
CN,PCO2 INCREASED,1
CN,PEMPHIGUS,1
CN,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
CN,PERITONITIS,1
CN,PETECHIAE,1
CN,PHARYNGEAL DISORDER,1
CN,PIGMENTATION DISORDER,1
CN,PLASMA CELL MYELOMA,1
CN,PLATELET COUNT INCREASED,1
CN,PNEUMONIA BACTERIAL,1
CN,PNEUMONIA FUNGAL,1
CN,PNEUMONITIS,1
CN,PO2 DECREASED,1
CN,POLYURIA,1
CN,POOR QUALITY SLEEP,1
CN,POSTOPERATIVE WOUND COMPLICATION,1
CN,POSTOPERATIVE WOUND INFECTION,1
CN,PROCALCITONIN INCREASED,1
CN,PROCTALGIA,1
CN,PRODUCT COUNTERFEIT,1
CN,PRURITUS GENERALISED,1
CN,PSORIASIS,1
CN,PULMONARY CONGESTION,1
CN,PULMONARY EMBOLISM,1
CN,PULMONARY HAEMORRHAGE,1
CN,PULMONARY HILAR ENLARGEMENT,1
CN,PULMONARY OEDEMA,1
CN,PURPURA,1
CN,RASH MACULAR,1
CN,RASH PAPULAR,1
CN,RED BLOOD CELLS URINE,1
CN,REGURGITATION,1
CN,RENAL FAILURE CHRONIC,1
CN,RENAL HAEMATOMA,1
CN,RENAL HYPERTENSION,1
CN,RENAL INJURY,1
CN,RENAL PAIN,1
CN,RENAL TUBULAR DISORDER,1
CN,RENAL VEIN THROMBOSIS,1
CN,RESPIRATORY DISTRESS,1
CN,RESPIRATORY RATE INCREASED,1
CN,RETICULOCYTE COUNT DECREASED,1
CN,SCROTAL SWELLING,1
CN,SECONDARY HYPOTHYROIDISM,1
CN,SELF-MEDICATION,1
CN,SENSATION OF FOREIGN BODY,1
CN,SENSORY DISTURBANCE,1
CN,SEPSIS,1
CN,SEPTIC SHOCK,1
CN,SHOCK,1
CN,SINUS ARREST,1
CN,SINUS TACHYCARDIA,1
CN,SKIN HAEMORRHAGE,1
CN,SOMNOLENCE,1
CN,SPINAL OSTEOARTHRITIS,1
CN,STOMATITIS,1
CN,STOOL ANALYSIS NORMAL,1
CN,STROKE IN EVOLUTION,1
CN,SUDDEN CARDIAC DEATH,1
CN,SUDDEN DEATH,1
CN,SUDDEN INFANT DEATH SYNDROME,1
CN,SUICIDE ATTEMPT,1
CN,TACHYCARDIA,1
CN,TACHYPNOEA,1
CN,THINKING ABNORMAL,1
CN,THROMBOCYTOPENIC PURPURA,1
CN,TINNITUS,1
CN,TONGUE DISCOLOURATION,1
CN,TONSILLITIS,1
CN,TOOTH DISCOLOURATION,1
CN,TOXICITY TO VARIOUS AGENTS,1
CN,TRANSPLANT DYSFUNCTION,1
CN,TREATMENT NONCOMPLIANCE,1
CN,TROPONIN I INCREASED,1
CN,URETERIC FISTULA,1
CN,URETERIC STENOSIS,1
CN,URETEROLITHIASIS,1
CN,URETHRAL STENOSIS,1
CN,URINARY INCONTINENCE,1
CN,URINE ABNORMALITY,1
CN,URINE ANALYSIS ABNORMAL,1
CN,URINE OUTPUT INCREASED,1
CN,URTICARIA,1
CN,VENOUS THROMBOSIS LIMB,1
CN,VENTRICULAR DYSKINESIA,1
CN,VENTRICULAR HYPOKINESIA,1
CN,VERTIGO,1
CN,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
CN,WEIGHT INCREASED,1
CN,WOUND INFECTION,1
CN,WRIST FRACTURE,1
CN,XEROPHTHALMIA,1
CO,ACUTE MYOCARDIAL INFARCTION,49
CO,MALAISE,42
CO,PYREXIA,37
CO,DIZZINESS,36
CO,CARDIO-RESPIRATORY ARREST,31
CO,PNEUMONIA,30
CO,DYSPNOEA,29
CO,HEADACHE,29
CO,CHEST PAIN,28
CO,DEATH,28
CO,FALL,27
CO,ARTHRALGIA,26
CO,ABDOMINAL PAIN,25
CO,GENERAL PHYSICAL HEALTH DETERIORATION,25
CO,PAIN,24
CO,FATIGUE,23
CO,PAIN IN EXTREMITY,22
CO,URINARY TRACT INFECTION,22
CO,ASTHENIA,21
CO,HYPERTENSIVE CRISIS,21
CO,DECREASED APPETITE,20
CO,WEIGHT DECREASED,20
CO,ABDOMINAL PAIN UPPER,18
CO,CEREBROVASCULAR ACCIDENT,17
CO,DIARRHOEA,17
CO,HYPOTENSION,17
CO,MYOCARDIAL INFARCTION,17
CO,TACHYCARDIA,17
CO,VOMITING,17
CO,HAEMOGLOBIN DECREASED,16
CO,DEPRESSED MOOD,15
CO,DRUG INEFFECTIVE,15
CO,INFLUENZA,14
CO,BLOOD PRESSURE INCREASED,13
CO,COUGH,13
CO,FEELING ABNORMAL,13
CO,HYPERTENSION,13
CO,PLATELET COUNT DECREASED,13
CO,PULMONARY OEDEMA,13
CO,CHOLELITHIASIS,12
CO,GAIT DISTURBANCE,12
CO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,12
CO,SEPSIS,12
CO,BLOOD CREATININE INCREASED,11
CO,CHILLS,11
CO,HYPERHIDROSIS,11
CO,NAUSEA,11
CO,ANXIETY,10
CO,ARRHYTHMIA,10
CO,BACK PAIN,10
CO,DIABETIC FOOT,10
CO,INFARCTION,10
CO,OEDEMA PERIPHERAL,10
CO,RESPIRATORY DISTRESS,10
CO,SYNCOPE,10
CO,BLOOD GLUCOSE INCREASED,9
CO,CARDIAC DISORDER,9
CO,CARDIAC FAILURE,9
CO,CATARACT,9
CO,LOSS OF CONSCIOUSNESS,9
CO,PERIPHERAL SWELLING,9
CO,SEIZURE,9
CO,THROMBOSIS,9
CO,ANAEMIA,8
CO,ASPHYXIA,8
CO,BLINDNESS,8
CO,CONSTIPATION,8
CO,GASTRITIS,8
CO,HIP FRACTURE,8
CO,INFLAMMATION,8
CO,MOBILITY DECREASED,8
CO,ABDOMINAL DISTENSION,7
CO,DYSPHONIA,7
CO,HAEMATURIA,7
CO,HYPERGLYCAEMIA,7
CO,PRURITUS,7
CO,RASH,7
CO,RENAL TRANSPLANT,7
CO,VISUAL IMPAIRMENT,7
CO,ANGINA UNSTABLE,6
CO,ARTERIAL OCCLUSIVE DISEASE,6
CO,ARTHROPATHY,6
CO,BONE PAIN,6
CO,CHOKING,6
CO,DEVICE RELATED INFECTION,6
CO,DISCOMFORT,6
CO,DRUG-INDUCED LIVER INJURY,6
CO,DYSURIA,6
CO,EATING DISORDER,6
CO,ERYTHEMA,6
CO,FEELING HOT,6
CO,FEELING OF DESPAIR,6
CO,GASTROINTESTINAL HAEMORRHAGE,6
CO,HAEMATOMA,6
CO,INSOMNIA,6
CO,NEPHROLITHIASIS,6
CO,RENAL FAILURE,6
CO,VIRAL INFECTION,6
CO,ABDOMINAL DISCOMFORT,5
CO,ARTHRITIS,5
CO,ATRIAL FIBRILLATION,5
CO,BLOOD CHOLESTEROL INCREASED,5
CO,CEREBRAL HAEMORRHAGE,5
CO,CHEST DISCOMFORT,5
CO,CORONARY ARTERY OCCLUSION,5
CO,DECREASED IMMUNE RESPONSIVENESS,5
CO,DEHYDRATION,5
CO,DEPRESSION,5
CO,DISORIENTATION,5
CO,ENCEPHALOPATHY,5
CO,FLUID RETENTION,5
CO,HYPOAESTHESIA,5
CO,HYPOGLYCAEMIA,5
CO,INFECTION,5
CO,INTESTINAL OBSTRUCTION,5
CO,MEMORY IMPAIRMENT,5
CO,NERVOUS SYSTEM DISORDER,5
CO,OSTEOARTHRITIS,5
CO,PLEURAL EFFUSION,5
CO,PSYCHIATRIC SYMPTOM,5
CO,RASH GENERALISED,5
CO,RENAL DISORDER,5
CO,SOMNOLENCE,5
CO,TRANSAMINASES INCREASED,5
CO,WHITE BLOOD CELL COUNT INCREASED,5
CO,BLOOD PRESSURE DECREASED,4
CO,CHOLECYSTITIS,4
CO,CHROMATURIA,4
CO,CONDITION AGGRAVATED,4
CO,DEEP VEIN THROMBOSIS,4
CO,DIABETES MELLITUS,4
CO,DIVERTICULITIS,4
CO,EYE DISORDER,4
CO,HEAD INJURY,4
CO,ISCHAEMIC STROKE,4
CO,LEUKOPENIA,4
CO,LIMB DISCOMFORT,4
CO,LUNG DISORDER,4
CO,MASS,4
CO,MUSCULAR WEAKNESS,4
CO,NERVOUSNESS,4
CO,OXYGEN SATURATION DECREASED,4
CO,PLATELET COUNT INCREASED,4
CO,PSORIASIS,4
CO,RENAL CYST,4
CO,RESPIRATORY FAILURE,4
CO,ROAD TRAFFIC ACCIDENT,4
CO,SPLENOMEGALY,4
CO,VISION BLURRED,4
CO,VISUAL ACUITY REDUCED,4
CO,ABSCESS,3
CO,ACUTE HEPATIC FAILURE,3
CO,AMNESIA,3
CO,ANKLE FRACTURE,3
CO,APHONIA,3
CO,ASCITES,3
CO,BACTERAEMIA,3
CO,BALANCE DISORDER,3
CO,BENIGN PROSTATIC HYPERPLASIA,3
CO,BLOOD PRESSURE ABNORMAL,3
CO,BLOOD UREA INCREASED,3
CO,BLOOD URIC ACID INCREASED,3
CO,BRAIN NEOPLASM,3
CO,BRONCHITIS,3
CO,BURNING SENSATION,3
CO,CARDIAC ARREST,3
CO,CARDIOMEGALY,3
CO,CARDIOVASCULAR DISORDER,3
CO,CELLULITIS,3
CO,CHRONIC GASTRITIS,3
CO,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
CO,CONTUSION,3
CO,CORONARY ARTERY DISEASE,3
CO,CRANIOCEREBRAL INJURY,3
CO,CYANOSIS,3
CO,DIABETIC COMPLICATION,3
CO,DISEASE COMPLICATION,3
CO,DRUG DOSE OMISSION,3
CO,DYSPHAGIA,3
CO,EPISTAXIS,3
CO,EXTREMITY NECROSIS,3
CO,FEELING COLD,3
CO,GROIN PAIN,3
CO,HAEMOPTYSIS,3
CO,HYPERCALCAEMIA,3
CO,HYPERKALAEMIA,3
CO,HYPERTHERMIA,3
CO,HYPONATRAEMIA,3
CO,HYPOPHAGIA,3
CO,IMMUNODEFICIENCY,3
CO,INTERNATIONAL NORMALISED RATIO INCREASED,3
CO,JOINT INJURY,3
CO,JOINT SWELLING,3
CO,LIVER DISORDER,3
CO,MALIGNANT NEOPLASM PROGRESSION,3
CO,MOUTH HAEMORRHAGE,3
CO,MOVEMENT DISORDER,3
CO,MYALGIA,3
CO,MYELOFIBROSIS,3
CO,NEOPLASM,3
CO,NEUTROPENIA,3
CO,OEDEMA,3
CO,PALLOR,3
CO,PANCREATITIS,3
CO,PAPILLARY THYROID CANCER,3
CO,PROCEDURAL COMPLICATION,3
CO,PRODUCT USE ISSUE,3
CO,PRODUCTIVE COUGH,3
CO,PRURITUS GENERALISED,3
CO,PULMONARY MASS,3
CO,RECTAL HAEMORRHAGE,3
CO,RESPIRATORY ARREST,3
CO,SEPTIC SHOCK,3
CO,SPLENITIS,3
CO,STOMATITIS,3
CO,SUBCUTANEOUS ABSCESS,3
CO,SWELLING,3
CO,SWELLING FACE,3
CO,THROMBOCYTOPENIA,3
CO,THYROID DISORDER,3
CO,UPPER LIMB FRACTURE,3
CO,URAEMIC ENCEPHALOPATHY,3
CO,URINARY RETENTION,3
CO,UROSEPSIS,3
CO,VAGINAL HAEMORRHAGE,3
CO,VERTIGO,3
CO,WEIGHT INCREASED,3
CO,WHITE BLOOD CELL COUNT DECREASED,3
CO,ABSCESS NECK,2
CO,ACUTE CORONARY SYNDROME,2
CO,ACUTE MYELOID LEUKAEMIA,2
CO,AFFECTIVE DISORDER,2
CO,AGITATION,2
CO,ALOPECIA,2
CO,ANGINA PECTORIS,2
CO,AORTIC ANEURYSM,2
CO,AORTIC ARTERIOSCLEROSIS,2
CO,BLINDNESS UNILATERAL,2
CO,BLISTER,2
CO,BLOOD CHOLESTEROL ABNORMAL,2
CO,BLOOD CREATININE ABNORMAL,2
CO,BLOOD GLUCOSE DECREASED,2
CO,BLOOD IRON INCREASED,2
CO,BLOOD TRIGLYCERIDES INCREASED,2
CO,BRADYCARDIA,2
CO,BREAST CANCER,2
CO,BREAST MASS,2
CO,CALCULUS URINARY,2
CO,CARDIAC FAILURE CONGESTIVE,2
CO,CARDIAC VALVE DISEASE,2
CO,CEREBROVASCULAR DISORDER,2
CO,CHIKUNGUNYA VIRUS INFECTION,2
CO,CHOROIDAL EFFUSION,2
CO,CHRONIC MYELOID LEUKAEMIA,2
CO,COAGULOPATHY,2
CO,COLITIS ULCERATIVE,2
CO,COMA,2
CO,CONCOMITANT DISEASE PROGRESSION,2
CO,CONVULSION,2
CO,CYSTOCELE,2
CO,DEAFNESS UNILATERAL,2
CO,DIABETES MELLITUS INADEQUATE CONTROL,2
CO,DRUG ADMINISTRATION ERROR,2
CO,DRUG HYPERSENSITIVITY,2
CO,DRUG INTOLERANCE,2
CO,DRY MOUTH,2
CO,DYSARTHRIA,2
CO,DYSCHEZIA,2
CO,DYSPEPSIA,2
CO,ESCHERICHIA URINARY TRACT INFECTION,2
CO,EYE IRRITATION,2
CO,FACE OEDEMA,2
CO,FACIAL PAIN,2
CO,FLATULENCE,2
CO,FOOT DEFORMITY,2
CO,FREQUENT BOWEL MOVEMENTS,2
CO,GASTRITIS EROSIVE,2
CO,GASTROINTESTINAL INFECTION,2
CO,GENERAL PHYSICAL CONDITION ABNORMAL,2
CO,GLAUCOMA,2
CO,GOITRE,2
CO,HAEMATOCHEZIA,2
CO,HAEMORRHAGE INTRACRANIAL,2
CO,HEART RATE INCREASED,2
CO,HEMIPARESIS,2
CO,HEPATITIS TOXIC,2
CO,HIATUS HERNIA,2
CO,HUMERUS FRACTURE,2
CO,HYPERTENSIVE NEPHROPATHY,2
CO,HYPOACUSIS,2
CO,HYPOAESTHESIA ORAL,2
CO,HYPOXIA,2
CO,IMMUNE SYSTEM DISORDER,2
CO,IMMUNOSUPPRESSION,2
CO,IMPAIRED HEALING,2
CO,INTESTINAL ISCHAEMIA,2
CO,INTRACRANIAL ANEURYSM,2
CO,KIDNEY INFECTION,2
CO,LACERATION,2
CO,LIMB INJURY,2
CO,LOCALISED OEDEMA,2
CO,LYMPHADENOPATHY,2
CO,METASTASES TO BONE,2
CO,MULTI-ORGAN FAILURE,2
CO,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
CO,MUSCLE SPASMS,2
CO,MYOCARDIAL ISCHAEMIA,2
CO,NASAL CONGESTION,2
CO,NASOPHARYNGITIS,2
CO,NEURALGIA,2
CO,NODULE,2
CO,OCULAR HYPERAEMIA,2
CO,OCULAR ICTERUS,2
CO,OCULAR NEOPLASM,2
CO,ORAL MUCOSAL EXFOLIATION,2
CO,OROPHARYNGEAL PAIN,2
CO,OVERDOSE,2
CO,PANCYTOPENIA,2
CO,PARAESTHESIA,2
CO,PARALYSIS,2
CO,PERICARDIAL EFFUSION,2
CO,PERITONEAL DIALYSIS COMPLICATION,2
CO,PERITONITIS,2
CO,PETECHIAE,2
CO,PLATELET COUNT ABNORMAL,2
CO,POST PROCEDURAL COMPLICATION,2
CO,POST PROCEDURAL HAEMORRHAGE,2
CO,PRESCRIBED UNDERDOSE,2
CO,PRESYNCOPE,2
CO,PRODUCT USE IN UNAPPROVED INDICATION,2
CO,PURULENT DISCHARGE,2
CO,RENAL IMPAIRMENT,2
CO,RENAL INJURY,2
CO,SALIVARY HYPERSECRETION,2
CO,SENILE DEMENTIA,2
CO,SHOCK,2
CO,SINUSITIS,2
CO,SKIN BURNING SENSATION,2
CO,SKIN DISCOLOURATION,2
CO,SKIN EXFOLIATION,2
CO,SLEEP DISORDER,2
CO,SPEECH DISORDER,2
CO,SPINAL DISORDER,2
CO,SPINAL FRACTURE,2
CO,SUDDEN DEATH,2
CO,SYNOVIAL CYST,2
CO,THERAPY CESSATION,2
CO,THERAPY NON-RESPONDER,2
CO,THROMBOPHLEBITIS,2
CO,TOOTHACHE,2
CO,TOXIC SKIN ERUPTION,2
CO,TOXICITY TO VARIOUS AGENTS,2
CO,TRANSIENT ISCHAEMIC ATTACK,2
CO,TRAUMATIC HAEMATOMA,2
CO,TREMOR,2
CO,TUBERCULOSIS,2
CO,UMBILICAL HERNIA,2
CO,UPPER GASTROINTESTINAL HAEMORRHAGE,2
CO,URETHRAL OBSTRUCTION,2
CO,URINE ODOUR ABNORMAL,2
CO,URTICARIA,2
CO,UTERINE HYPERSTIMULATION,2
CO,UTERINE LEIOMYOMA,2
CO,WOUND,2
CO,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
CO,ABDOMINAL INFECTION,1
CO,ABDOMINAL MASS,1
CO,ABDOMINAL PAIN LOWER,1
CO,ABDOMINAL WALL ABSCESS,1
CO,ABNORMAL BEHAVIOUR,1
CO,ACCIDENT,1
CO,ACCIDENT AT HOME,1
CO,ACNE,1
CO,ACTIVITIES OF DAILY LIVING IMPAIRED,1
CO,ACUTE LEUKAEMIA,1
CO,ACUTE PULMONARY OEDEMA,1
CO,ADRENAL INSUFFICIENCY,1
CO,ADVERSE DRUG REACTION,1
CO,ADVERSE EVENT,1
CO,AGEUSIA,1
CO,ALANINE AMINOTRANSFERASE INCREASED,1
CO,ALTERED STATE OF CONSCIOUSNESS,1
CO,ANAL FISTULA,1
CO,ANAL HAEMORRHAGE,1
CO,ANAL PRURITUS,1
CO,ANAPHYLACTIC REACTION,1
CO,ANEURYSM,1
CO,ANEURYSM RUPTURED,1
CO,ANGIOPATHY,1
CO,ANGIOPLASTY,1
CO,ANOXIA,1
CO,AORTIC CALCIFICATION,1
CO,AORTIC DILATATION,1
CO,AORTIC OCCLUSION,1
CO,AORTIC VALVE DISEASE,1
CO,AORTIC VALVE INCOMPETENCE,1
CO,AORTITIS,1
CO,APPARENT DEATH,1
CO,ARTERIAL DISORDER,1
CO,ARTERIAL RUPTURE,1
CO,ARTERIOSCLEROSIS CORONARY ARTERY,1
CO,ARTERIOVENOUS FISTULA,1
CO,ARTHRITIS BACTERIAL,1
CO,ASPARTATE AMINOTRANSFERASE INCREASED,1
CO,ASPIRATION,1
CO,ASPIRATION BRONCHIAL,1
CO,ASTHMATIC CRISIS,1
CO,ATRIAL FLUTTER,1
CO,ATROPHY,1
CO,B-CELL LYMPHOMA,1
CO,BACTERIAL INFECTION,1
CO,BILE DUCT STENOSIS,1
CO,BILE DUCT STONE,1
CO,BIPOLAR DISORDER,1
CO,BLADDER DISORDER,1
CO,BLADDER PROLAPSE,1
CO,BLEPHAROPLASTY,1
CO,BLOOD BILIRUBIN INCREASED,1
CO,BLOOD CALCIUM DECREASED,1
CO,BLOOD CORTISOL INCREASED,1
CO,BLOOD DISORDER,1
CO,BLOOD GLUCOSE ABNORMAL,1
CO,BLOOD GLUCOSE FLUCTUATION,1
CO,BLOOD GROWTH HORMONE ABNORMAL,1
CO,BLOOD LACTATE DEHYDROGENASE INCREASED,1
CO,BLOOD PARATHYROID HORMONE INCREASED,1
CO,BLOOD POTASSIUM ABNORMAL,1
CO,BLOOD POTASSIUM DECREASED,1
CO,BLOOD PRESSURE FLUCTUATION,1
CO,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
CO,BLOOD PRESSURE SYSTOLIC INCREASED,1
CO,BLOOD SODIUM DECREASED,1
CO,BLOOD THYROID STIMULATING HORMONE ABNORMAL,1
CO,BLOOD TRIGLYCERIDES ABNORMAL,1
CO,BLOOD TRIGLYCERIDES DECREASED,1
CO,BLOOD UREA ABNORMAL,1
CO,BLOOD URINE PRESENT,1
CO,BODY HEIGHT DECREASED,1
CO,BONE DEFORMITY,1
CO,BONE DENSITY ABNORMAL,1
CO,BONE DISORDER,1
CO,BONE EROSION,1
CO,BONE MARROW DISORDER,1
CO,BONE MARROW OEDEMA,1
CO,BRAIN DEATH,1
CO,BREATH ODOUR,1
CO,BREATHING-RELATED SLEEP DISORDER,1
CO,BROMHIDROSIS,1
CO,BRONCHIAL DISORDER,1
CO,BRONCHOPNEUMONIA,1
CO,BULBAR PALSY,1
CO,BURN OF INTERNAL ORGANS,1
CO,CACHEXIA,1
CO,CALCIPHYLAXIS,1
CO,CALCIUM DEFICIENCY,1
CO,CARDIAC FUNCTION TEST ABNORMAL,1
CO,CARDIAC PACEMAKER INSERTION,1
CO,CARDIAC PROCEDURE COMPLICATION,1
CO,CARDIAC STRESS TEST ABNORMAL,1
CO,CARDIAC TAMPONADE,1
CO,CARDIOMYOPATHY,1
CO,CARPAL TUNNEL SYNDROME,1
CO,CARTILAGE INJURY,1
CO,CATHETER REMOVAL,1
CO,CATHETER SITE INFECTION,1
CO,CELLULITIS ORBITAL,1
CO,CEREBELLAR ISCHAEMIA,1
CO,CEREBRAL CYST,1
CO,CEREBRAL DISORDER,1
CO,CEREBRAL HAEMATOMA,1
CO,CERVICAL DYSPLASIA,1
CO,CERVICAL VERTEBRAL FRACTURE,1
CO,CHEST X-RAY ABNORMAL,1
CO,CHOKING SENSATION,1
CO,CHOLECYSTITIS ACUTE,1
CO,CHONDROPATHY,1
CO,CHRONIC MYELOID LEUKAEMIA RECURRENT,1
CO,COGNITIVE DISORDER,1
CO,COLD SWEAT,1
CO,COLONIC ABSCESS,1
CO,COMPLICATION ASSOCIATED WITH DEVICE,1
CO,CONCOMITANT DISEASE AGGRAVATED,1
CO,CONFUSIONAL STATE,1
CO,CONJUNCTIVAL HAEMORRHAGE,1
CO,CONTRAINDICATED PRODUCT ADMINISTERED,1
CO,CRANIOTOMY,1
CO,CYANOSIS CENTRAL,1
CO,CYSTIC FIBROSIS,1
CO,CYSTITIS,1
CO,CYTOGENETIC ANALYSIS ABNORMAL,1
CO,DEAFNESS,1
CO,DELIRIUM,1
CO,DEMENTIA,1
CO,DENGUE FEVER,1
CO,DENTAL CARIES,1
CO,DEPRESSED LEVEL OF CONSCIOUSNESS,1
CO,DERMAL CYST,1
CO,DERMATITIS,1
CO,DERMATITIS ALLERGIC,1
CO,DERMATITIS BULLOUS,1
CO,DEVICE MALFUNCTION,1
CO,DIABETIC NEPHROPATHY,1
CO,DIABETIC NEUROPATHY,1
CO,DIABETIC RETINOPATHY,1
CO,DIARRHOEA HAEMORRHAGIC,1
CO,DILATATION VENTRICULAR,1
CO,DISEASE PROGRESSION,1
CO,DISEASE RECURRENCE,1
CO,DISTURBANCE IN ATTENTION,1
CO,DIVERTICULAR PERFORATION,1
CO,DIVERTICULUM INTESTINAL,1
CO,DRUG DEPENDENCE,1
CO,DRUG DOSE TITRATION NOT PERFORMED,1
CO,DRUG EFFECT DECREASED,1
CO,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
CO,DRUG PRESCRIBING ERROR,1
CO,DRUG TOLERANCE,1
CO,DRY EYE,1
CO,DRY SKIN,1
CO,DUODENAL ULCER HAEMORRHAGE,1
CO,DYSGEUSIA,1
CO,DYSLIPIDAEMIA,1
CO,EAR HAEMORRHAGE,1
CO,EAR NEOPLASM MALIGNANT,1
CO,EAR PAIN,1
CO,ECCHYMOSIS,1
CO,ECZEMA,1
CO,ELECTROLYTE IMBALANCE,1
CO,ENDOCARDITIS BACTERIAL,1
CO,EOSINOPHIL COUNT INCREASED,1
CO,EOSINOPHILIA,1
CO,EOSINOPHILIC COLITIS,1
CO,EROSIVE OESOPHAGITIS,1
CO,ERYSIPELAS,1
CO,EXCORIATION,1
CO,EXERCISE LACK OF,1
CO,EYE INFECTION,1
CO,EYE PAIN,1
CO,EYELID OEDEMA,1
CO,FACIAL ASYMMETRY,1
CO,FAECES DISCOLOURED,1
CO,FAT INTOLERANCE,1
CO,FEEDING DISORDER,1
CO,FEELING DRUNK,1
CO,FIBROMYALGIA,1
CO,FIBULA FRACTURE,1
CO,FOOD ALLERGY,1
CO,FOREIGN BODY,1
CO,FOREIGN BODY IN RESPIRATORY TRACT,1
CO,FOREIGN BODY SENSATION IN EYES,1
CO,FUNGAL INFECTION,1
CO,FURUNCLE,1
CO,GAIT INABILITY,1
CO,GALLBLADDER EMPYEMA,1
CO,GASTRIC DISORDER,1
CO,GASTRIC MUCOSA ERYTHEMA,1
CO,GASTRIC ULCER,1
CO,GASTROENTERITIS,1
CO,GASTROINTESTINAL DISORDER,1
CO,GASTROINTESTINAL FISTULA,1
CO,GASTROINTESTINAL INFLAMMATION,1
CO,GASTROINTESTINAL NEOPLASM,1
CO,GASTROSTOMY,1
CO,GENERALISED TONIC-CLONIC SEIZURE,1
CO,GINGIVAL BLEEDING,1
CO,GINGIVAL DISORDER,1
CO,GINGIVITIS,1
CO,GLOSSODYNIA,1
CO,HAEMATEMESIS,1
CO,HAEMODIALYSIS,1
CO,HAEMOGLOBIN ABNORMAL,1
CO,HAEMORRHAGE,1
CO,HAEMORRHAGIC STROKE,1
CO,HAEMORRHOIDS,1
CO,HAND FRACTURE,1
CO,HEAD DISCOMFORT,1
CO,HEARING IMPAIRED,1
CO,HEART RATE DECREASED,1
CO,HELICOBACTER GASTRITIS,1
CO,HELICOBACTER INFECTION,1
CO,HEPATIC CANCER,1
CO,HEPATIC ENZYME INCREASED,1
CO,HEPATIC FAILURE,1
CO,HEPATIC INFECTION,1
CO,HEPATIC LESION,1
CO,HEPATIC MASS,1
CO,HEPATIC NEOPLASM,1
CO,HEPATOMEGALY,1
CO,HERPES SIMPLEX,1
CO,HERPES ZOSTER,1
CO,HIP SURGERY,1
CO,HYDRONEPHROSIS,1
CO,HYPERTENSIVE CARDIOMYOPATHY,1
CO,HYPERTENSIVE ENCEPHALOPATHY,1
CO,HYPERTENSIVE HEART DISEASE,1
CO,HYPERTRIGLYCERIDAEMIA,1
CO,HYPOKALAEMIA,1
CO,HYPOPITUITARISM,1
CO,HYPOTHERMIA,1
CO,HYPOVOLAEMIC SHOCK,1
CO,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,1
CO,IDIOSYNCRATIC DRUG REACTION,1
CO,ILEOSTOMY,1
CO,IMPLANT SITE ABSCESS,1
CO,INCONTINENCE,1
CO,INCORRECT DOSE ADMINISTERED,1
CO,INCORRECT DRUG ADMINISTRATION DURATION,1
CO,INCORRECT PRODUCT FORMULATION ADMINISTERED,1
CO,INCREASED UPPER AIRWAY SECRETION,1
CO,INFECTED SKIN ULCER,1
CO,INFLUENZA LIKE ILLNESS,1
CO,INGUINAL HERNIA,1
CO,INJURY,1
CO,INSULIN-LIKE GROWTH FACTOR INCREASED,1
CO,INTENTIONAL DRUG MISUSE,1
CO,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
CO,INTERVERTEBRAL DISC COMPRESSION,1
CO,INTESTINAL ANGINA,1
CO,INTESTINAL HAEMORRHAGE,1
CO,INTRACRANIAL HAEMATOMA,1
CO,INVASIVE LOBULAR BREAST CARCINOMA,1
CO,IRRITABLE BOWEL SYNDROME,1
CO,ISCHAEMIA,1
CO,JAUNDICE,1
CO,JOINT DISLOCATION,1
CO,KLEBSIELLA INFECTION,1
CO,KNEE OPERATION,1
CO,LACRIMATION INCREASED,1
CO,LARYNGEAL CANCER,1
CO,LETHARGY,1
CO,LICHEN PLANUS,1
CO,LIMB FRACTURE,1
CO,LIP DISCOLOURATION,1
CO,LIPIDS ABNORMAL,1
CO,LIVER FUNCTION TEST INCREASED,1
CO,LIVER INJURY,1
CO,LOCALISED INFECTION,1
CO,LOWER LIMB FRACTURE,1
CO,LUNG CYST,1
CO,LUNG INFECTION,1
CO,LUNG NEOPLASM MALIGNANT,1
CO,LYMPHOMA,1
CO,MALNUTRITION,1
CO,MEDIASTINAL ABSCESS,1
CO,MEDICAL DEVICE COMPLICATION,1
CO,MEDICAL DEVICE DISCOMFORT,1
CO,MENINGIOMA BENIGN,1
CO,MENINGITIS,1
CO,MENINGITIS BACTERIAL,1
CO,MENTAL DISORDER,1
CO,METABOLIC SYNDROME,1
CO,METASTASES TO LUNG,1
CO,METASTASES TO PELVIS,1
CO,METASTATIC NEOPLASM,1
CO,MITRAL VALVE DISEASE,1
CO,MITRAL VALVE INCOMPETENCE,1
CO,MITRAL VALVE PROLAPSE,1
CO,MOUTH ULCERATION,1
CO,MUCOSAL INFLAMMATION,1
CO,MUCOUS STOOLS,1
CO,MULTI-ORGAN DISORDER,1
CO,MULTIMORBIDITY,1
CO,MULTIPLE INJURIES,1
CO,MUSCLE DISORDER,1
CO,MUSCLE HAEMORRHAGE,1
CO,MUSCLE RUPTURE,1
CO,MUSCULOSKELETAL CHEST PAIN,1
CO,MUSCULOSKELETAL PAIN,1
CO,MYELITIS TRANSVERSE,1
CO,MYOPATHY,1
CO,NAIL INJURY,1
CO,NASOPHARYNGEAL CANCER,1
CO,NECK MASS,1
CO,NECK PAIN,1
CO,NEOPLASM PROGRESSION,1
CO,NEOPLASM RECURRENCE,1
CO,NEPHROSCLEROSIS,1
CO,NERVE INJURY,1
CO,NEUTROPHIL COUNT DECREASED,1
CO,NIGHT SWEATS,1
CO,NONINFECTIVE GINGIVITIS,1
CO,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
CO,NOSOCOMIAL INFECTION,1
CO,OBESITY,1
CO,OBSTRUCTIVE PANCREATITIS,1
CO,ODYNOPHAGIA,1
CO,OEDEMA GENITAL,1
CO,OEDEMATOUS KIDNEY,1
CO,OESOPHAGITIS,1
CO,OLIGURIA,1
CO,OPEN FRACTURE,1
CO,OPTIC NERVE DISORDER,1
CO,ORAL HERPES,1
CO,ORAL MUCOSAL BLISTERING,1
CO,ORAL PAIN,1
CO,ORTHOPNOEA,1
CO,OSTEOPENIA,1
CO,OSTEOPOROSIS,1
CO,OSTEOSYNTHESIS,1
CO,PARATHYROID DISORDER,1
CO,PARONYCHIA,1
CO,PATELLA FRACTURE,1
CO,PATHOLOGICAL FRACTURE,1
CO,PELVIC CYST,1
CO,PELVIC FRACTURE,1
CO,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
CO,PERIPHERAL COLDNESS,1
CO,PERIPHERAL ISCHAEMIA,1
CO,PERITONEAL DISORDER,1
CO,PHARYNGEAL NEOPLASM,1
CO,PHLEBITIS,1
CO,PLEURAL DISORDER,1
CO,PNEUMONIA BACTERIAL,1
CO,POLYARTHRITIS,1
CO,POLYMYALGIA RHEUMATICA,1
CO,POLYNEUROPATHY,1
CO,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,1
CO,POLYP,1
CO,POLYURIA,1
CO,PORPHYRIA,1
CO,POST PROCEDURAL DISCHARGE,1
CO,POST-TRAUMATIC PAIN,1
CO,POSTOPERATIVE WOUND INFECTION,1
CO,PROCEDURAL DIZZINESS,1
CO,PROCEDURAL HAEMORRHAGE,1
CO,PROCEDURAL HYPERTENSION,1
CO,PROCEDURAL NAUSEA,1
CO,PROCEDURAL PAIN,1
CO,PRODUCT QUALITY ISSUE,1
CO,PROSTATE CANCER,1
CO,PROSTATE CANCER METASTATIC,1
CO,PROSTATITIS,1
CO,PROSTATOMEGALY,1
CO,PSEUDOMONAS INFECTION,1
CO,PSORIATIC ARTHROPATHY,1
CO,PTERYGIUM,1
CO,PULMONARY CONGESTION,1
CO,PULMONARY EMBOLISM,1
CO,PULMONARY FUNCTION TEST ABNORMAL,1
CO,PULMONARY HAEMORRHAGE,1
CO,PULMONARY HYPERTENSION,1
CO,PULMONARY PAIN,1
CO,PULMONARY SEPSIS,1
CO,PULMONARY THROMBOSIS,1
CO,PULMONARY VALVE STENOSIS,1
CO,PYODERMA GANGRENOSUM,1
CO,QUADRIPARESIS,1
CO,QUADRIPLEGIA,1
CO,RASH PRURITIC,1
CO,RASH PUSTULAR,1
CO,RECTAL FISSURE,1
CO,RED BLOOD CELL COUNT DECREASED,1
CO,RENAL ATROPHY,1
CO,RENAL CELL CARCINOMA,1
CO,RENAL FAILURE ACUTE,1
CO,RENAL SURGERY,1
CO,RENAL VESSEL DISORDER,1
CO,RESPIRATORY TRACT INFECTION,1
CO,RESPIRATORY TRACT INFECTION FUNGAL,1
CO,RHEUMATOID ARTHRITIS,1
CO,RHINORRHOEA,1
CO,SCAR,1
CO,SCOLIOSIS,1
CO,SCRATCH,1
CO,SEBORRHOEIC DERMATITIS,1
CO,SECOND PRIMARY MALIGNANCY,1
CO,SEDATION,1
CO,SERUM FERRITIN INCREASED,1
CO,SINUS BRADYCARDIA,1
CO,SKIN HYPERTROPHY,1
CO,SKIN INFECTION,1
CO,SKIN LESION,1
CO,SKIN ULCER,1
CO,SKIN WRINKLING,1
CO,SLEEP APNOEA SYNDROME,1
CO,SOFT TISSUE INFECTION,1
CO,SPINAL OPERATION,1
CO,SPINAL OSTEOARTHRITIS,1
CO,SPINAL PAIN,1
CO,SPONDYLOLYSIS,1
CO,STAPHYLOCOCCAL SEPSIS,1
CO,STOMAL HERNIA,1
CO,SUBARACHNOID HAEMORRHAGE,1
CO,SUBDURAL HAEMATOMA,1
CO,SUPERINFECTION,1
CO,SUPERIOR VENA CAVA SYNDROME,1
CO,SUPRAVENTRICULAR TACHYCARDIA,1
CO,SYNOVITIS,1
CO,TENDON PAIN,1
CO,TENDONITIS,1
CO,TENOSYNOVITIS,1
CO,THIRST,1
CO,THORACIC VERTEBRAL FRACTURE,1
CO,THROAT IRRITATION,1
CO,THROMBOCYTOPENIC PURPURA,1
CO,THROMBOPHLEBITIS SEPTIC,1
CO,THYROID FUNCTION TEST ABNORMAL,1
CO,TIBIA FRACTURE,1
CO,TONGUE DISCOLOURATION,1
CO,TONGUE ULCERATION,1
CO,TONSILLAR INFLAMMATION,1
CO,TOOTH ABSCESS,1
CO,TOOTH DISORDER,1
CO,TOOTH EROSION,1
CO,TOOTH FRACTURE,1
CO,TOOTH INFECTION,1
CO,TRACHEOSTOMY,1
CO,TREATMENT FAILURE,1
CO,TREATMENT NONCOMPLIANCE,1
CO,TRIGGER FINGER,1
CO,TUBERCULOSIS GASTROINTESTINAL,1
CO,TUMOUR MARKER INCREASED,1
CO,TUMOUR RUPTURE,1
CO,TYMPANIC MEMBRANE PERFORATION,1
CO,TYPE 2 DIABETES MELLITUS,1
CO,ULTRAFILTRATION FAILURE,1
CO,UNEVALUABLE EVENT,1
CO,UNRESPONSIVE TO STIMULI,1
CO,URETHRAL STENOSIS,1
CO,URINARY INCONTINENCE,1
CO,URINARY TRACT DISORDER,1
CO,URINARY TRACT INFECTION BACTERIAL,1
CO,URINE ABNORMALITY,1
CO,URINE ANALYSIS ABNORMAL,1
CO,URINE CYTOLOGY ABNORMAL,1
CO,UTERINE HAEMORRHAGE,1
CO,UTEROVAGINAL PROLAPSE,1
CO,VASCULITIS,1
CO,VEIN DISORDER,1
CO,VENA CAVA THROMBOSIS,1
CO,VENOUS OCCLUSION,1
CO,VENTRICULAR CISTERNOSTOMY,1
CO,VERTIGO CNS ORIGIN,1
CO,VULVOVAGINAL PAIN,1
CO,WALLENBERG SYNDROME,1
CO,WOUND COMPLICATION,1
CO,WOUND INFECTION,1
CO,WOUND SECRETION,1
CO,YELLOW SKIN,1
HR,ANGINA UNSTABLE,2
HR,ADENOCARCINOMA OF COLON,1
HR,AGITATION,1
HR,DAYDREAMING,1
HR,DEATH,1
HR,DYSARTHRIA,1
HR,FEAR OF EATING,1
HR,GAIT DISTURBANCE,1
HR,GASTRITIS,1
HR,HAEMARTHROSIS,1
HR,INSOMNIA,1
HR,MYDRIASIS,1
HR,OBSESSIVE THOUGHTS,1
HR,PALPITATIONS,1
HR,PARANOIA,1
HR,POLYP,1
HR,RECTAL HAEMORRHAGE,1
HR,WEIGHT DECREASED,1
CY,BREAST CANCER IN SITU,1
CY,CEREBRAL HAEMORRHAGE,1
CY,CHOKING SENSATION,1
CY,DRY MOUTH,1
CY,DYSPNOEA,1
CY,ERYTHEMA,1
CY,FLATULENCE,1
CY,GENERALISED OEDEMA,1
CY,HEADACHE,1
CY,HYPERSENSITIVITY,1
CY,INFECTION,1
CY,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
CY,OCULAR HYPERAEMIA,1
CY,PYREXIA,1
CY,RASH ERYTHEMATOUS,1
CY,TACHYCARDIA,1
CY,THROMBOCYTOPENIA,1
CZ,CARDIAC ARREST,20
CZ,TOXICITY TO VARIOUS AGENTS,14
CZ,ACUTE KIDNEY INJURY,9
CZ,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,9
CZ,OVERDOSE,9
CZ,BRAIN OEDEMA,8
CZ,INTENTIONAL OVERDOSE,8
CZ,LOSS OF CONSCIOUSNESS,8
CZ,SEIZURE,8
CZ,SUICIDE ATTEMPT,7
CZ,HAEMODYNAMIC INSTABILITY,6
CZ,ANAEMIA,5
CZ,CARDIAC FAILURE,5
CZ,COMPLETED SUICIDE,5
CZ,DYSPNOEA,5
CZ,OXYGEN SATURATION DECREASED,5
CZ,PARAESTHESIA,5
CZ,POLYMYOSITIS,5
CZ,ANAPHYLACTIC SHOCK,4
CZ,CIRCULATORY COLLAPSE,4
CZ,DEHYDRATION,4
CZ,EPISTAXIS,4
CZ,HYPOTENSION,4
CZ,RESPIRATORY ARREST,4
CZ,ATRIAL FIBRILLATION,3
CZ,HYPERTENSION,3
CZ,PULSELESS ELECTRICAL ACTIVITY,3
CZ,THERAPEUTIC RESPONSE DECREASED,3
CZ,APLASIA PURE RED CELL,2
CZ,CONDITION AGGRAVATED,2
CZ,DIABETES MELLITUS,2
CZ,DRUG LEVEL INCREASED,2
CZ,ERYTHROPOIESIS ABNORMAL,2
CZ,FATIGUE,2
CZ,FEMUR FRACTURE,2
CZ,HYPERKALAEMIA,2
CZ,INFECTION,2
CZ,MUSCULAR WEAKNESS,2
CZ,NEUTROPENIA,2
CZ,OEDEMA PERIPHERAL,2
CZ,PNEUMONIA,2
CZ,POTENTIATING DRUG INTERACTION,2
CZ,RENAL IMPAIRMENT,2
CZ,RESPIRATORY TRACT INFECTION,2
CZ,RETICULOCYTE COUNT DECREASED,2
CZ,SEPSIS,2
CZ,ABSCESS LIMB,1
CZ,ANAL FISSURE,1
CZ,ANXIETY,1
CZ,ARTHRALGIA,1
CZ,ASTHENIA,1
CZ,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
CZ,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
CZ,BLOOD CREATININE INCREASED,1
CZ,BLOOD PRESSURE INCREASED,1
CZ,BRONCHIAL OBSTRUCTION,1
CZ,BRONCHOPNEUMONIA,1
CZ,C-REACTIVE PROTEIN INCREASED,1
CZ,CARDIOGENIC SHOCK,1
CZ,CEREBRAL HAEMORRHAGE,1
CZ,CHEST PAIN,1
CZ,CHRONIC KIDNEY DISEASE,1
CZ,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
CZ,CLOSTRIDIUM DIFFICILE COLITIS,1
CZ,COGNITIVE DISORDER,1
CZ,CONFUSIONAL STATE,1
CZ,DEATH,1
CZ,DECREASED APPETITE,1
CZ,DEPENDENT PERSONALITY DISORDER,1
CZ,DIABETIC METABOLIC DECOMPENSATION,1
CZ,DIARRHOEA,1
CZ,DISORIENTATION,1
CZ,DRUG INEFFECTIVE,1
CZ,DRUG INTOLERANCE,1
CZ,DUODENAL ULCER HAEMORRHAGE,1
CZ,DUODENITIS,1
CZ,DYSKINESIA,1
CZ,DYSPNOEA EXERTIONAL,1
CZ,EJECTION FRACTION,1
CZ,EMOTIONAL DISORDER,1
CZ,EXPOSURE DURING PREGNANCY,1
CZ,EXTRAPYRAMIDAL DISORDER,1
CZ,FALL,1
CZ,FOETAL EXPOSURE DURING PREGNANCY,1
CZ,GASTRIC ULCER,1
CZ,GASTRIC ULCER HAEMORRHAGE,1
CZ,GASTROENTERITIS SALMONELLA,1
CZ,GESTATIONAL DIABETES,1
CZ,HAEMOPTYSIS,1
CZ,HALLUCINATION_ AUDITORY,1
CZ,HEART RATE DECREASED,1
CZ,HEPATIC ENZYME INCREASED,1
CZ,INFLAMMATORY MARKER INCREASED,1
CZ,INFLUENZA,1
CZ,LEFT VENTRICULAR DYSFUNCTION,1
CZ,LOW BIRTH WEIGHT BABY,1
CZ,LUNG INFILTRATION,1
CZ,MASKED FACIES,1
CZ,MENINGITIS,1
CZ,METABOLIC ENCEPHALOPATHY,1
CZ,MUSCLE CONTRACTIONS INVOLUNTARY,1
CZ,MUSCLE NECROSIS,1
CZ,MYOCARDIAL INFARCTION,1
CZ,MYOGLOBIN BLOOD INCREASED,1
CZ,MYOPATHY,1
CZ,NEPHROGENIC ANAEMIA,1
CZ,NEUROGLYCOPENIA,1
CZ,OEDEMA,1
CZ,OESOPHAGEAL CARCINOMA,1
CZ,ORTHOPNOEA,1
CZ,OSTEOARTHRITIS,1
CZ,OTITIS MEDIA ACUTE,1
CZ,PAIN,1
CZ,PATIENT RESTRAINT,1
CZ,PERIPHERAL ISCHAEMIA,1
CZ,PERIPHERAL SWELLING,1
CZ,PERSECUTORY DELUSION,1
CZ,POISONING,1
CZ,POST PROCEDURAL INFECTION,1
CZ,PSYCHIATRIC SYMPTOM,1
CZ,PSYCHOMOTOR RETARDATION,1
CZ,PYELONEPHRITIS,1
CZ,PYREXIA,1
CZ,RENAL CELL CARCINOMA,1
CZ,RENAL FAILURE,1
CZ,RENAL FAILURE ACUTE,1
CZ,RESPIRATORY FAILURE,1
CZ,RESPIRATORY TRACT HAEMORRHAGE,1
CZ,RESPIRATORY TRACT INFECTION BACTERIAL,1
CZ,SCHIZOPHRENIA_ PARANOID TYPE,1
CZ,SINUS BRADYCARDIA,1
CZ,SOMATIC HALLUCINATION,1
CZ,SOMATOFORM DISORDER,1
CZ,SOMNOLENCE,1
CZ,SPEECH DISORDER,1
CZ,STAPHYLOCOCCAL INFECTION,1
CZ,SUICIDAL IDEATION,1
CZ,TACHYPNOEA,1
CZ,TALIPES,1
CZ,TENSION,1
CZ,THINKING ABNORMAL,1
CZ,TRANSPLANT REJECTION,1
CZ,TRAUMATIC HAEMATOMA,1
CZ,URINARY TRACT INFECTION,1
CZ,VENTRICULAR FIBRILLATION,1
CZ,WEIGHT DECREASED,1
DK,HYPOTENSION,21
DK,BEZOAR,16
DK,DIZZINESS,16
DK,OESOPHAGEAL OBSTRUCTION,15
DK,PNEUMONIA ASPIRATION,15
DK,LOSS OF CONSCIOUSNESS,13
DK,TOXICITY TO VARIOUS AGENTS,13
DK,DYSPNOEA,12
DK,MYALGIA,12
DK,SYNCOPE,12
DK,ATRIAL FIBRILLATION,10
DK,GAIT DISTURBANCE,10
DK,NAUSEA,10
DK,OESOPHAGEAL HAEMORRHAGE,10
DK,ALANINE AMINOTRANSFERASE INCREASED,9
DK,BODY TEMPERATURE INCREASED,9
DK,CARDIOVASCULAR DISORDER,9
DK,INTENTIONAL OVERDOSE,9
DK,MENTAL STATUS CHANGES,9
DK,PAIN IN EXTREMITY,9
DK,SENSORY DISTURBANCE,9
DK,CEREBRAL HAEMORRHAGE,8
DK,COMPLETED SUICIDE,8
DK,MALAISE,8
DK,OVERDOSE,8
DK,PARAESTHESIA,8
DK,RESPIRATORY DISORDER,8
DK,SEPSIS,8
DK,DEPRESSED LEVEL OF CONSCIOUSNESS,7
DK,DISCOMFORT,7
DK,FATIGUE,7
DK,GENERAL PHYSICAL HEALTH DETERIORATION,7
DK,HEADACHE,7
DK,PRURITUS,7
DK,PYREXIA,7
DK,RESTLESSNESS,7
DK,RHABDOMYOLYSIS,7
DK,VENTRICULAR FIBRILLATION,7
DK,WEIGHT DECREASED,7
DK,CARDIAC FAILURE,6
DK,CORONARY ARTERY DISSECTION,6
DK,EPISTAXIS,6
DK,HYPERTENSION,6
DK,MUSCULAR WEAKNESS,6
DK,PALPITATIONS,6
DK,PERIPHERAL COLDNESS,6
DK,PNEUMONIA,6
DK,POST PROCEDURAL HAEMORRHAGE,6
DK,ACUTE KIDNEY INJURY,5
DK,BLOOD CREATININE INCREASED,5
DK,BRADYCARDIA,5
DK,BRAIN NEOPLASM,5
DK,CHEST PAIN,5
DK,CIRCULATORY COLLAPSE,5
DK,CONFUSIONAL STATE,5
DK,DECREASED APPETITE,5
DK,DEHYDRATION,5
DK,DEPRESSION,5
DK,HEMIPARESIS,5
DK,HYPOKALAEMIA,5
DK,MUSCLE SPASMS,5
DK,NASOPHARYNGITIS,5
DK,OEDEMA,5
DK,PANCREATITIS,5
DK,ABDOMINAL PAIN,4
DK,ABNORMAL FAECES,4
DK,ALTERED STATE OF CONSCIOUSNESS,4
DK,ASPARTATE AMINOTRANSFERASE INCREASED,4
DK,BLOOD CREATINE PHOSPHOKINASE INCREASED,4
DK,BURNING SENSATION,4
DK,COMA,4
DK,DIARRHOEA,4
DK,DRUG LEVEL INCREASED,4
DK,DRY MOUTH,4
DK,ELECTROCARDIOGRAM QT PROLONGED,4
DK,FALL,4
DK,HYPERHIDROSIS,4
DK,HYPONATRAEMIA,4
DK,MUSCULOSKELETAL PAIN,4
DK,NEUROPATHY PERIPHERAL,4
DK,OSTEONECROSIS OF JAW,4
DK,PRODUCT USE ISSUE,4
DK,SUICIDE ATTEMPT,4
DK,TENDON RUPTURE,4
DK,TREMOR,4
DK,VISUAL IMPAIRMENT,4
DK,VOMITING,4
DK,ABDOMINAL PAIN UPPER,3
DK,ACUTE MYOCARDIAL INFARCTION,3
DK,ARTHRALGIA,3
DK,ASTHENIA,3
DK,BLISTER,3
DK,BLOOD BILIRUBIN INCREASED,3
DK,BRAIN MIDLINE SHIFT,3
DK,BRAIN OEDEMA,3
DK,C-REACTIVE PROTEIN INCREASED,3
DK,CATARACT,3
DK,COGNITIVE DISORDER,3
DK,CONGESTIVE CARDIOMYOPATHY,3
DK,DISTURBANCE IN ATTENTION,3
DK,DRUG EFFECT DECREASED,3
DK,DYSPHAGIA,3
DK,ERYTHEMA,3
DK,FEELING OF BODY TEMPERATURE CHANGE,3
DK,GROIN PAIN,3
DK,HELLP SYNDROME,3
DK,HYPOAESTHESIA,3
DK,INTERNATIONAL NORMALISED RATIO INCREASED,3
DK,JAUNDICE,3
DK,KNEE OPERATION,3
DK,MEMORY IMPAIRMENT,3
DK,NEONATAL RESPIRATORY DISTRESS SYNDROME,3
DK,PARALYSIS,3
DK,POLYNEUROPATHY,3
DK,PRESYNCOPE,3
DK,PRODUCTIVE COUGH,3
DK,RASH,3
DK,RENAL IMPAIRMENT,3
DK,SMALL FIBRE NEUROPATHY,3
DK,URINARY INCONTINENCE,3
DK,ABDOMINAL DISTENSION,2
DK,AGITATION,2
DK,AMNESIA,2
DK,ANAEMIA,2
DK,ANAPHYLACTIC REACTION,2
DK,ANAPHYLACTIC SHOCK,2
DK,AORTIC ARTERIOSCLEROSIS,2
DK,APHASIA,2
DK,ATRIAL SEPTAL DEFECT,2
DK,BACK PAIN,2
DK,BLOOD ALKALINE PHOSPHATASE INCREASED,2
DK,BLOOD LACTATE DEHYDROGENASE INCREASED,2
DK,BLOOD PRESSURE DECREASED,2
DK,BONE PAIN,2
DK,BRAIN HERNIATION,2
DK,BRAIN INJURY,2
DK,CARDIAC ARREST,2
DK,CARDIOVERSION,2
DK,CEREBRAL HAEMATOMA,2
DK,CEREBRAL HYPOPERFUSION,2
DK,CEREBRAL INFARCTION,2
DK,CHEST DISCOMFORT,2
DK,CHILLS,2
DK,CONGENITAL HEART VALVE DISORDER,2
DK,CONSTIPATION,2
DK,DEAFNESS,2
DK,DEATH,2
DK,DELIRIUM,2
DK,DEPRESSED MOOD,2
DK,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
DK,DYSPNOEA EXERTIONAL,2
DK,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,2
DK,EXPOSED BONE IN JAW,2
DK,EYE PAIN,2
DK,GALLBLADDER ENLARGEMENT,2
DK,GASTRIC HAEMORRHAGE,2
DK,HAEMATURIA,2
DK,HAEMOGLOBIN DECREASED,2
DK,HAEMORRHAGE,2
DK,HALLUCINATION,2
DK,HEART DISEASE CONGENITAL,2
DK,HEART RATE DECREASED,2
DK,HEMIANOPIA HOMONYMOUS,2
DK,HEPATIC CONGESTION,2
DK,HEPATIC ENZYME INCREASED,2
DK,HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL,2
DK,HYPERKALAEMIA,2
DK,HYPOACUSIS,2
DK,HYPOTONIA,2
DK,INTERSTITIAL LUNG DISEASE,2
DK,LIVER DISORDER,2
DK,LUNG INFECTION,2
DK,LUNG INFILTRATION,2
DK,LUNG NEOPLASM MALIGNANT,2
DK,MEDICATION ERROR,2
DK,METABOLIC ALKALOSIS,2
DK,MITRAL VALVE INCOMPETENCE,2
DK,MOTOR DYSFUNCTION,2
DK,MYOSITIS,2
DK,NEPHROGENIC SYSTEMIC FIBROSIS,2
DK,ORAL FUNGAL INFECTION,2
DK,ORTHOSTATIC HYPOTENSION,2
DK,OXYGEN SATURATION DECREASED,2
DK,PAIN,2
DK,PANCYTOPENIA,2
DK,PATENT DUCTUS ARTERIOSUS,2
DK,PENILE CANCER,2
DK,PHARYNGEAL OEDEMA,2
DK,PLASMA CELL MYELOMA,2
DK,PREGNANCY,2
DK,PSEUDOPORPHYRIA,2
DK,PULMONARY FIBROSIS,2
DK,QUADRIPARESIS,2
DK,RENAL FAILURE ACUTE,2
DK,RESPIRATORY DEPRESSION,2
DK,RESPIRATORY FAILURE,2
DK,SEIZURE,2
DK,SURGERY,2
DK,SWELLING,2
DK,SWELLING FACE,2
DK,TACHYCARDIA,2
DK,TINNITUS,2
DK,TOXIC ENCEPHALOPATHY,2
DK,URINARY TRACT INFECTION,2
DK,VASCULAR MALFORMATION,2
DK,VENTRICULAR TACHYCARDIA,2
DK,VISION BLURRED,2
DK,VISUAL ACUITY REDUCED,2
DK,WALKING DISABILITY,2
DK,WHITE BLOOD CELL COUNT DECREASED,2
DK,WHITE BLOOD CELL COUNT INCREASED,2
DK,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
DK,ABDOMINAL INFECTION,1
DK,ADENOCARCINOMA PANCREAS,1
DK,AFFECT LABILITY,1
DK,AGGRESSION,1
DK,ALOPECIA,1
DK,ANGER,1
DK,ANGINA PECTORIS,1
DK,ANXIETY,1
DK,AORTIC VALVE INCOMPETENCE,1
DK,AORTIC VALVE STENOSIS,1
DK,APGAR SCORE ABNORMAL,1
DK,APNOEA,1
DK,ARTERIOGRAM CORONARY,1
DK,ARTHROPATHY,1
DK,ASPIRATION,1
DK,ATRIAL FLUTTER,1
DK,ATRIOVENTRICULAR BLOCK COMPLETE,1
DK,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
DK,BALANCE DISORDER,1
DK,BARRETT^S OESOPHAGUS,1
DK,BASEDOW^S DISEASE,1
DK,BICUSPID AORTIC VALVE,1
DK,BLOOD CREATINE INCREASED,1
DK,BLOOD DISORDER,1
DK,BLOOD POTASSIUM DECREASED,1
DK,BLOOD PRESSURE INCREASED,1
DK,BLOOD SODIUM DECREASED,1
DK,BONE MARROW FAILURE,1
DK,BRADYKINESIA,1
DK,BUNDLE BRANCH BLOCK RIGHT,1
DK,CALCULUS URETHRAL,1
DK,CARCINOID TUMOUR OF THE SMALL BOWEL,1
DK,CARDIAC ABLATION,1
DK,CARDIAC DISORDER,1
DK,CARDIAC MASSAGE,1
DK,CATARACT OPERATION,1
DK,CEREBELLAR HAEMORRHAGE,1
DK,CEREBRAL ATROPHY,1
DK,CEREBRAL VENTRICLE DILATATION,1
DK,CEREBROVASCULAR ACCIDENT,1
DK,CHEST X-RAY ABNORMAL,1
DK,CHOLECYSTECTOMY,1
DK,CHOLELITHIASIS,1
DK,CHOLESTASIS,1
DK,CHROMATURIA,1
DK,COAGULOPATHY,1
DK,COLITIS,1
DK,CONGENITAL AORTIC VALVE STENOSIS,1
DK,CORONARY ARTERY OCCLUSION,1
DK,COUGH,1
DK,CROHN^S DISEASE,1
DK,CRYING,1
DK,CSF SHUNT OPERATION,1
DK,CYANOSIS,1
DK,DEEP VEIN THROMBOSIS,1
DK,DEFORMITY,1
DK,DERMATITIS INFECTED,1
DK,DISORIENTATION,1
DK,DIZZINESS POSTURAL,1
DK,DRUG ADMINISTRATION ERROR,1
DK,DRUG INEFFECTIVE,1
DK,DRUG PRESCRIBING ERROR,1
DK,DRUG-INDUCED LIVER INJURY,1
DK,DUODENAL ULCER,1
DK,DUODENITIS,1
DK,DYSARTHRIA,1
DK,DYSPEPSIA,1
DK,DYSPHONIA,1
DK,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
DK,ENDOTRACHEAL INTUBATION,1
DK,EPILEPSY,1
DK,ERECTILE DYSFUNCTION,1
DK,EXPOSURE DURING PREGNANCY,1
DK,EXTRAPYRAMIDAL DISORDER,1
DK,FACIAL PAIN,1
DK,FACIAL PARESIS,1
DK,FAECES DISCOLOURED,1
DK,FEBRILE NEUTROPENIA,1
DK,FEELING ABNORMAL,1
DK,FINE MOTOR SKILL DYSFUNCTION,1
DK,FISTULA,1
DK,FLUID INTAKE REDUCED,1
DK,FOETAL EXPOSURE DURING PREGNANCY,1
DK,FOOD AVERSION,1
DK,FOREIGN BODY SENSATION IN EYES,1
DK,GAIT INABILITY,1
DK,GALLBLADDER POLYP,1
DK,GASTROINTESTINAL DISORDER,1
DK,GASTROOESOPHAGEAL REFLUX DISEASE,1
DK,GENERALISED ERYTHEMA,1
DK,GENERALISED OEDEMA,1
DK,GINGIVAL BLEEDING,1
DK,GRAND MAL CONVULSION,1
DK,GYNAECOMASTIA,1
DK,HAEMATOMA,1
DK,HAEMORRHAGIC CEREBRAL INFARCTION,1
DK,HALLUCINATION_ AUDITORY,1
DK,HEART RATE IRREGULAR,1
DK,HEMIPLEGIA,1
DK,HEPATIC ENZYME ABNORMAL,1
DK,HEPATIC FAILURE,1
DK,HEPATIC FUNCTION ABNORMAL,1
DK,HEPATITIS TOXIC,1
DK,HIATUS HERNIA,1
DK,HOT FLUSH,1
DK,HYDROCEPHALUS,1
DK,HYPOMAGNESAEMIA,1
DK,HYPOXIA,1
DK,INCORRECT DOSE ADMINISTERED,1
DK,INFECTION,1
DK,INSOMNIA,1
DK,INTENTIONAL PRODUCT MISUSE,1
DK,INTRA-ABDOMINAL FLUID COLLECTION,1
DK,INTRACRANIAL PRESSURE INCREASED,1
DK,IRON DEFICIENCY ANAEMIA,1
DK,JAW OPERATION,1
DK,JOINT RANGE OF MOTION DECREASED,1
DK,KIDNEY INFECTION,1
DK,LACTIC ACIDOSIS,1
DK,LARGE INTESTINAL HAEMORRHAGE,1
DK,LEARNING DISABILITY,1
DK,LEUKOPENIA,1
DK,LIFE SUPPORT,1
DK,LOSS OF LIBIDO,1
DK,LOWER EXTREMITY MASS,1
DK,LYMPHADENOPATHY,1
DK,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
DK,MEDICATION RESIDUE PRESENT,1
DK,MELAENA,1
DK,MENTAL DISORDER,1
DK,MESENTERIC ARTERY THROMBOSIS,1
DK,METASTASES TO BONE MARROW,1
DK,METASTASES TO LIVER,1
DK,METASTASES TO LYMPH NODES,1
DK,MOBILITY DECREASED,1
DK,MOOD SWINGS,1
DK,MOUTH SWELLING,1
DK,MULTI-ORGAN FAILURE,1
DK,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
DK,MUSCLE ATROPHY,1
DK,MUSCLE RIGIDITY,1
DK,MUSCULAR DYSTROPHY,1
DK,MUSCULOSKELETAL DISCOMFORT,1
DK,MUSCULOSKELETAL STIFFNESS,1
DK,MYOCARDIAL INFARCTION,1
DK,NASAL MUCOSAL DISORDER,1
DK,NEGLECT OF PERSONAL APPEARANCE,1
DK,NEOPLASM MALIGNANT,1
DK,NEUROLOGIC NEGLECT SYNDROME,1
DK,NEUTROPENIA,1
DK,NIGHT SWEATS,1
DK,NON-SMALL CELL LUNG CANCER,1
DK,OEDEMA PERIPHERAL,1
DK,OESOPHAGEAL ULCER,1
DK,ORAL CANDIDIASIS,1
DK,ORAL HERPES,1
DK,OROPHARYNGEAL OEDEMA,1
DK,OROPHARYNGEAL PAIN,1
DK,ORTHOPNOEA,1
DK,OSTEOARTHRITIS,1
DK,OSTEOPOROSIS,1
DK,PANCREATECTOMY,1
DK,PARANOIA,1
DK,PAROTITIS,1
DK,PERCUTANEOUS CORONARY INTERVENTION,1
DK,PERICARDIAL EFFUSION,1
DK,PERIPHERAL SWELLING,1
DK,PETIT MAL EPILEPSY,1
DK,PHOTOSENSITIVITY REACTION,1
DK,PLATELET COUNT DECREASED,1
DK,PLEURAL EFFUSION,1
DK,PLEURISY,1
DK,POOR QUALITY SLEEP,1
DK,PORPHYRIA NON-ACUTE,1
DK,PREMATURE BABY,1
DK,PREMATURE DELIVERY,1
DK,PRODUCT USE IN UNAPPROVED INDICATION,1
DK,PROSTATE CANCER,1
DK,PRURITUS GENERALISED,1
DK,PSYCHOMOTOR RETARDATION,1
DK,PSYCHOTIC DISORDER,1
DK,PULMONARY ARTERY THROMBOSIS,1
DK,PULMONARY EMBOLISM,1
DK,PULMONARY HYPERTENSION,1
DK,PULMONARY OEDEMA,1
DK,PULMONARY THROMBOSIS,1
DK,PYODERMA,1
DK,RABBIT SYNDROME,1
DK,RASH GENERALISED,1
DK,RASH MACULO-PAPULAR,1
DK,RASH PAPULAR,1
DK,RENAL FAILURE,1
DK,RESPIRATION ABNORMAL,1
DK,RESPIRATORY ACIDOSIS,1
DK,RESPIRATORY TRACT HAEMORRHAGE,1
DK,RESTING TREMOR,1
DK,RIB FRACTURE,1
DK,SALIVARY GLAND ENLARGEMENT,1
DK,SCAB,1
DK,SEPTIC SHOCK,1
DK,SHUNT INFECTION,1
DK,SINUS ARREST,1
DK,SKIN DISORDER,1
DK,SKIN EXFOLIATION,1
DK,SKIN FRAGILITY,1
DK,SKIN REACTION,1
DK,SKIN TIGHTNESS,1
DK,SLEEP DISORDER,1
DK,SOMNOLENCE,1
DK,SPEECH DISORDER,1
DK,SPLENECTOMY,1
DK,SPLENIC INFARCTION,1
DK,SPLENIC NEOPLASM MALIGNANCY UNSPECIFIED,1
DK,SQUAMOUS CELL CARCINOMA,1
DK,STAPHYLOCOCCAL INFECTION,1
DK,SUBDURAL HAEMATOMA,1
DK,SUICIDAL IDEATION,1
DK,TRANSPOSITION OF THE GREAT VESSELS,1
DK,URINARY RETENTION,1
DK,URINE OUTPUT DECREASED,1
DK,VASCULAR OPERATION,1
DK,VASCULAR PSEUDOANEURYSM,1
DK,VENTRICULAR ARRHYTHMIA,1
DK,VENTRICULAR HYPOKINESIA,1
DK,VERTIGO,1
DK,VITH NERVE PARALYSIS,1
DK,WHEELCHAIR USER,1
DK,WOUND,1
EG,BRADYCARDIA,1
EE,CEREBRAL INFARCTION,7
EE,MUSCULAR WEAKNESS,6
EE,THROMBOSIS,6
EE,CEREBRAL HAEMORRHAGE,4
EE,PROSTATE CANCER,4
EE,WOUND,4
EE,CYANOSIS,3
EE,SUDDEN DEATH,3
EE,WALKING AID USER,3
EE,HAEMORRHAGE,2
EE,PYREXIA,2
EE,ANXIETY DISORDER,1
EE,APHASIA,1
EE,ASTHENIA,1
EE,ATRIAL FIBRILLATION,1
EE,BLOOD PRESSURE DECREASED,1
EE,BRAIN OEDEMA,1
EE,CARDIAC FAILURE,1
EE,CEREBROVASCULAR ACCIDENT,1
EE,CHILLS,1
EE,COMA,1
EE,CONTRAST MEDIA ALLERGY,1
EE,CONTUSION,1
EE,COUGH,1
EE,DIARRHOEA,1
EE,DIZZINESS,1
EE,DRUG INEFFECTIVE,1
EE,DRUG INTOLERANCE,1
EE,EAR DISCOMFORT,1
EE,EAR HAEMORRHAGE,1
EE,EAR INFECTION,1
EE,EPISTAXIS,1
EE,HAEMATOCHEZIA,1
EE,HEADACHE,1
EE,HEART RATE INCREASED,1
EE,HEMIPLEGIA,1
EE,HEPATIC ENZYME INCREASED,1
EE,HEPATIC FAILURE,1
EE,HYDROCEPHALUS,1
EE,HYPERTENSION,1
EE,HYPERTENSIVE CRISIS,1
EE,ISCHAEMIC STROKE,1
EE,LARGE INTESTINAL HAEMORRHAGE,1
EE,LARGE INTESTINE POLYP,1
EE,LETHARGY,1
EE,MASTOIDITIS,1
EE,NEUTROPENIC INFECTION,1
EE,NYSTAGMUS,1
EE,OBSTRUCTIVE SHOCK,1
EE,ORAL CANDIDIASIS,1
EE,OVERDOSE,1
EE,PALPITATIONS,1
EE,PERIPHERAL COLDNESS,1
EE,PLASMA CELL MYELOMA,1
EE,PRODUCT USE ISSUE,1
EE,PSEUDOMONAL SEPSIS,1
EE,PULMONARY EMBOLISM,1
EE,RECTAL ADENOCARCINOMA,1
EE,RENAL FAILURE,1
EE,RESPIRATION ABNORMAL,1
EE,SYNCOPE,1
EE,TACHYCARDIA,1
EE,THROMBOEMBOLECTOMY,1
EE,TREMOR,1
EE,UNDERDOSE,1
FI,COMPLETED SUICIDE,5
FI,NEUTROPENIA,4
FI,TOXICITY TO VARIOUS AGENTS,4
FI,ACUTE MYOCARDIAL INFARCTION,3
FI,DYSPNOEA,3
FI,MALAISE,3
FI,MYOPATHY,3
FI,OVERDOSE,3
FI,ABDOMINAL PAIN,2
FI,AEROPHAGIA,2
FI,COLD SWEAT,2
FI,DYSARTHRIA,2
FI,GAIT DISTURBANCE,2
FI,INTENTIONAL OVERDOSE,2
FI,MUSCULAR WEAKNESS,2
FI,NAUSEA,2
FI,PHOTOPSIA,2
FI,PRURITUS,2
FI,ACUTE KIDNEY INJURY,1
FI,ALOPECIA,1
FI,AMYLASE INCREASED,1
FI,ANXIETY,1
FI,AORTIC VALVE SCLEROSIS,1
FI,ASPERGILLUS INFECTION,1
FI,ASTHENIA,1
FI,ATRIAL FIBRILLATION,1
FI,BONE DISORDER,1
FI,BONE MARROW FAILURE,1
FI,BREAST CANCER METASTATIC,1
FI,C-REACTIVE PROTEIN INCREASED,1
FI,CARDIAC DISCOMFORT,1
FI,CARDIAC FAILURE,1
FI,CHEST DISCOMFORT,1
FI,COGNITIVE DISORDER,1
FI,CONDITION AGGRAVATED,1
FI,COUGH,1
FI,DEAFNESS UNILATERAL,1
FI,DEATH,1
FI,DECREASED APPETITE,1
FI,DEMENTIA,1
FI,DEPRESSED MOOD,1
FI,DIZZINESS,1
FI,DIZZINESS POSTURAL,1
FI,DRUG INEFFECTIVE,1
FI,DRUG LEVEL DECREASED,1
FI,DRUG LEVEL INCREASED,1
FI,DRY SKIN,1
FI,DYSPHONIA,1
FI,ELECTROCARDIOGRAM ABNORMAL,1
FI,EPISTAXIS,1
FI,ERYTHEMA,1
FI,EYE OEDEMA,1
FI,FACE OEDEMA,1
FI,FATIGUE,1
FI,FEAR,1
FI,FEELING ABNORMAL,1
FI,FLUSHING,1
FI,FUNGAL INFECTION,1
FI,GAMMA-GLUTAMYLTRANSFERASE DECREASED,1
FI,GENERAL PHYSICAL HEALTH DETERIORATION,1
FI,HAEMOGLOBIN DECREASED,1
FI,HEART RATE DECREASED,1
FI,HYPERTENSION,1
FI,HYPOACUSIS,1
FI,HYPONATRAEMIA,1
FI,HYPOTENSION,1
FI,HYPOTHERMIA,1
FI,INCORRECT DOSE ADMINISTERED,1
FI,INCREASED TENDENCY TO BRUISE,1
FI,INFECTION,1
FI,INSOMNIA,1
FI,INTERNATIONAL NORMALISED RATIO INCREASED,1
FI,LIVER FUNCTION TEST ABNORMAL,1
FI,LOSS OF CONSCIOUSNESS,1
FI,MELAENA,1
FI,MEMORY IMPAIRMENT,1
FI,MUSCLE ATROPHY,1
FI,MUSCLE OEDEMA,1
FI,MYOCARDIAL ISCHAEMIA,1
FI,MYOSITIS,1
FI,NERVOUS SYSTEM DISORDER,1
FI,NEURALGIA,1
FI,NEURODEGENERATIVE DISORDER,1
FI,NEUROPATHY PERIPHERAL,1
FI,PANCREATITIS,1
FI,PERIPHERAL SWELLING,1
FI,PNEUMOCYSTIS JIROVECII INFECTION,1
FI,PNEUMONIA,1
FI,POISONING,1
FI,POST HERPETIC NEURALGIA,1
FI,PYREXIA,1
FI,RASH,1
FI,RASH VESICULAR,1
FI,RENAL FAILURE,1
FI,RHABDOMYOLYSIS,1
FI,SINUSITIS,1
FI,STEATOHEPATITIS,1
FI,TINNITUS,1
FI,UNDERWEIGHT,1
FI,URINARY TRACT INFECTION,1
FI,URTICARIA,1
FI,VAGINAL HAEMORRHAGE,1
FI,VISION BLURRED,1
FI,VOMITING,1
FI,WEIGHT DECREASED,1
FI,WHITE BLOOD CELL COUNT DECREASED,1
FR,CARDIAC ARREST,33
FR,RENAL FAILURE,26
FR,TOXICITY TO VARIOUS AGENTS,24
FR,ACUTE KIDNEY INJURY,22
FR,ANAEMIA,14
FR,OVERDOSE,14
FR,FALL,13
FR,LACTIC ACIDOSIS,13
FR,METABOLIC ACIDOSIS,13
FR,MYDRIASIS,13
FR,ATRIOVENTRICULAR BLOCK,12
FR,MALAISE,12
FR,GENERAL PHYSICAL HEALTH DETERIORATION,11
FR,HYPOTENSION,11
FR,ABDOMINAL PAIN,10
FR,PYREXIA,10
FR,DIARRHOEA,9
FR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,9
FR,SHOCK,9
FR,THROMBOCYTOPENIA,9
FR,BRADYCARDIA,8
FR,COMA,8
FR,CONFUSIONAL STATE,8
FR,DYSPNOEA,8
FR,HYPERKALAEMIA,8
FR,PANCYTOPENIA,8
FR,VOMITING,8
FR,ASTHENIA,7
FR,ATRIAL FIBRILLATION,7
FR,CONDITION AGGRAVATED,7
FR,HYPONATRAEMIA,7
FR,AGRANULOCYTOSIS,6
FR,CARDIO-RESPIRATORY ARREST,6
FR,EPILEPSY,6
FR,ISCHAEMIC STROKE,6
FR,LICHENOID KERATOSIS,6
FR,RESPIRATORY DISTRESS,6
FR,SEIZURE,6
FR,VITAMIN B12 DECREASED,6
FR,FATIGUE,5
FR,LUNG DISORDER,5
FR,NAUSEA,5
FR,PULMONARY EMBOLISM,5
FR,SUBDURAL HAEMATOMA,5
FR,WEIGHT DECREASED,5
FR,ARTHRALGIA,4
FR,CARDIAC FAILURE,4
FR,DEAFNESS BILATERAL,4
FR,DECREASED APPETITE,4
FR,HAEMORRHAGIC STROKE,4
FR,HEADACHE,4
FR,HEPATOCELLULAR INJURY,4
FR,RENAL FAILURE ACUTE,4
FR,TINNITUS,4
FR,UNRESPONSIVE TO STIMULI,4
FR,ACIDOSIS,3
FR,ACUTE CORONARY SYNDROME,3
FR,ANURIA,3
FR,BLOOD BILIRUBIN INCREASED,3
FR,BLOOD BLISTER,3
FR,BRADYPNOEA,3
FR,CHOLESTASIS,3
FR,COMPLETED SUICIDE,3
FR,DISTURBANCE IN ATTENTION,3
FR,DRUG LEVEL INCREASED,3
FR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,3
FR,EJECTION FRACTION DECREASED,3
FR,ERYTHEMA MULTIFORME,3
FR,GAIT DISTURBANCE,3
FR,HAEMATURIA,3
FR,HEAD INJURY,3
FR,HEPATIC FAILURE,3
FR,HYPERSENSITIVITY,3
FR,HYPERTENSION,3
FR,HYPERTHERMIA,3
FR,HYPOGLYCAEMIA,3
FR,HYPOKALAEMIA,3
FR,HYPOTHERMIA,3
FR,INTENTIONAL OVERDOSE,3
FR,INTERNATIONAL NORMALISED RATIO INCREASED,3
FR,INTESTINAL ISCHAEMIA,3
FR,JAUNDICE,3
FR,LUNG INFECTION,3
FR,MEDICATION ERROR,3
FR,MELAENA,3
FR,MUSCULAR WEAKNESS,3
FR,OEDEMA PERIPHERAL,3
FR,PARAESTHESIA,3
FR,PRODUCT USE ISSUE,3
FR,PROTEINURIA,3
FR,PURPURA,3
FR,SEPTIC SHOCK,3
FR,SOMNOLENCE,3
FR,STEVENS-JOHNSON SYNDROME,3
FR,SUBCUTANEOUS HAEMATOMA,3
FR,SUICIDE ATTEMPT,3
FR,THROMBOCYTOPENIC PURPURA,3
FR,TOXIC SKIN ERUPTION,3
FR,VISION BLURRED,3
FR,ABDOMINAL PAIN UPPER,2
FR,ACUTE HEPATIC FAILURE,2
FR,ACUTE RESPIRATORY DISTRESS SYNDROME,2
FR,ALANINE AMINOTRANSFERASE INCREASED,2
FR,APNOEA,2
FR,ARRHYTHMIA,2
FR,BLADDER CANCER,2
FR,BLOOD PRESSURE SYSTOLIC DECREASED,2
FR,BODY TEMPERATURE DECREASED,2
FR,BONE MARROW FAILURE,2
FR,C-REACTIVE PROTEIN INCREASED,2
FR,CARDIAC DISORDER,2
FR,CARDIOGENIC SHOCK,2
FR,CARDIOMYOPATHY,2
FR,CHILLS,2
FR,COUGH,2
FR,DEATH,2
FR,DEHYDRATION,2
FR,DERMO-HYPODERMITIS,2
FR,DISORIENTATION,2
FR,DIZZINESS,2
FR,DYSPHAGIA,2
FR,ELECTROCARDIOGRAM QT PROLONGED,2
FR,EOSINOPHILIA,2
FR,EPISTAXIS,2
FR,ERYSIPELAS,2
FR,ERYTHEMA,2
FR,ESCHERICHIA SEPSIS,2
FR,FEBRILE NEUTROPENIA,2
FR,FEMUR FRACTURE,2
FR,FOETAL EXPOSURE DURING PREGNANCY,2
FR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
FR,GASTROENTERITIS,2
FR,GENERALISED TONIC-CLONIC SEIZURE,2
FR,HAEMATOMA,2
FR,HAEMORRHOIDAL HAEMORRHAGE,2
FR,HALLUCINATIONS_ MIXED,2
FR,HEPATITIS,2
FR,HYPERBILIRUBINAEMIA,2
FR,HYPERHIDROSIS,2
FR,HYPOCALCAEMIA,2
FR,HYPOXIA,2
FR,INFECTION,2
FR,INTESTINAL INFARCTION,2
FR,LOSS OF CONSCIOUSNESS,2
FR,LOW BIRTH WEIGHT BABY,2
FR,LYMPHADENOPATHY,2
FR,MESENTERIC VEIN THROMBOSIS,2
FR,MIGRAINE,2
FR,MUCOSAL INFLAMMATION,2
FR,MYALGIA,2
FR,MYOCARDIAL INFARCTION,2
FR,NEUTROPENIA,2
FR,ODYNOPHAGIA,2
FR,OTOTOXICITY,2
FR,PALPITATIONS,2
FR,PANCREATITIS ACUTE,2
FR,PERIARTHRITIS,2
FR,PERITONITIS,2
FR,PERSECUTORY DELUSION,2
FR,PLEURAL EFFUSION,2
FR,PNEUMONIA,2
FR,PNEUMONIA ASPIRATION,2
FR,PRURITUS,2
FR,PSORIASIS,2
FR,PULMONARY FIBROSIS,2
FR,RASH,2
FR,RASH MACULO-PAPULAR,2
FR,RENAL FAILURE CHRONIC,2
FR,RESPIRATORY FAILURE,2
FR,SCIATICA,2
FR,SEPSIS,2
FR,SUPRAVENTRICULAR EXTRASYSTOLES,2
FR,TACHYCARDIA,2
FR,TREMOR,2
FR,UROSEPSIS,2
FR,VERTIGO,2
FR,ABDOMINAL WALL HAEMATOMA,1
FR,ACINETOBACTER BACTERAEMIA,1
FR,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
FR,ACTIVITIES OF DAILY LIVING IMPAIRED,1
FR,ACUTE MYOCARDIAL INFARCTION,1
FR,ACUTE PULMONARY OEDEMA,1
FR,ADENOCARCINOMA OF COLON,1
FR,AFFECT LABILITY,1
FR,AGITATION,1
FR,ALCOHOL WITHDRAWAL SYNDROME,1
FR,ALTERED STATE OF CONSCIOUSNESS,1
FR,AMNESIA,1
FR,AMNESTIC DISORDER,1
FR,ANAPHYLACTIC SHOCK,1
FR,ANGINA PECTORIS,1
FR,ANGIOEDEMA,1
FR,ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC,1
FR,ANXIETY,1
FR,AORTIC DISSECTION,1
FR,AORTIC STENOSIS,1
FR,AORTIC VALVE INCOMPETENCE,1
FR,APHAGIA,1
FR,APHTHOUS ULCER,1
FR,APLASIA PURE RED CELL,1
FR,APPLICATION SITE PAIN,1
FR,APPLICATION SITE ULCER,1
FR,ARTERIAL INSUFFICIENCY,1
FR,ARTERIOGRAM CORONARY,1
FR,ARTERIOSCLEROSIS,1
FR,ASCITES,1
FR,ASPARTATE AMINOTRANSFERASE INCREASED,1
FR,ATRIAL THROMBOSIS,1
FR,AUTOIMMUNE HEPATITIS,1
FR,BACK PAIN,1
FR,BACTERIAL SEPSIS,1
FR,BALANCE DISORDER,1
FR,BASAL CELL CARCINOMA,1
FR,BILIRUBIN CONJUGATED INCREASED,1
FR,BLISTER,1
FR,BLOOD ALKALINE PHOSPHATASE INCREASED,1
FR,BLOOD GLUCOSE DECREASED,1
FR,BLOOD HYPOSMOSIS,1
FR,BLOOD PRESSURE DECREASED,1
FR,BLOOD PRESSURE INCREASED,1
FR,BLOOD THYROID STIMULATING HORMONE DECREASED,1
FR,BLOOD THYROID STIMULATING HORMONE INCREASED,1
FR,BRONCHIAL OBSTRUCTION,1
FR,BRONCHITIS,1
FR,BRONCHOPULMONARY ASPERGILLOSIS,1
FR,CARDIAC MURMUR,1
FR,CARDIAC TAMPONADE,1
FR,CARDIOTOXICITY,1
FR,CATARACT,1
FR,CELL DEATH,1
FR,CELLULITIS,1
FR,CEREBRAL HAEMATOMA,1
FR,CEREBRAL HYPOPERFUSION,1
FR,CEREBROVASCULAR ACCIDENT,1
FR,CHEST DISCOMFORT,1
FR,CHEST WALL HAEMATOMA,1
FR,CHOLECYSTITIS,1
FR,CHOLECYSTITIS INFECTIVE,1
FR,COAGULATION FACTOR DECREASED,1
FR,COAGULATION FACTOR V LEVEL ABNORMAL,1
FR,CONSTIPATION,1
FR,COOMBS TEST POSITIVE,1
FR,COORDINATION ABNORMAL,1
FR,CROHN^S DISEASE,1
FR,CYTOMEGALOVIRUS INFECTION,1
FR,DEPRESSED MOOD,1
FR,DEPRESSION,1
FR,DERMATITIS ALLERGIC,1
FR,DIABETES MELLITUS,1
FR,DIABETIC FOOT INFECTION,1
FR,DIABETIC METABOLIC DECOMPENSATION,1
FR,DISSOCIATIVE FUGUE,1
FR,DRUG ADMINISTERED AT INAPPROPRIATE SITE,1
FR,DRUG ADMINISTRATION ERROR,1
FR,DRUG ERUPTION,1
FR,DRUG HYPERSENSITIVITY,1
FR,DRUG SCREEN POSITIVE,1
FR,DRUG USE DISORDER,1
FR,DYSARTHRIA,1
FR,DYSPNOEA EXERTIONAL,1
FR,DYSSTASIA,1
FR,EAR INFECTION,1
FR,EAR PAIN,1
FR,EATING DISORDER,1
FR,ELECTROCARDIOGRAM ABNORMAL,1
FR,ENCEPHALOPATHY,1
FR,ENTEROCOLITIS,1
FR,ESCHERICHIA TEST POSITIVE,1
FR,EYE DISCHARGE,1
FR,EYELID PTOSIS,1
FR,FACE INJURY,1
FR,FACIAL NEURALGIA,1
FR,FACIAL PAIN,1
FR,FACIAL PARALYSIS,1
FR,FEELING ABNORMAL,1
FR,FLATULENCE,1
FR,GASTROINTESTINAL HAEMORRHAGE,1
FR,GASTROINTESTINAL PAIN,1
FR,GENERAL PHYSICAL CONDITION ABNORMAL,1
FR,GENERALISED ERYTHEMA,1
FR,GLOMERULONEPHROPATHY,1
FR,HAEMATOTOXICITY,1
FR,HAEMODYNAMIC INSTABILITY,1
FR,HAEMOLYSIS,1
FR,HAEMOLYTIC ANAEMIA,1
FR,HAEMORRHAGIC DIATHESIS,1
FR,HAEMORRHAGIC TRANSFORMATION STROKE,1
FR,HALLUCINATION,1
FR,HALLUCINATION_ VISUAL,1
FR,HEMIPLEGIA,1
FR,HEPATIC ADENOMA,1
FR,HEPATIC HAEMATOMA,1
FR,HEPATIC HAEMORRHAGE,1
FR,HEPATITIS CHOLESTATIC,1
FR,HISTONE ANTIBODY POSITIVE,1
FR,HYPERCAPNIA,1
FR,HYPERLIPASAEMIA,1
FR,HYPERNATRAEMIA,1
FR,HYPERTHYROIDISM,1
FR,HYPERTONIA,1
FR,HYPOMAGNESAEMIA,1
FR,HYPOTHYROIDISM,1
FR,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
FR,INCOHERENT,1
FR,INCORRECT DOSE ADMINISTERED,1
FR,INCREASED BRONCHIAL SECRETION,1
FR,INFLAMMATION,1
FR,INSOMNIA,1
FR,INTERVERTEBRAL DISC DEGENERATION,1
FR,INTESTINAL OBSTRUCTION,1
FR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
FR,LACRIMATION INCREASED,1
FR,LARGE INTESTINE PERFORATION,1
FR,LEUKOPENIA,1
FR,LIVER INJURY,1
FR,LOBAR PNEUMONIA,1
FR,LYMPHOCYTOSIS,1
FR,MACROGLOSSIA,1
FR,MACULAR OEDEMA,1
FR,MALIGNANT HYPERTENSION,1
FR,MALIGNANT NEOPLASM PROGRESSION,1
FR,MATERNAL EXPOSURE DURING PREGNANCY,1
FR,MENTAL DISORDER,1
FR,MIDDLE EAR EFFUSION,1
FR,MIOSIS,1
FR,MOOD SWINGS,1
FR,MULTI-ORGAN FAILURE,1
FR,MUSCLE HAEMORRHAGE,1
FR,MUSCLE SPASMS,1
FR,MUSCLE TIGHTNESS,1
FR,MUSCULOSKELETAL CHEST PAIN,1
FR,MUSCULOSKELETAL PAIN,1
FR,MYELITIS,1
FR,MYOCARDITIS,1
FR,NEGATIVE THOUGHTS,1
FR,NEOPLASM MALIGNANT,1
FR,NEOPLASM PROGRESSION,1
FR,NIGHTMARE,1
FR,NO ADVERSE EVENT,1
FR,OCULAR HYPERAEMIA,1
FR,OESOPHAGITIS ULCERATIVE,1
FR,OLIGURIA,1
FR,OPTIC NEUROPATHY,1
FR,ORAL CANDIDIASIS,1
FR,OROPHARYNGEAL CANCER,1
FR,ORTHOSTATIC HYPOTENSION,1
FR,OXYGEN SATURATION DECREASED,1
FR,PACKED RED BLOOD CELL TRANSFUSION,1
FR,PAIN IN EXTREMITY,1
FR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
FR,PANCREATIC CARCINOMA,1
FR,PARAPARESIS,1
FR,PARAPLEGIA,1
FR,PARVOVIRUS B19 INFECTION,1
FR,PELVIC PAIN,1
FR,PERICARDIAL EFFUSION,1
FR,PERICARDIAL HAEMORRHAGE,1
FR,PERIORBITAL HAEMATOMA,1
FR,PERITONEAL HAEMORRHAGE,1
FR,PERNICIOUS ANAEMIA,1
FR,PHARYNGEAL NEOPLASM,1
FR,PHARYNGITIS,1
FR,PLATELET COUNT INCREASED,1
FR,PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL,1
FR,PNEUMONITIS,1
FR,PNEUMOPERITONEUM,1
FR,POISONING DELIBERATE,1
FR,POLYMYOSITIS,1
FR,POLYNEUROPATHY,1
FR,PORTAL VEIN THROMBOSIS,1
FR,POSITRON EMISSION TOMOGRAM ABNORMAL,1
FR,PREMATURE BABY,1
FR,PREMATURE DELIVERY,1
FR,PRODUCT FORMULATION ISSUE,1
FR,PROTHROMBIN TIME SHORTENED,1
FR,PSYCHOMOTOR RETARDATION,1
FR,PULMONARY ALVEOLAR HAEMORRHAGE,1
FR,PYELONEPHRITIS,1
FR,RASH MACULAR,1
FR,RASH PAPULAR,1
FR,RECTAL HAEMORRHAGE,1
FR,REFLEXES ABNORMAL,1
FR,RENAL TUBULAR DISORDER,1
FR,RESPIRATORY ARREST,1
FR,RETICULOCYTOPENIA,1
FR,RETINAL VEIN OCCLUSION,1
FR,RHABDOMYOLYSIS,1
FR,SALIVARY GLAND PAIN,1
FR,SCIATIC NERVE INJURY,1
FR,SHOCK HAEMORRHAGIC,1
FR,SIALOADENITIS,1
FR,SINUS BRADYCARDIA,1
FR,SKIN LESION,1
FR,SKIN ULCER,1
FR,SOCIAL PROBLEM,1
FR,SPONTANEOUS HAEMATOMA,1
FR,THROMBOPHLEBITIS,1
FR,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
FR,THYROID NEOPLASM,1
FR,TRANSAMINASES INCREASED,1
FR,TRANSFUSION,1
FR,TRANSIENT ISCHAEMIC ATTACK,1
FR,TUMOUR HAEMORRHAGE,1
FR,TUMOUR LYSIS SYNDROME,1
FR,URINARY INCONTINENCE,1
FR,URINARY RETENTION,1
FR,URINARY TRACT INFECTION,1
FR,URINE OUTPUT DECREASED,1
FR,VASCULAR DEMENTIA,1
FR,VASCULAR OCCLUSION,1
FR,VASCULAR PURPURA,1
FR,VASOPLEGIA SYNDROME,1
FR,VISUAL ACUITY REDUCED,1
FR,VITAMIN D DEFICIENCY,1
FR,WHEEZING,1
FR,WHITE BLOOD CELL COUNT INCREASED,1
GE,CHRONIC KIDNEY DISEASE,1
GE,ELECTROCARDIOGRAM QT PROLONGED,1
GE,GASTRIC ULCER HAEMORRHAGE,1
GE,GENERALISED OEDEMA,1
GE,HYPOALBUMINAEMIA,1
GE,HYPOPROTEINAEMIA,1
GE,NEPHROTIC SYNDROME,1
GE,PLATELET COUNT DECREASED,1
GE,RENAL FAILURE,1
DE,GENERAL PHYSICAL HEALTH DETERIORATION,163
DE,DYSPNOEA,146
DE,NAUSEA,137
DE,DIARRHOEA,130
DE,PNEUMONIA,122
DE,FATIGUE,116
DE,ATRIAL FIBRILLATION,110
DE,FALL,107
DE,FOETAL EXPOSURE DURING PREGNANCY,102
DE,RENAL FAILURE,97
DE,CARDIAC FAILURE,95
DE,VOMITING,95
DE,ATRIAL SEPTAL DEFECT,93
DE,PYREXIA,82
DE,WEIGHT DECREASED,81
DE,HYPOTENSION,80
DE,ASTHENIA,78
DE,HYPONATRAEMIA,77
DE,ANAEMIA,76
DE,CEREBRAL INFARCTION,74
DE,DIZZINESS,74
DE,HYPERTENSION,72
DE,ACUTE KIDNEY INJURY,70
DE,HEADACHE,70
DE,PLEURAL EFFUSION,69
DE,BLOOD CREATININE INCREASED,63
DE,EXPOSURE DURING PREGNANCY,61
DE,OEDEMA PERIPHERAL,61
DE,PAIN IN EXTREMITY,61
DE,SEPSIS,60
DE,LEUKOPENIA,59
DE,MYOCARDIAL INFARCTION,59
DE,CEREBROVASCULAR ACCIDENT,58
DE,HAEMOGLOBIN DECREASED,58
DE,GAIT DISTURBANCE,57
DE,ARTHRALGIA,54
DE,ABDOMINAL PAIN,53
DE,THROMBOCYTOPENIA,52
DE,DECREASED APPETITE,51
DE,HYPERTENSIVE CRISIS,51
DE,DEATH,49
DE,COUGH,48
DE,GASTROINTESTINAL HAEMORRHAGE,48
DE,PULMONARY EMBOLISM,48
DE,SOMNOLENCE,48
DE,URINARY TRACT INFECTION,47
DE,ACTINIC KERATOSIS,46
DE,PATENT DUCTUS ARTERIOSUS,46
DE,BASAL CELL CARCINOMA,45
DE,SYNCOPE,45
DE,ABDOMINAL PAIN UPPER,44
DE,DYSPHAGIA,43
DE,DEHYDRATION,42
DE,PRURITUS,42
DE,PAIN,41
DE,DRUG INEFFECTIVE,40
DE,RASH,40
DE,TRANSAMINASES INCREASED,40
DE,VISUAL IMPAIRMENT,40
DE,C-REACTIVE PROTEIN INCREASED,39
DE,CHEST PAIN,39
DE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,39
DE,ANGINA PECTORIS,38
DE,HYPOKALAEMIA,38
DE,MYALGIA,38
DE,WEIGHT INCREASED,38
DE,HYPOAESTHESIA,37
DE,OVERDOSE,37
DE,CEREBRAL HAEMORRHAGE,36
DE,HAEMORRHAGE,36
DE,LACTIC ACIDOSIS,36
DE,ALANINE AMINOTRANSFERASE INCREASED,35
DE,INFECTION,35
DE,DYSPNOEA EXERTIONAL,33
DE,HEPATIC FAILURE,33
DE,HAEMATOMA,32
DE,ALOPECIA,31
DE,HEMIPARESIS,31
DE,ISCHAEMIC STROKE,31
DE,RESPIRATORY FAILURE,31
DE,RESTLESSNESS,31
DE,ACUTE MYOCARDIAL INFARCTION,30
DE,APHASIA,30
DE,CONDITION AGGRAVATED,30
DE,CONFUSIONAL STATE,30
DE,EPISTAXIS,30
DE,VENTRICULAR SEPTAL DEFECT,30
DE,BLOOD GLUCOSE INCREASED,29
DE,DRUG-INDUCED LIVER INJURY,29
DE,BACK PAIN,28
DE,HYPOSPADIAS,28
DE,MALIGNANT NEOPLASM PROGRESSION,28
DE,PANCYTOPENIA,28
DE,RENAL FAILURE ACUTE,28
DE,TACHYCARDIA,28
DE,VERTIGO,28
DE,ASPARTATE AMINOTRANSFERASE INCREASED,27
DE,EPILEPSY,27
DE,LOSS OF CONSCIOUSNESS,27
DE,OEDEMA,27
DE,ARRHYTHMIA,26
DE,BLOOD PRESSURE INCREASED,26
DE,CIRCULATORY COLLAPSE,26
DE,POLYNEUROPATHY,26
DE,TOXICITY TO VARIOUS AGENTS,26
DE,BLOOD CREATINE PHOSPHOKINASE INCREASED,25
DE,BRONCHITIS,25
DE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,25
DE,ERYTHEMA,25
DE,HYPOGLYCAEMIA,25
DE,MELAENA,25
DE,MUCOSAL INFLAMMATION,25
DE,MUSCULAR WEAKNESS,25
DE,PREMATURE BABY,25
DE,RHABDOMYOLYSIS,25
DE,SMALL FOR DATES BABY,25
DE,THROMBOSIS,25
DE,DEPRESSION,24
DE,HYPERHIDROSIS,24
DE,MALAISE,24
DE,PANCREATITIS,24
DE,SEIZURE,24
DE,BOWEN^S DISEASE,23
DE,CHILLS,23
DE,CONSTIPATION,23
DE,DYSARTHRIA,23
DE,HEPATIC ENZYME INCREASED,23
DE,PRECANCEROUS SKIN LESION,23
DE,UPPER GASTROINTESTINAL HAEMORRHAGE,23
DE,BLOOD LACTATE DEHYDROGENASE INCREASED,22
DE,BRADYCARDIA,22
DE,CARDIAC ARREST,22
DE,DEEP VEIN THROMBOSIS,22
DE,DISORIENTATION,22
DE,HYPOGLYCAEMIA NEONATAL,22
DE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,22
DE,LIVER FUNCTION TEST ABNORMAL,22
DE,NEONATAL RESPIRATORY DISTRESS SYNDROME,22
DE,NEUTROPENIA,22
DE,PNEUMONITIS,22
DE,PULMONARY OEDEMA,22
DE,ALTERED STATE OF CONSCIOUSNESS,21
DE,ASCITES,21
DE,BRADYCARDIA NEONATAL,21
DE,DRUG LEVEL INCREASED,21
DE,FEBRILE NEUTROPENIA,21
DE,CEREBRAL ISCHAEMIA,20
DE,DELIRIUM,20
DE,DISTURBANCE IN ATTENTION,20
DE,GASTRITIS,20
DE,HAEMATOCHEZIA,20
DE,IMPAIRED HEALING,20
DE,PSYCHOTIC DISORDER,20
DE,SLEEP DISORDER,20
DE,TREMOR,20
DE,UROSEPSIS,20
DE,CARDIOGENIC SHOCK,19
DE,GASTRIC ULCER,19
DE,INSOMNIA,19
DE,JAUNDICE,19
DE,METABOLIC ACIDOSIS,19
DE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,19
DE,MUSCLE SPASMS,19
DE,MUSCULOSKELETAL PAIN,19
DE,POST PROCEDURAL HAEMORRHAGE,19
DE,PRESCRIBED UNDERDOSE,19
DE,SEPTIC SHOCK,19
DE,TRANSIENT ISCHAEMIC ATTACK,19
DE,COAGULOPATHY,18
DE,HYPOKINESIA,18
DE,NASOPHARYNGITIS,18
DE,PARAESTHESIA,18
DE,PARKINSON^S DISEASE,18
DE,PLATELET COUNT DECREASED,18
DE,SHOCK HAEMORRHAGIC,18
DE,VISION BLURRED,18
DE,ANXIETY,17
DE,CHOLELITHIASIS,17
DE,CONGENITAL AORTIC VALVE STENOSIS,17
DE,CORONARY ARTERY DISEASE,17
DE,DYSGEUSIA,17
DE,GASTROENTERITIS,17
DE,HYPERKALAEMIA,17
DE,HYPOTONIA,17
DE,MITRAL VALVE INCOMPETENCE,17
DE,OSTEOARTHRITIS,17
DE,SUBDURAL HAEMATOMA,17
DE,ACUTE HEPATIC FAILURE,16
DE,BLOOD PRESSURE DECREASED,16
DE,CYSTITIS,16
DE,DRY MOUTH,16
DE,HAEMORRHAGIC ANAEMIA,16
DE,HALLUCINATION,16
DE,INFLAMMATORY MARKER INCREASED,16
DE,INTENTIONAL OVERDOSE,16
DE,MATERNAL EXPOSURE DURING PREGNANCY,16
DE,METABOLIC SYNDROME,16
DE,MOBILITY DECREASED,16
DE,MULTIPLE SCLEROSIS RELAPSE,16
DE,PNEUMONIA ASPIRATION,16
DE,RENAL IMPAIRMENT,16
DE,AGITATION,15
DE,ATRIAL THROMBOSIS,15
DE,BALANCE DISORDER,15
DE,CARDIAC DISORDER,15
DE,CARDIOMYOPATHY,15
DE,CARDIOVASCULAR DISORDER,15
DE,CHEST DISCOMFORT,15
DE,DRUG PRESCRIBING ERROR,15
DE,GESTATIONAL DIABETES,15
DE,INTESTINAL HAEMORRHAGE,15
DE,MEMORY IMPAIRMENT,15
DE,PULMONARY HYPERTENSION,15
DE,TACHYARRHYTHMIA,15
DE,URINARY RETENTION,15
DE,WOUND,15
DE,ACIDOSIS,14
DE,COARCTATION OF THE AORTA,14
DE,CORONARY ARTERY STENOSIS,14
DE,DUODENAL ULCER,14
DE,ERYSIPELAS,14
DE,HEPATIC NECROSIS,14
DE,HYPOTHYROIDISM,14
DE,LIVER DISORDER,14
DE,LUNG INFILTRATION,14
DE,PERICARDIAL EFFUSION,14
DE,PRODUCT USE ISSUE,14
DE,SKIN CANCER,14
DE,SPEECH DISORDER,14
DE,ABORTION MISSED,13
DE,ACUTE MYELOID LEUKAEMIA,13
DE,AKINESIA,13
DE,ATRIAL FLUTTER,13
DE,BRAIN OEDEMA,13
DE,CHOLESTASIS,13
DE,CHROMATURIA,13
DE,COGNITIVE DISORDER,13
DE,DEPRESSED MOOD,13
DE,GLYCOSYLATED HAEMOGLOBIN INCREASED,13
DE,HOSPITALISATION,13
DE,INTERSTITIAL LUNG DISEASE,13
DE,PERIPHERAL SWELLING,13
DE,PETECHIAE,13
DE,SALIVARY HYPERSECRETION,13
DE,SENSORY DISTURBANCE,13
DE,SPLENOMEGALY,13
DE,SQUAMOUS CELL CARCINOMA,13
DE,STAPHYLOCOCCAL INFECTION,13
DE,ABSCESS,12
DE,AORTIC VALVE STENOSIS,12
DE,CARCINOMA IN SITU OF SKIN,12
DE,CONVULSION,12
DE,DEMENTIA,12
DE,DEVICE DISLOCATION,12
DE,DRUG INTOLERANCE,12
DE,GLOMERULAR FILTRATION RATE DECREASED,12
DE,HAEMATURIA,12
DE,HERPES ZOSTER,12
DE,HYPERGLYCAEMIA,12
DE,HYPERSENSITIVITY,12
DE,HYPERTONIA NEONATAL,12
DE,HYPOXIA,12
DE,MULTI-ORGAN FAILURE,12
DE,PARKINSONISM,12
DE,PARTIAL SEIZURES,12
DE,PERIODONTITIS,12
DE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,12
DE,PULPITIS DENTAL,12
DE,STOMATITIS,12
DE,SUICIDE ATTEMPT,12
DE,VENA CAVA THROMBOSIS,12
DE,VENTRICULAR TACHYCARDIA,12
DE,BLOOD ALKALINE PHOSPHATASE INCREASED,11
DE,BLOOD BILIRUBIN INCREASED,11
DE,BLOOD SODIUM DECREASED,11
DE,CAESAREAN SECTION,11
DE,CEREBRAL ARTERY OCCLUSION,11
DE,COLITIS,11
DE,COMPLETED SUICIDE,11
DE,CONTUSION,11
DE,DIPLOPIA,11
DE,DIVERTICULITIS,11
DE,DRUG ADMINISTRATION ERROR,11
DE,HEART RATE INCREASED,11
DE,HEPATIC FUNCTION ABNORMAL,11
DE,HEPATITIS,11
DE,INFLAMMATION,11
DE,INTERNATIONAL NORMALISED RATIO INCREASED,11
DE,INTERVERTEBRAL DISC PROTRUSION,11
DE,LEUKOCYTOSIS,11
DE,LIPASE INCREASED,11
DE,OCULAR ICTERUS,11
DE,PERITONITIS,11
DE,RESPIRATORY DISORDER NEONATAL,11
DE,RHEUMATOID ARTHRITIS,11
DE,TOOTH EROSION,11
DE,WHITE BLOOD CELL COUNT INCREASED,11
DE,ACUTE CORONARY SYNDROME,10
DE,AGRANULOCYTOSIS,10
DE,ATYPICAL PNEUMONIA,10
DE,BLOOD URIC ACID INCREASED,10
DE,CONGENITAL HYDRONEPHROSIS,10
DE,DIABETES MELLITUS,10
DE,DRUG WITHDRAWAL CONVULSIONS,10
DE,DYSTONIA,10
DE,DYSURIA,10
DE,ELECTROCARDIOGRAM QT PROLONGED,10
DE,ENTERITIS,10
DE,HYPOVOLAEMIC SHOCK,10
DE,INGUINAL HERNIA,10
DE,INTESTINAL ISCHAEMIA,10
DE,LYMPHADENOPATHY,10
DE,MICTURITION URGENCY,10
DE,PALPITATIONS,10
DE,PRERENAL FAILURE,10
DE,RABBIT SYNDROME,10
DE,RENAL DISORDER,10
DE,RESPIRATORY DISTRESS,10
DE,RESPIRATORY TRACT INFECTION,10
DE,SUICIDAL IDEATION,10
DE,VENTRICULAR FIBRILLATION,10
DE,ABDOMINAL ADHESIONS,9
DE,ABDOMINAL DISCOMFORT,9
DE,ARTHROPATHY,9
DE,BLOOD POTASSIUM DECREASED,9
DE,BLOOD UREA INCREASED,9
DE,BURSITIS,9
DE,CANDIDA INFECTION,9
DE,CAROTID ARTERY STENOSIS,9
DE,CHOLANGITIS,9
DE,CHRONIC KIDNEY DISEASE,9
DE,DIABETIC FOETOPATHY,9
DE,EJECTION FRACTION DECREASED,9
DE,GASTROOESOPHAGEAL REFLUX DISEASE,9
DE,GENERALISED TONIC-CLONIC SEIZURE,9
DE,HAEMATEMESIS,9
DE,HEPATIC CYST,9
DE,HEPATOTOXICITY,9
DE,HYPERTHYROIDISM,9
DE,INCORRECT DOSE ADMINISTERED,9
DE,IRON DEFICIENCY ANAEMIA,9
DE,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,9
DE,LARGE FOR DATES BABY,9
DE,NEUTROPENIC SEPSIS,9
DE,OROPHARYNGEAL PAIN,9
DE,SKIN DISORDER,9
DE,SKIN HAEMORRHAGE,9
DE,SUBCUTANEOUS ABSCESS,9
DE,SUDDEN CARDIAC DEATH,9
DE,TEMPERATURE REGULATION DISORDER,9
DE,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,8
DE,AGGRESSION,8
DE,AGITATION NEONATAL,8
DE,APATHY,8
DE,BLISTER,8
DE,CATARACT,8
DE,CHOLECYSTITIS,8
DE,CONGENITAL MUSCULOSKELETAL ANOMALY,8
DE,CONJUNCTIVITIS,8
DE,DRUG EFFECT DECREASED,8
DE,DRUG WITHDRAWAL SYNDROME NEONATAL,8
DE,DRY EYE,8
DE,DYSPEPSIA,8
DE,DYSPNOEA AT REST,8
DE,ENDOCARDITIS,8
DE,ESCHERICHIA URINARY TRACT INFECTION,8
DE,FLANK PAIN,8
DE,GASTROINTESTINAL DISORDER,8
DE,GOUT,8
DE,HAEMOPTYSIS,8
DE,HAEMOTHORAX,8
DE,HYPERBILIRUBINAEMIA,8
DE,HYPERBILIRUBINAEMIA NEONATAL,8
DE,HYPOCALCAEMIA,8
DE,INFANTILE APNOEA,8
DE,INTESTINAL OBSTRUCTION,8
DE,JOINT SWELLING,8
DE,LACERATION,8
DE,NAEVUS FLAMMEUS,8
DE,NIGHT SWEATS,8
DE,RENAL CYST,8
DE,RENAL FUNCTION TEST ABNORMAL,8
DE,ROAD TRAFFIC ACCIDENT,8
DE,SECOND PRIMARY MALIGNANCY,8
DE,SEDATION,8
DE,SUBARACHNOID HAEMORRHAGE,8
DE,SURGERY,8
DE,TACHYPNOEA,8
DE,TOOTH DISORDER,8
DE,TRICUSPID VALVE INCOMPETENCE,8
DE,TYPE 2 DIABETES MELLITUS,8
DE,URTICARIA,8
DE,VISUAL ACUITY REDUCED,8
DE,WHEEZING,8
DE,ANAEMIA OF MALIGNANT DISEASE,7
DE,ANEURYSM,7
DE,AORTA HYPOPLASIA,7
DE,ARTHRITIS,7
DE,ATAXIA,7
DE,BASAL GANGLIA HAEMORRHAGE,7
DE,BICUSPID AORTIC VALVE,7
DE,BONE MARROW FAILURE,7
DE,BONE PAIN,7
DE,BRAIN STEM INFARCTION,7
DE,CORNEA VERTICILLATA,7
DE,CREATININE RENAL CLEARANCE DECREASED,7
DE,CROHN^S DISEASE,7
DE,DIABETES MELLITUS INADEQUATE CONTROL,7
DE,DISSEMINATED INTRAVASCULAR COAGULATION,7
DE,EMBOLIC STROKE,7
DE,ESCHERICHIA INFECTION,7
DE,EXTRA DOSE ADMINISTERED,7
DE,FACIAL PARESIS,7
DE,FAECES PALE,7
DE,FEELING COLD,7
DE,GENITAL LABIAL ADHESIONS,7
DE,HAEMATOCRIT DECREASED,7
DE,HEPATOMEGALY,7
DE,HICCUPS,7
DE,HYPERSENSITIVITY VASCULITIS,7
DE,HYPERURICAEMIA,7
DE,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,7
DE,INFLUENZA,7
DE,INFLUENZA LIKE ILLNESS,7
DE,INTRAVENTRICULAR HAEMORRHAGE,7
DE,LABORATORY TEST ABNORMAL,7
DE,LOWER GASTROINTESTINAL HAEMORRHAGE,7
DE,LYMPHOCELE,7
DE,LYMPHOCYTE COUNT DECREASED,7
DE,MOTOR DYSFUNCTION,7
DE,MOVEMENT DISORDER,7
DE,MUSCULOSKELETAL STIFFNESS,7
DE,MYELODYSPLASTIC SYNDROME,7
DE,NASAL CONGESTION,7
DE,NEOPLASM,7
DE,NEUTROPHIL COUNT DECREASED,7
DE,OESOPHAGITIS,7
DE,OSTEONECROSIS OF JAW,7
DE,OXYGEN SATURATION DECREASED,7
DE,PALLOR,7
DE,POLYHYDRAMNIOS,7
DE,PRE-ECLAMPSIA,7
DE,PROSTATE CANCER,7
DE,RED BLOOD CELL COUNT DECREASED,7
DE,RENAL APLASIA,7
DE,RENAL INFARCT,7
DE,RESTLESS LEGS SYNDROME,7
DE,SINUS TACHYCARDIA,7
DE,SPINAL FRACTURE,7
DE,STAPHYLOCOCCAL SEPSIS,7
DE,URINARY INCONTINENCE,7
DE,ABORTION SPONTANEOUS,6
DE,ALVEOLITIS,6
DE,ANAPHYLACTIC REACTION,6
DE,ANGIOEDEMA,6
DE,AORTIC VALVE INCOMPETENCE,6
DE,BLOOD CALCIUM DECREASED,6
DE,BLOOD GLUCOSE ABNORMAL,6
DE,BLOOD TEST ABNORMAL,6
DE,BLOOD URINE PRESENT,6
DE,BREATH SOUNDS ABNORMAL,6
DE,BRONCHOPNEUMONIA,6
DE,BRONCHOSPASM,6
DE,BRUXISM,6
DE,CELLULITIS,6
DE,CHRONIC LYMPHOCYTIC LEUKAEMIA,6
DE,CONGESTIVE CARDIOMYOPATHY,6
DE,CONTRAINDICATED PRODUCT ADMINISTERED,6
DE,DEAFNESS,6
DE,DELUSION,6
DE,DERMATITIS ALLERGIC,6
DE,DIASTOLIC DYSFUNCTION,6
DE,DISCOMFORT,6
DE,DRUG HYPERSENSITIVITY,6
DE,DUODENITIS,6
DE,DYSPHONIA,6
DE,FAECES DISCOLOURED,6
DE,FEMORAL NECK FRACTURE,6
DE,FLATULENCE,6
DE,GASTRIC HAEMORRHAGE,6
DE,GINGIVAL BLEEDING,6
DE,HAEMORRHOIDAL HAEMORRHAGE,6
DE,HELLP SYNDROME,6
DE,HEPATIC CIRRHOSIS,6
DE,HEPATITIS CHOLESTATIC,6
DE,HEPATITIS FULMINANT,6
DE,HEPATITIS TOXIC,6
DE,HEPATOCELLULAR INJURY,6
DE,HYPERFERRITINAEMIA,6
DE,HYPOACUSIS,6
DE,ILEAL STENOSIS,6
DE,ILL-DEFINED DISORDER,6
DE,JOINT RANGE OF MOTION DECREASED,6
DE,LEFT VENTRICULAR DYSFUNCTION,6
DE,LEFT VENTRICULAR HYPERTROPHY,6
DE,LIVER FUNCTION TEST INCREASED,6
DE,LOW BIRTH WEIGHT BABY,6
DE,LUNG DISORDER,6
DE,MICROCEPHALY,6
DE,MITRAL VALVE HYPOPLASIA,6
DE,MUSCLE HAEMORRHAGE,6
DE,MYOCARDIAL ISCHAEMIA,6
DE,NAIL DISORDER,6
DE,ORTHOPNOEA,6
DE,ORTHOSTATIC INTOLERANCE,6
DE,PANCREATITIS ACUTE,6
DE,PANIC ATTACK,6
DE,PERIPHERAL ISCHAEMIA,6
DE,PHOTOPHOBIA,6
DE,PLATELET COUNT INCREASED,6
DE,PNEUMONIA BACTERIAL,6
DE,PNEUMONIA FUNGAL,6
DE,PORTAL FIBROSIS,6
DE,PROTHROMBIN TIME PROLONGED,6
DE,PULMONARY CONGESTION,6
DE,PULMONARY HAEMORRHAGE,6
DE,RIGHT VENTRICULAR FAILURE,6
DE,SKIN NECROSIS,6
DE,STATUS EPILEPTICUS,6
DE,SUBILEUS,6
DE,SYSTEMIC LUPUS ERYTHEMATOSUS,6
DE,THROMBOCYTOSIS,6
DE,TROPONIN INCREASED,6
DE,UMBILICAL HERNIA,6
DE,URETERIC STENOSIS,6
DE,VENOUS THROMBOSIS LIMB,6
DE,VENTRICULAR HYPERTROPHY,6
DE,WHITE BLOOD CELL COUNT DECREASED,6
DE,ABDOMINAL DISTENSION,5
DE,AKATHISIA,5
DE,AMYLASE INCREASED,5
DE,ANAL HAEMORRHAGE,5
DE,ANGINA UNSTABLE,5
DE,ANURIA,5
DE,AORTIC VALVE SCLEROSIS,5
DE,ARTERIOSCLEROSIS,5
DE,ASPIRATION,5
DE,ASTHMA,5
DE,ATRIOVENTRICULAR BLOCK COMPLETE,5
DE,BEDRIDDEN,5
DE,BENIGN PROSTATIC HYPERPLASIA,5
DE,BLOOD ALKALINE PHOSPHATASE ABNORMAL,5
DE,BREAST CANCER,5
DE,CARDIAC ABLATION,5
DE,CARDIAC DISCOMFORT,5
DE,CARDIAC FAILURE CHRONIC,5
DE,CARDIAC FAILURE CONGESTIVE,5
DE,CARDIOMEGALY,5
DE,CARDIOVERSION,5
DE,CEREBELLAR INFARCTION,5
DE,CLOSTRIDIUM DIFFICILE COLITIS,5
DE,COLD SWEAT,5
DE,COLITIS ULCERATIVE,5
DE,CONCOMITANT DISEASE AGGRAVATED,5
DE,CONGENITAL CYSTIC LUNG,5
DE,CONJUNCTIVAL HAEMORRHAGE,5
DE,DEVICE OCCLUSION,5
DE,DEVICE RELATED INFECTION,5
DE,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,5
DE,DRY SKIN,5
DE,DYSKINESIA,5
DE,EMBOLIC CEREBRAL INFARCTION,5
DE,EMBOLISM,5
DE,EMPHYSEMA,5
DE,ENCEPHALOPATHY,5
DE,ERECTILE DYSFUNCTION,5
DE,EXPOSURE DURING BREAST FEEDING,5
DE,EYE SWELLING,5
DE,FAECALOMA,5
DE,FEBRILE INFECTION,5
DE,FLUID RETENTION,5
DE,FOOT DEFORMITY,5
DE,GASTROINTESTINAL INFECTION,5
DE,GOITRE,5
DE,HAEMOGLOBIN INCREASED,5
DE,HAEMORRHAGE INTRACRANIAL,5
DE,HEMIPLEGIA,5
DE,HIP FRACTURE,5
DE,HYDROPS FOETALIS,5
DE,HYPERCALCAEMIA,5
DE,HYPERKINESIA,5
DE,HYPOCHROMIC ANAEMIA,5
DE,IDIOPATHIC PULMONARY FIBROSIS,5
DE,ILEUS,5
DE,ILEUS PARALYTIC,5
DE,IMMUNOSUPPRESSION,5
DE,INCONTINENCE,5
DE,INJECTION SITE PAIN,5
DE,KNEE ARTHROPLASTY,5
DE,LACRIMAL DISORDER,5
DE,LIMB DISCOMFORT,5
DE,LUNG INFECTION,5
DE,MAGNESIUM DEFICIENCY,5
DE,MASKED FACIES,5
DE,MEDICATION ERROR,5
DE,MENTAL DISORDER,5
DE,METASTASES TO BONE,5
DE,METASTASES TO CENTRAL NERVOUS SYSTEM,5
DE,MONOCYTE COUNT INCREASED,5
DE,MUCOUS STOOLS,5
DE,MUSCLE SPASTICITY,5
DE,NASAL DRYNESS,5
DE,NECK PAIN,5
DE,NEPHROLITHIASIS,5
DE,NERVOUSNESS,5
DE,NEUROLOGIC NEGLECT SYNDROME,5
DE,NEUTROPHIL FUNCTION DISORDER,5
DE,OLIGOHYDRAMNIOS,5
DE,OROMANDIBULAR DYSTONIA,5
DE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,5
DE,POLLAKIURIA,5
DE,POLYURIA,5
DE,PULMONARY ARTERY STENOSIS,5
DE,PULMONARY VALVE STENOSIS CONGENITAL,5
DE,PYELONEPHRITIS,5
DE,RECTAL HAEMORRHAGE,5
DE,RHINITIS,5
DE,RHINORRHOEA,5
DE,SCAR,5
DE,SEXUAL DYSFUNCTION,5
DE,SHOCK,5
DE,SINUS NODE DYSFUNCTION,5
DE,SKIN ULCER,5
DE,SWOLLEN TONGUE,5
DE,THALAMUS HAEMORRHAGE,5
DE,THROMBOTIC THROMBOCYTOPENIC PURPURA,5
DE,UPPER LIMB FRACTURE,5
DE,URINARY TRACT OBSTRUCTION,5
DE,VARICOSE VEIN,5
DE,VIRAL INFECTION,5
DE,WOUND HAEMORRHAGE,5
DE,ABASIA,4
DE,ABDOMINAL HERNIA,4
DE,ABDOMINAL PAIN LOWER,4
DE,ACCIDENTAL EXPOSURE TO PRODUCT,4
DE,ACUTE ABDOMEN,4
DE,ANAL ABSCESS,4
DE,APHTHOUS STOMATITIS,4
DE,ARNOLD-CHIARI MALFORMATION,4
DE,ARTERIAL OCCLUSIVE DISEASE,4
DE,ATELECTASIS,4
DE,AUTOIMMUNE HEPATITIS,4
DE,BILE DUCT STONE,4
DE,BLINDNESS,4
DE,BLOOD CHOLESTEROL INCREASED,4
DE,BLOOD CREATINE INCREASED,4
DE,BLOOD POTASSIUM INCREASED,4
DE,BLOOD PRESSURE SYSTOLIC INCREASED,4
DE,BRADYARRHYTHMIA,4
DE,BRAIN INJURY,4
DE,BUNDLE BRANCH BLOCK LEFT,4
DE,BUNDLE BRANCH BLOCK RIGHT,4
DE,CARDIOPULMONARY FAILURE,4
DE,CAROTID ARTERY OCCLUSION,4
DE,CEREBELLAR HAEMORRHAGE,4
DE,CEREBRAL ARTERY EMBOLISM,4
DE,CHOLECYSTECTOMY,4
DE,CHRONIC GASTRITIS,4
DE,COMA,4
DE,COMPARTMENT SYNDROME,4
DE,CYSTITIS HAEMORRHAGIC,4
DE,CYTOMEGALOVIRUS INFECTION,4
DE,DERMAL CYST,4
DE,DISEASE PROGRESSION,4
DE,DROOLING,4
DE,DYSSTASIA,4
DE,ELECTROLYTE IMBALANCE,4
DE,EOSINOPHILIA,4
DE,FEELING ABNORMAL,4
DE,FIBRIN D DIMER INCREASED,4
DE,FINE MOTOR SKILL DYSFUNCTION,4
DE,FISTULA,4
DE,FLUSHING,4
DE,FOETAL HEART RATE DECELERATION ABNORMALITY,4
DE,FUNGAL INFECTION,4
DE,GANGRENE,4
DE,GASTRIC DISORDER,4
DE,GASTRITIS EROSIVE,4
DE,HAEMORRHAGIC DIATHESIS,4
DE,HALLUCINATION_ VISUAL,4
DE,HEART RATE IRREGULAR,4
DE,HENOCH-SCHONLEIN PURPURA,4
DE,HEPATIC STEATOSIS,4
DE,HIATUS HERNIA,4
DE,HUMERUS FRACTURE,4
DE,HYPERNATRAEMIA,4
DE,HYPOCHLORAEMIA,4
DE,IMMOBILE,4
DE,INFARCTION,4
DE,INTENTIONAL PRODUCT MISUSE,4
DE,INTRACRANIAL ANEURYSM,4
DE,JOINT INJURY,4
DE,KETOACIDOSIS,4
DE,LACRIMATION INCREASED,4
DE,LEFT VENTRICULAR FAILURE,4
DE,LISTLESS,4
DE,MALLORY-WEISS SYNDROME,4
DE,MATERNAL DRUGS AFFECTING FOETUS,4
DE,MENINGOMYELOCELE,4
DE,METASTASES TO LIVER,4
DE,METASTASES TO LUNG,4
DE,METASTASES TO LYMPH NODES,4
DE,MIGRAINE,4
DE,MOUTH HAEMORRHAGE,4
DE,MUCOSAL HAEMORRHAGE,4
DE,MUSCLE DISORDER,4
DE,MYOPATHY,4
DE,NON-CARDIAC CHEST PAIN,4
DE,OBESITY,4
DE,ON AND OFF PHENOMENON,4
DE,ORGANISING PNEUMONIA,4
DE,PACKED RED BLOOD CELL TRANSFUSION,4
DE,PANCREATITIS NECROTISING,4
DE,PAROTITIS,4
DE,PERICARDITIS,4
DE,PERIPHERAL COLDNESS,4
DE,PERIPHERAL SENSORY NEUROPATHY,4
DE,PHOTOSENSITIVITY REACTION,4
DE,PLASMA CELL MYELOMA,4
DE,PNEUMOTHORAX,4
DE,POST PROCEDURAL COMPLICATION,4
DE,PREGNANCY,4
DE,PREMATURE DELIVERY,4
DE,PRODUCT USE IN UNAPPROVED INDICATION,4
DE,PRODUCTIVE COUGH,4
DE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,4
DE,PSEUDOMEMBRANOUS COLITIS,4
DE,PSORIASIS,4
DE,PSORIATIC ARTHROPATHY,4
DE,PULMONARY ARTERIAL HYPERTENSION,4
DE,PULMONARY FIBROSIS,4
DE,PULMONARY SEPSIS,4
DE,PULMONARY TOXICITY,4
DE,RENAL FAILURE CHRONIC,4
DE,RENAL IMPAIRMENT NEONATAL,4
DE,SELECTIVE EATING DISORDER,4
DE,SEROMA,4
DE,SINUS BRADYCARDIA,4
DE,SINUSITIS,4
DE,SKIN LESION,4
DE,SLEEP APNOEA SYNDROME,4
DE,SPINA BIFIDA,4
DE,SPINAL PAIN,4
DE,STENT PLACEMENT,4
DE,SUPRAVENTRICULAR TACHYCARDIA,4
DE,SWELLING,4
DE,SWELLING FACE,4
DE,TESTICULAR PAIN,4
DE,THROMBIN TIME PROLONGED,4
DE,THROMBOCYTOPENIA NEONATAL,4
DE,THROMBOTIC MICROANGIOPATHY,4
DE,TINNITUS,4
DE,TORSADE DE POINTES,4
DE,TRANSFUSION,4
DE,TREATMENT NONCOMPLIANCE,4
DE,TUMOUR HAEMORRHAGE,4
DE,TYPE I HYPERSENSITIVITY,4
DE,UNDERDOSE,4
DE,VASCULITIS,4
DE,VENTRICULAR ASSIST DEVICE INSERTION,4
DE,WOUND INFECTION,4
DE,ABNORMAL BEHAVIOUR,3
DE,ABSCESS LIMB,3
DE,ACCIDENT,3
DE,ACUTE PRERENAL FAILURE,3
DE,ADRENAL GLAND CANCER,3
DE,ADVERSE EVENT,3
DE,ANTIPSYCHOTIC DRUG LEVEL INCREASED,3
DE,APPENDICITIS PERFORATED,3
DE,ARTERIOSCLEROSIS CORONARY ARTERY,3
DE,AUTOIMMUNE THYROIDITIS,3
DE,BASEDOW^S DISEASE,3
DE,BLADDER DISORDER,3
DE,BLOOD GLUCOSE FLUCTUATION,3
DE,BLOOD PRESSURE ABNORMAL,3
DE,BLOOD PRESSURE FLUCTUATION,3
DE,BLOOD THYROID STIMULATING HORMONE INCREASED,3
DE,BLOOD TRIGLYCERIDES INCREASED,3
DE,BODY TEMPERATURE INCREASED,3
DE,BRAIN STEM STROKE,3
DE,BREAST CANCER METASTATIC,3
DE,BREAST DISCHARGE,3
DE,BREECH PRESENTATION,3
DE,BRONCHIAL CARCINOMA,3
DE,BRONCHITIS CHRONIC,3
DE,BURNING SENSATION,3
DE,CACHEXIA,3
DE,CARDIAC MURMUR,3
DE,CARDIOVASCULAR INSUFFICIENCY,3
DE,CENTRAL NERVOUS SYSTEM LESION,3
DE,CEREBRAL MICROANGIOPATHY,3
DE,CHEILITIS,3
DE,CHRONIC MYELOID LEUKAEMIA,3
DE,COLITIS ISCHAEMIC,3
DE,CONGENITAL AORTIC STENOSIS,3
DE,CONGENITAL CHOROID PLEXUS CYST,3
DE,CONJUNCTIVAL OEDEMA,3
DE,COORDINATION ABNORMAL,3
DE,CORONARY ARTERY OCCLUSION,3
DE,CYTOPENIA,3
DE,DEMENTIA ALZHEIMER^S TYPE,3
DE,DEMYELINATING POLYNEUROPATHY,3
DE,DIABETIC FOOT,3
DE,DISABILITY,3
DE,DIVERTICULUM,3
DE,DIVERTICULUM INTESTINAL HAEMORRHAGIC,3
DE,DRUG CLEARANCE DECREASED,3
DE,DRUG DOSE OMISSION,3
DE,DRUG ERUPTION,3
DE,ENTEROCOCCAL SEPSIS,3
DE,ENURESIS,3
DE,ESCHERICHIA SEPSIS,3
DE,EYE IRRITATION,3
DE,EYE PAIN,3
DE,EYELID PTOSIS,3
DE,FISTULA OF SMALL INTESTINE,3
DE,FOETAL MACROSOMIA,3
DE,FRACTURE,3
DE,GASTRIC CANCER,3
DE,GASTRIC CYST,3
DE,GASTRIC MUCOSA ERYTHEMA,3
DE,GASTRITIS HAEMORRHAGIC,3
DE,GASTROENTERITIS NOROVIRUS,3
DE,GASTROINTESTINAL INFLAMMATION,3
DE,GENERAL PHYSICAL CONDITION ABNORMAL,3
DE,GLAUCOMA,3
DE,GRAND MAL CONVULSION,3
DE,GRANULOCYTE COUNT DECREASED,3
DE,GRANULOMATOSIS WITH POLYANGIITIS,3
DE,HAEMODYNAMIC INSTABILITY,3
DE,HAEMOLYTIC URAEMIC SYNDROME,3
DE,HAEMORRHAGE SUBCUTANEOUS,3
DE,HAEMORRHOIDS,3
DE,HALO VISION,3
DE,HEART VALVE INCOMPETENCE,3
DE,HEPATIC ENCEPHALOPATHY,3
DE,HORNER^S SYNDROME,3
DE,HYPOAESTHESIA ORAL,3
DE,HYPOVENTILATION,3
DE,HYPOVOLAEMIA,3
DE,IMPAIRED SELF-CARE,3
DE,INCISIONAL HERNIA,3
DE,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,3
DE,INJECTION SITE ABSCESS,3
DE,INJECTION SITE REACTION,3
DE,INTESTINAL PERFORATION,3
DE,INTESTINAL STENOSIS,3
DE,IRRITABILITY,3
DE,ISCHAEMIA,3
DE,ISCHAEMIC CARDIOMYOPATHY,3
DE,ISCHAEMIC CEREBRAL INFARCTION,3
DE,JOINT EFFUSION,3
DE,JOINT STIFFNESS,3
DE,LACUNAR INFARCTION,3
DE,LARGE INTESTINAL HAEMORRHAGE,3
DE,LEG AMPUTATION,3
DE,LETHARGY,3
DE,LIMB INJURY,3
DE,LIVER ABSCESS,3
DE,LIVER INJURY,3
DE,LOCAL SWELLING,3
DE,LUNG HYPERINFLATION,3
DE,LUNG NEOPLASM MALIGNANT,3
DE,LYMPHOCYTE COUNT INCREASED,3
DE,MENISCUS INJURY,3
DE,MICROANGIOPATHY,3
DE,MONOCLONAL GAMMOPATHY,3
DE,MONOPARESIS,3
DE,MOUTH SWELLING,3
DE,MUSCLE ATROPHY,3
DE,MUSCULOSKELETAL CHEST PAIN,3
DE,MUSCULOSKELETAL DISCOMFORT,3
DE,NEOPLASM PROGRESSION,3
DE,NEPHROTIC SYNDROME,3
DE,NERVOUS SYSTEM DISORDER,3
DE,NEUTROPHIL COUNT INCREASED,3
DE,NIGHTMARE,3
DE,NOCTURIA,3
DE,NOSOCOMIAL INFECTION,3
DE,OESOPHAGEAL ADENOCARCINOMA,3
DE,OESOPHAGEAL CANDIDIASIS,3
DE,ORAL DISORDER,3
DE,ORAL HERPES,3
DE,ORAL PAIN,3
DE,OSTEOPOROSIS,3
DE,PANCREATIC CARCINOMA,3
DE,PANCREATIC INSUFFICIENCY,3
DE,PAPILLOEDEMA,3
DE,PARESIS,3
DE,PEMPHIGOID,3
DE,PERFORMANCE STATUS DECREASED,3
DE,PERIPHERAL ARTERY STENOSIS,3
DE,PERSONALITY CHANGE,3
DE,PHARYNGEAL HAEMORRHAGE,3
DE,PHARYNGITIS,3
DE,PLASMACYTOMA,3
DE,PNEUMOCYSTIS JIROVECII PNEUMONIA,3
DE,PO2 DECREASED,3
DE,POLYDIPSIA,3
DE,PRETERM PREMATURE RUPTURE OF MEMBRANES,3
DE,PROCEDURAL COMPLICATION,3
DE,PRODUCT QUALITY ISSUE,3
DE,PROTEINURIA,3
DE,PSEUDOMONAS INFECTION,3
DE,PSYCHOMOTOR SKILLS IMPAIRED,3
DE,PULMONARY EOSINOPHILIA,3
DE,PURULENT DISCHARGE,3
DE,RASH MACULAR,3
DE,RASH MACULO-PAPULAR,3
DE,RASH PAPULAR,3
DE,RASH PRURITIC,3
DE,RED BLOOD CELL SEDIMENTATION RATE INCREASED,3
DE,RENAL CELL CARCINOMA,3
DE,RENAL TRANSPLANT FAILURE,3
DE,RESPIRATORY ARREST,3
DE,RESPIRATORY SYNCYTIAL VIRUS INFECTION,3
DE,RETINAL DETACHMENT,3
DE,RETINAL HAEMORRHAGE,3
DE,RETROPERITONEAL HAEMATOMA,3
DE,SCIATICA,3
DE,SKIN MASS,3
DE,SKIN REACTION,3
DE,SKIN TOXICITY,3
DE,SPINAL OSTEOARTHRITIS,3
DE,SQUAMOUS CELL CARCINOMA OF LUNG,3
DE,STAPHYLOCOCCUS TEST POSITIVE,3
DE,STASIS DERMATITIS,3
DE,STRESS,3
DE,SUDDEN HEARING LOSS,3
DE,THINKING ABNORMAL,3
DE,THIRST,3
DE,THROAT IRRITATION,3
DE,THROMBOSIS IN DEVICE,3
DE,THYROIDECTOMY,3
DE,TOOTH EXTRACTION,3
DE,TRACHEOBRONCHITIS,3
DE,TRANSPLANT FAILURE,3
DE,TRAUMATIC INTRACRANIAL HAEMORRHAGE,3
DE,TUMOUR LYSIS SYNDROME,3
DE,UNEVALUABLE EVENT,3
DE,UPPER RESPIRATORY TRACT INFECTION,3
DE,UTERINE DILATION AND CURETTAGE,3
DE,VASODILATATION,3
DE,VENOUS THROMBOSIS,3
DE,VITAMIN B12 DEFICIENCY,3
DE,VITAMIN D DEFICIENCY,3
DE,VOMITING NEONATAL,3
DE,WHITE BLOOD CELLS URINE POSITIVE,3
DE,ABDOMINAL MASS,2
DE,ABDOMINAL WALL ABSCESS,2
DE,ABDOMINAL WALL HAEMORRHAGE,2
DE,ABNORMAL FAECES,2
DE,ABNORMAL LOSS OF WEIGHT,2
DE,ABNORMAL WEIGHT GAIN,2
DE,ABSCESS NECK,2
DE,ACCIDENTAL OVERDOSE,2
DE,ACRODYNIA,2
DE,ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL,2
DE,ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED,2
DE,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,2
DE,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,2
DE,ACUTE RESPIRATORY DISTRESS SYNDROME,2
DE,ACUTE RESPIRATORY FAILURE,2
DE,ADENOCARCINOMA OF COLON,2
DE,ADHESIOLYSIS,2
DE,ADJUSTMENT DISORDER,2
DE,ADRENAL INSUFFICIENCY,2
DE,AMNESIA,2
DE,AMYOTROPHIC LATERAL SCLEROSIS,2
DE,ANAL FISSURE,2
DE,ANAL FISTULA,2
DE,ANAL INCONTINENCE,2
DE,ANAL INFLAMMATION,2
DE,ANAPHYLACTIC SHOCK,2
DE,ANASTOMOTIC ULCER,2
DE,ANKYLOSING SPONDYLITIS,2
DE,ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC,2
DE,ANTINUCLEAR ANTIBODY POSITIVE,2
DE,AORTIC ARTERIOSCLEROSIS,2
DE,APALLIC SYNDROME,2
DE,APLASTIC ANAEMIA,2
DE,APPENDICITIS,2
DE,APRAXIA,2
DE,ARRHYTHMIA SUPRAVENTRICULAR,2
DE,ARTERIAL STENOSIS,2
DE,ARTERIOGRAM CORONARY,2
DE,ARTHRITIS BACTERIAL,2
DE,ARTHRITIS INFECTIVE,2
DE,ATRIAL TACHYCARDIA,2
DE,ATRIOVENTRICULAR BLOCK,2
DE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,2
DE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,2
DE,AUTOIMMUNE PANCREATITIS,2
DE,BACTERIAL INFECTION,2
DE,BENIGN NEOPLASM,2
DE,BLADDER CANCER,2
DE,BLADDER PAIN,2
DE,BLEPHAROSPASM,2
GR,ATRIAL FIBRILLATION,10
GR,DRUG INEFFECTIVE,10
GR,HAEMATOCRIT DECREASED,8
GR,DIZZINESS,7
GR,PYREXIA,7
GR,DEATH,6
GR,DYSPNOEA,6
GR,ASTHENIA,5
GR,BLOOD PRESSURE INCREASED,5
GR,EPISTAXIS,5
GR,FATIGUE,5
GR,PRURITUS,5
GR,VOMITING,5
GR,ANAEMIA,4
GR,CEREBROVASCULAR ACCIDENT,4
GR,DIARRHOEA,4
GR,GASTROINTESTINAL HAEMORRHAGE,4
GR,MYALGIA,4
GR,OEDEMA PERIPHERAL,4
GR,OROPHARYNGEAL PAIN,4
GR,RASH,4
GR,RESPIRATORY TRACT INFECTION,4
GR,ABDOMINAL PAIN,3
GR,ALANINE AMINOTRANSFERASE INCREASED,3
GR,ALOPECIA,3
GR,ASPARTATE AMINOTRANSFERASE INCREASED,3
GR,ATRIOVENTRICULAR BLOCK COMPLETE,3
GR,BLOOD CREATININE INCREASED,3
GR,BLOOD UREA INCREASED,3
GR,CARDIOGENIC SHOCK,3
GR,DYSURIA,3
GR,ERYTHEMA,3
GR,HAEMORRHAGE,3
GR,HALLUCINATION,3
GR,HYPERTENSION,3
GR,HYPOKALAEMIA,3
GR,HYPOTENSION,3
GR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
GR,INFECTION,3
GR,METABOLIC ALKALOSIS,3
GR,MUSCULAR WEAKNESS,3
GR,MYOCARDIAL INFARCTION,3
GR,PALPITATIONS,3
GR,RENAL FAILURE,3
GR,STOMATITIS,3
GR,URINARY TRACT INFECTION,3
GR,URINE OUTPUT DECREASED,3
GR,VERTIGO,3
GR,WHITE BLOOD CELL COUNT INCREASED,3
GR,ACUTE KIDNEY INJURY,2
GR,ANGIOPLASTY,2
GR,ARRHYTHMIA,2
GR,ARTHRALGIA,2
GR,BACK PAIN,2
GR,BLOOD ALBUMIN ABNORMAL,2
GR,BLOOD GLUCOSE INCREASED,2
GR,CHEST PAIN,2
GR,CONFUSIONAL STATE,2
GR,CONSTIPATION,2
GR,COUGH,2
GR,DISCOMFORT,2
GR,DRUG ADMINISTRATION ERROR,2
GR,DRUG HYPERSENSITIVITY,2
GR,DRY SKIN,2
GR,EYELID PTOSIS,2
GR,FEELING ABNORMAL,2
GR,GAIT INABILITY,2
GR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
GR,GASTRIC ULCER,2
GR,GINGIVAL DISORDER,2
GR,GINGIVAL HYPERPLASIA,2
GR,HAEMATOCHEZIA,2
GR,HAEMOPTYSIS,2
GR,HAEMORRHAGIC STROKE,2
GR,HYPERALDOSTERONISM,2
GR,HYPERKALAEMIA,2
GR,HYPOGLYCAEMIA,2
GR,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
GR,INSOMNIA,2
GR,ISCHAEMIC STROKE,2
GR,LUNG INFECTION,2
GR,MOVEMENT DISORDER,2
GR,NAUSEA,2
GR,NODULE,2
GR,OSTEONECROSIS OF JAW,2
GR,OVERDOSE,2
GR,PAIN IN EXTREMITY,2
GR,PNEUMONIA,2
GR,PULMONARY EMBOLISM,2
GR,PULMONARY HAEMORRHAGE,2
GR,RENAL FAILURE ACUTE,2
GR,SEPSIS,2
GR,SHOCK,2
GR,SKIN REACTION,2
GR,SUDDEN DEATH,2
GR,SYNCOPE,2
GR,TACHYCARDIA,2
GR,VENTRICULAR HYPOKINESIA,2
GR,WEIGHT INCREASED,2
GR,ABDOMINAL DISTENSION,1
GR,ABNORMAL DREAMS,1
GR,ACUTE MYOCARDIAL INFARCTION,1
GR,ACUTE PULMONARY OEDEMA,1
GR,ACUTE RESPIRATORY FAILURE,1
GR,AGGRESSION,1
GR,AMNESIA,1
GR,ANEURYSM,1
GR,ANGINA PECTORIS,1
GR,ANGINA UNSTABLE,1
GR,ANXIETY,1
GR,AORTIC ANEURYSM RUPTURE,1
GR,AORTIC THROMBOSIS,1
GR,APHAGIA,1
GR,APHTHOUS STOMATITIS,1
GR,APPENDICITIS,1
GR,ARTERIAL RUPTURE,1
GR,ARTHRITIS,1
GR,ASTHENOPIA,1
GR,ATRIAL THROMBOSIS,1
GR,BACTERAEMIA,1
GR,BACTERIAL INFECTION,1
GR,BACTERIAL TEST POSITIVE,1
GR,BALANCE DISORDER,1
GR,BLISTER,1
GR,BLOOD ALKALINE PHOSPHATASE INCREASED,1
GR,BLOOD POTASSIUM INCREASED,1
GR,BLOOD PRESSURE DECREASED,1
GR,BLOOD SODIUM DECREASED,1
GR,BRONCHOSPASM,1
GR,C-REACTIVE PROTEIN INCREASED,1
GR,CARDIAC ARREST,1
GR,CARDIAC DISORDER,1
GR,CARDIAC FAILURE,1
GR,CARDIO-RESPIRATORY ARREST,1
GR,CARDIOVASCULAR DISORDER,1
GR,CEREBRAL HAEMORRHAGE,1
GR,CHEST DISCOMFORT,1
GR,CHILLS,1
GR,CHOKING SENSATION,1
GR,CHOLANGITIS,1
GR,CHRONIC KIDNEY DISEASE,1
GR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
GR,COLON CANCER,1
GR,CONJUNCTIVAL HAEMORRHAGE,1
GR,CONJUNCTIVITIS,1
GR,CORONARY ARTERY THROMBOSIS,1
GR,CUSHING^S SYNDROME,1
GR,DEEP VEIN THROMBOSIS,1
GR,DEHYDRATION,1
GR,DEPRESSED LEVEL OF CONSCIOUSNESS,1
GR,DERMATITIS ALLERGIC,1
GR,DERMATITIS EXFOLIATIVE,1
GR,DEVICE INTERACTION,1
GR,DIALYSIS,1
GR,DISEASE PROGRESSION,1
GR,DISTURBANCE IN ATTENTION,1
GR,DRESSLER^S SYNDROME,1
GR,DRY MOUTH,1
GR,DYSARTHRIA,1
GR,DYSPEPSIA,1
GR,DYSPHAGIA,1
GR,DYSPNOEA EXERTIONAL,1
GR,EAR DISCOMFORT,1
GR,EAR INFECTION,1
GR,EJECTION FRACTION DECREASED,1
GR,EPILEPSY,1
GR,ERECTILE DYSFUNCTION,1
GR,EYE MOVEMENT DISORDER,1
GR,FALL,1
GR,FAT TISSUE INCREASED,1
GR,FLUID OVERLOAD,1
GR,FLUSHING,1
GR,GASTROENTERITIS,1
GR,GASTROINTESTINAL INFLAMMATION,1
GR,GENERALISED ERYTHEMA,1
GR,GINGIVAL PAIN,1
GR,GLOMERULAR FILTRATION RATE DECREASED,1
GR,GLOSSODYNIA,1
GR,HAEMANGIOMA OF LIVER,1
GR,HAEMATEMESIS,1
GR,HAEMATOCRIT ABNORMAL,1
GR,HAEMATOMA,1
GR,HAEMOGLOBIN DECREASED,1
GR,HEART VALVE CALCIFICATION,1
GR,HEART VALVE INCOMPETENCE,1
GR,HEPATIC ENZYME INCREASED,1
GR,HEPATIC FAILURE,1
GR,HEPATIC FUNCTION ABNORMAL,1
GR,HIGH DENSITY LIPOPROTEIN DECREASED,1
GR,HYPERAEMIA,1
GR,HYPERBILIRUBINAEMIA,1
GR,HYPERHIDROSIS,1
GR,HYPOTHERMIA,1
GR,HYPOXIA,1
GR,ILEUS,1
GR,ILLUSION,1
GR,INCORRECT DOSE ADMINISTERED,1
GR,INCREASED APPETITE,1
GR,INTENTIONAL DRUG MISUSE,1
GR,INTENTIONAL PRODUCT MISUSE,1
GR,INTERNAL HAEMORRHAGE,1
GR,INTERNATIONAL NORMALISED RATIO INCREASED,1
GR,IRON BINDING CAPACITY TOTAL DECREASED,1
GR,JAUNDICE,1
GR,LARGE INTESTINE POLYP,1
GR,LARYNGEAL OEDEMA,1
GR,LEUKAEMIA,1
GR,LEUKOCYTOSIS,1
GR,LOSS OF CONSCIOUSNESS,1
GR,LOWER GASTROINTESTINAL HAEMORRHAGE,1
GR,LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT,1
GR,LYMPHOCYTOSIS,1
GR,MEDICATION ERROR,1
GR,MEGACOLON,1
GR,MELAENA,1
GR,METASTASES TO CENTRAL NERVOUS SYSTEM,1
GR,METASTASES TO LIVER,1
GR,METASTASES TO LUNG,1
GR,MOBILITY DECREASED,1
GR,MONOCYTOSIS,1
GR,MOUTH ULCERATION,1
GR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
GR,MUSCLE SPASMS,1
GR,MUSCULOSKELETAL PAIN,1
GR,MUSCULOSKELETAL STIFFNESS,1
GR,NASAL CONGESTION,1
GR,NASAL DRYNESS,1
GR,NASAL MUCOSAL ULCER,1
GR,NEPHROPATHY,1
GR,NEUTROPENIA,1
GR,NON-HODGKIN^S LYMPHOMA,1
GR,OBSESSIVE THOUGHTS,1
GR,OCCULT BLOOD POSITIVE,1
GR,OCULAR HYPERAEMIA,1
GR,OEDEMA,1
GR,OESOPHAGEAL DISORDER,1
GR,ONYCHOCLASIS,1
GR,ORAL DISCOMFORT,1
GR,ORAL PAIN,1
GR,ORAL PRURITUS,1
GR,OSTEOPOROSIS,1
GR,PERIARTHRITIS,1
GR,PERICARDITIS CONSTRICTIVE,1
GR,PERIORBITAL OEDEMA,1
GR,PERIPHERAL VASCULAR DISORDER,1
GR,PHARYNGEAL HAEMATOMA,1
GR,PIGMENTATION DISORDER,1
GR,POLYPECTOMY,1
GR,PRODUCT USE ISSUE,1
GR,PROSTATITIS,1
GR,PSEUDOMONAS TEST POSITIVE,1
GR,PSORIASIS,1
GR,PSORIATIC ARTHROPATHY,1
GR,PULMONARY FIBROSIS,1
GR,RASH GENERALISED,1
GR,RASH MACULO-PAPULAR,1
GR,RECTAL HAEMORRHAGE,1
GR,RENAL DISORDER,1
GR,RENAL IMPAIRMENT,1
GR,RESPIRATORY DISORDER,1
GR,RETCHING,1
GR,RHINORRHOEA,1
GR,RIGHT VENTRICULAR FAILURE,1
GR,SEIZURE,1
GR,SEPTIC SHOCK,1
GR,SERUM FERRITIN DECREASED,1
GR,SERUM FERRITIN INCREASED,1
GR,SKIN DISCOLOURATION,1
GR,SKIN HAEMORRHAGE,1
GR,SKIN INFECTION,1
GR,SKIN LESION,1
GR,SPEECH DISORDER,1
GR,SPINAL PAIN,1
GR,SPLENOMEGALY,1
GR,STATUS EPILEPTICUS,1
GR,STENT PLACEMENT,1
GR,STRESS,1
GR,STUPOR,1
GR,SUICIDE ATTEMPT,1
GR,SWELLING FACE,1
GR,TACHYARRHYTHMIA,1
GR,THERAPY RESPONDER,1
GR,THROMBOPHLEBITIS SUPERFICIAL,1
GR,THROMBOSIS,1
GR,TONGUE ULCERATION,1
GR,TOOTH DISORDER,1
GR,TRANSAMINASES INCREASED,1
GR,TREMOR,1
GR,TRICUSPID VALVE INCOMPETENCE,1
GR,TROPONIN INCREASED,1
GR,TUMOUR MARKER INCREASED,1
GR,ULCER,1
GR,ULCERATIVE KERATITIS,1
GR,ULTRAFILTRATION FAILURE,1
GR,UPPER GASTROINTESTINAL HAEMORRHAGE,1
GR,VASCULAR RUPTURE,1
GR,VASCULAR STENT THROMBOSIS,1
GR,VENTRICULAR TACHYCARDIA,1
GR,VISION BLURRED,1
GR,WEIGHT DECREASED,1
GR,WHEEZING,1
GR,WHITE BLOOD CELL COUNT DECREASED,1
GT,CANDIDA INFECTION,1
GT,CYSTITIS,1
GT,DYSPHONIA,1
GT,ESCHERICHIA URINARY TRACT INFECTION,1
GT,GASTRIC CANCER,1
GT,GENERAL PHYSICAL HEALTH DETERIORATION,1
GT,HAEMATURIA,1
GT,NASOPHARYNGITIS,1
GT,PULMONARY THROMBOSIS,1
GT,TONSILLAR EXUDATE,1
GT,TONSILLITIS BACTERIAL,1
HK,SPINAL OSTEOARTHRITIS,2
HK,AGNOSIA,1
HK,ANGINA PECTORIS,1
HK,BLOOD ALKALINE PHOSPHATASE INCREASED,1
HK,CONFUSIONAL STATE,1
HK,DRUG DISPENSING ERROR,1
HK,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
HK,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,1
HK,ELECTROLYTE IMBALANCE,1
HK,HALLUCINATION_ VISUAL,1
HK,HEPATOCELLULAR CARCINOMA,1
HK,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
HK,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
HK,LOWER RESPIRATORY TRACT INFECTION,1
HK,LUNG CONSOLIDATION,1
HK,OVERDOSE,1
HK,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
HK,SHOCK,1
HK,SICK SINUS SYNDROME,1
HK,SUBDURAL EFFUSION,1
HK,SYNCOPE,1
HK,THERAPY PARTIAL RESPONDER,1
HK,TOXIC ENCEPHALOPATHY,1
HK,TOXIC EPIDERMAL NECROLYSIS,1
HK,TOXICITY TO VARIOUS AGENTS,1
HK,TRANSIENT ISCHAEMIC ATTACK,1
HK,VERTIGO,1
HU,SEPSIS,8
HU,DRUG INEFFECTIVE,7
HU,RENAL FAILURE,6
HU,ANAEMIA,5
HU,FATIGUE,5
HU,PSEUDOPHAEOCHROMOCYTOMA,5
HU,BREAST CANCER,4
HU,CARDIAC FAILURE,4
HU,CHOLELITHIASIS,4
HU,DIARRHOEA,4
HU,HYPOTENSION,4
HU,MALIGNANT NEOPLASM PROGRESSION,4
HU,OSTEOPOROSIS,4
HU,PYREXIA,4
HU,RENAL CYST,4
HU,SUICIDE ATTEMPT,4
HU,BLOOD LACTATE DEHYDROGENASE INCREASED,3
HU,CONDITION AGGRAVATED,3
HU,INTENTIONAL OVERDOSE,3
HU,ISCHAEMIC STROKE,3
HU,NAUSEA,3
HU,SOMNOLENCE,3
HU,VENTRICULAR TACHYCARDIA,3
HU,ASTHENIA,2
HU,BLOOD BILIRUBIN INCREASED,2
HU,CARDIOGENIC SHOCK,2
HU,DECREASED APPETITE,2
HU,DIVERTICULITIS,2
HU,DIZZINESS,2
HU,DRUG WITHDRAWAL SYNDROME,2
HU,FALL,2
HU,GAIT DISTURBANCE,2
HU,GENERAL PHYSICAL HEALTH DETERIORATION,2
HU,GLIOBLASTOMA,2
HU,GLOMERULAR FILTRATION RATE DECREASED,2
HU,HYPOXIA,2
HU,INJURY,2
HU,OEDEMA,2
HU,OEDEMA PERIPHERAL,2
HU,PLATELET COUNT DECREASED,2
HU,POLYNEUROPATHY,2
HU,RENAL IMPAIRMENT,2
HU,RIGHT VENTRICULAR FAILURE,2
HU,WHITE BLOOD CELL COUNT DECREASED,2
HU,ABDOMINAL PAIN,1
HU,ABDOMINAL PAIN UPPER,1
HU,ACUTE ABDOMEN,1
HU,ACUTE CORONARY SYNDROME,1
HU,AGEUSIA,1
HU,ALANINE AMINOTRANSFERASE DECREASED,1
HU,AMYLASE INCREASED,1
HU,ANGINA PECTORIS,1
HU,ANURIA,1
HU,APHASIA,1
HU,ARRHYTHMIA,1
HU,ARTERIAL THROMBOSIS,1
HU,ASCITES,1
HU,ASPARTATE AMINOTRANSFERASE DECREASED,1
HU,ASPARTATE AMINOTRANSFERASE INCREASED,1
HU,ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME,1
HU,ATRIAL FIBRILLATION,1
HU,AUTOIMMUNE DISORDER,1
HU,AZOTAEMIA,1
HU,BALANCE DISORDER,1
HU,BILE DUCT STONE,1
HU,BLISTER,1
HU,BLOOD ALKALINE PHOSPHATASE INCREASED,1
HU,BLOOD CALCIUM DECREASED,1
HU,BLOOD CHROMOGRANIN A INCREASED,1
HU,BLOOD CREATININE INCREASED,1
HU,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
HU,BLOOD URINE PRESENT,1
HU,BRONCHITIS,1
HU,CARDIAC FAILURE CONGESTIVE,1
HU,CATHETER SITE PAIN,1
HU,CEREBRAL ISCHAEMIA,1
HU,CEREBROVASCULAR ACCIDENT,1
HU,CHEST PAIN,1
HU,CHEST WALL ABSCESS,1
HU,CONCOMITANT DISEASE PROGRESSION,1
HU,CONSTIPATION,1
HU,CONTUSION,1
HU,CYSTITIS,1
HU,DEATH,1
HU,DEHYDRATION,1
HU,DEVICE RELATED INFECTION,1
HU,DIVERTICULUM INTESTINAL HAEMORRHAGIC,1
HU,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
HU,DRUG DEPENDENCE,1
HU,DUODENAL ULCER,1
HU,DYSPEPSIA,1
HU,DYSPHAGIA,1
HU,DYSPHONIA,1
HU,DYSPNOEA,1
HU,DYSPNOEA EXERTIONAL,1
HU,ENCEPHALOPATHY,1
HU,ENTEROCOLITIS BACTERIAL,1
HU,ERUCTATION,1
HU,ERYTHEMA,1
HU,EYE HAEMATOMA,1
HU,EYE SWELLING,1
HU,EYELID OEDEMA,1
HU,FEMUR FRACTURE,1
HU,FLUID RETENTION,1
HU,FLUSHING,1
HU,GAMMA-GLUTAMYLTRANSFERASE DECREASED,1
HU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
HU,GASTROENTERITIS,1
HU,HAEMATOCRIT DECREASED,1
HU,HAEMATOTOXICITY,1
HU,HAEMOGLOBIN INCREASED,1
HU,HAEMOLYSIS,1
HU,HAEMORRHAGE SUBCUTANEOUS,1
HU,HEADACHE,1
HU,HEPATIC FAILURE,1
HU,HEPATIC FUNCTION ABNORMAL,1
HU,HEPATOCELLULAR CARCINOMA,1
HU,HEPATOSPLENOMEGALY,1
HU,HYPERHIDROSIS,1
HU,HYPERTENSION,1
HU,HYPERTENSIVE CRISIS,1
HU,ILEUS PARALYTIC,1
HU,IMMUNOSUPPRESSION,1
HU,INFECTION,1
HU,INTRACARDIAC THROMBUS,1
HU,JAUNDICE,1
HU,JOINT INJURY,1
HU,LACRIMATION INCREASED,1
HU,LIPASE INCREASED,1
HU,LIVER FUNCTION TEST INCREASED,1
HU,LOSS OF CONSCIOUSNESS,1
HU,LOWER GASTROINTESTINAL HAEMORRHAGE,1
HU,LUNG ADENOCARCINOMA,1
HU,LYMPHOPROLIFERATIVE DISORDER,1
HU,MALIGNANT HYPERTENSION,1
HU,MALNUTRITION,1
HU,MANDIBULAR MASS,1
HU,MEDICAL DEVICE SITE BRUISE,1
HU,MENTAL STATUS CHANGES,1
HU,METABOLIC ACIDOSIS,1
HU,MUSCLE TWITCHING,1
HU,NAIL BED INFECTION,1
HU,NASAL MUCOSAL ULCER,1
HU,NERVOUS SYSTEM DISORDER,1
HU,NEUTROPHIL COUNT DECREASED,1
HU,NO ADVERSE EVENT,1
HU,OLIGURIA,1
HU,OVERDOSE,1
HU,PAIN IN EXTREMITY,1
HU,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
HU,PANCREATIC CARCINOMA,1
HU,PARKINSON^S DISEASE,1
HU,PERICARDIAL EFFUSION,1
HU,PETECHIAE,1
HU,POST PROCEDURAL INFLAMMATION,1
HU,PROCALCITONIN INCREASED,1
HU,PRURITUS,1
HU,PSITTACOSIS,1
HU,PULMONARY OEDEMA,1
HU,RASH PUSTULAR,1
HU,SHOCK,1
HU,SHOCK HAEMORRHAGIC,1
HU,SINUS TACHYCARDIA,1
HU,SKIN DISORDER,1
HU,SKIN EXFOLIATION,1
HU,SKIN MASS,1
HU,STAPHYLOCOCCAL ABSCESS,1
HU,STOMA SITE DISCHARGE,1
HU,SUDDEN CARDIAC DEATH,1
HU,SWELLING,1
HU,SWOLLEN TONGUE,1
HU,TACHYCARDIA,1
HU,THROMBOPHLEBITIS,1
HU,TINNITUS,1
HU,TONGUE BLISTERING,1
HU,TONGUE ULCERATION,1
HU,TRACHEO-OESOPHAGEAL FISTULA,1
HU,TUBULOINTERSTITIAL NEPHRITIS,1
HU,TUMOUR LYSIS SYNDROME,1
HU,VENTRICULAR EXTRASYSTOLES,1
HU,VENTRICULAR FIBRILLATION,1
HU,VERTIGO,1
HU,VISUAL IMPAIRMENT,1
HU,VOMITING,1
HU,WEIGHT DECREASED,1
HU,WHEEZING,1
HU,WITHDRAWAL SYNDROME,1
HU,WOUND,1
IS,JAUNDICE,3
IS,DRUG-INDUCED LIVER INJURY,2
IS,GASTROINTESTINAL HAEMORRHAGE,2
IS,APNOEA,1
IS,ARRHYTHMIA,1
IS,ATRIAL FIBRILLATION,1
IS,BLOOD CREATININE INCREASED,1
IS,BRADYCARDIA,1
IS,CARDIAC ARREST,1
IS,CARDIAC FAILURE CONGESTIVE,1
IS,CEREBRAL HAEMORRHAGE,1
IS,CHRONIC KIDNEY DISEASE,1
IS,HAEMOGLOBIN DECREASED,1
IS,HEPATIC ENZYME INCREASED,1
IS,HYPERKALAEMIA,1
IS,LUNG ADENOCARCINOMA,1
IS,NON-CARDIAC CHEST PAIN,1
IS,PLEURAL EFFUSION,1
IS,PROTHROMBIN TIME PROLONGED,1
IS,RECTAL HAEMORRHAGE,1
IS,THROMBIN TIME PROLONGED,1
IN,TOXICITY TO VARIOUS AGENTS,18
IN,HYPOTENSION,17
IN,BRADYCARDIA,11
IN,DRUG INEFFECTIVE,9
IN,FOETAL EXPOSURE DURING PREGNANCY,9
IN,LACTIC ACIDOSIS,8
IN,MATERNAL EXPOSURE DURING PREGNANCY,7
IN,ATRIAL FIBRILLATION,6
IN,CONDITION AGGRAVATED,6
IN,HYPERTENSION,6
IN,LOW BIRTH WEIGHT BABY,6
IN,MENINGITIS CRYPTOCOCCAL,6
IN,PREMATURE BABY,6
IN,ATRIOVENTRICULAR BLOCK COMPLETE,5
IN,DRUG-INDUCED LIVER INJURY,5
IN,HYPERTENSIVE CRISIS,5
IN,HYPOPERFUSION,5
IN,CRYPTOCOCCOSIS,4
IN,DEATH,4
IN,HEPATIC ENCEPHALOPATHY,4
IN,METABOLIC ACIDOSIS,4
IN,PREMATURE DELIVERY,4
IN,PYREXIA,4
IN,SINUS BRADYCARDIA,4
IN,TRANSPLANT DYSFUNCTION,4
IN,TREMOR,4
IN,URINARY TRACT INFECTION,4
IN,ATAXIA,3
IN,ATRIOVENTRICULAR BLOCK FIRST DEGREE,3
IN,DIABETES MELLITUS,3
IN,DIZZINESS,3
IN,ELECTROCARDIOGRAM QT PROLONGED,3
IN,FOETAL GROWTH RESTRICTION,3
IN,HYPONATRAEMIA,3
IN,MYOCARDIAL INFARCTION,3
IN,NODAL RHYTHM,3
IN,SEIZURE,3
IN,VOMITING,3
IN,ABDOMINAL PAIN,2
IN,ARRHYTHMIA,2
IN,ASTHENIA,2
IN,ATRIAL TACHYCARDIA,2
IN,ATRIOVENTRICULAR BLOCK,2
IN,BLOOD CREATININE INCREASED,2
IN,CARDIAC ARREST,2
IN,CARDIAC FAILURE,2
IN,CARDIO-RESPIRATORY ARREST,2
IN,CEREBROVASCULAR ACCIDENT,2
IN,CHOLELITHIASIS,2
IN,CHRONIC ALLOGRAFT NEPHROPATHY,2
IN,DECREASED APPETITE,2
IN,DIARRHOEA,2
IN,DYSPNOEA,2
IN,GASTROENTERITIS,2
IN,HEADACHE,2
IN,HYPERKALAEMIA,2
IN,HYPOTHERMIA,2
IN,HYPOTHYROIDISM,2
IN,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,2
IN,MECONIUM IN AMNIOTIC FLUID,2
IN,NEUROTOXICITY,2
IN,PRETERM PREMATURE RUPTURE OF MEMBRANES,2
IN,PRODUCT USE IN UNAPPROVED INDICATION,2
IN,PROSTATOMEGALY,2
IN,RENAL TUBULAR NECROSIS,2
IN,SEPTIC SHOCK,2
IN,SINUS NODE DYSFUNCTION,2
IN,STEVENS-JOHNSON SYNDROME,2
IN,SUBDURAL HAEMATOMA,2
IN,THROMBOSIS IN DEVICE,2
IN,TREATMENT FAILURE,2
IN,URINE OUTPUT DECREASED,2
IN,VENOUS PRESSURE JUGULAR INCREASED,2
IN,VENTRICULAR TACHYCARDIA,2
IN,WEIGHT DECREASED,2
IN,ABDOMINAL ABSCESS,1
IN,ABNORMAL BEHAVIOUR,1
IN,ACCIDENTAL OVERDOSE,1
IN,ACUTE KIDNEY INJURY,1
IN,ALANINE AMINOTRANSFERASE INCREASED,1
IN,ANAEMIA,1
IN,ANGINA PECTORIS,1
IN,ANGINA UNSTABLE,1
IN,ANXIETY,1
IN,APGAR SCORE LOW,1
IN,ASPARTATE AMINOTRANSFERASE INCREASED,1
IN,BENIGN PROSTATIC HYPERPLASIA,1
IN,BLOOD BILIRUBIN INCREASED,1
IN,BLOOD CORTISOL INCREASED,1
IN,BLOOD GLUCOSE INCREASED,1
IN,BLOOD OSMOLARITY DECREASED,1
IN,BLOOD POTASSIUM ABNORMAL,1
IN,BLOOD PRESSURE DECREASED,1
IN,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
IN,BLOOD PRESSURE INCREASED,1
IN,BLOOD THYROID STIMULATING HORMONE INCREASED,1
IN,BONE LOSS,1
IN,BRADYCARDIA NEONATAL,1
IN,CANDIDA INFECTION,1
IN,CAPILLARITIS,1
IN,CARDIAC DISORDER,1
IN,CARDIOTOXICITY,1
IN,CARDIOVASCULAR INSUFFICIENCY,1
IN,CATATONIA,1
IN,CEREBRAL HAEMORRHAGE,1
IN,CHILLS,1
IN,CHROMATURIA,1
IN,CIRCULATORY COLLAPSE,1
IN,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
IN,CONCOMITANT DISEASE PROGRESSION,1
IN,CONDUCTION DISORDER,1
IN,CONTRAINDICATED PRODUCT ADMINISTERED,1
IN,CORONARY ARTERY DISEASE,1
IN,CORONARY ARTERY OCCLUSION,1
IN,CYTOMEGALOVIRUS INFECTION,1
IN,DECUBITUS ULCER,1
IN,DELAYED GRAFT FUNCTION,1
IN,DEPRESSED LEVEL OF CONSCIOUSNESS,1
IN,DEPRESSION,1
IN,DIABETIC AMYOTROPHY,1
IN,DIAPHRAGMATIC PARALYSIS,1
IN,DISSEMINATED TUBERCULOSIS,1
IN,DRUG ADMINISTRATION ERROR,1
IN,DRUG WITHDRAWAL SYNDROME,1
IN,DYSKINESIA,1
IN,EJECTION FRACTION DECREASED,1
IN,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,1
IN,ELECTROCARDIOGRAM T WAVE INVERSION,1
IN,ENCEPHALOPATHY,1
IN,ESCHERICHIA INFECTION,1
IN,EXTRAPYRAMIDAL DISORDER,1
IN,FATIGUE,1
IN,FEELING COLD,1
IN,FOETAL DISTRESS SYNDROME,1
IN,FUNGAL INFECTION,1
IN,FUNGAL SEPSIS,1
IN,GASTRIC HAEMORRHAGE,1
IN,GASTRIC ULCER,1
IN,GASTRITIS,1
IN,GENERALISED OEDEMA,1
IN,GLOMERULAR FILTRATION RATE DECREASED,1
IN,GLOMERULONEPHRITIS,1
IN,GOUT,1
IN,GRANULOMATOSIS WITH POLYANGIITIS,1
IN,HAEMATEMESIS,1
IN,HAEMATURIA,1
IN,HAEMOGLOBIN DECREASED,1
IN,HAEMORRHAGE INTRACRANIAL,1
IN,HALLUCINATION,1
IN,HEART DISEASE CONGENITAL,1
IN,HEART RATE INCREASED,1
IN,HEPATIC ENZYME INCREASED,1
IN,HEPATIC STEATOSIS,1
IN,HEPATITIS C,1
IN,HEPATOCELLULAR CARCINOMA,1
IN,HEPATOMEGALY,1
IN,HYPERCHLORHYDRIA,1
IN,HYPERURICAEMIA,1
IN,HYPOGLYCAEMIA,1
IN,HYPOVOLAEMIA,1
IN,ILLUSION,1
IN,INFARCTION,1
IN,INFECTION,1
IN,INFECTION REACTIVATION,1
IN,INFLUENZA LIKE ILLNESS,1
IN,INSOMNIA,1
IN,INTENTIONAL OVERDOSE,1
IN,INTESTINAL PERFORATION,1
IN,INVESTIGATION ABNORMAL,1
IN,IRRITABILITY,1
IN,ISCHAEMIC STROKE,1
IN,JAUNDICE,1
IN,KIDNEY TRANSPLANT REJECTION,1
IN,LACUNAR INFARCTION,1
IN,LARGE INTESTINAL HAEMORRHAGE,1
IN,LEFT VENTRICULAR DYSFUNCTION,1
IN,LEUKOCYTOSIS,1
IN,LEUKOPENIA,1
IN,LOWER RESPIRATORY TRACT INFECTION,1
IN,LYMPHOCELE,1
IN,MAJOR DEPRESSION,1
IN,MEDICATION ERROR,1
IN,MELAENA,1
IN,MUCOSAL INFLAMMATION,1
IN,MYALGIA,1
IN,MYOPATHY TOXIC,1
IN,NAUSEA,1
IN,NEPHRECTOMY,1
IN,NEUTROPENIA,1
IN,NEUTROPENIC SEPSIS,1
IN,NODULE,1
IN,OCULOGYRIC CRISIS,1
IN,OEDEMA PERIPHERAL,1
IN,OPTIC ISCHAEMIC NEUROPATHY,1
IN,OVERDOSE,1
IN,PAIN IN EXTREMITY,1
IN,PANCREATITIS ACUTE,1
IN,PANCYTOPENIA,1
IN,PERINEPHRIC COLLECTION,1
IN,PLEUROPERICARDITIS,1
IN,PNEUMONIA,1
IN,PORTAL VEIN THROMBOSIS,1
IN,POST PROCEDURAL PERSISTENT DRAIN FLUID,1
IN,PROCEDURAL HAEMORRHAGE,1
IN,PRODUCT PREPARATION ERROR,1
IN,PRURITUS,1
IN,PULMONARY OEDEMA,1
IN,PULMONARY TUBERCULOSIS,1
IN,PYURIA,1
IN,RASH MACULO-PAPULAR,1
IN,RED BLOOD CELL COUNT DECREASED,1
IN,RENAL ARTERY STENOSIS,1
IN,RENAL DISORDER,1
IN,RENAL FAILURE CHRONIC,1
IN,RENAL IMPAIRMENT,1
IN,RENAL VESSEL DISORDER,1
IN,RESTLESSNESS,1
IN,ROAD TRAFFIC ACCIDENT,1
IN,SELF INJURIOUS BEHAVIOUR,1
IN,SEPSIS,1
IN,SEROTONIN SYNDROME,1
IN,SHOCK,1
IN,SINOATRIAL BLOCK,1
IN,SLEEP DISORDER,1
IN,SOMNOLENCE,1
IN,SPINAL CORD INJURY CERVICAL,1
IN,SUBARACHNOID HAEMORRHAGE,1
IN,SUBDURAL HAEMORRHAGE,1
IN,SUICIDE ATTEMPT,1
IN,SYNCOPE,1
IN,TACHYARRHYTHMIA,1
IN,TACHYCARDIA,1
IN,TACHYCARDIA FOETAL,1
IN,THERAPY NON-RESPONDER,1
IN,THINKING ABNORMAL,1
IN,THROMBOSIS,1
IN,TOXIC EPIDERMAL NECROLYSIS,1
IN,TUBERCULOSIS,1
IN,TUBULOINTERSTITIAL NEPHRITIS,1
IN,URINARY INCONTINENCE,1
IN,URINE SODIUM INCREASED,1
IN,VEIN COLLAPSE,1
IN,VENTRICULAR FIBRILLATION,1
IN,VISION BLURRED,1
IN,WITHDRAWAL HYPERTENSION,1
IR,DEATH,1
IR,DRUG INEFFECTIVE,1
IR,HAEMORRHAGE INTRACRANIAL,1
IR,HYPERTENSION,1
IR,HYPERTENSIVE CRISIS,1
IR,INTRAVENTRICULAR HAEMORRHAGE,1
IR,STEVENS-JOHNSON SYNDROME,1
IQ,THALAMUS HAEMORRHAGE,4
IQ,DEATH,2
IQ,DEPRESSED LEVEL OF CONSCIOUSNESS,2
IQ,DYSPHAGIA,2
IQ,EXTENSOR PLANTAR RESPONSE,2
IQ,HEADACHE,2
IQ,HEMIPARESIS,2
IQ,QUADRIPLEGIA,2
IQ,APHASIA,1
IQ,CIRCULATORY COLLAPSE,1
IQ,HYPERREFLEXIA,1
IQ,HYPOREFLEXIA,1
IQ,LEFT VENTRICULAR HYPERTROPHY,1
IQ,LOSS OF CONSCIOUSNESS,1
IQ,QUADRIPARESIS,1
IE,HYPERTENSION,4
IE,CEREBRAL HAEMORRHAGE,3
IE,CHEST PAIN,3
IE,DEATH,3
IE,DYSPHAGIA,3
IE,FALL,3
IE,SEPSIS,3
IE,BLOOD CREATININE INCREASED,2
IE,CARDIAC ARREST,2
IE,CARDIOGENIC SHOCK,2
IE,CONVULSION,2
IE,DIARRHOEA,2
IE,GASTROINTESTINAL HAEMORRHAGE,2
IE,HAEMATEMESIS,2
IE,HAEMOGLOBIN DECREASED,2
IE,HYPOCALCAEMIA,2
IE,HYPOKALAEMIA,2
IE,HYPOMAGNESAEMIA,2
IE,NAUSEA,2
IE,NEUTROPHIL COUNT DECREASED,2
IE,PLATELET COUNT DECREASED,2
IE,PNEUMONIA,2
IE,SYNCOPE,2
IE,TACHYCARDIA,2
IE,UNRESPONSIVE TO STIMULI,2
IE,VENTRICULAR TACHYCARDIA,2
IE,ABDOMINAL PAIN,1
IE,AMYLASE INCREASED,1
IE,ANGINA PECTORIS,1
IE,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
IE,AREFLEXIA,1
IE,ARTERIOSCLEROSIS CORONARY ARTERY,1
IE,ASTHENIA,1
IE,ATRIAL FIBRILLATION,1
IE,BACK PAIN,1
IE,BLOOD LACTIC ACID INCREASED,1
IE,CAESAREAN SECTION,1
IE,CARDIAC DISORDER,1
IE,CARDIAC FAILURE,1
IE,CEREBROVASCULAR ACCIDENT,1
IE,CONSTIPATION,1
IE,CORONARY ARTERY OCCLUSION,1
IE,DEPRESSION,1
IE,DYSKINESIA,1
IE,DYSURIA,1
IE,ELECTROCARDIOGRAM QT PROLONGED,1
IE,ENDOTRACHEAL INTUBATION,1
IE,EOSINOPHIL COUNT INCREASED,1
IE,FEELING ABNORMAL,1
IE,FOETAL EXPOSURE DURING PREGNANCY,1
IE,HEADACHE,1
IE,HIP FRACTURE,1
IE,HOSPITALISATION,1
IE,HYDROCEPHALUS,1
IE,HYPOTENSION,1
IE,HYPOTONIA,1
IE,INFECTION,1
IE,INTENTIONAL DRUG MISUSE,1
IE,INTERNATIONAL NORMALISED RATIO INCREASED,1
IE,INTESTINAL ISCHAEMIA,1
IE,INVESTIGATION,1
IE,LOWER RESPIRATORY TRACT INFECTION,1
IE,MALAISE,1
IE,MATERNAL EXPOSURE DURING PREGNANCY,1
IE,MENINGITIS CRYPTOCOCCAL,1
IE,MENINGITIS TUBERCULOUS,1
IE,MENTAL DISORDER,1
IE,MENTAL IMPAIRMENT,1
IE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
IE,MUSCLE SPASMS,1
IE,MUSCULAR WEAKNESS,1
IE,MYOCARDIAL INFARCTION,1
IE,MYOCARDIAL ISCHAEMIA,1
IE,NEUTROPHIL COUNT INCREASED,1
IE,NORMAL NEWBORN,1
IE,PALPITATIONS,1
IE,PARAPARESIS,1
IE,PLEURAL EFFUSION,1
IE,POLYARTERITIS NODOSA,1
IE,PRODUCT USE IN UNAPPROVED INDICATION,1
IE,PSYCHOTIC DISORDER,1
IE,PULMONARY EMBOLISM,1
IE,PULMONARY VALVE INCOMPETENCE,1
IE,RASH MACULAR,1
IE,RENAL FAILURE,1
IE,RESPIRATORY FAILURE,1
IE,RESUSCITATION,1
IE,SENSORY DISTURBANCE,1
IE,SINUS BRADYCARDIA,1
IE,SINUS TACHYCARDIA,1
IE,SPINAL CORD COMPRESSION,1
IE,SPINAL CORD HAEMORRHAGE,1
IE,SPINAL SUBDURAL HAEMATOMA,1
IE,TYPE 2 DIABETES MELLITUS,1
IE,UNINTENTIONAL MEDICAL DEVICE REMOVAL,1
IE,URINARY RETENTION,1
IE,VOMITING,1
IE,WHITE BLOOD CELL COUNT INCREASED,1
IL,PNEUMONITIS,5
IL,ASTHENIA,3
IL,CHEST PAIN,3
IL,DIARRHOEA,3
IL,HAEMOGLOBIN DECREASED,3
IL,MATERNAL EXPOSURE DURING PREGNANCY,3
IL,TOXICITY TO VARIOUS AGENTS,3
IL,ABDOMINAL PAIN,2
IL,ANGINA UNSTABLE,2
IL,FATIGUE,2
IL,HEADACHE,2
IL,NAUSEA,2
IL,NORMAL NEWBORN,2
IL,OCULAR DISCOMFORT,2
IL,PYREXIA,2
IL,RETROPERITONEAL HAEMATOMA,2
IL,SYNCOPE,2
IL,VENTRICULAR TACHYCARDIA,2
IL,VISION BLURRED,2
IL,VOMITING,2
IL,ACUTE CORONARY SYNDROME,1
IL,ACUTE KIDNEY INJURY,1
IL,ACUTE MYOCARDIAL INFARCTION,1
IL,ANAEMIA,1
IL,ANGIOEDEMA,1
IL,BLOOD CREATININE INCREASED,1
IL,BLOOD GLUCOSE INCREASED,1
IL,BLOOD IRON DECREASED,1
IL,BLOOD PRESSURE ABNORMAL,1
IL,BLOOD PRESSURE INCREASED,1
IL,CARDIAC DISORDER,1
IL,CARDIAC FAILURE CHRONIC,1
IL,CARDIAC FAILURE CONGESTIVE,1
IL,CELLULITIS,1
IL,CEREBRAL HAEMORRHAGE,1
IL,CEREBROVASCULAR ACCIDENT,1
IL,CHILLS,1
IL,COMPUTERISED TOMOGRAM CORONARY ARTERY ABNORMAL,1
IL,CONSTIPATION,1
IL,DECREASED ACTIVITY,1
IL,DIASTOLIC DYSFUNCTION,1
IL,DISCOMFORT,1
IL,DIZZINESS,1
IL,DRUG ERUPTION,1
IL,ERYTHEMA,1
IL,EXTRASYSTOLES,1
IL,GASTROINTESTINAL NECROSIS,1
IL,GINGIVAL ERYTHEMA,1
IL,GINGIVAL HYPERTROPHY,1
IL,GINGIVAL PAIN,1
IL,GINGIVAL SWELLING,1
IL,GINGIVITIS,1
IL,HAEMORRHAGE,1
IL,HEART RATE DECREASED,1
IL,HEPATIC PAIN,1
IL,HYPERSENSITIVITY,1
IL,HYPOCALCAEMIA,1
IL,HYPONATRAEMIA,1
IL,IMPAIRED QUALITY OF LIFE,1
IL,INFLAMMATION,1
IL,LEFT VENTRICULAR HYPERTROPHY,1
IL,LUMBAR VERTEBRAL FRACTURE,1
IL,MENISCUS INJURY,1
IL,MESENTERIC ARTERY EMBOLISM,1
IL,MITRAL VALVE CALCIFICATION,1
IL,MUSCLE HAEMORRHAGE,1
IL,MUSCLE SPASMS,1
IL,NONINFECTIVE GINGIVITIS,1
IL,PALPITATIONS,1
IL,PARAESTHESIA,1
IL,PARASITIC GASTROENTERITIS,1
IL,PERIPHERAL COLDNESS,1
IL,PERIPHERAL EMBOLISM,1
IL,PNEUMONIA,1
IL,PRESYNCOPE,1
IL,PRODUCTIVE COUGH,1
IL,PRURITUS,1
IL,PULMONARY CONGESTION,1
IL,PULMONARY HYPERTENSION,1
IL,PULMONARY OEDEMA,1
IL,PULSE ABSENT,1
IL,RETINAL SCAR,1
IL,RETINITIS,1
IL,RETINOPATHY,1
IL,SLEEP DISORDER,1
IL,SPEECH DISORDER,1
IL,SUBARACHNOID HAEMORRHAGE,1
IL,TACHYCARDIA,1
IL,THROMBOCYTOPENIA,1
IL,TUBULOINTERSTITIAL NEPHRITIS,1
IL,VASCULAR DEVICE INFECTION,1
IL,VASCULITIS,1
IL,VIRAL INFECTION,1
IL,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
IT,DYSPNOEA,37
IT,PRESYNCOPE,30
IT,SYNCOPE,29
IT,HYPOTENSION,28
IT,ASTHENIA,27
IT,ANAEMIA,26
IT,NAUSEA,26
IT,LOSS OF CONSCIOUSNESS,19
IT,PYREXIA,17
IT,APHASIA,16
IT,BRADYCARDIA,16
IT,DRUG INEFFECTIVE,16
IT,HYPOGLYCAEMIA,16
IT,ACUTE KIDNEY INJURY,15
IT,ERYTHEMA,15
IT,MALAISE,15
IT,TOXICITY TO VARIOUS AGENTS,15
IT,ATRIAL FIBRILLATION,14
IT,HAEMATURIA,14
IT,SUICIDE ATTEMPT,14
IT,VOMITING,14
IT,CHEST PAIN,13
IT,HEMIPLEGIA,13
IT,HYPOKALAEMIA,13
IT,HYPOMAGNESAEMIA,13
IT,RESPIRATORY FAILURE,13
IT,ELECTROCARDIOGRAM QT PROLONGED,12
IT,MYOCARDIAL ISCHAEMIA,12
IT,CONFUSIONAL STATE,11
IT,CORONARY ARTERY OCCLUSION,11
IT,DIZZINESS,11
IT,HEAD INJURY,11
IT,PANIC ATTACK,11
IT,THROMBOCYTOPENIA,11
IT,BLOOD PRESSURE INCREASED,10
IT,FATIGUE,10
IT,HYPERPARATHYROIDISM,10
IT,HYPOCALCAEMIA,10
IT,SOPOR,10
IT,VERTIGO,10
IT,BRADYKINESIA,9
IT,BRADYPHRENIA,9
IT,CAROTID ARTERIOSCLEROSIS,9
IT,CEREBRAL ARTERY OCCLUSION,9
IT,COMA,9
IT,EPIGASTRIC DISCOMFORT,9
IT,FLATULENCE,9
IT,HEADACHE,9
IT,HYPONATRAEMIA,9
IT,MELAENA,9
IT,NIH STROKE SCALE SCORE INCREASED,9
IT,RHABDOMYOLYSIS,9
IT,SOMNOLENCE,9
IT,DIARRHOEA,8
IT,FEELING COLD,8
IT,HYPERHIDROSIS,8
IT,HYPERKALAEMIA,8
IT,HYPOTHYROIDISM,8
IT,INTENTIONAL OVERDOSE,8
IT,MYOPATHY,8
IT,SUBDURAL HAEMATOMA,8
IT,ABDOMINAL PAIN,7
IT,CONDITION AGGRAVATED,7
IT,CORROSIVE OROPHARYNGEAL INJURY,7
IT,ELECTROCARDIOGRAM T WAVE INVERSION,7
IT,FALL,7
IT,FEBRILE NEUTROPENIA,7
IT,INTERNATIONAL NORMALISED RATIO INCREASED,7
IT,ORAL MUCOSA EROSION,7
IT,PAIN,7
IT,RECTAL HAEMORRHAGE,7
IT,RENAL FAILURE,7
IT,VITAMIN D DEFICIENCY,7
IT,WEIGHT INCREASED,7
IT,ACCIDENTAL OVERDOSE,6
IT,AGITATION,6
IT,ANXIETY,6
IT,ASPARTATE AMINOTRANSFERASE INCREASED,6
IT,CEREBRAL HAEMORRHAGE,6
IT,DRUG LEVEL INCREASED,6
IT,HYPERTENSIVE CRISIS,6
IT,LIP OEDEMA,6
IT,MYOCARDIAL INFARCTION,6
IT,NEUTROPENIA,6
IT,PALPITATIONS,6
IT,PRURITUS,6
IT,RENAL TUBULAR DISORDER,6
IT,RESPIRATORY ACIDOSIS,6
IT,SEPSIS,6
IT,UNRESPONSIVE TO STIMULI,6
IT,ACUTE RESPIRATORY FAILURE,5
IT,ALANINE AMINOTRANSFERASE INCREASED,5
IT,ANGIOEDEMA,5
IT,BLOOD CREATININE INCREASED,5
IT,CARDIAC FAILURE,5
IT,DISCOMFORT,5
IT,DRUG HYPERSENSITIVITY,5
IT,EPILEPSY,5
IT,FEELING HOT,5
IT,HYPERTENSION,5
IT,PANCYTOPENIA,5
IT,PRURITUS GENERALISED,5
IT,RASH,5
IT,TREMOR,5
IT,URTICARIA,5
IT,ACIDOSIS,4
IT,ACTIVITIES OF DAILY LIVING IMPAIRED,4
IT,ARTHRALGIA,4
IT,CARDIAC ARREST,4
IT,CARDIAC FAILURE CHRONIC,4
IT,CORONARY ARTERY STENOSIS,4
IT,EPISTAXIS,4
IT,GAIT DISTURBANCE,4
IT,HAEMATEMESIS,4
IT,HAEMOGLOBIN DECREASED,4
IT,HOT FLUSH,4
IT,ISCHAEMIC STROKE,4
IT,LEUKOPENIA,4
IT,OBSTRUCTIVE AIRWAYS DISORDER,4
IT,OVERDOSE,4
IT,PAIN IN EXTREMITY,4
IT,PALATAL OEDEMA,4
IT,PLATELET COUNT DECREASED,4
IT,PORTAL VEIN THROMBOSIS,4
IT,RASH PRURITIC,4
IT,SELF INJURIOUS BEHAVIOUR,4
IT,SWELLING,4
IT,TACHYCARDIA,4
IT,THROMBOSIS MESENTERIC VESSEL,4
IT,TRANSFUSION,4
IT,URINARY RETENTION,4
IT,AMNESIA,3
IT,ANGINA PECTORIS,3
IT,ATRIOVENTRICULAR BLOCK COMPLETE,3
IT,CEREBRAL ISCHAEMIA,3
IT,CHILLS,3
IT,CHROMATURIA,3
IT,CONSTIPATION,3
IT,COUGH,3
IT,DRUG ABUSE,3
IT,DRUG USE DISORDER,3
IT,DRY MOUTH,3
IT,EJECTION FRACTION DECREASED,3
IT,ELECTROLYTE IMBALANCE,3
IT,EXPOSURE DURING PREGNANCY,3
IT,GASTROINTESTINAL HYPOMOTILITY,3
IT,HAEMATOCHEZIA,3
IT,HAEMATOMA,3
IT,HAEMORRHAGE URINARY TRACT,3
IT,HEPATIC CIRRHOSIS,3
IT,HYPERSENSITIVITY,3
IT,INSOMNIA,3
IT,INTERNATIONAL NORMALISED RATIO ABNORMAL,3
IT,INTERSTITIAL LUNG DISEASE,3
IT,INTESTINAL HAEMORRHAGE,3
IT,MEDICATION ERROR,3
IT,NIGHTMARE,3
IT,NORMOCHROMIC NORMOCYTIC ANAEMIA,3
IT,PARAESTHESIA,3
IT,PARALYSIS,3
IT,PNEUMONIA,3
IT,PNEUMONITIS,3
IT,PSYCHOMOTOR HYPERACTIVITY,3
IT,PULMONARY EMBOLISM,3
IT,RENAL FAILURE ACUTE,3
IT,SINUS BRADYCARDIA,3
IT,TONGUE BITING,3
IT,TRANSIENT ISCHAEMIC ATTACK,3
IT,TUBULOINTERSTITIAL NEPHRITIS,3
IT,WEIGHT DECREASED,3
IT,ABDOMINAL PAIN UPPER,2
IT,ARTERIOSCLEROSIS CORONARY ARTERY,2
IT,ATRIAL FLUTTER,2
IT,BACK PAIN,2
IT,BRADYARRHYTHMIA,2
IT,BRONCHOSPASM,2
IT,BUNDLE BRANCH BLOCK RIGHT,2
IT,CAESAREAN SECTION,2
IT,CONCOMITANT DISEASE PROGRESSION,2
IT,DEEP VEIN THROMBOSIS,2
IT,DEHYDRATION,2
IT,DEPRESSION,2
IT,DIARRHOEA HAEMORRHAGIC,2
IT,DISTURBANCE IN ATTENTION,2
IT,DRUG ADMINISTRATION ERROR,2
IT,DUODENAL ULCER,2
IT,DYSARTHRIA,2
IT,ECCHYMOSIS,2
IT,EYE OEDEMA,2
IT,FACE OEDEMA,2
IT,FAECES DISCOLOURED,2
IT,FEELING ABNORMAL,2
IT,FISTULA,2
IT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
IT,GASTRIC HAEMORRHAGE,2
IT,GASTRIC ULCER HAEMORRHAGE,2
IT,HAEMATOCRIT DECREASED,2
IT,HAEMORRHAGE INTRACRANIAL,2
IT,HAEMORRHAGIC ANAEMIA,2
IT,HALLUCINATION_ AUDITORY,2
IT,HEART RATE INCREASED,2
IT,HEMIPARESIS,2
IT,HEPATITIS ACUTE,2
IT,HEPATOCELLULAR INJURY,2
IT,HYPERTRANSAMINASAEMIA,2
IT,ILEUS PARALYTIC,2
IT,JAUNDICE,2
IT,LANGUAGE DISORDER,2
IT,LEUKOCYTOSIS,2
IT,LIVER DISORDER,2
IT,MATERNAL EXPOSURE DURING PREGNANCY,2
IT,MUSCLE SPASMS,2
IT,MUSCULOSKELETAL STIFFNESS,2
IT,NEUTROPHILIA,2
IT,NODAL ARRHYTHMIA,2
IT,OEDEMA PERIPHERAL,2
IT,ORTHOSTATIC HYPOTENSION,2
IT,OSTEONECROSIS,2
IT,OSTEONECROSIS OF JAW,2
IT,PALLOR,2
IT,PARAPARESIS,2
IT,PEMPHIGOID,2
IT,PETECHIAE,2
IT,POLLAKIURIA,2
IT,PRODUCTIVE COUGH,2
IT,PULMONARY TOXICITY,2
IT,RED BLOOD CELL COUNT DECREASED,2
IT,RENAL IMPAIRMENT,2
IT,RESPIRATORY ARREST,2
IT,SEPTIC SHOCK,2
IT,SHOCK HAEMORRHAGIC,2
IT,SINUS ARREST,2
IT,SINUS TACHYCARDIA,2
IT,SNEEZING,2
IT,SPINAL CORD HAEMORRHAGE,2
IT,SPONTANEOUS HAEMATOMA,2
IT,STAPHYLOCOCCAL SEPSIS,2
IT,SUDDEN DEATH,2
IT,THIRST,2
IT,TRANSAMINASES INCREASED,2
IT,TROPONIN I INCREASED,2
IT,UTERINE HYPOTONUS,2
IT,VENTRICULAR EXTRASYSTOLES,2
IT,ABDOMINAL DISTENSION,1
IT,ABDOMINAL WALL HAEMATOMA,1
IT,ABNORMAL BEHAVIOUR,1
IT,ABNORMAL DREAMS,1
IT,ABNORMAL LOSS OF WEIGHT,1
IT,ACUTE MYOCARDIAL INFARCTION,1
IT,ADENOCARCINOMA OF COLON,1
IT,ALCOHOL INTERACTION,1
IT,ALTERED STATE OF CONSCIOUSNESS,1
IT,ANAEMIA MACROCYTIC,1
IT,ANAPHYLACTOID REACTION,1
IT,ANASTOMOTIC ULCER HAEMORRHAGE,1
IT,ANGINA UNSTABLE,1
IT,ANTIPHOSPHOLIPID SYNDROME,1
IT,ANURIA,1
IT,AORTIC VALVE INCOMPETENCE,1
IT,APNOEA,1
IT,AREFLEXIA,1
IT,ARRHYTHMIA,1
IT,ASCITES,1
IT,ASTHMA,1
IT,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
IT,AUTOIMMUNE THROMBOCYTOPENIA,1
IT,AZOTAEMIA,1
IT,BLADDER DYSPLASIA,1
IT,BLISTER,1
IT,BLOOD CREATINE INCREASED,1
IT,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
IT,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,1
IT,BLOOD PHOSPHORUS,1
IT,BLOOD PHOSPHORUS ABNORMAL,1
IT,BLOOD PHOSPHORUS DECREASED,1
IT,BLOOD PRESSURE ABNORMAL,1
IT,BLOOD PRESSURE DECREASED,1
IT,BLOOD PRESSURE FLUCTUATION,1
IT,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
IT,BLOOD SODIUM INCREASED,1
IT,BLOODY DISCHARGE,1
IT,BONE MARROW FAILURE,1
IT,BRAIN OEDEMA,1
IT,BREATH SOUNDS ABNORMAL,1
IT,BRONCHOPNEUMONIA,1
IT,C-REACTIVE PROTEIN INCREASED,1
IT,CARBON MONOXIDE DIFFUSING CAPACITY DECREASED,1
IT,CARDIAC FAILURE ACUTE,1
IT,CARDIAC FAILURE CONGESTIVE,1
IT,CATHETER PLACEMENT,1
IT,CEREBELLAR HAEMORRHAGE,1
IT,CEREBRAL HYPOPERFUSION,1
IT,CEREBROVASCULAR DISORDER,1
IT,CHILD-PUGH-TURCOTTE SCORE ABNORMAL,1
IT,CHOLECYSTITIS,1
IT,CHOLESTASIS,1
IT,CHRONIC KIDNEY DISEASE,1
IT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
IT,CLOSTRIDIUM DIFFICILE COLITIS,1
IT,COLD SWEAT,1
IT,COLITIS,1
IT,COORDINATION ABNORMAL,1
IT,CRANIAL NERVE DISORDER,1
IT,CRANIOCEREBRAL INJURY,1
IT,CRANIOTOMY,1
IT,CYLINDRURIA,1
IT,DEATH,1
IT,DECREASED APPETITE,1
IT,DECREASED VIBRATORY SENSE,1
IT,DERMATITIS,1
IT,DERMATITIS BULLOUS,1
IT,DERMATITIS EXFOLIATIVE GENERALISED,1
IT,DERMATOSIS,1
IT,DEVICE RELATED SEPSIS,1
IT,DISCOLOURED VOMIT,1
IT,DISEASE PROGRESSION,1
IT,DISORIENTATION,1
IT,DIVERTICULITIS,1
IT,DRUG CLEARANCE DECREASED,1
IT,DUODENITIS,1
IT,DYSPHAGIA,1
IT,DYSPNOEA AT REST,1
IT,DYSSTASIA,1
IT,DYSURIA,1
IT,EMBOLISM VENOUS,1
IT,EOSINOPHILIC PNEUMONIA,1
IT,ERYTHEMA INFECTIOSUM,1
IT,EXCESSIVE CERUMEN PRODUCTION,1
IT,EXPOSED BONE IN JAW,1
IT,EYELID OEDEMA,1
IT,FRACTURE,1
IT,FRACTURED COCCYX,1
IT,FUNGAL INFECTION,1
IT,GASTROINTESTINAL ANGIODYSPLASIA HAEMORRHAGIC,1
IT,GASTROINTESTINAL MOTILITY DISORDER,1
IT,GENERAL PHYSICAL HEALTH DETERIORATION,1
IT,GENERALISED ERYTHEMA,1
IT,GENERALISED OEDEMA,1
IT,GINGIVITIS,1
IT,GRAVITATIONAL OEDEMA,1
IT,HAEMOGLOBIN INCREASED,1
IT,HAEMOLYTIC ANAEMIA,1
IT,HAEMOPTYSIS,1
IT,HAEMORRHAGE,1
IT,HALLUCINATION,1
IT,HEART RATE DECREASED,1
IT,HELICOBACTER GASTRITIS,1
IT,HEPATIC ENZYME INCREASED,1
IT,HEPATIC FAILURE,1
IT,HEPATOCELLULAR CARCINOMA,1
IT,HEPATORENAL FAILURE,1
IT,HEPATOTOXICITY,1
IT,HYPERBILIRUBINAEMIA,1
IT,HYPERGLYCAEMIA,1
IT,HYPERINSULINAEMIC HYPOGLYCAEMIA,1
IT,HYPERPYREXIA,1
IT,HYPERSENSITIVITY VASCULITIS,1
IT,HYPERTROPHIC CARDIOMYOPATHY,1
IT,HYPERURICAEMIA,1
IT,HYPOCALCAEMIC SEIZURE,1
IT,HYPOCOAGULABLE STATE,1
IT,HYPONATRAEMIC SYNDROME,1
IT,HYPOREFLEXIA,1
IT,HYPOTONIA,1
IT,HYPOXIA,1
IT,ILLUSION,1
IT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
IT,INCORRECT DOSE ADMINISTERED,1
IT,INCORRECT DRUG DOSAGE FORM ADMINISTERED,1
IT,INFARCTION,1
IT,INFUSION RELATED REACTION,1
IT,INTENTIONAL PRODUCT MISUSE,1
IT,INTERSTITIAL GRANULOMATOUS DERMATITIS,1
IT,INTESTINAL POLYP,1
IT,INTRAVASCULAR HAEMOLYSIS,1
IT,IRON DEFICIENCY ANAEMIA,1
IT,IRRITABILITY,1
IT,JAUNDICE CHOLESTATIC,1
IT,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
IT,LACTIC ACIDOSIS,1
IT,LARYNGEAL OEDEMA,1
IT,LONG QT SYNDROME,1
IT,LOWER RESPIRATORY TRACT INFECTION,1
IT,LYMPHANGITIS,1
IT,MEDICATION RESIDUE PRESENT,1
IT,METRORRHAGIA,1
IT,MICROCYTIC ANAEMIA,1
IT,MIGRAINE,1
IT,MITRAL VALVE INCOMPETENCE,1
IT,MUCOSAL INFLAMMATION,1
IT,MUCOUS MEMBRANE DISORDER,1
IT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
IT,MUSCLE RIGIDITY,1
IT,MUSCULAR WEAKNESS,1
IT,MYALGIA,1
IT,MYELODYSPLASTIC SYNDROME,1
IT,MYOCARDIAL NECROSIS MARKER INCREASED,1
IT,NO ADVERSE EVENT,1
IT,ORAL CANDIDIASIS,1
IT,ORTHOSTATIC INTOLERANCE,1
IT,PANCREATITIS ACUTE,1
IT,PARAPLEGIA,1
IT,PARESIS,1
IT,PAROSMIA,1
IT,PAROXYSMAL ATRIOVENTRICULAR BLOCK,1
IT,PEMPHIGUS,1
IT,PERINEAL PAIN,1
IT,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
IT,PHARYNGEAL ERYTHEMA,1
IT,PLASMA CELL LEUKAEMIA,1
IT,PLEURAL EFFUSION,1
IT,PNEUMATOSIS INTESTINALIS,1
IT,PNEUMOCYSTIS JIROVECII INFECTION,1
IT,PNEUMONIA KLEBSIELLA,1
IT,POISONING,1
IT,POLYURIA,1
IT,POST PROCEDURAL HAEMATOMA,1
IT,PREGNANCY,1
IT,PRERENAL FAILURE,1
IT,PRODUCT QUALITY ISSUE,1
IT,PRODUCT USE ISSUE,1
IT,PROTEINURIA,1
IT,PSYCHOTIC DISORDER DUE TO A GENERAL MEDICAL CONDITION,1
IT,PULMONARY CONGESTION,1
IT,PULMONARY INFARCTION,1
IT,QUADRIPARESIS,1
IT,QUADRIPLEGIA,1
IT,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
IT,RENAL FAILURE CHRONIC,1
IT,RENAL INJURY,1
IT,RESPIRATORY TRACT INFECTION,1
IT,RETINAL VASCULAR THROMBOSIS,1
IT,SEIZURE,1
IT,SEROTONIN SYNDROME,1
IT,SLUGGISHNESS,1
IT,SPEECH DISORDER,1
IT,SPINAL CORD COMPRESSION,1
IT,SUBARACHNOID HAEMORRHAGE,1
IT,SUBCUTANEOUS HAEMATOMA,1
IT,SUBILEUS,1
IT,SUPRAVENTRICULAR TACHYCARDIA,1
IT,THERAPEUTIC RESPONSE DECREASED,1
IT,THERAPY NON-RESPONDER,1
IT,THROMBOPHLEBITIS,1
IT,THROMBOPHLEBITIS SUPERFICIAL,1
IT,TONGUE PRURITUS,1
IT,TOXIC EPIDERMAL NECROLYSIS,1
IT,TOXIC NODULAR GOITRE,1
IT,TRANSPLANT REJECTION,1
IT,TRICUSPID VALVE INCOMPETENCE,1
IT,TYPE IIA HYPERLIPIDAEMIA,1
IT,ULCER HAEMORRHAGE,1
IT,UNEVALUABLE EVENT,1
IT,URINARY CASTS,1
IT,URINARY TRACT DISORDER,1
IT,URINARY TRACT INFECTION PSEUDOMONAL,1
IT,VAGINAL HAEMORRHAGE,1
IT,VARICELLA,1
IT,VASCULAR ENCEPHALOPATHY,1
IT,VASCULITIS,1
IT,VENTRICULAR HYPOKINESIA,1
IT,VISUAL IMPAIRMENT,1
IT,WHITE BLOOD CELL COUNT DECREASED,1
IT,WRONG PATIENT RECEIVED MEDICATION,1
JP,MATERNAL EXPOSURE DURING PREGNANCY,9
JP,PLATELET COUNT DECREASED,8
JP,ANAEMIA,7
JP,ELECTROCARDIOGRAM QT PROLONGED,6
JP,RENAL IMPAIRMENT,6
JP,ATRIAL FIBRILLATION,5
JP,DRUG INEFFECTIVE,5
JP,FOETAL EXPOSURE DURING PREGNANCY,5
JP,LOSS OF CONSCIOUSNESS,5
JP,ALTERED STATE OF CONSCIOUSNESS,4
JP,BLOOD PRESSURE DECREASED,4
JP,BRADYCARDIA,4
JP,DYSPNOEA,4
JP,ELECTROCARDIOGRAM T WAVE ABNORMAL,4
JP,HAEMOGLOBIN DECREASED,4
JP,HEPATIC FUNCTION ABNORMAL,4
JP,MALAISE,4
JP,NAUSEA,4
JP,PNEUMONIA,4
JP,RENAL FAILURE,4
JP,TORSADE DE POINTES,4
JP,WHITE BLOOD CELL COUNT DECREASED,4
JP,ASCITES,3
JP,CARDIAC FAILURE,3
JP,CEREBRAL INFARCTION,3
JP,DECREASED APPETITE,3
JP,DIZZINESS,3
JP,GAIT DISTURBANCE,3
JP,HYPOTENSION,3
JP,LOW BIRTH WEIGHT BABY,3
JP,OEDEMA PERIPHERAL,3
JP,PREMATURE BABY,3
JP,PYREXIA,3
JP,RASH,3
JP,VENTRICULAR EXTRASYSTOLES,3
JP,VENTRICULAR TACHYCARDIA,3
JP,ABDOMINAL PAIN,2
JP,ABORTION SPONTANEOUS,2
JP,ANGINA PECTORIS,2
JP,ANGINA UNSTABLE,2
JP,ANURIA,2
JP,ARRHYTHMIA,2
JP,ARTHRITIS,2
JP,ATRIOVENTRICULAR BLOCK COMPLETE,2
JP,AUTOIMMUNE HEPATITIS,2
JP,BILIARY CIRRHOSIS PRIMARY,2
JP,BLOOD POTASSIUM INCREASED,2
JP,BUNDLE BRANCH BLOCK RIGHT,2
JP,CARDIAC OUTPUT DECREASED,2
JP,COLITIS ULCERATIVE,2
JP,COMA,2
JP,CONCOMITANT DISEASE AGGRAVATED,2
JP,CONDITION AGGRAVATED,2
JP,DECREASED ACTIVITY,2
JP,DEPRESSED LEVEL OF CONSCIOUSNESS,2
JP,DEPRESSION,2
JP,DIZZINESS POSTURAL,2
JP,DUODENAL ULCER,2
JP,FEBRILE NEUTROPENIA,2
JP,FOETAL DISTRESS SYNDROME,2
JP,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
JP,HEART RATE DECREASED,2
JP,HEPATIC ENCEPHALOPATHY,2
JP,HEPATIC STEATOSIS,2
JP,HYPOGLYCAEMIA,2
JP,IGA NEPHROPATHY,2
JP,INJECTION SITE VESICLES,2
JP,LIVER DISORDER,2
JP,LOWER GASTROINTESTINAL HAEMORRHAGE,2
JP,MATERNAL DRUGS AFFECTING FOETUS,2
JP,MITRAL VALVE INCOMPETENCE,2
JP,NEUROGENIC BLADDER,2
JP,NON-ALCOHOLIC STEATOHEPATITIS,2
JP,OCCULT BLOOD POSITIVE,2
JP,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,2
JP,PERITONEAL DISORDER,2
JP,PLEURAL EFFUSION,2
JP,PNEUMONIA BACTERIAL,2
JP,PREMATURE LABOUR,2
JP,PRODUCT USE IN UNAPPROVED INDICATION,2
JP,PYELONEPHRITIS,2
JP,RED BLOOD CELL COUNT DECREASED,2
JP,SEPSIS,2
JP,SHOCK,2
JP,SINUS ARREST,2
JP,STEVENS-JOHNSON SYNDROME,2
JP,SUBCUTANEOUS ABSCESS,2
JP,SUPRAVENTRICULAR EXTRASYSTOLES,2
JP,SYNCOPE,2
JP,THROMBOCYTOPENIA,2
JP,UPPER GASTROINTESTINAL HAEMORRHAGE,2
JP,UTERINE LEIOMYOMA,2
JP,VOMITING,2
JP,WEIGHT DECREASED,2
JP,ABDOMINAL DISCOMFORT,1
JP,ABDOMINAL PAIN UPPER,1
JP,ABDOMINAL REBOUND TENDERNESS,1
JP,ACCIDENTAL OVERDOSE,1
JP,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
JP,ACUTE KIDNEY INJURY,1
JP,ACUTE MYOCARDIAL INFARCTION,1
JP,ALOPECIA,1
JP,AMMONIA INCREASED,1
JP,ANAPHYLACTIC SHOCK,1
JP,AORTIC CALCIFICATION,1
JP,ARTERIOSCLEROSIS CORONARY ARTERY,1
JP,ARTERIOVENOUS SHUNT OPERATION,1
JP,ASPARTATE AMINOTRANSFERASE INCREASED,1
JP,ASPIRATION,1
JP,ASTHMA,1
JP,ATRIAL TACHYCARDIA,1
JP,BASILAR ARTERY OCCLUSION,1
JP,BLOOD BILIRUBIN INCREASED,1
JP,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
JP,BLOOD POTASSIUM DECREASED,1
JP,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
JP,BLOOD PRESSURE INCREASED,1
JP,BONE MARROW FAILURE,1
JP,BRADYPHRENIA,1
JP,BRONCHIECTASIS,1
JP,BRONCHOPNEUMONIA,1
JP,BURSITIS,1
JP,CAESAREAN SECTION,1
JP,CARDIAC ARREST,1
JP,CARDIAC FAILURE CHRONIC,1
JP,CARDIAC FAILURE CONGESTIVE,1
JP,CARDIO-RESPIRATORY ARREST,1
JP,CARDIOGENIC SHOCK,1
JP,CEREBRAL HAEMORRHAGE,1
JP,CHOLECYSTITIS,1
JP,CHOLELITHIASIS,1
JP,CHRONIC KIDNEY DISEASE,1
JP,COCCYDYNIA,1
JP,COLON CANCER,1
JP,COMPARTMENT SYNDROME,1
JP,COMPUTERISED TOMOGRAM THORAX ABNORMAL,1
JP,CONFUSIONAL STATE,1
JP,CONGESTIVE CARDIOMYOPATHY,1
JP,CONTINUOUS HAEMODIAFILTRATION,1
JP,CONTRAINDICATED PRODUCT ADMINISTERED,1
JP,DEHYDRATION,1
JP,DELIVERY,1
JP,DERMATITIS ACNEIFORM,1
JP,DIARRHOEA,1
JP,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
JP,DRUG LEVEL INCREASED,1
JP,DRUG-INDUCED LIVER INJURY,1
JP,DYSGEUSIA,1
JP,DYSPNOEA EXERTIONAL,1
JP,EJECTION FRACTION DECREASED,1
JP,EMBOLIC STROKE,1
JP,ENCEPHALOPATHY,1
JP,ENTERITIS,1
JP,ENTEROCOLITIS,1
JP,ERYTHEMA,1
JP,FAECES SOFT,1
JP,FALL,1
JP,FATIGUE,1
JP,FEELING ABNORMAL,1
JP,FOAMING AT MOUTH,1
JP,FOETAL GROWTH RESTRICTION,1
JP,FOLLICULITIS,1
JP,FUNGAL INFECTION,1
JP,GALLBLADDER POLYP,1
JP,GASTRIC ULCER HAEMORRHAGE,1
JP,GASTROENTERITIS,1
JP,GASTROENTERITIS NOROVIRUS,1
JP,GASTROOESOPHAGEAL REFLUX DISEASE,1
JP,GINGIVAL BLEEDING,1
JP,GINGIVAL DISORDER,1
JP,HAEMATOCHEZIA,1
JP,HAEMATOMA,1
JP,HAEMATURIA,1
JP,HEADACHE,1
JP,HEART SOUNDS ABNORMAL,1
JP,HEPATIC CIRRHOSIS,1
JP,HEPATIC ENZYME INCREASED,1
JP,HEPATIC FAILURE,1
JP,HYPERKALAEMIA,1
JP,HYPOKALAEMIA,1
JP,HYPONATRAEMIA,1
JP,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
JP,INFLAMMATION,1
JP,INJECTION SITE ERYTHEMA,1
JP,INJECTION SITE PAIN,1
JP,INJECTION SITE SWELLING,1
JP,INJECTION SITE VASCULITIS,1
JP,INJURY,1
JP,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
JP,INTERNATIONAL NORMALISED RATIO INCREASED,1
JP,INTERSTITIAL LUNG DISEASE,1
JP,INTESTINAL HAEMORRHAGE,1
JP,JEJUNAL ULCER,1
JP,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
JP,LACUNAR INFARCTION,1
JP,LONG QT SYNDROME,1
JP,MALABSORPTION,1
JP,MILIARIA,1
JP,MITRAL VALVE CALCIFICATION,1
JP,MUSCULOSKELETAL PAIN,1
JP,MYOCARDIAL INFARCTION,1
JP,NEUROLOGIC NEGLECT SYNDROME,1
JP,NEUTROPENIA,1
JP,NEUTROPHIL COUNT DECREASED,1
JP,NONREASSURING FOETAL HEART RATE PATTERN,1
JP,NORMAL NEWBORN,1
JP,OBSTRUCTED LABOUR,1
JP,OSTEOMYELITIS,1
JP,PAIN,1
JP,PALPITATIONS,1
JP,PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA,1
JP,PEMPHIGOID,1
JP,PERIARTHRITIS,1
JP,PERITONITIS,1
JP,PHLEBITIS,1
JP,PNEUMONIA ASPIRATION,1
JP,POLLAKIURIA,1
JP,PRESCRIBED UNDERDOSE,1
JP,PROLONGED LABOUR,1
JP,PRURITUS,1
JP,PULMONARY ALVEOLAR HAEMORRHAGE,1
JP,PULMONARY EMBOLISM,1
JP,PULMONARY HYPERTENSION,1
JP,PURPURA,1
JP,RENAL ABSCESS,1
JP,RENAL DISORDER,1
JP,RHABDOMYOLYSIS,1
JP,RIGHT VENTRICULAR HYPERTROPHY,1
JP,ROAD TRAFFIC ACCIDENT,1
JP,SINUS NODE DYSFUNCTION,1
JP,SKIN HAEMORRHAGE,1
JP,SQUAMOUS CELL CARCINOMA OF SKIN,1
JP,STOMATITIS,1
JP,SUDDEN DEATH,1
JP,SUDDEN HEARING LOSS,1
JP,SUPRAVENTRICULAR TACHYCARDIA,1
JP,TACHYCARDIA,1
JP,TINEA PEDIS,1
JP,TINNITUS,1
JP,TRANSIENT ISCHAEMIC ATTACK,1
JP,ULCER,1
JP,UPPER RESPIRATORY TRACT INFECTION,1
JP,URINARY TRACT INFECTION,1
JP,URINE ABNORMALITY,1
JP,URINE SODIUM INCREASED,1
JP,VENTRICULAR FIBRILLATION,1
JP,VERTIGO,1
JP,WEIGHT INCREASED,1
JP,WHITE MATTER LESION,1
JP,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
JP,YERSINIA SEPSIS,1
KE,PANCREATITIS ACUTE,1
KR,ASPARTATE AMINOTRANSFERASE INCREASED,2
KR,ABDOMINAL PAIN,1
KR,ACUTE KIDNEY INJURY,1
KR,ALANINE AMINOTRANSFERASE INCREASED,1
KR,ASCITES,1
KR,BLOOD ALKALINE PHOSPHATASE INCREASED,1
KR,DEATH,1
KR,FATIGUE,1
KR,HYPERKALAEMIA,1
KR,HYPOTENSION,1
KR,LARGE INTESTINAL OBSTRUCTION,1
KR,MENTAL STATUS CHANGES,1
KR,SINUS BRADYCARDIA,1
KW,ANAEMIA,3
KW,RHABDOMYOLYSIS,3
KW,ACUTE KIDNEY INJURY,2
KW,ANURIA,2
KW,ASPARTATE AMINOTRANSFERASE INCREASED,1
KW,BLOOD BILIRUBIN INCREASED,1
KW,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
KW,DRUG INEFFECTIVE,1
KW,DRUG LEVEL INCREASED,1
KW,DYSURIA,1
KW,FATIGUE,1
KW,GASTROENTERITIS ESCHERICHIA COLI,1
KW,MYALGIA,1
KW,PROSTATIC DISORDER,1
KW,PROSTATIC PAIN,1
LV,OEDEMA PERIPHERAL,2
LV,ABDOMINAL PAIN,1
LV,HEPATIC PAIN,1
LV,NAUSEA,1
LV,PAIN IN EXTREMITY,1
LV,PULMONARY HYPERTENSION,1
LV,RIGHT VENTRICULAR FAILURE,1
LV,UTERINE HAEMORRHAGE,1
LV,WEIGHT INCREASED,1
LT,DRUG INEFFECTIVE,7
LT,CARDIAC FAILURE ACUTE,5
LT,CONDITION AGGRAVATED,5
LT,DIABETES MELLITUS,3
LT,ALANINE AMINOTRANSFERASE INCREASED,2
LT,ASPARTATE AMINOTRANSFERASE INCREASED,2
LT,BLOOD ALKALINE PHOSPHATASE INCREASED,2
LT,BLOOD BILIRUBIN INCREASED,2
LT,BLOOD LACTATE DEHYDROGENASE INCREASED,2
LT,CEREBROVASCULAR ACCIDENT,2
LT,DIZZINESS,2
LT,ELECTROCARDIOGRAM QT PROLONGED,2
LT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
LT,HEPATIC ENZYME INCREASED,2
LT,HEPATITIS ACUTE,2
LT,HEPATOTOXICITY,2
LT,HYPOTENSION,2
LT,ISCHAEMIC STROKE,2
LT,LIVER DISORDER,2
LT,RESPIRATORY FAILURE,2
LT,RETROVIRAL REBOUND SYNDROME,2
LT,ABSCESS LIMB,1
LT,AMNESIA,1
LT,ANXIETY,1
LT,ASTHENIA,1
LT,ATRIAL FIBRILLATION,1
LT,BLISTER,1
LT,BLOOD URINE PRESENT,1
LT,BRONCHITIS,1
LT,C-REACTIVE PROTEIN INCREASED,1
LT,CARDIAC FAILURE,1
LT,CEREBRAL ISCHAEMIA,1
LT,CHRONIC KIDNEY DISEASE,1
LT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
LT,CONFUSIONAL STATE,1
LT,DIARRHOEA,1
LT,DISORIENTATION,1
LT,EPISTAXIS,1
LT,EXOSTOSIS,1
LT,FEBRILE NEUTROPENIA,1
LT,FLANK PAIN,1
LT,FOETAL EXPOSURE DURING PREGNANCY,1
LT,FUNGAL SEPSIS,1
LT,HEADACHE,1
LT,INFLAMMATION,1
LT,LUNG ADENOCARCINOMA,1
LT,MALAISE,1
LT,MATERNAL EXPOSURE DURING PREGNANCY,1
LT,MUSCULAR WEAKNESS,1
LT,NEUROENDOCRINE CARCINOMA OF THE SKIN,1
LT,NEUROLEPTIC MALIGNANT SYNDROME,1
LT,POISONING,1
LT,PREMATURE BABY,1
LT,PREMATURE DELIVERY,1
LT,SOMNOLENCE,1
LT,SPEECH DISORDER,1
LT,SUBCUTANEOUS ABSCESS,1
LT,TONSILLITIS,1
LT,VENTRICULAR TACHYCARDIA,1
LT,VESTIBULAR ATAXIA,1
MO,ACUTE RESPIRATORY FAILURE,1
MO,ENCEPHALOPATHY,1
MO,HEPATIC FAILURE,1
MO,PLASMA CELL MYELOMA,1
MO,PULMONARY OEDEMA,1
MY,DYSPNOEA,7
MY,ATRIAL FIBRILLATION,4
MY,CARDIAC FAILURE,3
MY,FOETAL EXPOSURE DURING PREGNANCY,3
MY,LOW BIRTH WEIGHT BABY,3
MY,PREMATURE BABY,3
MY,ABDOMINAL PAIN UPPER,2
MY,ACUTE PULMONARY OEDEMA,2
MY,ANAEMIA,2
MY,END STAGE RENAL DISEASE,2
MY,FLUID OVERLOAD,2
MY,HYPOGLYCAEMIA,2
MY,INFECTION,2
MY,NOSOCOMIAL INFECTION,2
MY,SEPSIS,2
MY,STEVENS-JOHNSON SYNDROME,2
MY,ABDOMINAL PAIN,1
MY,ACUTE ABDOMEN,1
MY,ACUTE CORONARY SYNDROME,1
MY,ACUTE KIDNEY INJURY,1
MY,ACUTE MYOCARDIAL INFARCTION,1
MY,ANEURYSM,1
MY,ANGIOEDEMA,1
MY,AORTIC ANEURYSM,1
MY,AORTIC ARTERIOSCLEROSIS,1
MY,BLOOD ALKALINE PHOSPHATASE INCREASED,1
MY,BLOOD BILIRUBIN INCREASED,1
MY,BLOOD CREATININE INCREASED,1
MY,BLOOD LACTATE DEHYDROGENASE INCREASED,1
MY,CARDIAC TAMPONADE,1
MY,CARDIOMEGALY,1
MY,CEREBRAL INFARCTION,1
MY,CHEST DISCOMFORT,1
MY,CHRONIC KIDNEY DISEASE,1
MY,CONSTIPATION,1
MY,CONTUSION,1
MY,CORONARY ARTERY DISEASE,1
MY,CREPITATIONS,1
MY,DEATH,1
MY,DECREASED APPETITE,1
MY,DEVICE RELATED INFECTION,1
MY,DIARRHOEA,1
MY,DRUG INEFFECTIVE,1
MY,DRUG INTOLERANCE,1
MY,DYSKINESIA,1
MY,DYSPHAGIA,1
MY,FACE OEDEMA,1
MY,FLUID RETENTION,1
MY,GINGIVAL BLEEDING,1
MY,GLOMERULAR FILTRATION RATE,1
MY,GLOMERULAR FILTRATION RATE DECREASED,1
MY,HAEMODIALYSIS,1
MY,HAEMORRHAGE,1
MY,HAEMORRHOIDAL HAEMORRHAGE,1
MY,HYPERACUSIS,1
MY,HYPORESPONSIVE TO STIMULI,1
MY,INTERNATIONAL NORMALISED RATIO FLUCTUATION,1
MY,INTERNATIONAL NORMALISED RATIO INCREASED,1
MY,INTERVERTEBRAL DISCITIS,1
MY,INTESTINAL ISCHAEMIA,1
MY,LIPASE INCREASED,1
MY,MYOCARDIAL ISCHAEMIA,1
MY,NAUSEA,1
MY,NECROTISING FASCIITIS,1
MY,NEPHROGENIC ANAEMIA,1
MY,ORBITAL OEDEMA,1
MY,PERIPHERAL SWELLING,1
MY,PLEURAL EFFUSION,1
MY,PNEUMONIA,1
MY,PROTHROMBIN TIME PROLONGED,1
MY,PURPURA,1
MY,PYREXIA,1
MY,REFUSAL OF TREATMENT BY PATIENT,1
MY,RENAL FAILURE ACUTE,1
MY,RENAL IMPAIRMENT,1
MY,RESPIRATORY DISTRESS,1
MY,RHABDOMYOLYSIS,1
MY,SPINAL DISORDER,1
MY,STAPHYLOCOCCAL INFECTION,1
MY,THERAPEUTIC RESPONSE DECREASED,1
MY,THROMBOPHLEBITIS,1
MY,TOXICITY TO VARIOUS AGENTS,1
MY,TUBERCULOSIS,1
MY,VISION BLURRED,1
MY,VOMITING,1
MY,WEIGHT INCREASED,1
MX,BLOOD PRESSURE INCREASED,28
MX,HYPERTENSION,24
MX,DIZZINESS,16
MX,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,16
MX,DYSPNOEA,15
MX,BLOOD GLUCOSE INCREASED,14
MX,HEADACHE,14
MX,RENAL FAILURE,14
MX,FATIGUE,13
MX,DRUG PRESCRIBING ERROR,12
MX,MALAISE,12
MX,URINARY TRACT INFECTION,12
MX,ASTHENIA,11
MX,WRONG TECHNIQUE IN DRUG USAGE PROCESS,11
MX,DIABETES MELLITUS,10
MX,FALL,10
MX,INFARCTION,10
MX,BLOOD PRESSURE DECREASED,9
MX,DIARRHOEA,9
MX,MYOCARDIAL INFARCTION,9
MX,DRUG INEFFECTIVE,8
MX,GENERAL PHYSICAL HEALTH DETERIORATION,8
MX,HYPERGLYCAEMIA,8
MX,INCORRECT DOSE ADMINISTERED,8
MX,PRODUCT USE IN UNAPPROVED INDICATION,8
MX,ARRHYTHMIA,7
MX,CARDIAC FAILURE,7
MX,CARDIOMEGALY,7
MX,CATARACT,7
MX,GAIT DISTURBANCE,7
MX,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,7
MX,PAIN,7
MX,PNEUMONIA,7
MX,ARTHRALGIA,6
MX,BLOOD PRESSURE INADEQUATELY CONTROLLED,6
MX,CARDIAC DISORDER,6
MX,CEREBROVASCULAR ACCIDENT,6
MX,CHEST PAIN,6
MX,GASTRITIS,6
MX,HYPOGLYCAEMIA,6
MX,HYPOTENSION,6
MX,NAUSEA,6
MX,PAIN IN EXTREMITY,6
MX,PRODUCT USE ISSUE,6
MX,VOMITING,6
MX,WEIGHT DECREASED,6
MX,ABDOMINAL PAIN UPPER,5
MX,ANAEMIA,5
MX,APPENDICITIS,5
MX,ARTHROPATHY,5
MX,CARDIO-RESPIRATORY ARREST,5
MX,DECREASED APPETITE,5
MX,DEPRESSED MOOD,5
MX,FEELING ABNORMAL,5
MX,HYPERTENSIVE CRISIS,5
MX,MOBILITY DECREASED,5
MX,VISION BLURRED,5
MX,ABASIA,4
MX,ANXIETY,4
MX,BLOOD CHOLESTEROL INCREASED,4
MX,BLOOD CREATININE INCREASED,4
MX,CONSTIPATION,4
MX,DEPRESSION,4
MX,DISCOMFORT,4
MX,DRY SKIN,4
MX,INFLUENZA,4
MX,LOCAL SWELLING,4
MX,MUSCULAR WEAKNESS,4
MX,NEPHROLITHIASIS,4
MX,OEDEMA PERIPHERAL,4
MX,ORAL CANDIDIASIS,4
MX,PALLOR,4
MX,PERIPHERAL SWELLING,4
MX,PLEURAL EFFUSION,4
MX,RESPIRATORY FAILURE,4
MX,SKIN DISCOLOURATION,4
MX,SOMNOLENCE,4
MX,TACHYCARDIA,4
MX,VISUAL IMPAIRMENT,4
MX,WEIGHT INCREASED,4
MX,ABDOMINAL DISCOMFORT,3
MX,ABDOMINAL PAIN,3
MX,ACUTE RESPIRATORY DISTRESS SYNDROME,3
MX,ALOPECIA,3
MX,ANGINA PECTORIS,3
MX,BLOOD GLUCOSE DECREASED,3
MX,BLOOD PRESSURE FLUCTUATION,3
MX,BLOOD TRIGLYCERIDES INCREASED,3
MX,BONE PAIN,3
MX,CHEILITIS,3
MX,CHONDROPATHY,3
MX,CONCOMITANT DISEASE AGGRAVATED,3
MX,COUGH,3
MX,DEAFNESS,3
MX,DEATH,3
MX,DEHYDRATION,3
MX,DRY MOUTH,3
MX,ERYTHEMA,3
MX,FEAR,3
MX,FLUID RETENTION,3
MX,GASTRIC ULCER,3
MX,GLUCOSE TOLERANCE IMPAIRED,3
MX,HAEMOGLOBIN DECREASED,3
MX,HEART RATE INCREASED,3
MX,HEPATIC STEATOSIS,3
MX,INSOMNIA,3
MX,LIMB DISCOMFORT,3
MX,LYMPHOCYTE COUNT DECREASED,3
MX,MUCOSAL ATROPHY,3
MX,MUCOSAL INFLAMMATION,3
MX,OEDEMA,3
MX,OVERWEIGHT,3
MX,PLATELET COUNT DECREASED,3
MX,POST INFLAMMATORY PIGMENTATION CHANGE,3
MX,PRURITUS,3
MX,SEPSIS,3
MX,SPEECH DISORDER,3
MX,SYNCOPE,3
MX,URTICARIA,3
MX,ACUTE KIDNEY INJURY,2
MX,ALANINE AMINOTRANSFERASE INCREASED,2
MX,ANGINA UNSTABLE,2
MX,ARTERIAL OCCLUSIVE DISEASE,2
MX,ASPARTATE AMINOTRANSFERASE INCREASED,2
MX,ASPHYXIA,2
MX,BALANCE DISORDER,2
MX,BLISTER,2
MX,BLOOD PRESSURE ABNORMAL,2
MX,BONE DISORDER,2
MX,BRADYCARDIA,2
MX,BRAIN HYPOXIA,2
MX,BREAST CANCER,2
MX,BURNING SENSATION,2
MX,CEREBRAL INFARCTION,2
MX,CEREBRAL THROMBOSIS,2
MX,CHEST DISCOMFORT,2
MX,CHILLS,2
MX,CHRONIC KIDNEY DISEASE,2
MX,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
MX,COAGULOPATHY,2
MX,COMMUNICATION DISORDER,2
MX,CONDITION AGGRAVATED,2
MX,CONGESTIVE CARDIOMYOPATHY,2
MX,CORONARY ARTERY OCCLUSION,2
MX,CYANOSIS,2
MX,CYST,2
MX,DEMENTIA ALZHEIMER^S TYPE,2
MX,DISORIENTATION,2
MX,DRUG DOSE OMISSION,2
MX,DRUG HYPERSENSITIVITY,2
MX,DRUG INTOLERANCE,2
MX,DYSPEPSIA,2
MX,DYSPHONIA,2
MX,DYSURIA,2
MX,EATING DISORDER,2
MX,ELECTROLYTE IMBALANCE,2
MX,EXPOSURE DURING PREGNANCY,2
MX,EYE IRRITATION,2
MX,EYELID OEDEMA,2
MX,FACE OEDEMA,2
MX,FEELING OF DESPAIR,2
MX,GALLBLADDER DISORDER,2
MX,GASTRIC DISORDER,2
MX,GASTROINTESTINAL HAEMORRHAGE,2
MX,HAEMATURIA,2
MX,HAND FRACTURE,2
MX,HEAD INJURY,2
MX,HEMIPLEGIA,2
MX,HYPERHIDROSIS,2
MX,HYPOAESTHESIA,2
MX,HYPONATRAEMIA,2
MX,INJECTION SITE HAEMORRHAGE,2
MX,INJECTION SITE PAIN,2
MX,KIDNEY INFECTION,2
MX,LIMB INJURY,2
MX,LOSS OF CONSCIOUSNESS,2
MX,MASS,2
MX,MEMORY IMPAIRMENT,2
MX,METABOLIC SYNDROME,2
MX,METASTASES TO LIVER,2
MX,METASTASES TO SPLEEN,2
MX,MOVEMENT DISORDER,2
MX,MULTI-ORGAN FAILURE,2
MX,MUSCLE SPASMS,2
MX,MYALGIA,2
MX,NECK PAIN,2
MX,ORAL DISORDER,2
MX,PAIN OF SKIN,2
MX,PALPITATIONS,2
MX,PERITONITIS,2
MX,PROSTATOMEGALY,2
MX,PULMONARY EMBOLISM,2
MX,PYREXIA,2
MX,RENAL DISORDER,2
MX,RENAL INJURY,2
MX,RENAL PAIN,2
MX,SEPTIC SHOCK,2
MX,SKIN EXFOLIATION,2
MX,SWELLING,2
MX,THIRST,2
MX,TINNITUS,2
MX,TREMOR,2
MX,VARICOSE VEIN,2
MX,VENOUS OCCLUSION,2
MX,VISUAL ACUITY REDUCED,2
MX,ABDOMINAL DISTENSION,1
MX,ABNORMAL BEHAVIOUR,1
MX,ABSCESS,1
MX,ACCIDENT,1
MX,ACUTE MYOCARDIAL INFARCTION,1
MX,ACUTE PULMONARY OEDEMA,1
MX,ACUTE RESPIRATORY FAILURE,1
MX,ADVERSE EVENT,1
MX,AGITATION,1
MX,AMNESIA,1
MX,ANAL HAEMORRHAGE,1
MX,ANGER,1
MX,ANGIOEDEMA,1
MX,ANGIOPATHY,1
MX,ANKLE FRACTURE,1
MX,ANURIA,1
MX,AORTIC STENOSIS,1
MX,AORTIC VALVE REPLACEMENT,1
MX,APPLICATION SITE BURN,1
MX,APPLICATION SITE EXFOLIATION,1
MX,APPLICATION SITE INJURY,1
MX,APPLICATION SITE IRRITATION,1
MX,APPLICATION SITE LACERATION,1
MX,APPLICATION SITE PAIN,1
MX,APPLICATION SITE PRURITUS,1
MX,APPLICATION SITE SCAR,1
MX,ARTHRITIS,1
MX,ARTHRITIS BACTERIAL,1
MX,ARTHRITIS REACTIVE,1
MX,ASPIRATION BRONCHIAL,1
MX,ASTHENOPIA,1
MX,ASTHMA,1
MX,ASTHMATIC CRISIS,1
MX,ATYPICAL PNEUMONIA,1
MX,AZOTAEMIA,1
MX,BACK PAIN,1
MX,BILE DUCT STONE,1
MX,BLINDNESS TRANSIENT,1
MX,BLINDNESS UNILATERAL,1
MX,BLOOD ANDROSTENEDIONE INCREASED,1
MX,BLOOD BILIRUBIN INCREASED,1
MX,BLOOD CHOLESTEROL ABNORMAL,1
MX,BLOOD CREATININE DECREASED,1
MX,BLOOD DISORDER,1
MX,BLOOD GLUCOSE FLUCTUATION,1
MX,BLOOD POTASSIUM ABNORMAL,1
MX,BLOOD PRESSURE SYSTOLIC INCREASED,1
MX,BLOOD TESTOSTERONE INCREASED,1
MX,BLOOD UREA INCREASED,1
MX,BLOOD URIC ACID INCREASED,1
MX,BODY TEMPERATURE INCREASED,1
MX,BONE CYST,1
MX,BONE DENSITY ABNORMAL,1
MX,BONE TUBERCULOSIS,1
MX,BOWEL MOVEMENT IRREGULARITY,1
MX,BRAIN INJURY,1
MX,BRAIN NEOPLASM,1
MX,BREAST PAIN,1
MX,BRONCHIAL DISORDER,1
MX,BRONCHITIS,1
MX,CARBOHYDRATE INTOLERANCE,1
MX,CARDIAC FAILURE CONGESTIVE,1
MX,CARDIAC OUTPUT DECREASED,1
MX,CARDIOMYOPATHY,1
MX,CEREBRAL ATROPHY,1
MX,CEREBROVASCULAR DISORDER,1
MX,CERVIX CARCINOMA STAGE II,1
MX,CHOKING SENSATION,1
MX,COGNITIVE DISORDER,1
MX,COLITIS,1
MX,COLON CANCER,1
MX,COLOUR BLINDNESS ACQUIRED,1
MX,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
MX,CONVULSION,1
MX,CORONARY ARTERY DISEASE,1
MX,CREATININE RENAL CLEARANCE DECREASED,1
MX,CROHN^S DISEASE,1
MX,CYTOMEGALOVIRUS INFECTION,1
MX,DEAFNESS TRANSITORY,1
MX,DEAFNESS UNILATERAL,1
MX,DEHYDROEPIANDROSTERONE DECREASED,1
MX,DELIRIUM,1
MX,DERMATITIS ALLERGIC,1
MX,DIABETES MELLITUS INADEQUATE CONTROL,1
MX,DIABETIC COMPLICATION,1
MX,DIABETIC NEPHROPATHY,1
MX,DIABETIC NEUROPATHY,1
MX,DISEASE COMPLICATION,1
MX,DISSEMINATED INTRAVASCULAR COAGULATION,1
MX,DISTURBANCE IN ATTENTION,1
MX,DIVERTICULITIS,1
MX,DRUG ADMINISTRATION ERROR,1
MX,DRUG DEPENDENCE,1
MX,DRUG EFFECT DECREASED,1
MX,DYSGEUSIA,1
MX,DYSGRAPHIA,1
MX,DYSLIPIDAEMIA,1
MX,DYSPHEMIA,1
MX,EAR CONGESTION,1
MX,EAR DISORDER,1
MX,EJECTION FRACTION DECREASED,1
MX,EMBOLISM,1
MX,EMPHYSEMA,1
MX,ENDOMETRIAL CANCER STAGE IV,1
MX,ENTERITIS INFECTIOUS,1
MX,ENTEROCOLITIS INFECTIOUS,1
MX,EPILEPSY,1
MX,ERECTILE DYSFUNCTION,1
MX,ERUCTATION,1
MX,ERYTHEMA OF EYELID,1
MX,ESCHERICHIA TEST POSITIVE,1
MX,ESCHERICHIA URINARY TRACT INFECTION,1
MX,EXPIRED DRUG ADMINISTERED,1
MX,EYE DISORDER,1
MX,EYE PAIN,1
MX,FEELING COLD,1
MX,FEELING HOT,1
MX,FEELING OF BODY TEMPERATURE CHANGE,1
MX,FEMUR FRACTURE,1
MX,FINGER DEFORMITY,1
MX,FLANK PAIN,1
MX,FLATULENCE,1
MX,FOOD POISONING,1
MX,FOOT DEFORMITY,1
MX,FOREIGN BODY SENSATION IN EYES,1
MX,GASTRIC CANCER,1
MX,GASTRIC ULCER PERFORATION,1
MX,GASTRITIS EROSIVE,1
MX,GASTROENTERITIS,1
MX,GASTROINTESTINAL PAIN,1
MX,GASTROOESOPHAGEAL REFLUX DISEASE,1
MX,GINGIVAL ULCERATION,1
MX,GLAUCOMA,1
MX,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
MX,H1N1 INFLUENZA,1
MX,HAEMATOCRIT DECREASED,1
MX,HAEMATOMA,1
MX,HAEMATOTOXICITY,1
MX,HAEMORRHAGE,1
MX,HEARING IMPAIRED,1
MX,HEART RATE DECREASED,1
MX,HEPATIC CANCER,1
MX,HEPATIC CIRRHOSIS,1
MX,HEPATIC FAILURE,1
MX,HEPATIC FUNCTION ABNORMAL,1
MX,HEPATIC PAIN,1
MX,HEPATITIS,1
MX,HEPATOCELLULAR CARCINOMA,1
MX,HERPES ZOSTER,1
MX,HIP FRACTURE,1
MX,HUNGER,1
MX,HYPERKERATOSIS,1
MX,HYPERSENSITIVITY,1
MX,HYPERSOMNIA,1
MX,HYPERURICAEMIA,1
MX,HYPERVOLAEMIA,1
MX,HYPOACUSIS,1
MX,HYPOCHROMIC ANAEMIA,1
MX,HYPOTHYROIDISM,1
MX,IIIRD NERVE PARALYSIS,1
MX,INCOHERENT,1
MX,INCREASED UPPER AIRWAY SECRETION,1
MX,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
MX,INFLAMMATION,1
MX,INFLUENZA LIKE ILLNESS,1
MX,INFUSION RELATED REACTION,1
MX,INGUINAL HERNIA,1
MX,INJECTION SITE HAEMATOMA,1
MX,INJECTION SITE SWELLING,1
MX,INTENTIONAL OVERDOSE,1
MX,INTENTIONAL PRODUCT MISUSE,1
MX,INTENTIONAL PRODUCT USE ISSUE,1
MX,INTERNAL INJURY,1
MX,INTESTINAL ISCHAEMIA,1
MX,INTESTINAL OBSTRUCTION,1
MX,INTESTINAL PERFORATION,1
MX,INTRACRANIAL ANEURYSM,1
MX,JAUNDICE,1
MX,JOINT INJURY,1
MX,KETOACIDOSIS,1
MX,LACUNAR INFARCTION,1
MX,LEUKOPENIA,1
MX,LIGAMENT RUPTURE,1
MX,LIGAMENT SPRAIN,1
MX,LISTLESS,1
MX,LIVER DISORDER,1
MX,LIVER FUNCTION TEST ABNORMAL,1
MX,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
MX,LOWER LIMB FRACTURE,1
MX,LUMBAR VERTEBRAL FRACTURE,1
MX,LUNG DISORDER,1
MX,LYMPHOEDEMA,1
MX,MACULAR OEDEMA,1
MX,MACULOPATHY,1
MX,MATERNAL EXPOSURE DURING PREGNANCY,1
MX,MENINGIOMA,1
MX,METABOLIC ACIDOSIS,1
MX,METABOLIC DISORDER,1
MX,METASTASES TO CENTRAL NERVOUS SYSTEM,1
MX,METASTASES TO STOMACH,1
MX,METASTATIC GASTRIC CANCER,1
MX,MICTURITION URGENCY,1
MX,MITRAL VALVE INCOMPETENCE,1
MX,MOOD ALTERED,1
MX,MOUTH SWELLING,1
MX,MUSCLE CONTRACTIONS INVOLUNTARY,1
MX,MUSCLE INJURY,1
MX,MUSCULOSKELETAL PAIN,1
MX,MYCOBACTERIAL INFECTION,1
MX,MYOCARDITIS,1
MX,MYOPATHY,1
MX,NASOPHARYNGITIS,1
MX,NEOPLASM MALIGNANT,1
MX,NEOPLASM SKIN,1
MX,NEPHRITIS,1
MX,NEPHROTIC SYNDROME,1
MX,NERVOUS SYSTEM DISORDER,1
MX,NERVOUSNESS,1
MX,NEUROPATHY PERIPHERAL,1
MX,NEUTROPENIA,1
MX,OBSTRUCTIVE AIRWAYS DISORDER,1
MX,OLIGURIA,1
MX,ORAL PAIN,1
MX,OSTEOPOROSIS,1
MX,OVARIAN CANCER,1
MX,PANCREATIC DISORDER,1
MX,PANCREATITIS,1
MX,PARALYSIS,1
MX,PARKINSON^S DISEASE,1
MX,PAROSMIA,1
MX,PERCUTANEOUS CORONARY INTERVENTION,1
MX,PERIPHERAL COLDNESS,1
MX,PETIT MAL EPILEPSY,1
MX,PHARYNGEAL MASS,1
MX,PHARYNGEAL ULCERATION,1
MX,PHARYNGITIS,1
MX,PNEUMOPERITONEUM,1
MX,POLLAKIURIA,1
MX,POLYARTHRITIS,1
MX,POLYURIA,1
MX,PRESCRIBED OVERDOSE,1
MX,PRESCRIBED UNDERDOSE,1
MX,PRODUCT SUBSTITUTION,1
MX,PRODUCT SUPPLY ISSUE,1
MX,PRODUCTIVE COUGH,1
MX,PROSOPAGNOSIA,1
MX,PROSTATE CANCER,1
MX,PROSTATIC DISORDER,1
MX,PROSTATITIS,1
MX,PROTEINURIA,1
MX,PSEUDOMONAS INFECTION,1
MX,PULMONARY THROMBOSIS,1
MX,RASH,1
MX,RASH MACULO-PAPULAR,1
MX,RECTAL HAEMORRHAGE,1
MX,RENAL CANCER,1
MX,RENAL FAILURE ACUTE,1
MX,RENAL IMPAIRMENT,1
MX,RENAL NEOPLASM,1
MX,RESPIRATORY DISORDER,1
MX,RESPIRATORY DISTRESS,1
MX,RETINAL TEAR,1
MX,RETINAL VEIN THROMBOSIS,1
MX,RHABDOMYOLYSIS,1
MX,RHEUMATOID ARTHRITIS,1
MX,RIGHT VENTRICULAR FAILURE,1
MX,ROTATOR CUFF SYNDROME,1
MX,SENILE DEMENTIA,1
MX,SILENT MYOCARDIAL INFARCTION,1
MX,SKIN BURNING SENSATION,1
MX,SKIN HAEMORRHAGE,1
MX,SKIN INDURATION,1
MX,SKIN LESION,1
MX,SKIN SWELLING,1
MX,SLEEP DISORDER,1
MX,SOFT TISSUE INFECTION,1
MX,SPINAL COMPRESSION FRACTURE,1
MX,SPINAL DEFORMITY,1
MX,SPINAL PAIN,1
MX,STOMATITIS,1
MX,STRESS,1
MX,SUFFOCATION FEELING,1
MX,SURGERY,1
MX,SWELLING FACE,1
MX,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
MX,SYSTEMIC LUPUS ERYTHEMATOSUS,1
MX,TENSION,1
MX,THORACIC VERTEBRAL FRACTURE,1
MX,THROMBOSIS,1
MX,THYROID CANCER,1
MX,THYROID DISORDER,1
MX,THYROID NEOPLASM,1
MX,TONGUE OEDEMA,1
MX,TONGUE ULCERATION,1
MX,TORTICOLLIS,1
MX,TRANSFUSION,1
MX,TREATMENT NONCOMPLIANCE,1
MX,TYPE 2 DIABETES MELLITUS,1
MX,ULCERATIVE KERATITIS,1
MX,UNDERDOSE,1
MX,UPPER GASTROINTESTINAL HAEMORRHAGE,1
MX,UPPER LIMB FRACTURE,1
MX,URINE ANALYSIS ABNORMAL,1
MX,URINE FLOW DECREASED,1
MX,UTERINE HAEMORRHAGE,1
MX,VARICOCELE,1
MX,VENTRICULAR EXTRASYSTOLES,1
MX,VERTIGO,1
MX,VITREOUS HAEMORRHAGE,1
MX,WEIGHT ABNORMAL,1
MX,WHEELCHAIR USER,1
MX,WHITE BLOOD CELL COUNT DECREASED,1
MX,WOUND,1
MD,CEREBROVASCULAR ACCIDENT,1
MD,DYSARTHRIA,1
MD,HEMIPARESIS,1
NL,DEATH,78
NL,FATIGUE,42
NL,DYSPNOEA,41
NL,NAUSEA,40
NL,PNEUMONIA,40
NL,CARDIAC FAILURE,36
NL,VOMITING,31
NL,MALAISE,30
NL,RENAL IMPAIRMENT,29
NL,TOXICITY TO VARIOUS AGENTS,29
NL,DIARRHOEA,27
NL,RENAL FAILURE,27
NL,HYPOKALAEMIA,26
NL,PYREXIA,25
NL,ATRIAL FIBRILLATION,24
NL,DIZZINESS,24
NL,HYPOTENSION,24
NL,BACK PAIN,21
NL,ACUTE KIDNEY INJURY,20
NL,DEHYDRATION,20
NL,FALL,20
NL,CONFUSIONAL STATE,19
NL,HEADACHE,19
NL,ANAEMIA,18
NL,LACTIC ACIDOSIS,18
NL,PROSTATE CANCER METASTATIC,18
NL,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,18
NL,MYOCARDIAL INFARCTION,17
NL,PAIN,17
NL,PROSTATIC SPECIFIC ANTIGEN INCREASED,17
NL,SHOCK,17
NL,CHEST PAIN,16
NL,HYPONATRAEMIA,16
NL,TERMINAL STATE,16
NL,URINARY TRACT INFECTION,16
NL,WEIGHT DECREASED,16
NL,CARDIAC ARREST,15
NL,HEPATIC FAILURE,15
NL,HYPERTENSION,15
NL,HYPOMAGNESAEMIA,15
NL,MUSCULAR WEAKNESS,15
NL,OVERDOSE,15
NL,ARTHRALGIA,14
NL,HAEMOGLOBIN DECREASED,14
NL,METASTASES TO BONE,14
NL,CARDIAC DISORDER,13
NL,DRUG INEFFECTIVE,13
NL,FLUID RETENTION,13
NL,MYALGIA,13
NL,ASTHENIA,12
NL,CONDITION AGGRAVATED,12
NL,CONSTIPATION,12
NL,DELIRIUM,12
NL,FEBRILE NEUTROPENIA,12
NL,HOT FLUSH,12
NL,HYPOCALCAEMIA,12
NL,MUSCULOSKELETAL PAIN,12
NL,PALPITATIONS,12
NL,RHABDOMYOLYSIS,12
NL,SYNCOPE,12
NL,ANGIOEDEMA,11
NL,MUSCLE RUPTURE,11
NL,ABDOMINAL PAIN,10
NL,CEREBROVASCULAR ACCIDENT,10
NL,GENERAL PHYSICAL HEALTH DETERIORATION,10
NL,HYPERKALAEMIA,10
NL,PAIN IN EXTREMITY,10
NL,WEIGHT INCREASED,10
NL,ACUTE CORONARY SYNDROME,9
NL,BALANCE DISORDER,9
NL,CHEST DISCOMFORT,9
NL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,9
NL,GAIT DISTURBANCE,9
NL,HYPERHIDROSIS,9
NL,LOSS OF CONSCIOUSNESS,9
NL,MALIGNANT NEOPLASM PROGRESSION,9
NL,PARANOIA,9
NL,PRODUCT USE ISSUE,9
NL,RESPIRATORY FAILURE,9
NL,SEROTONIN SYNDROME,9
NL,UROSEPSIS,9
NL,VENTRICULAR FIBRILLATION,9
NL,VISUAL ACUITY REDUCED,9
NL,ARRHYTHMIA,8
NL,DECREASED APPETITE,8
NL,DYSKINESIA,8
NL,HAEMODYNAMIC INSTABILITY,8
NL,HAEMORRHAGE,8
NL,HALLUCINATION,8
NL,INITIAL INSOMNIA,8
NL,OEDEMA PERIPHERAL,8
NL,URINARY RETENTION,8
NL,VENTRICULAR TACHYCARDIA,8
NL,ABDOMINAL PAIN UPPER,7
NL,BLOOD CREATININE INCREASED,7
NL,BRADYCARDIA,7
NL,CHILLS,7
NL,COGNITIVE DISORDER,7
NL,COUGH,7
NL,FIBROMA,7
NL,GASTROOESOPHAGEAL REFLUX DISEASE,7
NL,HYPERKINESIA,7
NL,HYPERSENSITIVITY,7
NL,INJECTION SITE INDURATION,7
NL,INTERNATIONAL NORMALISED RATIO INCREASED,7
NL,PANCREATITIS,7
NL,PROSTATE CANCER,7
NL,PSYCHOTIC DISORDER,7
NL,PULMONARY EMBOLISM,7
NL,RESTLESSNESS,7
NL,AGITATION,6
NL,BLOOD PRESSURE INCREASED,6
NL,CATARACT,6
NL,CIRCULATORY COLLAPSE,6
NL,DEPRESSED LEVEL OF CONSCIOUSNESS,6
NL,DRUG EFFECT INCOMPLETE,6
NL,DRUG LEVEL DECREASED,6
NL,HYPOAESTHESIA,6
NL,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,6
NL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,6
NL,INFLUENZA LIKE ILLNESS,6
NL,INTENTIONAL OVERDOSE,6
NL,MUSCLE SPASMS,6
NL,ON AND OFF PHENOMENON,6
NL,PRODUCT USE IN UNAPPROVED INDICATION,6
NL,PRURITUS,6
NL,RECTAL HAEMORRHAGE,6
NL,REGURGITATION,6
NL,SEPSIS,6
NL,STOMA SITE ERYTHEMA,6
NL,STRESS,6
NL,VISION BLURRED,6
NL,ALOPECIA,5
NL,ANGINA PECTORIS,5
NL,AORTIC ANEURYSM RUPTURE,5
NL,BLOOD GLUCOSE INCREASED,5
NL,CEREBRAL INFARCTION,5
NL,DISEASE PROGRESSION,5
NL,DRUG ADMINISTRATION ERROR,5
NL,EPISTAXIS,5
NL,ERYSIPELAS,5
NL,FEELING ABNORMAL,5
NL,HAEMATURIA,5
NL,HYPOVOLAEMIA,5
NL,IMMUNE THROMBOCYTOPENIC PURPURA,5
NL,INJECTION SITE REACTION,5
NL,INSOMNIA,5
NL,NEOPLASM PROGRESSION,5
NL,PARAESTHESIA,5
NL,PERIPHERAL COLDNESS,5
NL,PLEURAL EFFUSION,5
NL,POST-ANOXIC MYOCLONUS,5
NL,PROTEINURIA,5
NL,PULMONARY OEDEMA,5
NL,RENAL DISORDER,5
NL,SINUS TACHYCARDIA,5
NL,TRANSIENT ISCHAEMIC ATTACK,5
NL,TREMOR,5
NL,TUBULOINTERSTITIAL NEPHRITIS,5
NL,ABNORMAL FAECES,4
NL,ANXIETY,4
NL,CARDIAC ASTHMA,4
NL,CARDIOMYOPATHY,4
NL,CEREBRAL HAEMORRHAGE,4
NL,CORONARY ARTERY STENOSIS,4
NL,DEPRESSED MOOD,4
NL,DIABETES MELLITUS,4
NL,DRUG LEVEL INCREASED,4
NL,DYSPHAGIA,4
NL,EPILEPSY,4
NL,ERYTHEMA,4
NL,EYE PAIN,4
NL,FEELING COLD,4
NL,GASTROENTERITIS,4
NL,GASTROINTESTINAL DISORDER,4
NL,HAEMATOCHEZIA,4
NL,HAEMOPTYSIS,4
NL,HEART RATE INCREASED,4
NL,HIP FRACTURE,4
NL,HYPOXIA,4
NL,INFLUENZA,4
NL,INJECTION SITE MASS,4
NL,INJECTION SITE PAIN,4
NL,INTESTINAL ISCHAEMIA,4
NL,ISCHAEMIC CEREBRAL INFARCTION,4
NL,LIVER DISORDER,4
NL,LUNG INFECTION,4
NL,MOBILITY DECREASED,4
NL,MULTI-ORGAN FAILURE,4
NL,MUSCLE RIGIDITY,4
NL,NECK PAIN,4
NL,NIGHT SWEATS,4
NL,PALLOR,4
NL,PULMONARY SEPSIS,4
NL,RENAL FAILURE ACUTE,4
NL,RETROPERITONEAL FIBROSIS,4
NL,SENSE OF OPPRESSION,4
NL,SPEECH DISORDER,4
NL,SUICIDAL IDEATION,4
NL,THINKING ABNORMAL,4
NL,THROMBOCYTOPENIA,4
NL,WOUND,4
NL,ABDOMINAL DISTENSION,3
NL,ACIDOSIS,3
NL,ACTIVITIES OF DAILY LIVING IMPAIRED,3
NL,ACUTE MYOCARDIAL INFARCTION,3
NL,ANGINA UNSTABLE,3
NL,ARTERIOSCLEROSIS,3
NL,ARTHROPATHY,3
NL,ASCITES,3
NL,ASPARTATE AMINOTRANSFERASE INCREASED,3
NL,ATRIAL FLUTTER,3
NL,BACTERIAL INFECTION,3
NL,BLADDER CANCER,3
NL,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
NL,BRAIN INJURY,3
NL,BREAST CANCER METASTATIC,3
NL,C-REACTIVE PROTEIN INCREASED,3
NL,CARDIAC OPERATION,3
NL,CHOLANGITIS,3
NL,CHOLELITHIASIS,3
NL,CHROMATURIA,3
NL,COLITIS,3
NL,DEEP VEIN THROMBOSIS,3
NL,DYSPHONIA,3
NL,DYSURIA,3
NL,ELECTROCARDIOGRAM ABNORMAL,3
NL,EMOTIONAL DISORDER,3
NL,GASTRITIS,3
NL,HAEMATOMA,3
NL,HAEMORRHOIDS,3
NL,HALLUCINATION_ VISUAL,3
NL,HEMIPARESIS,3
NL,HEPATIC ENZYME ABNORMAL,3
NL,HEPATITIS TOXIC,3
NL,HEPATOTOXICITY,3
NL,HYPOKINESIA,3
NL,HYPOPHOSPHATAEMIA,3
NL,ILEUS,3
NL,INJECTION SITE ERYTHEMA,3
NL,INTERSTITIAL LUNG DISEASE,3
NL,LIMB DISCOMFORT,3
NL,LIVER FUNCTION TEST ABNORMAL,3
NL,MEMORY IMPAIRMENT,3
NL,METABOLIC ACIDOSIS,3
NL,METASTASES TO LYMPH NODES,3
NL,METASTASIS,3
NL,MOOD SWINGS,3
NL,MUSCULOSKELETAL STIFFNESS,3
NL,NEPHROLITHIASIS,3
NL,NERVOUS SYSTEM DISORDER,3
NL,OEDEMA,3
NL,OESOPHAGITIS CHEMICAL,3
NL,OSTEOPOROSIS,3
NL,OXYGEN SATURATION DECREASED,3
NL,PAIN IN JAW,3
NL,PANCYTOPENIA,3
NL,PERICARDIAL EFFUSION,3
NL,PERIPHERAL VASCULAR DISORDER,3
NL,PLASMA CELL MYELOMA,3
NL,PNEUMONIA ASPIRATION,3
NL,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,3
NL,PULSE ABSENT,3
NL,SQUAMOUS CELL CARCINOMA,3
NL,SWOLLEN TONGUE,3
NL,THERAPEUTIC RESPONSE DECREASED,3
NL,THROMBOSIS,3
NL,VIRAL INFECTION,3
NL,VISUAL IMPAIRMENT,3
NL,WAIST CIRCUMFERENCE INCREASED,3
NL,ABASIA,2
NL,ABDOMINAL ABSCESS,2
NL,ABDOMINAL DISCOMFORT,2
NL,ACUTE HEPATIC FAILURE,2
NL,ADENOCARCINOMA OF COLON,2
NL,ALANINE AMINOTRANSFERASE INCREASED,2
NL,AMNESIA,2
NL,AMYOTROPHIC LATERAL SCLEROSIS,2
NL,ANAL FISTULA,2
NL,APATHY,2
NL,APHASIA,2
NL,ARTERIAL OCCLUSIVE DISEASE,2
NL,ARTERIOSPASM CORONARY,2
NL,ARTHRITIS,2
NL,ATRIOVENTRICULAR BLOCK,2
NL,BACTERAEMIA,2
NL,BACTERIAL TEST POSITIVE,2
NL,BEDRIDDEN,2
NL,BLINDNESS,2
NL,BLOOD ALBUMIN DECREASED,2
NL,BLOOD ALKALINE PHOSPHATASE INCREASED,2
NL,BLOOD BILIRUBIN INCREASED,2
NL,BLOOD PHOSPHORUS DECREASED,2
NL,BLOOD PRESSURE FLUCTUATION,2
NL,BLOOD URINE PRESENT,2
NL,BLUE TOE SYNDROME,2
NL,BRADYPHRENIA,2
NL,BREAST CANCER,2
NL,BRONCHOSPASM,2
NL,CAMPYLOBACTER GASTROENTERITIS,2
NL,CARDIAC FAILURE CHRONIC,2
NL,CARDIAC FAILURE CONGESTIVE,2
NL,CARDIAC SEPTAL HYPERTROPHY,2
NL,CEREBRAL ISCHAEMIA,2
NL,CHILLBLAINS,2
NL,CHOKING,2
NL,CHOLECYSTITIS,2
NL,CLONIC CONVULSION,2
NL,COLON CANCER,2
NL,CONTUSION,2
NL,CONVULSION,2
NL,CORONARY ARTERY DISEASE,2
NL,CYANOSIS,2
NL,CYSTITIS,2
NL,DELUSION,2
NL,DELUSIONAL PERCEPTION,2
NL,DEVICE DISLOCATION,2
NL,DEVICE OCCLUSION,2
NL,DEVICE RELATED INFECTION,2
NL,DISCOMFORT,2
NL,DIVERTICULITIS,2
NL,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
NL,DRY SKIN,2
NL,DYSGEUSIA,2
NL,DYSPNOEA EXERTIONAL,2
NL,DYSSTASIA,2
NL,EAR DISORDER,2
NL,EJECTION FRACTION DECREASED,2
NL,ELECTROCARDIOGRAM QT PROLONGED,2
NL,ESCHERICHIA SEPSIS,2
NL,ESCHERICHIA URINARY TRACT INFECTION,2
NL,EXTREMITY NECROSIS,2
NL,FACIAL PARESIS,2
NL,FAECES DISCOLOURED,2
NL,FINE MOTOR DELAY,2
NL,FLANK PAIN,2
NL,FLATULENCE,2
NL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
NL,GASTRIC HAEMORRHAGE,2
NL,GASTRIC PERFORATION,2
NL,GASTRIC ULCER,2
NL,GASTROENTERITIS NOROVIRUS,2
NL,GASTROENTERITIS VIRAL,2
NL,GASTROINTESTINAL CARCINOMA,2
NL,GASTROINTESTINAL HAEMORRHAGE,2
NL,HAEMATOCRIT DECREASED,2
NL,HAIR GROWTH ABNORMAL,2
NL,HEART RATE DECREASED,2
NL,HEART RATE IRREGULAR,2
NL,HEPATITIS,2
NL,HERNIA,2
NL,HIP SURGERY,2
NL,HOSPITALISATION,2
NL,HYPERCALCAEMIA,2
NL,HYPERNATRAEMIA,2
NL,HYPERTHYROIDISM,2
NL,HYPERVENTILATION,2
NL,HYPOVOLAEMIC SHOCK,2
NL,INCORRECT DRUG ADMINISTRATION DURATION,2
NL,INFARCTION,2
NL,INJECTION SITE BRUISING,2
NL,INJECTION SITE INFECTION,2
NL,INJECTION SITE PRURITUS,2
NL,JOINT STIFFNESS,2
NL,KERATOACANTHOMA,2
NL,LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION,2
NL,LEFT VENTRICULAR FAILURE,2
NL,LEUKOCYTOCLASTIC VASCULITIS,2
NL,LEUKOPENIA,2
NL,LIVER ABSCESS,2
NL,LUNG CANCER METASTATIC,2
NL,LYMPHADENECTOMY,2
NL,METASTASES TO CENTRAL NERVOUS SYSTEM,2
NL,METASTASES TO LIVER,2
NL,METASTASES TO SPINE,2
NL,METASTATIC RENAL CELL CARCINOMA,2
NL,MULTIPLE SCLEROSIS RELAPSE,2
NL,MUSCLE DISORDER,2
NL,MUSCULOSKELETAL DISORDER,2
NL,MYOCARDIAL DEPRESSION,2
NL,MYOCARDIAL ISCHAEMIA,2
NL,NEPHROTIC SYNDROME,2
NL,NEUROPATHY PERIPHERAL,2
NL,NEUTROPENIA,2
NL,NON-CARDIAC CHEST PAIN,2
NL,OCULAR HYPERAEMIA,2
NL,OESOPHAGEAL ULCER,2
NL,OESOPHAGITIS,2
NL,OSTEONECROSIS OF JAW,2
NL,PANCREATIC CARCINOMA,2
NL,PANCREATITIS ACUTE,2
NL,PARAPLEGIA,2
NL,PARKINSONISM,2
NL,PARKINSON^S DISEASE,2
NL,PELVIC FRACTURE,2
NL,PELVIC PAIN,2
NL,PERITONITIS,2
NL,POLYNEUROPATHY CHRONIC,2
NL,POST PROCEDURAL HAEMORRHAGE,2
NL,PROCEDURAL PAIN,2
NL,PROCTALGIA,2
NL,PROCTITIS,2
NL,PULMONARY HAEMORRHAGE,2
NL,PULMONARY HYPERTENSION,2
NL,PULMONARY MASS,2
NL,PYELONEPHRITIS,2
NL,RASH,2
NL,REBOUND EFFECT,2
NL,RECTAL ADENOCARCINOMA,2
NL,RED BLOOD CELL COUNT DECREASED,2
NL,RENAL FAILURE CHRONIC,2
NL,RETINAL INFARCTION,2
NL,SECOND PRIMARY MALIGNANCY,2
NL,SECRETION DISCHARGE,2
NL,SINUS BRADYCARDIA,2
NL,SLEEP APNOEA SYNDROME,2
NL,SOMNOLENCE,2
NL,SQUAMOUS CELL CARCINOMA OF THE TONGUE,2
NL,SUBDURAL HAEMATOMA,2
NL,SUDDEN DEATH,2
NL,SUPRAVENTRICULAR TACHYCARDIA,2
NL,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,2
NL,TACHYCARDIA,2
NL,TENDON PAIN,2
NL,TOE AMPUTATION,2
NL,TOOTH FRACTURE,2
NL,TOXIC EPIDERMAL NECROLYSIS,2
NL,TRANSITIONAL CELL CARCINOMA,2
NL,TREATMENT FAILURE,2
NL,UPPER RESPIRATORY TRACT INFECTION,2
NL,WHITE BLOOD CELL COUNT DECREASED,2
NL,WITHDRAWAL SYNDROME,2
NL,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
NL,ABDOMINAL INJURY,1
NL,ABDOMINAL PAIN LOWER,1
NL,ABDOMINAL SEPSIS,1
NL,ABDOMINAL WALL HAEMATOMA,1
NL,ABNORMAL DREAMS,1
NL,ABNORMAL SENSATION IN EYE,1
NL,ABSCESS,1
NL,ACCIDENTAL OVERDOSE,1
NL,ACINETOBACTER INFECTION,1
NL,ACNE,1
NL,ACUTE RESPIRATORY DISTRESS SYNDROME,1
NL,ADENOCARCINOMA GASTRIC,1
NL,ADMINISTRATION SITE PAIN,1
NL,ADRENAL INSUFFICIENCY,1
NL,ADRENOCORTICAL INSUFFICIENCY ACUTE,1
NL,ADVERSE DRUG REACTION,1
NL,ADVERSE EVENT,1
NL,ADVERSE REACTION,1
NL,AFFECT LABILITY,1
NL,AGGRESSION,1
NL,AGRANULOCYTOSIS,1
NL,ALCOHOL ABUSE,1
NL,ALCOHOLIC PANCREATITIS,1
NL,AMYLASE INCREASED,1
NL,ANAEMIA POSTOPERATIVE,1
NL,ANAL FISSURE,1
NL,ANAL INFLAMMATION,1
NL,ANAL ULCER,1
NL,ANAPHYLACTIC SHOCK,1
NL,ANEURYSM,1
NL,ANGIOPATHY,1
NL,ANGIOPLASTY,1
NL,ANKYLOSING SPONDYLITIS,1
NL,ANORECTAL DISCOMFORT,1
NL,ANTERIOR CHAMBER DISORDER,1
NL,ANTIDIURETIC HORMONE ABNORMALITY,1
NL,ANURIA,1
NL,AORTIC ANEURYSM,1
NL,AORTIC CALCIFICATION,1
NL,AORTIC THROMBOSIS,1
NL,AORTIC VALVE REPLACEMENT,1
NL,AORTO-DUODENAL FISTULA,1
NL,APPLICATION SITE VESICLES,1
NL,AQUEOUS HUMOUR LEAKAGE,1
NL,ARTERIAL THROMBOSIS,1
NL,ARTHRITIS BACTERIAL,1
NL,ARTHRITIS REACTIVE,1
NL,ASPIRATION,1
NL,ASPIRATION BONE MARROW,1
NL,ASTHMA,1
NL,ATHEROEMBOLISM,1
NL,ATRIAL SEPTAL DEFECT REPAIR,1
NL,ATRIAL TACHYCARDIA,1
NL,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
NL,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,1
NL,B-CELL LYMPHOMA,1
NL,BACK DISORDER,1
NL,BACTERIAL SEPSIS,1
NL,BASILAR ARTERY THROMBOSIS,1
NL,BENIGN BREAST NEOPLASM,1
NL,BENIGN PROSTATIC HYPERPLASIA,1
NL,BILE DUCT STENOSIS,1
NL,BILE DUCT STONE,1
NL,BILIARY COLIC,1
NL,BLADDER CATHETERISATION,1
NL,BLADDER PAPILLOMA,1
NL,BLADDER TRANSITIONAL CELL CARCINOMA,1
NL,BLINDNESS CORTICAL,1
NL,BLINDNESS TRANSIENT,1
NL,BLINDNESS UNILATERAL,1
NL,BLISTER,1
NL,BLOOD BICARBONATE INCREASED,1
NL,BLOOD CALCIUM DECREASED,1
NL,BLOOD CHLORIDE DECREASED,1
NL,BLOOD CREATININE DECREASED,1
NL,BLOOD DISORDER,1
NL,BLOOD GLUCOSE ABNORMAL,1
NL,BLOOD GLUCOSE FLUCTUATION,1
NL,BLOOD INSULIN INCREASED,1
NL,BLOOD IRON INCREASED,1
NL,BLOOD LACTIC ACID INCREASED,1
NL,BLOOD PH DECREASED,1
NL,BLOOD PRESSURE ABNORMAL,1
NL,BLOOD PRESSURE DECREASED,1
NL,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
NL,BLOOD PRESSURE SYSTOLIC INCREASED,1
NL,BLOOD SODIUM DECREASED,1
NL,BODY TEMPERATURE ABNORMAL,1
NL,BONE DENSITY DECREASED,1
NL,BONE DISORDER,1
NL,BONE MARROW FAILURE,1
NL,BONE PAIN,1
NL,BOWEL MOVEMENT IRREGULARITY,1
NL,BRADYARRHYTHMIA,1
NL,BRADYKINESIA,1
NL,BRAIN NEOPLASM,1
NL,BRAIN STEM ISCHAEMIA,1
NL,BREAST CANCER FEMALE,1
NL,BREAST ENLARGEMENT,1
NL,BREAST INFLAMMATION,1
NL,BREAST PAIN,1
NL,BRONCHIECTASIS,1
NL,BRONCHOPULMONARY ASPERGILLOSIS,1
NL,CALCULUS URETERIC,1
NL,CAMPYLOBACTER INFECTION,1
NL,CARDIAC MURMUR,1
NL,CARDIAC OUTPUT DECREASED,1
NL,CARDIAC VALVE DISEASE,1
NL,CARDIOGENIC SHOCK,1
NL,CARDIOVASCULAR DISORDER,1
NL,CAROTID ARTERY THROMBOSIS,1
NL,CATHETER SITE PAIN,1
NL,CELLULITIS,1
NL,CEREBELLAR HAEMORRHAGE,1
NL,CERVICAL VERTEBRAL FRACTURE,1
NL,CHEILITIS,1
NL,CHOKING SENSATION,1
NL,CHOLESTASIS,1
NL,CHORDAE TENDINAE RUPTURE,1
NL,CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY,1
NL,CLAVICLE FRACTURE,1
NL,CLONUS,1
NL,COAGULATION TEST ABNORMAL,1
NL,COELIAC ARTERY OCCLUSION,1
NL,COLITIS MICROSCOPIC,1
NL,COLONIC PSEUDO-OBSTRUCTION,1
NL,COMA,1
NL,COMPLICATIONS OF TRANSPLANT SURGERY,1
NL,COMPRESSION FRACTURE,1
NL,CONCOMITANT DISEASE PROGRESSION,1
NL,CONNECTIVE TISSUE INFLAMMATION,1
NL,CONVULSIONS LOCAL,1
NL,CORNEAL EPITHELIUM DEFECT,1
NL,CORNEAL INFILTRATES,1
NL,CORNEAL OEDEMA,1
NL,CORNEAL PERFORATION,1
NL,CORNEAL SCAR,1
NL,CORNEAL THINNING,1
NL,CORONARY ARTERY DISSECTION,1
NL,CORONARY ARTERY OCCLUSION,1
NL,CRITICAL ILLNESS POLYNEUROPATHY,1
NL,CRYING,1
NL,CUSHINGOID,1
NL,CUTANEOUS SYMPTOM,1
NL,CYST,1
NL,CYSTITIS NONINFECTIVE,1
NL,DEAFNESS,1
NL,DEMENTIA,1
NL,DEMYELINATION,1
NL,DEPRESSION,1
NL,DEVICE KINK,1
NL,DEVICE RELATED SEPSIS,1
NL,DIABETES MELLITUS INADEQUATE CONTROL,1
NL,DIABETIC NEUROPATHY,1
NL,DIALYSIS,1
NL,DIAPHRAGMATIC DISORDER,1
NL,DIFFUSE ALVEOLAR DAMAGE,1
NL,DISSOCIATION,1
NL,DISTURBANCE IN ATTENTION,1
NL,DIVERTICULAR PERFORATION,1
NL,DRUG ABUSE,1
NL,DRUG HYPERSENSITIVITY,1
NL,DRUG LEVEL BELOW THERAPEUTIC,1
NL,DRUG PRESCRIBING ERROR,1
NL,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
NL,DRUG-INDUCED LIVER INJURY,1
NL,DRY EYE,1
NL,DRY MOUTH,1
NL,DUODENITIS,1
NL,DYSARTHRIA,1
NL,DYSPLASIA,1
NL,EAR NEOPLASM,1
NL,EATING DISORDER,1
NL,EJECTION FRACTION ABNORMAL,1
NL,ELECTROCARDIOGRAM CHANGE,1
NL,ELECTROCARDIOGRAM ST SEGMENT,1
NL,EMBOLISM,1
NL,EMOTIONAL DISTRESS,1
NL,ENCEPHALITIS,1
NL,ENCEPHALOPATHY,1
NL,ENDOCARDITIS,1
NL,ENTEROSTOMY,1
NL,ESCHERICHIA BACTERAEMIA,1
NL,ESSENTIAL HYPERTENSION,1
NL,ESSENTIAL THROMBOCYTHAEMIA,1
NL,EXTRADURAL NEOPLASM,1
NL,EXTRASYSTOLES,1
NL,EYE DISCHARGE,1
NL,EYE DISORDER,1
NL,EYE HAEMORRHAGE,1
NL,EYE INFECTION,1
NL,EYELID OEDEMA,1
NL,EYELID PTOSIS,1
NL,FEAR,1
NL,FEAR OF FALLING,1
NL,FEELING HOT,1
NL,FEELING OF BODY TEMPERATURE CHANGE,1
NL,FEELING OF DESPAIR,1
NL,FEMOROACETABULAR IMPINGEMENT,1
NL,FLAT ANTERIOR CHAMBER OF EYE,1
NL,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
NL,FOOD AVERSION,1
NL,FOREIGN BODY,1
NL,FOREIGN BODY SENSATION IN EYES,1
NL,GASTRECTOMY,1
NL,GASTRIC BANDING,1
NL,GASTRIC DISORDER,1
NL,GASTRIC INFECTION,1
NL,GASTRIC ULCER HAEMORRHAGE,1
NL,GASTRITIS EROSIVE,1
NL,GASTRITIS HYPERTROPHIC,1
NL,GASTROINTESTINAL BACTERIAL INFECTION,1
NL,GASTROINTESTINAL INFECTION,1
NL,GASTROINTESTINAL INJURY,1
NL,GASTROINTESTINAL PAIN,1
NL,GASTROINTESTINAL TRACT ADENOMA,1
NL,GENERAL PHYSICAL CONDITION ABNORMAL,1
NL,GENERAL SYMPTOM,1
NL,GENITAL HERPES ZOSTER,1
NL,GLAUCOMA,1
NL,GLOMERULAR FILTRATION RATE DECREASED,1
NL,GLOMERULONEPHRITIS,1
NL,GLOMERULONEPHRITIS MEMBRANOUS,1
NL,GLOSSODYNIA,1
NL,GRANULOMATOSIS WITH POLYANGIITIS,1
NL,GROIN INFECTION,1
NL,GYNAECOMASTIA,1
NL,HAEMATEMESIS,1
NL,HAEMOGLOBIN INCREASED,1
NL,HAEMOLYTIC ANAEMIA,1
NL,HAEMOPHILUS INFECTION,1
NL,HAEMORRHAGE INTRACRANIAL,1
NL,HEAD INJURY,1
NL,HEAD TITUBATION,1
NL,HEART RATE ABNORMAL,1
NL,HEART VALVE INCOMPETENCE,1
NL,HEART VALVE REPLACEMENT,1
NL,HEMIANOPIA,1
NL,HEMIPLEGIA,1
NL,HEPARIN-INDUCED THROMBOCYTOPENIA,1
NL,HEPATIC CANCER RECURRENT,1
NL,HEPATIC CYST INFECTION,1
NL,HEPATIC ENZYME INCREASED,1
NL,HEPATIC FUNCTION ABNORMAL,1
NL,HEPATIC NEOPLASM,1
NL,HERPES VIRUS INFECTION,1
NL,HORMONE-DEPENDENT PROSTATE CANCER,1
NL,HUMERUS FRACTURE,1
NL,HYDRONEPHROSIS,1
NL,HYPERBILIRUBINAEMIA,1
NL,HYPERCAPNIA,1
NL,HYPERKERATOSIS,1
NL,HYPERMOBILITY SYNDROME,1
NL,HYPERPARATHYROIDISM,1
NL,HYPERREFLEXIA,1
NL,HYPERSENSITIVITY VASCULITIS,1
NL,HYPERTENSIVE CRISIS,1
NL,HYPERTROPHIC CARDIOMYOPATHY,1
NL,HYPOGLYCAEMIA,1
NL,HYPOGLYCAEMIC COMA,1
NL,HYPOKALAEMIC SYNDROME,1
NL,HYPOPHAGIA,1
NL,HYPOPHYSITIS,1
NL,HYPOTHERMIA,1
NL,ILIAC ARTERY OCCLUSION,1
NL,IMPAIRED HEALING,1
NL,IMPLANTABLE DEFIBRILLATOR INSERTION,1
NL,INCARCERATED UMBILICAL HERNIA,1
NL,INCONTINENCE,1
NL,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
NL,INCREASED APPETITE,1
NL,INFECTION,1
NL,INFLAMMATION,1
NL,INFLAMMATORY BOWEL DISEASE,1
NL,INGUINAL HERNIA,1
NL,INJECTION SITE HAEMATOMA,1
NL,INTENTIONAL PRODUCT MISUSE,1
NL,INTERNATIONAL NORMALISED RATIO DECREASED,1
NL,INTERVERTEBRAL DISC OPERATION,1
NL,INTERVERTEBRAL DISC PROTRUSION,1
NL,INTERVERTEBRAL DISCITIS,1
NL,INTESTINAL ADENOCARCINOMA,1
NL,INTRA-ABDOMINAL HAEMATOMA,1
NL,INTRAOCULAR LENS IMPLANT,1
NL,INTRAOCULAR PRESSURE INCREASED,1
NL,IRON DEFICIENCY ANAEMIA,1
NL,ISCHAEMIA,1
NL,ISCHAEMIC STROKE,1
NL,JAW CYST,1
NL,JAW DISORDER,1
NL,JAW OPERATION,1
NL,JOINT INJURY,1
NL,KIDNEY INFECTION,1
NL,KIDNEY TRANSPLANT REJECTION,1
NL,LACUNAR INFARCTION,1
NL,LAPAROTOMY,1
NL,LARGE INTESTINE BENIGN NEOPLASM,1
NL,LARYNGOSPASM,1
NL,LEFT VENTRICULAR HYPERTROPHY,1
NL,LEUKOCYTOSIS,1
NL,LIMB INJURY,1
NL,LOCAL SWELLING,1
NL,LOCALISED INFECTION,1
NL,LOCALISED OEDEMA,1
NL,LONG QT SYNDROME,1
NL,LUNG NEOPLASM MALIGNANT,1
NL,LUPUS NEPHRITIS,1
NL,LYMPHOCYTE COUNT DECREASED,1
NL,MACULAR DEGENERATION,1
NL,MACULAR OEDEMA,1
NL,MAJOR DEPRESSION,1
NL,MALIGNANT HYPERTENSION,1
NL,MALLORY-WEISS SYNDROME,1
NL,MALNUTRITION,1
NL,MANIA,1
NL,MEAN CELL VOLUME INCREASED,1
NL,MEDICAL DEVICE COMPLICATION,1
NL,MEDICATION ERROR,1
NL,MELAENA,1
NL,MENINGITIS,1
NL,MENINGITIS ASEPTIC,1
NL,MENTAL DISORDER,1
NL,METABOLIC ENCEPHALOPATHY,1
NL,METASTASES TO BONE MARROW,1
NL,METASTASES TO LUNG,1
NL,METASTATIC CARCINOMA OF THE BLADDER,1
NL,METHAEMOGLOBINAEMIA,1
NL,MICROCYTIC ANAEMIA,1
NL,MICTURITION DISORDER,1
NL,MITRAL VALVE INCOMPETENCE,1
NL,MONOPARESIS,1
NL,MONOPLEGIA,1
NL,MOROSE,1
NL,MOUTH ULCERATION,1
NL,MOVEMENT DISORDER,1
NL,MULTIPLE FRACTURES,1
NL,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
NL,MULTIPLE SCLEROSIS,1
NL,MUSCLE ATROPHY,1
NL,MUSCULOSKELETAL DISCOMFORT,1
NL,MYASTHENIA GRAVIS,1
NL,MYDRIASIS,1
NL,MYELODYSPLASTIC SYNDROME,1
NL,MYELOFIBROSIS,1
NL,MYELOPROLIFERATIVE DISORDER,1
NL,MYOCARDIAL NECROSIS MARKER INCREASED,1
NL,MYOCLONUS,1
NL,MYOPATHY,1
NL,NAIL GROWTH ABNORMAL,1
NL,NASAL CONGESTION,1
NL,NASAL DISORDER,1
NL,NASOPHARYNGITIS,1
NL,NEURALGIA,1
NL,NEUROLOGIC NEGLECT SYNDROME,1
NL,NEUROLOGICAL SYMPTOM,1
NL,NEUTROPHIL COUNT ABNORMAL,1
NL,NEUTROPHIL COUNT DECREASED,1
NL,NIGHTMARE,1
NL,NOCTURIA,1
NL,NODAL RHYTHM,1
NL,NON-ALCOHOLIC STEATOHEPATITIS,1
NL,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
NL,NOSOCOMIAL INFECTION,1
NL,OCULAR RETROBULBAR HAEMORRHAGE,1
NL,OEDEMA GENITAL,1
NL,OESOPHAGEAL DISORDER,1
NL,OLIGURIA,1
NL,OPTIC ISCHAEMIC NEUROPATHY,1
NL,ORAL DISCHARGE,1
NL,OROMANDIBULAR DYSTONIA,1
NL,OROPHARYNGEAL PAIN,1
NL,ORTHOPNOEA,1
NL,ORTHOSTATIC HYPOTENSION,1
NL,OSTEITIS,1
NL,OSTEOARTHRITIS,1
NL,OVARIAN CYST,1
NL,OVERWEIGHT,1
NL,OXYGEN CONSUMPTION DECREASED,1
NL,PAINFUL RESPIRATION,1
NL,PALLIATIVE CARE,1
NL,PANCREATIC CARCINOMA METASTATIC,1
NL,PANCREATIC CARCINOMA RECURRENT,1
NL,PANCREATITIS NECROTISING,1
NL,PANCREATITIS RELAPSING,1
NL,PARANEOPLASTIC SYNDROME,1
NL,PARASOMNIA,1
NL,PARATHYROID TUMOUR BENIGN,1
NL,PARESIS,1
NL,PAROTID GLAND ENLARGEMENT,1
NL,PARTIAL SEIZURES,1
NL,PARVOVIRUS INFECTION,1
NL,PERICARDIAL EFFUSION MALIGNANT,1
NL,PERIORBITAL OEDEMA,1
NL,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
NL,PERIPHERAL ARTERY STENOSIS,1
NL,PERIPHERAL SENSORIMOTOR NEUROPATHY,1
NL,PERITONEAL HAEMORRHAGE,1
NL,PETIT MAL EPILEPSY,1
NL,PHARYNGEAL DISORDER,1
NL,PHARYNGEAL OEDEMA,1
NL,PITUITARY TUMOUR BENIGN,1
NL,PLATELET DISORDER,1
NL,PNEUMONIA ESCHERICHIA,1
NL,POLLAKIURIA,1
NL,POLYNEUROPATHY,1
NL,POLYURIA,1
NL,POOR QUALITY SLEEP,1
NL,POST PROCEDURAL COMPLICATION,1
NL,POST-TRAUMATIC PAIN,1
NL,POSTICTAL PARALYSIS,1
NL,POSTOPERATIVE WOUND INFECTION,1
NL,POSTURE ABNORMAL,1
NL,PRE-EXISTING CONDITION IMPROVED,1
NL,PRESCRIBED OVERDOSE,1
NL,PROCEDURAL COMPLICATION,1
NL,PROCTITIS ULCERATIVE,1
NL,PRODUCT QUALITY ISSUE,1
NL,PRODUCT SUBSTITUTION ISSUE,1
NL,PRODUCTIVE COUGH,1
NL,PROSTATISM,1
NL,PSOAS ABSCESS,1
NL,PULMONARY ARTERIAL HYPERTENSION,1
NL,PULMONARY ARTERIAL WEDGE PRESSURE INCREASED,1
NL,PULMONARY INFARCTION,1
NL,PULMONARY NECROSIS,1
NL,RADIOTHERAPY,1
NL,RAPID EYE MOVEMENTS SLEEP ABNORMAL,1
NL,RASH ERYTHEMATOUS,1
NL,RASH PRURITIC,1
NL,RAYNAUD^S PHENOMENON,1
NL,RECTAL CANCER,1
NL,RED CELL DISTRIBUTION WIDTH INCREASED,1
NL,REHABILITATION THERAPY,1
NL,RENAL ABSCESS,1
NL,RENAL CELL CARCINOMA,1
NL,RENAL COLIC,1
NL,RENAL FUNCTION TEST ABNORMAL,1
NL,RENAL HAEMORRHAGE,1
NL,RENAL INFARCT,1
NL,RENAL TUBULAR NECROSIS,1
NL,RESPIRATION ABNORMAL,1
NL,RESPIRATORY TRACT INFECTION,1
NL,RESTLESS LEGS SYNDROME,1
NL,RETCHING,1
NL,RETICULOCYTE COUNT INCREASED,1
NL,RETINAL DEGENERATION,1
NL,RETINAL DISORDER,1
NL,RETINAL VASCULAR THROMBOSIS,1
NL,RETINAL VEIN OCCLUSION,1
NL,RETROPERITONEAL HAEMORRHAGE,1
NL,RHEUMATIC DISORDER,1
NL,RHEUMATOID VASCULITIS,1
NL,RHINITIS,1
NL,RIGHT VENTRICULAR DYSFUNCTION,1
NL,ROAD TRAFFIC ACCIDENT,1
NL,SALIVARY HYPERSECRETION,1
NL,SCAPULA FRACTURE,1
NL,SCROTAL SWELLING,1
NL,SEDATION,1
NL,SEIZURE,1
NL,SENSATION OF HEAVINESS,1
NL,SENSORY DISTURBANCE,1
NL,SERUM FERRITIN INCREASED,1
NL,SINUS ARREST,1
NL,SINUSITIS,1
NL,SKIN BURNING SENSATION,1
NL,SKIN DISORDER,1
NL,SKIN HYPERPIGMENTATION,1
NL,SKIN INFECTION,1
NL,SKIN LESION,1
NL,SKIN NECROSIS,1
NL,SKIN ULCER,1
NL,SKULL FRACTURE,1
NL,SLEEP DISORDER,1
NL,SOFT TISSUE INFLAMMATION,1
NL,SPINAL COLUMN INJURY,1
NL,SPINAL COMPRESSION FRACTURE,1
NL,SPINAL CORD HAEMORRHAGE,1
NL,SPINAL CORD HERNIATION,1
NL,SPINAL CORPECTOMY,1
NL,SPINAL FRACTURE,1
NL,SPLENIC HAEMORRHAGE,1
NL,SPLENOMEGALY,1
NL,STAPHYLOCOCCAL BACTERAEMIA,1
NL,STAPHYLOCOCCAL INFECTION,1
NL,STAPHYLOCOCCAL SEPSIS,1
NL,STUPOR,1
NL,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,1
NL,SUBARACHNOID HAEMORRHAGE,1
NL,SUBCLAVIAN ARTERY THROMBOSIS,1
NL,SUDDEN CARDIAC DEATH,1
NL,SUICIDE ATTEMPT,1
NL,SUPPORTIVE CARE,1
NL,SURGERY,1
NL,SUSPECTED COUNTERFEIT PRODUCT,1
NL,SWELLING FACE,1
NL,SYSTEMIC LUPUS ERYTHEMATOSUS,1
NL,TENDON RUPTURE,1
NL,TENDONITIS,1
NL,TENSION HEADACHE,1
NL,THERAPEUTIC RESPONSE UNEXPECTED,1
NL,THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION,1
NL,THERAPY CESSATION,1
NL,THROAT CANCER,1
NL,THROAT TIGHTNESS,1
NL,THYROID DISORDER,1
NL,TINEA INFECTION,1
NL,TINNITUS,1
NL,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
NL,TONSIL CANCER,1
NL,TONSILLITIS,1
NL,TOOTH INJURY,1
NL,TOOTH LOSS,1
NL,TOOTHACHE,1
NL,TORSADE DE POINTES,1
NL,TOXIC OPTIC NEUROPATHY,1
NL,TRANSITIONAL CELL CANCER OF THE RENAL PELVIS AND URETER,1
NL,TRANSPLANT DYSFUNCTION,1
NL,TRANSPLANT FAILURE,1
NL,TRANSURETHRAL PROSTATECTOMY,1
NL,TRAUMATIC HAEMATOMA,1
NL,TROPONIN INCREASED,1
NL,TUMOUR EXCISION,1
NL,TUMOUR MARKER INCREASED,1
NL,TYPE 2 DIABETES MELLITUS,1
NL,ULCERATIVE KERATITIS,1
NL,UNDERDOSE,1
NL,UNEVALUABLE EVENT,1
NL,UNRESPONSIVE TO STIMULI,1
NL,UPPER LIMB FRACTURE,1
NL,URETERIC RUPTURE,1
NL,URETEROLITHIASIS,1
NL,URETHRAL DISORDER,1
NL,URETHRAL STENOSIS,1
NL,URETHRITIS,1
NL,URINARY BLADDER HAEMORRHAGE,1
NL,URINARY TRACT DISORDER,1
NL,URINARY TRACT INFECTION BACTERIAL,1
NL,URINE ANALYSIS ABNORMAL,1
NL,URTICARIA,1
NL,UTERINE PROLAPSE REPAIR,1
NL,UVEITIS,1
NL,VAGINAL HAEMORRHAGE,1
NL,VASCULAR GRAFT,1
NL,VASCULAR STENT RESTENOSIS,1
NL,VASCULITIS,1
NL,VASOCONSTRICTION,1
NL,VERTEBRAL ARTERY OCCLUSION,1
NL,VERTIGO,1
NL,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
NL,WALKING AID USER,1
NL,WHEELCHAIR USER,1
NL,WOUND DEHISCENCE,1
NL,WOUND SEPSIS,1
NL,WRIST FRACTURE,1
NL,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
NZ,DYSPNOEA,13
NZ,ACUTE MYOCARDIAL INFARCTION,9
NZ,CEREBROVASCULAR ACCIDENT,8
NZ,CHEST PAIN,8
NZ,NAUSEA,8
NZ,MALAISE,7
NZ,DEHYDRATION,6
NZ,PNEUMONIA,6
NZ,VOMITING,6
NZ,COUGH,5
NZ,DEATH,5
NZ,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,5
NZ,FATIGUE,5
NZ,GAIT DISTURBANCE,5
NZ,HEADACHE,5
NZ,INSOMNIA,5
NZ,MYOCARDIAL INFARCTION,5
NZ,PALPITATIONS,5
NZ,PRURITUS,5
NZ,ABDOMINAL PAIN UPPER,4
NZ,ACUTE KIDNEY INJURY,4
NZ,ANAEMIA,4
NZ,ARTHRALGIA,4
NZ,ARTHRITIS,4
NZ,BACK PAIN,4
NZ,CARDIOTOXICITY,4
NZ,CONFUSIONAL STATE,4
NZ,DEPRESSION,4
NZ,DIARRHOEA,4
NZ,FALL,4
NZ,GOUT,4
NZ,HYPERTENSION,4
NZ,HYPERTHYROIDISM,4
NZ,HYPOKALAEMIA,4
NZ,HYPOTENSION,4
NZ,MELAENA,4
NZ,MYALGIA,4
NZ,MYASTHENIA GRAVIS,4
NZ,NEUTROPENIA,4
NZ,PAIN,4
NZ,RENAL FAILURE,4
NZ,SEPSIS,4
NZ,TORSADE DE POINTES,4
NZ,VASCULITIS CEREBRAL,4
NZ,AMNESIA,3
NZ,ANGINA PECTORIS,3
NZ,ASTHENIA,3
NZ,ATRIAL FIBRILLATION,3
NZ,CARDIAC ARREST,3
NZ,CARDIAC FAILURE,3
NZ,CARDIAC FAILURE CONGESTIVE,3
NZ,CELLULITIS,3
NZ,CHOLECYSTITIS,3
NZ,CONDITION AGGRAVATED,3
NZ,DELIRIUM,3
NZ,DIZZINESS,3
NZ,DRUG INEFFECTIVE,3
NZ,EPISTAXIS,3
NZ,GASTROINTESTINAL HAEMORRHAGE,3
NZ,HYPOCALCAEMIA,3
NZ,HYPOMAGNESAEMIA,3
NZ,HYPONATRAEMIA,3
NZ,JOINT EFFUSION,3
NZ,LETHARGY,3
NZ,MUSCULAR WEAKNESS,3
NZ,OEDEMA PERIPHERAL,3
NZ,PAIN IN EXTREMITY,3
NZ,PYREXIA,3
NZ,RASH ERYTHEMATOUS,3
NZ,RECTAL HAEMORRHAGE,3
NZ,RHABDOMYOLYSIS,3
NZ,SPINAL SUBDURAL HAEMATOMA,3
NZ,SUBDURAL HAEMORRHAGE,3
NZ,SUICIDAL IDEATION,3
NZ,SUPRAVENTRICULAR TACHYCARDIA,3
NZ,TACHYCARDIA,3
NZ,TRANSIENT ISCHAEMIC ATTACK,3
NZ,URINARY RETENTION,3
NZ,ABASIA,2
NZ,ACTIVITIES OF DAILY LIVING IMPAIRED,2
NZ,ALANINE AMINOTRANSFERASE INCREASED,2
NZ,ANXIETY,2
NZ,ARRHYTHMIA,2
NZ,ARTHROPATHY,2
NZ,BLOOD BILIRUBIN INCREASED,2
NZ,BLOOD CREATININE INCREASED,2
NZ,BLOOD PARATHYROID HORMONE DECREASED,2
NZ,BRONCHITIS,2
NZ,CARDIOGENIC SHOCK,2
NZ,CARPAL TUNNEL SYNDROME,2
NZ,CEREBELLAR HAEMORRHAGE,2
NZ,CEREBRAL INFARCTION,2
NZ,CHOKING,2
NZ,CHRONIC KIDNEY DISEASE,2
NZ,CIRCULATORY COLLAPSE,2
NZ,COMA,2
NZ,COMPLETED SUICIDE,2
NZ,CONTUSION,2
NZ,CYANOSIS,2
NZ,DEMYELINATION,2
NZ,DRUG LEVEL INCREASED,2
NZ,DYSPHAGIA,2
NZ,ELECTROCARDIOGRAM T WAVE INVERSION,2
NZ,EOSINOPHILIA,2
NZ,ERYTHEMA,2
NZ,FLUSHING,2
NZ,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
NZ,HAEMATOMA,2
NZ,HAEMOPTYSIS,2
NZ,HAEMORRHAGE,2
NZ,HEMIPARESIS,2
NZ,HEPATIC ENZYME INCREASED,2
NZ,HYPERLIPIDAEMIA,2
NZ,HYPOPHAGIA,2
NZ,IMPAIRED WORK ABILITY,2
NZ,INTENTIONAL OVERDOSE,2
NZ,ISCHAEMIC STROKE,2
NZ,LACTIC ACIDOSIS,2
NZ,LIVER FUNCTION TEST INCREASED,2
NZ,LUMBAR VERTEBRAL FRACTURE,2
NZ,LYMPHADENOPATHY,2
NZ,METASTASES TO LUNG,2
NZ,METASTATIC MALIGNANT MELANOMA,2
NZ,MUSCULOSKELETAL CHEST PAIN,2
NZ,MUSCULOSKELETAL PAIN,2
NZ,MUSCULOSKELETAL STIFFNESS,2
NZ,MYOCARDIAL ISCHAEMIA,2
NZ,NEPHROLITHIASIS,2
NZ,NEUROPATHY PERIPHERAL,2
NZ,OEDEMA,2
NZ,PARAESTHESIA,2
NZ,PERIPHERAL SWELLING,2
NZ,PNEUMONIA ASPIRATION,2
NZ,PNEUMONITIS,2
NZ,POLYARTHRITIS,2
NZ,POST PROCEDURAL HAEMORRHAGE,2
NZ,PRESYNCOPE,2
NZ,PROSTATISM,2
NZ,PULMONARY OEDEMA,2
NZ,RASH,2
NZ,RENAL FAILURE ACUTE,2
NZ,RENAL IMPAIRMENT,2
NZ,RESPIRATORY DISTRESS,2
NZ,RHEUMATIC DISORDER,2
NZ,RHEUMATOID ARTHRITIS,2
NZ,RHINITIS,2
NZ,SEIZURE,2
NZ,SHOCK,2
NZ,SOMNOLENCE,2
NZ,SPINAL COLUMN STENOSIS,2
NZ,STAPHYLOCOCCAL ABSCESS,2
NZ,THERAPEUTIC RESPONSE DECREASED,2
NZ,THROMBOSIS,2
NZ,TREATMENT FAILURE,2
NZ,TYPE 2 DIABETES MELLITUS,2
NZ,UPPER GASTROINTESTINAL HAEMORRHAGE,2
NZ,URINARY TRACT INFECTION,2
NZ,URTICARIA,2
NZ,VISUAL IMPAIRMENT,2
NZ,WEIGHT DECREASED,2
NZ,ABDOMINAL PAIN,1
NZ,ABDOMINAL TENDERNESS,1
NZ,ABNORMAL BEHAVIOUR,1
NZ,ABNORMAL LOSS OF WEIGHT,1
NZ,ACUTE LEFT VENTRICULAR FAILURE,1
NZ,ACUTE RESPIRATORY DISTRESS SYNDROME,1
NZ,AGITATION,1
NZ,ALOPECIA,1
NZ,ALTERED STATE OF CONSCIOUSNESS,1
NZ,ANAL SPHINCTER ATONY,1
NZ,ANAPHYLACTIC REACTION,1
NZ,ANAPHYLACTIC SHOCK,1
NZ,ANGIOEDEMA,1
NZ,ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE,1
NZ,ANTIBIOTIC LEVEL ABOVE THERAPEUTIC,1
NZ,AORTIC ARTERIOSCLEROSIS,1
NZ,AORTIC DILATATION,1
NZ,AORTIC DISSECTION,1
NZ,AREFLEXIA,1
NZ,ASPHYXIA,1
NZ,ATAXIA,1
NZ,BALANCE DISORDER,1
NZ,BASAL CELL CARCINOMA,1
NZ,BIPOLAR DISORDER,1
NZ,BIPOLAR II DISORDER,1
NZ,BLISTER,1
NZ,BLOOD GLUCOSE ABNORMAL,1
NZ,BLOOD PRESSURE DECREASED,1
NZ,BLOOD PRESSURE INCREASED,1
NZ,BLOOD SODIUM DECREASED,1
NZ,BODY TEMPERATURE INCREASED,1
NZ,BRADYCARDIA,1
NZ,C-REACTIVE PROTEIN ABNORMAL,1
NZ,C-REACTIVE PROTEIN INCREASED,1
NZ,CARDIAC ANEURYSM,1
NZ,CARDIAC DISORDER,1
NZ,CARDIAC FAILURE HIGH OUTPUT,1
NZ,CARDIOMEGALY,1
NZ,CARDIOMYOPATHY,1
NZ,CAROTID ARTERY STENOSIS,1
NZ,CEREBELLAR INFARCTION,1
NZ,CEREBRAL HAEMATOMA,1
NZ,CEREBRAL HAEMORRHAGE,1
NZ,CHEST DISCOMFORT,1
NZ,CHILLS,1
NZ,CHOLANGITIS,1
NZ,CHOLESTASIS,1
NZ,CHONDROCALCINOSIS PYROPHOSPHATE,1
NZ,COAGULOPATHY,1
NZ,CONSTIPATION,1
NZ,CORONARY ARTERY BYPASS,1
NZ,CORONARY ARTERY DISEASE,1
NZ,CRANIOCEREBRAL INJURY,1
NZ,DEPRESSED LEVEL OF CONSCIOUSNESS,1
NZ,DERMATITIS PSORIASIFORM,1
NZ,DIASTOLIC DYSFUNCTION,1
NZ,DIPLEGIA,1
NZ,DIPLOPIA,1
NZ,DISEASE PROGRESSION,1
NZ,DISEASE RECURRENCE,1
NZ,DIVERTICULITIS,1
NZ,DROOLING,1
NZ,DRUG ADMINISTRATION ERROR,1
NZ,DRUG DOSE OMISSION,1
NZ,DRUG EFFECT DECREASED,1
NZ,DRUG ERUPTION,1
NZ,DRUG SCREEN NEGATIVE,1
NZ,DRUG SPECIFIC ANTIBODY PRESENT,1
NZ,DRUG-INDUCED LIVER INJURY,1
NZ,DRY MOUTH,1
NZ,DRY SKIN,1
NZ,DUODENAL ULCER,1
NZ,DYSARTHRIA,1
NZ,DYSGEUSIA,1
NZ,DYSKINESIA,1
NZ,ECZEMA,1
NZ,ELECTROCARDIOGRAM ABNORMAL,1
NZ,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,1
NZ,ELECTROCARDIOGRAM QT PROLONGED,1
NZ,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
NZ,EOSINOPHIL COUNT INCREASED,1
NZ,EYE HAEMORRHAGE,1
NZ,EYELID PTOSIS,1
NZ,FEELING ABNORMAL,1
NZ,FEELING HOT,1
NZ,FRACTURE,1
NZ,GASTRIC DISORDER,1
NZ,GASTRIC MUCOSAL LESION,1
NZ,GASTROENTERITIS AEROMONAS,1
NZ,GASTROINTESTINAL ANGIODYSPLASIA,1
NZ,GASTROINTESTINAL HYPOMOTILITY,1
NZ,GLIOSIS,1
NZ,GLYCOSURIA,1
NZ,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
NZ,GRAFT HAEMORRHAGE,1
NZ,GRAND MAL CONVULSION,1
NZ,HAEMATEMESIS,1
NZ,HAEMATOCHEZIA,1
NZ,HAEMATURIA,1
NZ,HAEMODYNAMIC INSTABILITY,1
NZ,HAEMORRHAGE INTRACRANIAL,1
NZ,HAEMORRHAGIC STROKE,1
NZ,HEAD DISCOMFORT,1
NZ,HEART RATE DECREASED,1
NZ,HEART RATE INCREASED,1
NZ,HEART RATE IRREGULAR,1
NZ,HEMIANOPIA,1
NZ,HEPATIC CIRRHOSIS,1
NZ,HIP ARTHROPLASTY,1
NZ,HOSPITALISATION,1
NZ,HYPERBILIRUBINAEMIA,1
NZ,HYPERHIDROSIS,1
NZ,HYPERURICAEMIA,1
NZ,HYPOAESTHESIA,1
NZ,HYPOTONIA,1
NZ,IMPAIRED HEALING,1
NZ,INCORRECT DRUG ADMINISTRATION RATE,1
NZ,INCREASED APPETITE,1
NZ,INFECTION,1
NZ,INFLUENZA LIKE ILLNESS,1
NZ,INFUSION RELATED REACTION,1
NZ,INJECTION SITE ERYTHEMA,1
NZ,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
NZ,INTERVERTEBRAL DISC DISORDER,1
NZ,INTESTINAL ULCER,1
NZ,ISCHAEMIA,1
NZ,JOINT INJECTION,1
NZ,JOINT SWELLING,1
NZ,KIDNEY TRANSPLANT REJECTION,1
NZ,KNEE ARTHROPLASTY,1
NZ,LEFT VENTRICULAR DYSFUNCTION,1
NZ,LIMB DISCOMFORT,1
NZ,LIVER FUNCTION TEST ABNORMAL,1
NZ,LOCAL SWELLING,1
NZ,LOSS OF CONSCIOUSNESS,1
NZ,LUNG ADENOCARCINOMA,1
NZ,LUNG CONSOLIDATION,1
NZ,LUNG INFILTRATION,1
NZ,LUPUS-LIKE SYNDROME,1
NZ,MALABSORPTION,1
NZ,MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE,1
NZ,MEDICATION ERROR,1
NZ,MEMORY IMPAIRMENT,1
NZ,MENTAL DISORDER,1
NZ,METABOLIC ACIDOSIS,1
NZ,METASTASES TO BONE,1
NZ,METASTASES TO MUSCLE,1
NZ,METASTASES TO PERITONEUM,1
NZ,METASTASES TO SKIN,1
NZ,METASTASES TO THE MEDIASTINUM,1
NZ,MIDDLE INSOMNIA,1
NZ,MULTIPLE FRACTURES,1
NZ,MUSCLE RUPTURE,1
NZ,MUSCLE TWITCHING,1
NZ,MYCOBACTERIAL INFECTION,1
NZ,MYELOPATHY,1
NZ,MYOCARDIAL STRAIN,1
NZ,MYOCARDITIS,1
NZ,MYOSITIS,1
NZ,NECK MASS,1
NZ,NECK PAIN,1
NZ,NERVOUS SYSTEM DISORDER,1
NZ,NIGHTMARE,1
NZ,OBSTRUCTIVE AIRWAYS DISORDER,1
NZ,OCCULT BLOOD POSITIVE,1
NZ,OESOPHAGITIS,1
NZ,OPTIC NEUROPATHY,1
NZ,ORTHOSTATIC HYPOTENSION,1
NZ,OSTEOARTHRITIS,1
NZ,OSTEONECROSIS,1
NZ,OTOTOXICITY,1
NZ,OVERDOSE,1
NZ,PAIN IN JAW,1
NZ,PATHOLOGICAL FRACTURE,1
NZ,PELVIC FRACTURE,1
NZ,PEMPHIGUS,1
NZ,PERICARDITIS,1
NZ,PERIORBITAL OEDEMA,1
NZ,PETECHIAE,1
NZ,POISONING DELIBERATE,1
NZ,POLYPECTOMY,1
NZ,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
NZ,POSTURAL TREMOR,1
NZ,PROCTALGIA,1
NZ,PRODUCT SUBSTITUTION ISSUE,1
NZ,PRODUCT USE ISSUE,1
NZ,PSORIASIS,1
NZ,PSYCHIATRIC DECOMPENSATION,1
NZ,PULMONARY ARTERIAL PRESSURE DECREASED,1
NZ,PULMONARY EMBOLISM,1
NZ,PURPURA,1
NZ,RASH GENERALISED,1
NZ,RASH MACULAR,1
NZ,RASH MACULO-PAPULAR,1
NZ,RESPIRATORY FAILURE,1
NZ,RETINAL EXUDATES,1
NZ,RETROGRADE EJACULATION,1
NZ,RETROPERITONEAL HAEMATOMA,1
NZ,RETROPERITONEAL HAEMORRHAGE,1
NZ,REVERSIBLE ISCHAEMIC NEUROLOGICAL DEFICIT,1
NZ,RHINORRHOEA,1
NZ,SALIVARY HYPERSECRETION,1
NZ,SEDATION,1
NZ,SELF-MEDICATION,1
NZ,SINUS BRADYCARDIA,1
NZ,SJOGREN^S SYNDROME,1
NZ,SKIN BURNING SENSATION,1
NZ,SKIN CANCER,1
NZ,SKIN DISORDER,1
NZ,SKIN GRAFT FAILURE,1
NZ,SLEEP TERROR,1
NZ,SOFT TISSUE SWELLING,1
NZ,SPINAL OSTEOARTHRITIS,1
NZ,SPLENECTOMY,1
NZ,SPONTANEOUS HAEMORRHAGE,1
NZ,SQUAMOUS CELL CARCINOMA,1
NZ,STENT PLACEMENT,1
NZ,STREPTOCOCCAL BACTERAEMIA,1
NZ,STREPTOCOCCUS TEST POSITIVE,1
NZ,STRESS,1
NZ,STRIDOR,1
NZ,SUBDURAL HAEMATOMA,1
NZ,SUDDEN DEATH,1
NZ,SYNCOPE,1
NZ,THYROID GLAND SCAN ABNORMAL,1
NZ,TONGUE BITING,1
NZ,TOXICITY TO VARIOUS AGENTS,1
NZ,TRANSAMINASES INCREASED,1
NZ,TREMOR,1
NZ,TROPONIN INCREASED,1
NZ,TROPONIN T INCREASED,1
NZ,UNRESPONSIVE TO STIMULI,1
NZ,URINARY INCONTINENCE,1
NZ,UROSEPSIS,1
NZ,VAGINAL HAEMORRHAGE,1
NZ,VASCULAR STENT OCCLUSION,1
NZ,VASCULAR STENT THROMBOSIS,1
NZ,VENTRICULAR FIBRILLATION,1
NZ,VENTRICULAR TACHYCARDIA,1
NZ,VERTIGO,1
NZ,VIITH NERVE PARALYSIS,1
NZ,VISION BLURRED,1
NZ,WEIGHT INCREASED,1
NZ,WHEEZING,1
NZ,WHITE BLOOD CELL COUNT INCREASED,1
NZ,WITHDRAWAL SYNDROME,1
NZ,WOUND,1
NO,DYSPNOEA,23
NO,DIZZINESS,17
NO,OSTEONECROSIS OF JAW,17
NO,PNEUMONIA,17
NO,NAUSEA,15
NO,LACTIC ACIDOSIS,14
NO,OSTEITIS,14
NO,CHEST PAIN,13
NO,DRUG INEFFECTIVE,13
NO,RENAL FAILURE,13
NO,CEREBRAL HAEMORRHAGE,12
NO,FATIGUE,12
NO,HEADACHE,10
NO,PYREXIA,10
NO,GENERAL PHYSICAL HEALTH DETERIORATION,9
NO,HYPOTENSION,9
NO,MYALGIA,9
NO,BALANCE DISORDER,8
NO,CARDIAC FAILURE,8
NO,COUGH,8
NO,MYOCARDIAL INFARCTION,8
NO,PALPITATIONS,8
NO,POLYNEUROPATHY,8
NO,WEIGHT DECREASED,8
NO,ATRIAL FIBRILLATION,7
NO,DEPRESSION,7
NO,DIARRHOEA,7
NO,FALL,7
NO,HEPATIC FAILURE,7
NO,HYPOAESTHESIA,7
NO,MALAISE,7
NO,PLEURAL EFFUSION,7
NO,VOMITING,7
NO,ACUTE KIDNEY INJURY,6
NO,CEREBRAL INFARCTION,6
NO,SEPSIS,6
NO,SYNCOPE,6
NO,TREMOR,6
NO,ALANINE AMINOTRANSFERASE INCREASED,5
NO,ASPARTATE AMINOTRANSFERASE INCREASED,5
NO,BLOOD CREATININE INCREASED,5
NO,BRADYCARDIA,5
NO,DECREASED APPETITE,5
NO,GASTRIC ULCER,5
NO,HYPOGLYCAEMIA,5
NO,INSOMNIA,5
NO,MUSCULAR WEAKNESS,5
NO,PARAESTHESIA,5
NO,PERONEAL NERVE PALSY,5
NO,SENSORY LOSS,5
NO,ASTHENIA,4
NO,ATRIOVENTRICULAR BLOCK,4
NO,CARDIAC ARREST,4
NO,CONDITION AGGRAVATED,4
NO,CONFUSIONAL STATE,4
NO,DEATH,4
NO,DIPLOPIA,4
NO,DUODENAL ULCER HAEMORRHAGE,4
NO,EYELID PTOSIS,4
NO,GAMMA-GLUTAMYLTRANSFERASE INCREASED,4
NO,INTERSTITIAL LUNG DISEASE,4
NO,LIP BLISTER,4
NO,MYASTHENIA GRAVIS,4
NO,PULMONARY FIBROSIS,4
NO,TONGUE BLISTERING,4
NO,ABDOMINAL PAIN,3
NO,ABDOMINAL PAIN UPPER,3
NO,AMNESIA,3
NO,ANXIETY,3
NO,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
NO,COGNITIVE DISORDER,3
NO,CONTRAINDICATED PRODUCT ADMINISTERED,3
NO,CONTUSION,3
NO,DEHYDRATION,3
NO,DISTURBANCE IN ATTENTION,3
NO,DUODENAL ULCER,3
NO,DYSARTHRIA,3
NO,EPISTAXIS,3
NO,GASTROINTESTINAL HAEMORRHAGE,3
NO,HAEMOGLOBIN DECREASED,3
NO,HYPERKALAEMIA,3
NO,HYPERTENSION,3
NO,HYPOACUSIS,3
NO,INTERMITTENT CLAUDICATION,3
NO,LONG QT SYNDROME,3
NO,MEDICATION ERROR,3
NO,MEMORY IMPAIRMENT,3
NO,MENTAL DISORDER,3
NO,MIGRAINE,3
NO,MOOD SWINGS,3
NO,MUSCLE TIGHTNESS,3
NO,MUSCULOSKELETAL STIFFNESS,3
NO,NECK PAIN,3
NO,PARALYSIS,3
NO,PERICARDIAL EFFUSION,3
NO,PRODUCT SUBSTITUTION ISSUE,3
NO,PULMONARY HYPERTENSION,3
NO,QUALITY OF LIFE DECREASED,3
NO,RENAL IMPAIRMENT,3
NO,SINUS NODE DYSFUNCTION,3
NO,SOMNOLENCE,3
NO,SPEECH DISORDER,3
NO,TINNITUS,3
NO,VISUAL IMPAIRMENT,3
NO,WEIGHT INCREASED,3
NO,ABDOMINAL DISTENSION,2
NO,ACUTE MYOCARDIAL INFARCTION,2
NO,ACUTE RESPIRATORY DISTRESS SYNDROME,2
NO,ANAEMIA,2
NO,ANAPHYLACTIC REACTION,2
NO,ANGINA UNSTABLE,2
NO,ANKYLOSING SPONDYLITIS,2
NO,AORTIC ANEURYSM,2
NO,APHASIA,2
NO,ATRIAL THROMBOSIS,2
NO,BACK PAIN,2
NO,BLADDER CANCER,2
NO,BLOOD BILIRUBIN INCREASED,2
NO,BLOOD PRESSURE FLUCTUATION,2
NO,BLOOD PRESSURE INCREASED,2
NO,BONE MARROW FAILURE,2
NO,C-REACTIVE PROTEIN INCREASED,2
NO,CARDIAC FAILURE CHRONIC,2
NO,CARDIOVERSION,2
NO,CAROTID ARTERY OCCLUSION,2
NO,CEREBROVASCULAR ACCIDENT,2
NO,CHEILITIS,2
NO,CHRONIC KIDNEY DISEASE,2
NO,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
NO,CIRCULATORY COLLAPSE,2
NO,CLUMSINESS,2
NO,COMA,2
NO,COMMUNICATION DISORDER,2
NO,CORONARY ARTERY DISEASE,2
NO,DELIRIUM,2
NO,DIABETIC KETOACIDOSIS,2
NO,DISSEMINATED INTRAVASCULAR COAGULATION,2
NO,DRUG LEVEL INCREASED,2
NO,DRY MOUTH,2
NO,DYSPHAGIA,2
NO,DYSPHONIA,2
NO,DYSPNOEA EXERTIONAL,2
NO,ECZEMA,2
NO,ERYTHEMA MULTIFORME,2
NO,EXPOSED BONE IN JAW,2
NO,FACIAL PAIN,2
NO,GAIT DISTURBANCE,2
NO,GASTROENTERITIS,2
NO,GASTROOESOPHAGEAL REFLUX DISEASE,2
NO,HAEMATOMA,2
NO,HAEMATURIA,2
NO,HAEMORRHAGE,2
NO,HEPATIC ENZYME INCREASED,2
NO,HEPATITIS,2
NO,HOT FLUSH,2
NO,HYPERBILIRUBINAEMIA,2
NO,HYPERNATRAEMIA,2
NO,HYPOAESTHESIA ORAL,2
NO,IRIDOCYCLITIS,2
NO,JAUNDICE,2
NO,KETOACIDOSIS,2
NO,LISTLESS,2
NO,LUNG INFILTRATION,2
NO,MEDICAL DEVICE COMPLICATION,2
NO,MELAENA,2
NO,METABOLIC ACIDOSIS,2
NO,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
NO,NASOPHARYNGITIS,2
NO,OVARIAN CANCER STAGE IV,2
NO,OVERDOSE,2
NO,PAIN,2
NO,PANCYTOPENIA,2
NO,PARAESTHESIA ORAL,2
NO,PLATELET COUNT DECREASED,2
NO,POLLAKIURIA,2
NO,POST PROCEDURAL HAEMORRHAGE,2
NO,PRESCRIBED OVERDOSE,2
NO,PRODUCTIVE COUGH,2
NO,PSORIASIS,2
NO,PSYCHOTIC DISORDER,2
NO,PULMONARY CONGESTION,2
NO,PULMONARY EMBOLISM,2
NO,RASH,2
NO,RECTAL HAEMORRHAGE,2
NO,RESPIRATION ABNORMAL,2
NO,RESPIRATORY FAILURE,2
NO,RESPIRATORY TRACT INFECTION,2
NO,RHABDOMYOLYSIS,2
NO,SERUM FERRITIN INCREASED,2
NO,SLEEP DISORDER,2
NO,SMALL INTESTINAL HAEMORRHAGE,2
NO,SUBARACHNOID HAEMORRHAGE,2
NO,SUBDURAL HAEMATOMA,2
NO,SURGERY,2
NO,TACHYCARDIA,2
NO,THORACIC HAEMORRHAGE,2
NO,THROMBOTIC CEREBRAL INFARCTION,2
NO,TOOTHACHE,2
NO,TRANSAMINASES INCREASED,2
NO,TRANSIENT ISCHAEMIC ATTACK,2
NO,URINARY RETENTION,2
NO,URTICARIA,2
NO,VIRAL INFECTION,2
NO,VISUAL FIELD DEFECT,2
NO,WHEEZING,2
NO,ABDOMINAL DISCOMFORT,1
NO,ABNORMAL DREAMS,1
NO,ACIDOSIS,1
NO,ACQUIRED EPILEPTIC APHASIA,1
NO,ACTIVITIES OF DAILY LIVING IMPAIRED,1
NO,ACUTE HEPATIC FAILURE,1
NO,ADVERSE DRUG REACTION,1
NO,ANAL HYPOAESTHESIA,1
NO,AORTIC DISSECTION,1
NO,APATHY,1
NO,APPETITE DISORDER,1
NO,ARTHRALGIA,1
NO,ASCITES,1
NO,ASTHMA,1
NO,ATELECTASIS,1
NO,ATRIOVENTRICULAR BLOCK COMPLETE,1
NO,AUDITORY DISORDER,1
NO,BASEDOW^S DISEASE,1
NO,BLOOD ALKALINE PHOSPHATASE DECREASED,1
NO,BLOOD ALKALINE PHOSPHATASE INCREASED,1
NO,BLOOD POTASSIUM DECREASED,1
NO,BLOOD POTASSIUM INCREASED,1
NO,BODY TEMPERATURE DECREASED,1
NO,BODY TEMPERATURE INCREASED,1
NO,BRAIN STEM HAEMORRHAGE,1
NO,BRONCHITIS,1
NO,CARDIAC DISORDER,1
NO,CARDIOMYOPATHY,1
NO,CEREBELLAR HAEMORRHAGE,1
NO,CEREBRAL ARTERY OCCLUSION,1
NO,CHEST DISCOMFORT,1
NO,CHILLS,1
NO,CHOLELITHIASIS,1
NO,CHOLESTASIS,1
NO,CHROMATOPSIA,1
NO,CLOSTRIDIUM TEST POSITIVE,1
NO,COLD SWEAT,1
NO,COMA SCALE ABNORMAL,1
NO,CONSTIPATION,1
NO,CORONARY ARTERY STENOSIS,1
NO,CRANIOTOMY,1
NO,CYANOSIS,1
NO,CYSTITIS,1
NO,DEAFNESS,1
NO,DEAFNESS UNILATERAL,1
NO,DERMATITIS,1
NO,DISCOMFORT,1
NO,DISORIENTATION,1
NO,DIVERTICULITIS,1
NO,DROOLING,1
NO,DRUG EFFECT INCOMPLETE,1
NO,DRUG-INDUCED LIVER INJURY,1
NO,DYSKINESIA,1
NO,DYSPEPSIA,1
NO,EAR DISCOMFORT,1
NO,EJECTION FRACTION DECREASED,1
NO,ELECTROCARDIOGRAM PQ INTERVAL PROLONGED,1
NO,ELECTROCARDIOGRAM QRS COMPLEX,1
NO,EMBOLIC CEREBRAL INFARCTION,1
NO,ERUCTATION,1
NO,EYE HAEMORRHAGE,1
NO,FACIAL PARESIS,1
NO,FEELING ABNORMAL,1
NO,FEELING COLD,1
NO,FEELING DRUNK,1
NO,FEMUR FRACTURE,1
NO,FLATULENCE,1
NO,FLUID INTAKE REDUCED,1
NO,GANGRENE,1
NO,GASTRITIS HAEMORRHAGIC,1
NO,GASTRODUODENITIS,1
NO,GASTROINTESTINAL PAIN,1
NO,GASTROOESOPHAGEAL SPHINCTER INSUFFICIENCY,1
NO,GENERALISED TONIC-CLONIC SEIZURE,1
NO,HAEMATOCHEZIA,1
NO,HAEMATURIA TRAUMATIC,1
NO,HAEMODYNAMIC INSTABILITY,1
NO,HAEMOGLOBIN INCREASED,1
NO,HAEMORRHAGIC CEREBRAL INFARCTION,1
NO,HAEMORRHAGIC STROKE,1
NO,HAIR GROWTH ABNORMAL,1
NO,HALLUCINATION,1
NO,HALLUCINATION_ AUDITORY,1
NO,HEAD TITUBATION,1
NO,HEART RATE INCREASED,1
NO,HEMIANOPIA HOMONYMOUS,1
NO,HEMIPARESIS,1
NO,HEMIPLEGIA,1
NO,HEPATIC CIRRHOSIS,1
NO,HEPATITIS ACUTE,1
NO,HEPATITIS FULMINANT,1
NO,HOSPITALISATION,1
NO,HYPERAEMIA,1
NO,HYPERHIDROSIS,1
NO,HYPERSENSITIVITY VASCULITIS,1
NO,HYPERTENSIVE CARDIOMYOPATHY,1
NO,HYPOKALAEMIA,1
NO,HYPOMETABOLISM,1
NO,HYPONATRAEMIA,1
NO,HYPOPHOSPHATAEMIA,1
NO,HYPOTHYROIDISM,1
NO,HYPOXIA,1
NO,ILEUS,1
NO,INFECTION,1
NO,INFLAMMATORY PSEUDOTUMOUR,1
NO,INFLUENZA,1
NO,INFLUENZA LIKE ILLNESS,1
NO,INTERNATIONAL NORMALISED RATIO FLUCTUATION,1
NO,IRRITABILITY,1
NO,ISCHAEMIC CARDIOMYOPATHY,1
NO,ISCHAEMIC STROKE,1
NO,LARGE INTESTINE POLYP,1
NO,LEFT VENTRICULAR HYPERTROPHY,1
NO,LIGAMENT LAXITY,1
NO,LIMB DISCOMFORT,1
NO,LIP SWELLING,1
NO,LIPOMA,1
NO,LIVER FUNCTION TEST INCREASED,1
NO,LOSS OF CONSCIOUSNESS,1
NO,LUMBAR SPINAL STENOSIS,1
NO,LUNG DISORDER,1
NO,MENTAL IMPAIRMENT,1
NO,MIXED DEMENTIA,1
NO,MOUTH ULCERATION,1
NO,MULTI-ORGAN FAILURE,1
NO,MUSCLE HAEMORRHAGE,1
NO,MUSCLE TWITCHING,1
NO,MUSCULOSKELETAL CHEST PAIN,1
NO,MYOCLONUS,1
NO,MYOPATHY,1
NO,MYOSITIS,1
NO,NAIL INJURY,1
NO,NASAL CONGESTION,1
NO,NASAL DISCOMFORT,1
NO,NECROSIS,1
NO,NEURALGIC AMYOTROPHY,1
NO,NIGHTMARE,1
NO,NOCTURIA,1
NO,NON-HODGKIN^S LYMPHOMA,1
NO,OBSESSIVE-COMPULSIVE PERSONALITY DISORDER,1
NO,OEDEMA PERIPHERAL,1
NO,OESOPHAGITIS,1
NO,OPHTHALMIC VEIN THROMBOSIS,1
NO,ORTHOSTATIC HYPOTENSION,1
NO,OSTEOMYELITIS,1
NO,OSTEORRHAGIA,1
NO,OVERWEIGHT,1
NO,PAIN IN EXTREMITY,1
NO,PAIN IN JAW,1
NO,PANCREATIC CARCINOMA,1
NO,PANCREATITIS CHRONIC,1
NO,PANIC REACTION,1
NO,PARESIS,1
NO,PCO2 INCREASED,1
NO,PERCUTANEOUS CORONARY INTERVENTION,1
NO,PERFORMANCE STATUS DECREASED,1
NO,PERIPHERAL ARTERY THROMBOSIS,1
NO,PERIPHERAL SWELLING,1
NO,PHOTOPHOBIA,1
NO,PNEUMATURIA,1
NO,PNEUMOCYSTIS JIROVECII INFECTION,1
NO,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
NO,PNEUMONIA BACTERIAL,1
NO,PNEUMOTHORAX,1
NO,POEMS SYNDROME,1
NO,POLYMYOSITIS,1
NO,PRODUCT USE ISSUE,1
NO,PROTEINURIA,1
NO,PSYCHOTIC BEHAVIOUR,1
NO,PULSE ABNORMAL,1
NO,RECTAL CANCER METASTATIC,1
NO,RECTAL POLYP,1
NO,RESPIRATORY DISORDER,1
NO,RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE,1
NO,RESTLESSNESS,1
NO,RETINAL ARTERY OCCLUSION,1
NO,RETROPERITONEAL MASS,1
NO,RHEUMATOID ARTHRITIS,1
NO,RHINORRHOEA,1
NO,SCREAMING,1
NO,SEPTIC SHOCK,1
NO,SINUS ARRHYTHMIA,1
NO,SINUS TACHYCARDIA,1
NO,SKIN DISCOLOURATION,1
NO,SKIN EXFOLIATION,1
NO,SOCIAL PHOBIA,1
NO,SPINAL COMPRESSION FRACTURE,1
NO,SUBDURAL HAEMATOMA EVACUATION,1
NO,SUBDURAL HAEMORRHAGE,1
NO,SUDDEN DEATH,1
NO,SUPRAVENTRICULAR TACHYCARDIA,1
NO,TACHYPNOEA,1
NO,TARDIVE DYSKINESIA,1
NO,THALAMUS HAEMORRHAGE,1
NO,THIRST,1
NO,THROAT IRRITATION,1
NO,THROMBOCYTOSIS,1
NO,THYMOMA,1
NO,THYMUS ENLARGEMENT,1
NO,TOOTH INJURY,1
NO,TORSADE DE POINTES,1
NO,TRANSFUSION,1
NO,TREATMENT FAILURE,1
NO,TROPONIN INCREASED,1
NO,UNDERDOSE,1
NO,URINARY TRACT DISORDER,1
NO,URINARY TRACT INFECTION,1
NO,UROSEPSIS,1
NO,VESICAL FISTULA,1
NO,VISION BLURRED,1
NO,VISUAL ACUITY REDUCED,1
NO,VITAMIN D DEFICIENCY,1
NO,VTH NERVE INJURY,1
NO,WOUND,1
NO,WRONG PATIENT RECEIVED MEDICATION,1
PK,DIABETES MELLITUS INADEQUATE CONTROL,1
PK,GENERAL PHYSICAL HEALTH DETERIORATION,1
PK,HYPOGLYCAEMIA,1
PK,LETHARGY,1
PK,MYALGIA,1
PK,PYREXIA,1
PE,ARRHYTHMIA,1
PH,PERITONEAL DIALYSIS COMPLICATION,3
PH,PERITONITIS BACTERIAL,3
PH,PYREXIA,3
PH,CHEST PAIN,2
PH,CHOREA,2
PH,MYOCARDIAL INFARCTION,2
PH,PLEURAL EFFUSION,2
PH,ABDOMINAL DISCOMFORT,1
PH,ABDOMINAL PAIN UPPER,1
PH,ADVERSE EVENT,1
PH,ANAEMIA,1
PH,ARTERIAL OCCLUSIVE DISEASE,1
PH,BLOOD CREATININE INCREASED,1
PH,BLOOD GLUCOSE FLUCTUATION,1
PH,BLOOD GLUCOSE INCREASED,1
PH,BLOOD PRESSURE DECREASED,1
PH,BRADYCARDIA,1
PH,CARDIAC ARREST,1
PH,CARDIAC DISORDER,1
PH,CEREBRAL INFARCTION,1
PH,CEREBROVASCULAR ACCIDENT,1
PH,CHRONIC KIDNEY DISEASE,1
PH,CIRCULATORY COLLAPSE,1
PH,DEATH,1
PH,DEEP VEIN THROMBOSIS,1
PH,DERMATITIS EXFOLIATIVE,1
PH,DIZZINESS,1
PH,DRUG INEFFECTIVE,1
PH,DYSPNOEA,1
PH,EMBOLIC STROKE,1
PH,EXTENSOR PLANTAR RESPONSE,1
PH,GASTRITIS,1
PH,GOUTY ARTHRITIS,1
PH,HAEMATOCRIT INCREASED,1
PH,HAEMOGLOBIN ABNORMAL,1
PH,HAEMORRHAGE INTRACRANIAL,1
PH,HAEMORRHAGIC STROKE,1
PH,HALLUCINATION,1
PH,HYPERTENSION,1
PH,HYPERTENSIVE CRISIS,1
PH,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
PH,LUPUS NEPHRITIS,1
PH,MULTI-ORGAN FAILURE,1
PH,MULTIPLE FRACTURES,1
PH,OESOPHAGEAL ULCER,1
PH,ORTHOSTATIC HYPOTENSION,1
PH,PEPTIC ULCER,1
PH,PLATELET COUNT INCREASED,1
PH,RASH MACULO-PAPULAR,1
PH,RASH PRURITIC,1
PH,SEPTIC SHOCK,1
PH,SKIN EXFOLIATION,1
PH,SKIN HYPERTROPHY,1
PH,TESTICULAR MASS,1
PH,THROMBOCYTOPENIA,1
PH,URINARY TRACT INFECTION,1
PH,VENOUS OCCLUSION,1
PH,VOMITING,1
PL,DRUG INEFFECTIVE,30
PL,CHEST PAIN,14
PL,FOETAL EXPOSURE DURING PREGNANCY,13
PL,PREMATURE BABY,13
PL,DYSPNOEA,12
PL,FATIGUE,11
PL,PALPITATIONS,10
PL,ANAEMIA,9
PL,ARRHYTHMIA,9
PL,COUGH,9
PL,MYALGIA,9
PL,PNEUMONIA,9
PL,CARDIAC FAILURE,8
PL,DRUG INTOLERANCE,8
PL,EPISTAXIS,8
PL,EXPOSURE DURING PREGNANCY,8
PL,INSOMNIA,8
PL,LEFT VENTRICULAR HYPERTROPHY,8
PL,MUSCLE SPASMS,8
PL,TINNITUS,8
PL,TRANSIENT ISCHAEMIC ATTACK,8
PL,ALANINE AMINOTRANSFERASE INCREASED,7
PL,BRADYCARDIA,7
PL,CONFUSIONAL STATE,7
PL,DEATH,7
PL,FACIAL ASYMMETRY,7
PL,MUSCULAR WEAKNESS,7
PL,SPEECH DISORDER,7
PL,SYNCOPE,7
PL,THROMBOCYTOPENIA,7
PL,ASTHENIA,6
PL,ELECTROCARDIOGRAM QT PROLONGED,6
PL,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,6
PL,LABILE HYPERTENSION,6
PL,OEDEMA PERIPHERAL,6
PL,BRONCHITIS,5
PL,CARDIAC ARREST,5
PL,CORONARY ARTERY DISEASE,5
PL,DIARRHOEA,5
PL,GENERAL PHYSICAL HEALTH DETERIORATION,5
PL,HYPERTENSION,5
PL,LEUKOPENIA,5
PL,MALAISE,5
PL,NAUSEA,5
PL,OVERDOSE,5
PL,PYREXIA,5
PL,TOXIC EPIDERMAL NECROLYSIS,5
PL,ACUTE RESPIRATORY FAILURE,4
PL,ATRIAL TACHYCARDIA,4
PL,BLOOD CREATINE INCREASED,4
PL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,4
PL,DEHYDRATION,4
PL,DIZZINESS,4
PL,DRUG EFFECT INCOMPLETE,4
PL,HEADACHE,4
PL,HEART RATE IRREGULAR,4
PL,HEPATIC ENZYME INCREASED,4
PL,HEPATIC FAILURE,4
PL,INITIAL INSOMNIA,4
PL,ISCHAEMIC STROKE,4
PL,MACULAR DETACHMENT,4
PL,MIDDLE INSOMNIA,4
PL,NEUTROPENIA,4
PL,PERIPHERAL SWELLING,4
PL,PULMONARY EMBOLISM,4
PL,RENAL FAILURE,4
PL,RESPIRATORY TRACT INFECTION,4
PL,STAPHYLOCOCCAL SEPSIS,4
PL,ABDOMINAL PAIN,3
PL,ABDOMINAL PAIN LOWER,3
PL,ANURIA,3
PL,BLISTER,3
PL,BLOOD PRESSURE ABNORMAL,3
PL,CONTUSION,3
PL,DYSPEPSIA,3
PL,ELECTROCARDIOGRAM QRS COMPLEX SHORTENED,3
PL,FEELING ABNORMAL,3
PL,GASTROINTESTINAL HAEMORRHAGE,3
PL,HEPATOTOXICITY,3
PL,HYPOAESTHESIA,3
PL,LABILE BLOOD PRESSURE,3
PL,LOW BIRTH WEIGHT BABY,3
PL,MYOCARDIAL INFARCTION,3
PL,NORMAL NEWBORN,3
PL,OLIGURIA,3
PL,PAIN,3
PL,PRURITUS,3
PL,SEIZURE,3
PL,STAPHYLOCOCCAL INFECTION,3
PL,TACHYCARDIA,3
PL,TACHYPNOEA,3
PL,VAGINAL HAEMORRHAGE,3
PL,VASCULAR PSEUDOANEURYSM,3
PL,ASPARTATE AMINOTRANSFERASE INCREASED,2
PL,ATRIAL FIBRILLATION,2
PL,BLOOD PRESSURE INCREASED,2
PL,CLOSTRIDIUM DIFFICILE COLITIS,2
PL,CONJUNCTIVITIS,2
PL,EJECTION FRACTION DECREASED,2
PL,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,2
PL,ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL,2
PL,ERYTHEMA,2
PL,FEBRILE NEUTROPENIA,2
PL,HAEMOGLOBIN DECREASED,2
PL,HAEMOLYTIC URAEMIC SYNDROME,2
PL,HAEMORRHAGIC TRANSFORMATION STROKE,2
PL,LEIOMYOMA,2
PL,LOSS OF CONSCIOUSNESS,2
PL,LYMPHOPENIA,2
PL,MATERNAL EXPOSURE DURING PREGNANCY,2
PL,METASTASES TO CENTRAL NERVOUS SYSTEM,2
PL,MUCOSAL HAEMORRHAGE,2
PL,OSTEONECROSIS,2
PL,PANCREATITIS ACUTE,2
PL,PANCYTOPENIA,2
PL,PLASMA CELL MYELOMA,2
PL,PROTEINURIA,2
PL,RASH,2
PL,RENAL ARTERY STENOSIS,2
PL,SCAB,2
PL,SEPSIS,2
PL,SINUS BRADYCARDIA,2
PL,SKIN INJURY,2
PL,SKIN TOXICITY,2
PL,SUICIDE ATTEMPT,2
PL,TOXICITY TO VARIOUS AGENTS,2
PL,TREATMENT NONCOMPLIANCE,2
PL,TREMOR,2
PL,VENTRICULAR FIBRILLATION,2
PL,VENTRICULAR TACHYCARDIA,2
PL,ABDOMINAL PAIN UPPER,1
PL,ACIDOSIS,1
PL,ACTINIC KERATOSIS,1
PL,ACTINOMYCOSIS,1
PL,ACUTE KIDNEY INJURY,1
PL,ACUTE MYOCARDIAL INFARCTION,1
PL,ADENOCARCINOMA OF COLON,1
PL,ADENOMYOSIS,1
PL,ADMINISTRATION SITE HAEMATOMA,1
PL,ANXIETY,1
PL,AORTIC ANEURYSM,1
PL,AORTIC BRUIT,1
PL,ARTERIAL RUPTURE,1
PL,ARTERIOSCLEROSIS,1
PL,ASCITES,1
PL,ASPERGILLUS INFECTION,1
PL,ATRIAL FLUTTER,1
PL,AUTOIMMUNE MYOCARDITIS,1
PL,BALANCE DISORDER,1
PL,BASAL CELL CARCINOMA,1
PL,BENIGN PANCREATIC NEOPLASM,1
PL,BLADDER DILATATION,1
PL,BLOOD CHOLESTEROL INCREASED,1
PL,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
PL,BLOOD CREATININE,1
PL,BLOOD PRESSURE DECREASED,1
PL,BLOOD PRESSURE FLUCTUATION,1
PL,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
PL,BONE LESION,1
PL,BONE PAIN,1
PL,BRAIN DEATH,1
PL,BREAST CANCER,1
PL,BRUGADA SYNDROME,1
PL,C-REACTIVE PROTEIN INCREASED,1
PL,CAMPYLOBACTER INFECTION,1
PL,CAPNOCYTOPHAGA INFECTION,1
PL,CARDIAC DISORDER,1
PL,CARDIAC FAILURE CHRONIC,1
PL,CARDIAC MURMUR,1
PL,CARDIOGENIC SHOCK,1
PL,CARDIOMYOPATHY,1
PL,CARDIOTOXICITY,1
PL,CARDIOVERSION,1
PL,CENTRAL NERVOUS SYSTEM HAEMORRHAGE,1
PL,CEREBRAL ATAXIA,1
PL,CEREBRAL HAEMORRHAGE,1
PL,CHEST DISCOMFORT,1
PL,CHOLANGITIS,1
PL,CHOLECYSTITIS,1
PL,CHOLELITHIASIS,1
PL,CHORIORETINOPATHY,1
PL,CIRCULATORY COLLAPSE,1
PL,COLON CANCER METASTATIC,1
PL,CONDITION AGGRAVATED,1
PL,CORONARY ARTERY EMBOLISM,1
PL,CORONARY ARTERY INSUFFICIENCY,1
PL,CROHN^S DISEASE,1
PL,CUSHINGOID,1
PL,CYTOMEGALOVIRUS INFECTION,1
PL,DECUBITUS ULCER,1
PL,DEEP VEIN THROMBOSIS,1
PL,DEPRESSED LEVEL OF CONSCIOUSNESS,1
PL,DEPRESSED MOOD,1
PL,DERMATITIS ALLERGIC,1
PL,DIABETES MELLITUS INADEQUATE CONTROL,1
PL,DISEASE PROGRESSION,1
PL,DISEASE RECURRENCE,1
PL,DRUG ADMINISTRATION ERROR,1
PL,DRUG-INDUCED LIVER INJURY,1
PL,DRY GANGRENE,1
PL,DRY MOUTH,1
PL,DYSARTHRIA,1
PL,DYSKINESIA,1
PL,DYSPNOEA AT REST,1
PL,DYSTONIA,1
PL,ELECTROCARDIOGRAM ABNORMAL,1
PL,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,1
PL,ENCEPHALITIS,1
PL,ENTERITIS,1
PL,ESCHERICHIA URINARY TRACT INFECTION,1
PL,EXERCISE TOLERANCE DECREASED,1
PL,EXTRAPYRAMIDAL DISORDER,1
PL,EYELID OEDEMA,1
PL,FACE OEDEMA,1
PL,FEAR,1
PL,FLATULENCE,1
PL,FOETAL GROWTH RESTRICTION,1
PL,FOETAL HYPOKINESIA,1
PL,FRACTURE,1
PL,FUSOBACTERIUM INFECTION,1
PL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
PL,GASTRIC DISORDER,1
PL,GASTRIC ULCER,1
PL,GASTROENTERITIS ROTAVIRUS,1
PL,GASTROINTESTINAL DISORDER,1
PL,GASTROOESOPHAGEAL REFLUX DISEASE,1
PL,GENERALISED ERYTHEMA,1
PL,GENITAL HAEMORRHAGE,1
PL,GINGIVAL HYPERPLASIA,1
PL,GINGIVITIS,1
PL,GLIOMA,1
PL,GROIN PAIN,1
PL,HAEMARTHROSIS,1
PL,HAEMORRHAGE INTRACRANIAL,1
PL,HAEMORRHAGIC DIATHESIS,1
PL,HEART RATE INCREASED,1
PL,HEPATIC LESION,1
PL,HEPATIC STEATOSIS,1
PL,HEPATOMEGALY,1
PL,HIRSUTISM,1
PL,HOSPITALISATION,1
PL,HYPERAEMIA,1
PL,HYPERHIDROSIS,1
PL,HYPERKALAEMIA,1
PL,HYPERKERATOSIS,1
PL,HYPERTHYROIDISM,1
PL,HYPERTRANSAMINASAEMIA,1
PL,HYPOALBUMINAEMIA,1
PL,HYPOKALAEMIA,1
PL,HYPOPHYSITIS,1
PL,HYPOTENSION,1
PL,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
PL,INCOHERENT,1
PL,INFUSION RELATED REACTION,1
PL,INTERSTITIAL LUNG DISEASE,1
PL,IRON DEFICIENCY ANAEMIA,1
PL,JAUNDICE,1
PL,JOINT DISLOCATION,1
PL,KIDNEY TRANSPLANT REJECTION,1
PL,KLEBSIELLA TEST POSITIVE,1
PL,LACTOBACILLUS INFECTION,1
PL,LATENT TUBERCULOSIS,1
PL,LEFT VENTRICULAR DYSFUNCTION,1
PL,LEUKOCYTOSIS,1
PL,LIVE BIRTH,1
PL,LIVER DISORDER,1
PL,LIVER FUNCTION TEST ABNORMAL,1
PL,LOWER GASTROINTESTINAL HAEMORRHAGE,1
PL,LOWER RESPIRATORY TRACT INFECTION,1
PL,LUNG ADENOCARCINOMA,1
PL,LUNG NEOPLASM,1
PL,MALIGNANT NEOPLASM PROGRESSION,1
PL,MALNUTRITION,1
PL,METABOLIC ACIDOSIS,1
PL,MONOCYTOSIS,1
PL,MOUTH HAEMORRHAGE,1
PL,MULTIPLE SCLEROSIS RELAPSE,1
PL,MYDRIASIS,1
PL,NEOPLASM MALIGNANT,1
PL,NEPHRITIC SYNDROME,1
PL,NEUTROPHIL COUNT DECREASED,1
PL,NEUTROPHILIA,1
PL,NIKOLSKY^S SIGN,1
PL,NODAL RHYTHM,1
PL,NON-CARDIAC CHEST PAIN,1
PL,OCULAR HYPERAEMIA,1
PL,OEDEMA MOUTH,1
PL,ONYCHOMYCOSIS,1
PL,ORAL CANDIDIASIS,1
PL,ORAL DISORDER,1
PL,ORAL MUCOSAL ERYTHEMA,1
PL,OSTEOMYELITIS CHRONIC,1
PL,OSTEONECROSIS OF JAW,1
PL,PALATAL DISORDER,1
PL,PANCREATIC DISORDER,1
PL,PAPILLA OF VATER STENOSIS,1
PL,PEPTOSTREPTOCOCCUS INFECTION,1
PL,PERIPHERAL ARTERY ANEURYSM,1
PL,PLEURAL EFFUSION,1
PL,PNEUMONIA CYTOMEGALOVIRAL,1
PL,PNEUMONIA FUNGAL,1
PL,PNEUMONIA STAPHYLOCOCCAL,1
PL,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,1
PL,POST PROCEDURAL FISTULA,1
PL,POST-TRAUMATIC STRESS DISORDER,1
PL,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
PL,PREMATURE DELIVERY,1
PL,PREMATURE LABOUR,1
PL,PREMATURE SEPARATION OF PLACENTA,1
PL,PSYCHOMOTOR HYPERACTIVITY,1
PL,PULMONARY OEDEMA,1
PL,PULSE ABNORMAL,1
PL,PYELOCALIECTASIS,1
PL,RECTAL HAEMORRHAGE,1
PL,REGURGITATION,1
PL,RENAL INJURY,1
PL,RESPIRATORY FAILURE,1
PL,RESPIRATORY TRACT HAEMORRHAGE,1
PL,RHABDOMYOLYSIS,1
PL,SEBORRHOEIC KERATOSIS,1
PL,SEPTIC SHOCK,1
PL,SHOCK,1
PL,SKIN PAPILLOMA,1
PL,SPLENOMEGALY,1
PL,SQUAMOUS CELL CARCINOMA,1
PL,STREPTOCOCCAL INFECTION,1
PL,SUBARACHNOID HAEMORRHAGE,1
PL,SYSTEMIC INFECTION,1
PL,TACHYCARDIA INDUCED CARDIOMYOPATHY,1
PL,THERAPEUTIC RESPONSE SHORTENED,1
PL,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
PL,TRANSAMINASES INCREASED,1
PL,TREATMENT FAILURE,1
PL,URETERIC DILATATION,1
PL,URETERIC STENOSIS,1
PL,URINARY RETENTION,1
PL,URINARY TRACT INFECTION ENTEROCOCCAL,1
PL,VASCULAR STENT THROMBOSIS,1
PL,VENOOCCLUSIVE LIVER DISEASE,1
PL,VENTRICULAR ARRHYTHMIA,1
PL,VENTRICULAR DYSFUNCTION,1
PL,VENTRICULAR EXTRASYSTOLES,1
PL,VOMITING,1
PL,WHITE BLOOD CELL COUNT DECREASED,1
PL,WOUND ABSCESS,1
PL,WOUND INFECTION,1
PT,DRUG INEFFECTIVE,4
PT,HYPERGLYCAEMIA,4
PT,CARDIAC ARREST,3
PT,METABOLIC ACIDOSIS,3
PT,BLOOD LACTIC ACID INCREASED,2
PT,BLOOD PH DECREASED,2
PT,ANAEMIA,1
PT,BACTERIAL SEPSIS,1
PT,BLOOD CREATININE INCREASED,1
PT,BONE PAIN,1
PT,BRADYCARDIA,1
PT,CELL DEATH,1
PT,CEREBROVASCULAR ACCIDENT,1
PT,CONFUSIONAL STATE,1
PT,DEATH,1
PT,DIABETIC HYPERGLYCAEMIC COMA,1
PT,DIZZINESS,1
PT,EYELID OEDEMA,1
PT,FACIAL PARESIS,1
PT,FATIGUE,1
PT,HEADACHE,1
PT,HEPATIC FAILURE,1
PT,HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME,1
PT,HYPERKALAEMIA,1
PT,HYPERTENSION,1
PT,HYPERTONIC BLADDER,1
PT,LACTIC ACIDOSIS,1
PT,MALAISE,1
PT,PAIN,1
PT,PALPITATIONS,1
PT,PERIPHERAL EMBOLISM,1
PT,PRODUCT USE ISSUE,1
PT,RENAL FAILURE,1
PT,SHOCK,1
PT,SUPRAPUBIC PAIN,1
PT,TRANSIENT ISCHAEMIC ATTACK,1
PT,URAEMIA ODOUR,1
PT,VOMITING,1
PR,INJECTION SITE PAIN,30
PR,NASOPHARYNGITIS,16
PR,DRUG INEFFECTIVE,15
PR,PAIN,12
PR,HEADACHE,11
PR,PERIPHERAL SWELLING,9
PR,MALAISE,7
PR,PAIN IN EXTREMITY,7
PR,PSORIASIS,7
PR,ARTHRALGIA,6
PR,ASTHENIA,6
PR,BURNING SENSATION,6
PR,DIARRHOEA,6
PR,DIZZINESS,6
PR,GAIT DISTURBANCE,6
PR,NAUSEA,6
PR,ABDOMINAL PAIN,5
PR,CHIKUNGUNYA VIRUS INFECTION,5
PR,DYSPHAGIA,5
PR,FALL,5
PR,HAEMOGLOBIN DECREASED,5
PR,HYPERKALAEMIA,5
PR,HYPERSENSITIVITY,5
PR,HYPERTENSION,5
PR,PYREXIA,5
PR,ANAEMIA,4
PR,BRONCHITIS,4
PR,CHEST PAIN,4
PR,DECREASED APPETITE,4
PR,FATIGUE,4
PR,OROPHARYNGEAL PAIN,4
PR,UNRESPONSIVE TO STIMULI,4
PR,URINARY TRACT INFECTION,4
PR,ASTHMA,3
PR,DYSPNOEA,3
PR,ERYTHEMA,3
PR,HYPERCHOLESTEROLAEMIA,3
PR,INFLAMMATION,3
PR,JOINT SWELLING,3
PR,PRURITUS GENERALISED,3
PR,RECTAL HAEMORRHAGE,3
PR,RHEUMATOID ARTHRITIS,3
PR,VOMITING,3
PR,WEIGHT DECREASED,3
PR,ABDOMINAL PAIN UPPER,2
PR,ABSCESS,2
PR,ATRIOVENTRICULAR BLOCK,2
PR,ATRIOVENTRICULAR BLOCK COMPLETE,2
PR,BACK PAIN,2
PR,BLOOD GLUCOSE INCREASED,2
PR,BLOOD PRESSURE INCREASED,2
PR,BONE PAIN,2
PR,BRAIN NEOPLASM,2
PR,CARDIAC ARREST,2
PR,CELLULITIS,2
PR,CHILLS,2
PR,CONSTIPATION,2
PR,CONTUSION,2
PR,COUGH,2
PR,DECREASED ACTIVITY,2
PR,DERMATITIS ALLERGIC,2
PR,DIABETES MELLITUS,2
PR,DIABETES MELLITUS INADEQUATE CONTROL,2
PR,DRUG EFFECT DECREASED,2
PR,DRUG EFFECT INCOMPLETE,2
PR,FEELING HOT,2
PR,HYPOAESTHESIA,2
PR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
PR,INCORRECT DOSE ADMINISTERED,2
PR,INFLUENZA,2
PR,INJECTION SITE ERYTHEMA,2
PR,INJECTION SITE HAEMATOMA,2
PR,INJECTION SITE HAEMORRHAGE,2
PR,INJECTION SITE PRURITUS,2
PR,INTESTINAL POLYP,2
PR,INTRACRANIAL ANEURYSM,2
PR,MOBILITY DECREASED,2
PR,MYALGIA,2
PR,MYOCARDIAL NECROSIS MARKER INCREASED,2
PR,NECK PAIN,2
PR,PNEUMONIA,2
PR,PRODUCT USE ISSUE,2
PR,PSORIATIC ARTHROPATHY,2
PR,RASH,2
PR,RESPIRATORY TRACT CONGESTION,2
PR,SEIZURE,2
PR,SKIN ULCER,2
PR,SOMNOLENCE,2
PR,SPINAL DISORDER,2
PR,SWELLING,2
PR,SWELLING FACE,2
PR,TINNITUS,2
PR,VAGINAL CANCER,2
PR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
PR,ABSCESS INTESTINAL,1
PR,ABSCESS NECK,1
PR,AMNESIA,1
PR,ANGIOEDEMA,1
PR,ANXIETY,1
PR,APHASIA,1
PR,ARTERIAL OCCLUSIVE DISEASE,1
PR,ARTHRITIS,1
PR,ASPHYXIA,1
PR,BEDRIDDEN,1
PR,BENIGN NEOPLASM,1
PR,BLOOD CREATININE INCREASED,1
PR,BLOOD POTASSIUM DECREASED,1
PR,BLOOD POTASSIUM INCREASED,1
PR,BLOOD PRESSURE ABNORMAL,1
PR,BRONCHOSPASM,1
PR,BURNS SECOND DEGREE,1
PR,CARDIAC ENZYMES INCREASED,1
PR,CARDIAC MURMUR,1
PR,CARDIO-RESPIRATORY ARREST,1
PR,CAROTID ARTERY OCCLUSION,1
PR,CATARACT,1
PR,CHEST DISCOMFORT,1
PR,CHEST X-RAY ABNORMAL,1
PR,CLOSTRIDIUM DIFFICILE SEPSIS,1
PR,COLITIS,1
PR,COMA,1
PR,CROHN^S DISEASE,1
PR,DECREASED IMMUNE RESPONSIVENESS,1
PR,DECREASED INTEREST,1
PR,DEPRESSION,1
PR,DIABETIC NEUROPATHY,1
PR,DISCOMFORT,1
PR,DIVERTICULITIS,1
PR,DRUG PRESCRIBING ERROR,1
PR,DRY MOUTH,1
PR,DRY THROAT,1
PR,DYSARTHRIA,1
PR,DYSGEUSIA,1
PR,ECHOCARDIOGRAM ABNORMAL,1
PR,FACE INJURY,1
PR,FLATULENCE,1
PR,FLUID RETENTION,1
PR,FORMICATION,1
PR,FUNGAL INFECTION,1
PR,GASTRITIS,1
PR,GASTROINTESTINAL FUNGAL INFECTION,1
PR,GASTROINTESTINAL INFLAMMATION,1
PR,GINGIVAL INFECTION,1
PR,GINGIVAL SWELLING,1
PR,HAEMODIALYSIS,1
PR,HAEMORRHAGE,1
PR,HEAD DISCOMFORT,1
PR,HEPATITIS,1
PR,HIATUS HERNIA,1
PR,HIP FRACTURE,1
PR,HYPERHIDROSIS,1
PR,IMPETIGO,1
PR,INFARCTION,1
PR,INJECTION SITE CELLULITIS,1
PR,INJECTION SITE DISCOMFORT,1
PR,INJECTION SITE INFECTION,1
PR,INJECTION SITE REACTION,1
PR,INJECTION SITE SWELLING,1
PR,INJECTION SITE URTICARIA,1
PR,INJECTION SITE WARMTH,1
PR,INJURY,1
PR,INTERNAL HAEMORRHAGE,1
PR,INTERVERTEBRAL DISC PROTRUSION,1
PR,INTESTINAL INFARCTION,1
PR,INTESTINAL ULCER,1
PR,ISCHAEMIC CARDIOMYOPATHY,1
PR,LIMB DISCOMFORT,1
PR,LIMB INJURY,1
PR,LIPIDS INCREASED,1
PR,LIVER DISORDER,1
PR,MEMORY IMPAIRMENT,1
PR,MENISCUS INJURY,1
PR,MENORRHAGIA,1
PR,MOVEMENT DISORDER,1
PR,MUSCLE ATROPHY,1
PR,MUSCLE SPASMS,1
PR,MUSCULOSKELETAL STIFFNESS,1
PR,MYOCARDIAL INFARCTION,1
PR,NEUROPATHY PERIPHERAL,1
PR,NODAL RHYTHM,1
PR,OEDEMA PERIPHERAL,1
PR,ORAL HERPES,1
PR,OSTEOARTHRITIS,1
PR,OXYGEN SATURATION DECREASED,1
PR,PALPITATIONS,1
PR,PANCREATIC ENZYMES INCREASED,1
PR,PANIC ATTACK,1
PR,PARAESTHESIA,1
PR,PHARYNGEAL INFLAMMATION,1
PR,PHARYNGITIS,1
PR,POLYMYOSITIS,1
PR,POST PROCEDURAL COMPLICATION,1
PR,PRODUCT PREPARATION ERROR,1
PR,PRURITUS,1
PR,PTERYGIUM,1
PR,PURULENT DISCHARGE,1
PR,PUSTULAR PSORIASIS,1
PR,RASH GENERALISED,1
PR,RASH MACULAR,1
PR,RENAL DISORDER,1
PR,RENAL FAILURE,1
PR,RENAL FAILURE CHRONIC,1
PR,RENAL IMPAIRMENT,1
PR,SALIVARY GLAND CALCULUS,1
PR,SERONEGATIVE ARTHRITIS,1
PR,SHOULDER OPERATION,1
PR,SKELETAL INJURY,1
PR,SKIN ABRASION,1
PR,SMALL INTESTINAL OBSTRUCTION,1
PR,SNEEZING,1
PR,SPEECH DISORDER,1
PR,SPINAL PAIN,1
PR,SUICIDAL IDEATION,1
PR,SWOLLEN TONGUE,1
PR,SYNCOPE,1
PR,TENDON INJURY,1
PR,TENDON RUPTURE,1
PR,THROMBOPHLEBITIS,1
PR,TOE AMPUTATION,1
PR,TRANSIENT ISCHAEMIC ATTACK,1
PR,TREATMENT NONCOMPLIANCE,1
PR,URTICARIA,1
PR,VAGINAL HAEMORRHAGE,1
PR,VENOUS OCCLUSION,1
PR,VISION BLURRED,1
PR,VITAMIN D DECREASED,1
PR,WOUND DEHISCENCE,1
PR,WOUND INFECTION,1
QA,TOXIC EPIDERMAL NECROLYSIS,3
QA,DERMATITIS BULLOUS,1
QA,DRUG INEFFECTIVE,1
QA,GASTROINTESTINAL HAEMORRHAGE,1
QA,GENERALISED OEDEMA,1
QA,MYOCARDIAL INFARCTION,1
QA,RASH,1
QA,RASH ERYTHEMATOUS,1
QA,RASH MACULAR,1
QA,SKIN LESION,1
QA,SKIN PLAQUE,1
QA,THROMBOSIS IN DEVICE,1
RO,ASTHENIA,11
RO,HEADACHE,10
RO,HYPERTENSION,10
RO,ANGIOEDEMA,9
RO,URTICARIA,9
RO,ANAEMIA,8
RO,PRURITUS,8
RO,ALLERGIC REACTION TO EXCIPIENT,7
RO,PSORIATIC ARTHROPATHY,7
RO,DIZZINESS,6
RO,NAUSEA,6
RO,SOMNOLENCE,6
RO,SWELLING FACE,6
RO,ATRIAL FIBRILLATION,5
RO,CARDIO-RESPIRATORY ARREST,5
RO,CONDITION AGGRAVATED,5
RO,DECREASED APPETITE,5
RO,DYSPNOEA,5
RO,FATIGUE,5
RO,HEPATIC FAILURE,5
RO,PALPITATIONS,5
RO,URINARY TRACT INFECTION,5
RO,VOMITING,5
RO,ANXIETY,4
RO,ASCITES,4
RO,CHEST PAIN,4
RO,DIARRHOEA,4
RO,DRY MOUTH,4
RO,PNEUMONIA,4
RO,SYNCOPE,4
RO,TREMOR,4
RO,ARTHRALGIA,3
RO,BALANCE DISORDER,3
RO,BLOOD GLUCOSE INCREASED,3
RO,CHOLESTASIS,3
RO,CHRONIC KIDNEY DISEASE,3
RO,CONSTIPATION,3
RO,MYALGIA,3
RO,NASOPHARYNGITIS,3
RO,OEDEMA PERIPHERAL,3
RO,PAIN IN EXTREMITY,3
RO,PLEURISY,3
RO,PYREXIA,3
RO,RECTAL HAEMORRHAGE,3
RO,SPINAL PAIN,3
RO,TREATMENT NONCOMPLIANCE,3
RO,UPPER GASTROINTESTINAL HAEMORRHAGE,3
RO,ABDOMINAL PAIN,2
RO,ADRENAL MASS,2
RO,ATRIOVENTRICULAR BLOCK FIRST DEGREE,2
RO,BLOOD BILIRUBIN INCREASED,2
RO,BLOOD PRESSURE INCREASED,2
RO,BRADYCARDIA,2
RO,BRAIN OEDEMA,2
RO,CARDIAC FAILURE,2
RO,CHOLECYSTITIS ACUTE,2
RO,COGNITIVE DISORDER,2
RO,COMA,2
RO,DEATH,2
RO,DEHYDRATION,2
RO,DIARRHOEA INFECTIOUS,2
RO,DISSEMINATED INTRAVASCULAR COAGULATION,2
RO,DYSGEUSIA,2
RO,FALL,2
RO,GASTRIC ULCER,2
RO,GENERAL PHYSICAL HEALTH DETERIORATION,2
RO,HAEMATEMESIS,2
RO,HAEMORRHOIDS,2
RO,HEPATIC CIRRHOSIS,2
RO,HEPATIC ENCEPHALOPATHY,2
RO,HEPATITIS CHOLESTATIC,2
RO,HYPERBILIRUBINAEMIA,2
RO,HYPERKALAEMIA,2
RO,HYPONATRAEMIA,2
RO,INFLUENZA,2
RO,INSOMNIA,2
RO,ISCHAEMIC STROKE,2
RO,LIMB DISCOMFORT,2
RO,MELAENA,2
RO,MUSCULAR WEAKNESS,2
RO,PANCREATITIS,2
RO,PANIC REACTION,2
RO,PSORIASIS,2
RO,QUADRIPLEGIA,2
RO,RASH ERYTHEMATOUS,2
RO,RENAL PAIN,2
RO,RESPIRATORY TRACT INFECTION,2
RO,SEPSIS,2
RO,SINUS ARREST,2
RO,TELANGIECTASIA,2
RO,TOXICITY TO VARIOUS AGENTS,2
RO,TRANSAMINASES INCREASED,2
RO,VENTRICULAR TACHYCARDIA,2
RO,ABDOMINAL DISCOMFORT,1
RO,ABDOMINAL DISTENSION,1
RO,ACQUIRED IMMUNODEFICIENCY SYNDROME,1
RO,ACUTE CORONARY SYNDROME,1
RO,ACUTE KIDNEY INJURY,1
RO,ACUTE RESPIRATORY FAILURE,1
RO,ADVERSE EVENT,1
RO,AMNESIA,1
RO,AMYLOIDOSIS,1
RO,ANAPHYLACTIC REACTION,1
RO,ANAPHYLACTIC SHOCK,1
RO,ANGINA PECTORIS,1
RO,ANGIOLIPOMA,1
RO,AORTIC ARTERIOSCLEROSIS,1
RO,AORTIC VALVE CALCIFICATION,1
RO,AORTIC VALVE INCOMPETENCE,1
RO,AORTIC VALVE SCLEROSIS,1
RO,ARRHYTHMIA,1
RO,ARTERIOVENOUS FISTULA THROMBOSIS,1
RO,ATRIOVENTRICULAR BLOCK,1
RO,ATRIOVENTRICULAR BLOCK COMPLETE,1
RO,BACK PAIN,1
RO,BALLISMUS,1
RO,BLOOD CHOLESTEROL INCREASED,1
RO,BLOOD GLUCOSE DECREASED,1
RO,BLOOD GLUCOSE FLUCTUATION,1
RO,BLOOD PRESSURE FLUCTUATION,1
RO,BLOOD TRIGLYCERIDES INCREASED,1
RO,BLOOD UREA INCREASED,1
RO,BONE PAIN,1
RO,CALCIUM DEFICIENCY,1
RO,CARDIAC ARREST,1
RO,CARDIAC DEATH,1
RO,CARDIAC FAILURE CHRONIC,1
RO,CARDIAC FAILURE CONGESTIVE,1
RO,CARDIAC VALVE DISEASE,1
RO,CELL DEATH,1
RO,CEREBRAL ATROPHY,1
RO,CEREBROVASCULAR ACCIDENT,1
RO,CHILLS,1
RO,CLOSTRIDIUM DIFFICILE COLITIS,1
RO,COMPLETED SUICIDE,1
RO,CONFUSIONAL STATE,1
RO,CORONARY ARTERIAL STENT INSERTION,1
RO,CORONARY ARTERY DISEASE,1
RO,CREATININE RENAL CLEARANCE DECREASED,1
RO,CRYOGLOBULINS PRESENT,1
RO,CYSTITIS INTERSTITIAL,1
RO,DECUBITUS ULCER,1
RO,DEMENTIA,1
RO,DEPRESSED LEVEL OF CONSCIOUSNESS,1
RO,DEPRESSION,1
RO,DIVERTICULUM INTESTINAL,1
RO,DIVERTICULUM INTESTINAL HAEMORRHAGIC,1
RO,DRUG-INDUCED LIVER INJURY,1
RO,DYSLIPIDAEMIA,1
RO,ENCEPHALOPATHY,1
RO,ENTEROCOLITIS HAEMORRHAGIC,1
RO,EOSINOPHILIA,1
RO,EPISTAXIS,1
RO,ERYTHEMA,1
RO,ESCHAR,1
RO,EYE DISORDER,1
RO,EYE OEDEMA,1
RO,FEMUR FRACTURE,1
RO,FLUSHING,1
RO,GALLBLADDER DISORDER,1
RO,GASTRIC PH DECREASED,1
RO,GASTROINTESTINAL MOTILITY DISORDER,1
RO,HAEMANGIOMA OF BONE,1
RO,HAEMATURIA,1
RO,HAEMOPTYSIS,1
RO,HAEMORRHAGIC STROKE,1
RO,HEART RATE INCREASED,1
RO,HEMIPARESIS,1
RO,HEPATIC CANCER RECURRENT,1
RO,HEPATIC CYST,1
RO,HEPATIC STEATOSIS,1
RO,HEPATITIS TOXIC,1
RO,HEPATORENAL FAILURE,1
RO,HIGH DENSITY LIPOPROTEIN DECREASED,1
RO,HYPERCALCAEMIA,1
RO,HYPERHIDROSIS,1
RO,HYPOAESTHESIA,1
RO,HYPOKALAEMIA,1
RO,HYPOPERFUSION,1
RO,HYPOPROTEINAEMIA,1
RO,IGA NEPHROPATHY,1
RO,IMMUNOGLOBULINS DECREASED,1
RO,INFLAMMATION,1
RO,INTENTIONAL DEVICE MISUSE,1
RO,INTENTIONAL OVERDOSE,1
RO,INTENTIONAL PRODUCT MISUSE,1
RO,INTERNATIONAL NORMALISED RATIO INCREASED,1
RO,INTERSTITIAL LUNG DISEASE,1
RO,JAUNDICE,1
RO,JOINT RANGE OF MOTION DECREASED,1
RO,LEUKOCYTOSIS,1
RO,LIMB IMMOBILISATION,1
RO,LIPASE INCREASED,1
RO,LIPOSARCOMA,1
RO,LOSS OF CONSCIOUSNESS,1
RO,LOW DENSITY LIPOPROTEIN INCREASED,1
RO,LOWER LIMB FRACTURE,1
RO,LUNG DISORDER,1
RO,MAJOR DEPRESSION,1
RO,MALAISE,1
RO,METASTASES TO LIVER,1
RO,MITRAL VALVE INCOMPETENCE,1
RO,MOBILITY DECREASED,1
RO,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
RO,MULTIPLE SCLEROSIS,1
RO,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
RO,MYOCARDIAL BRIDGING,1
RO,MYOCARDIAL INFARCTION,1
RO,MYOCARDIAL ISCHAEMIA,1
RO,MYOPATHY,1
RO,NECK PAIN,1
RO,NEUTROPENIA,1
RO,ORGAN FAILURE,1
RO,PAIN,1
RO,PALLOR,1
RO,PANCREATIC DISORDER,1
RO,PANCREATITIS ACUTE,1
RO,PANCREATITIS HAEMORRHAGIC,1
RO,PERITONITIS,1
RO,PLEURAL EFFUSION,1
RO,PLEURAL THICKENING,1
RO,PNEUMONIA BACTERIAL,1
RO,PNEUMONIA PSEUDOMONAL,1
RO,PRODUCT USE ISSUE,1
RO,PROSTATE CANCER,1
RO,PSEUDOMONAL SEPSIS,1
RO,PULMONARY EMBOLISM,1
RO,PULMONARY MICROEMBOLI,1
RO,REACTION TO EXCIPIENT,1
RO,RENAL FAILURE,1
RO,RENAL FAILURE ACUTE,1
RO,RENAL FAILURE CHRONIC,1
RO,RESPIRATORY ARREST,1
RO,RHONCHI,1
RO,ROAD TRAFFIC ACCIDENT,1
RO,SCIATICA,1
RO,SEIZURE,1
RO,SHOCK HAEMORRHAGIC,1
RO,SUPRAVENTRICULAR TACHYCARDIA,1
RO,THROMBOCYTOPENIA,1
RO,TOOTHACHE,1
RO,TRANSIENT ISCHAEMIC ATTACK,1
RO,TUBERCULOUS PLEURISY,1
RO,TUMOUR HAEMORRHAGE,1
RO,URINARY TRACT DISORDER,1
RO,URINARY TRACT OBSTRUCTION,1
RO,VARICOSE VEIN,1
RO,VASCULAR STENT THROMBOSIS,1
RO,VASCULITIS,1
RO,VENTRICULAR FIBRILLATION,1
RO,VENTRICULAR HYPOKINESIA,1
RO,VISUAL IMPAIRMENT,1
RO,VULVOVAGINAL DRYNESS,1
RO,WEIGHT DECREASED,1
RO,WEIGHT INCREASED,1
RO,YELLOW SKIN,1
RU,BLOOD PRESSURE INCREASED,10
RU,DYSPNOEA,10
RU,MYOCARDIAL INFARCTION,10
RU,CONTUSION,8
RU,CHEST PAIN,7
RU,VASCULAR STENT THROMBOSIS,6
RU,ANGINA PECTORIS,5
RU,EPISTAXIS,5
RU,PRODUCT USE ISSUE,5
RU,ANAEMIA,4
RU,NEPHROLITHIASIS,4
RU,PULMONARY OEDEMA,4
RU,VASCULAR STENT OCCLUSION,4
RU,ACUTE MYOCARDIAL INFARCTION,3
RU,ALANINE AMINOTRANSFERASE INCREASED,3
RU,ASPARTATE AMINOTRANSFERASE INCREASED,3
RU,CARDIAC FAILURE,3
RU,HEADACHE,3
RU,HYPERTENSIVE CRISIS,3
RU,ISCHAEMIC STROKE,3
RU,URINARY RETENTION,3
RU,VASCULAR STENT RESTENOSIS,3
RU,ACUTE CORONARY SYNDROME,2
RU,ANGINA UNSTABLE,2
RU,ASTHENIA,2
RU,BACK PAIN,2
RU,CALCULUS URINARY,2
RU,CARDIAC VENTRICULAR THROMBOSIS,2
RU,COAGULOPATHY,2
RU,CORONARY ARTERY OCCLUSION,2
RU,CORONARY ARTERY THROMBOSIS,2
RU,DISEASE PROGRESSION,2
RU,DRUG INEFFECTIVE,2
RU,DUODENAL ULCER,2
RU,FATIGUE,2
RU,FOREARM FRACTURE,2
RU,GASTROINTESTINAL HAEMORRHAGE,2
RU,HAEMOPTYSIS,2
RU,HYPERTENSION,2
RU,PAIN,2
RU,PLATELET COUNT DECREASED,2
RU,PYREXIA,2
RU,RENAL COLIC,2
RU,TACHYCARDIA,2
RU,TRANSIENT ISCHAEMIC ATTACK,2
RU,TYPE 2 DIABETES MELLITUS,2
RU,VASCULAR OCCLUSION,2
RU,WEIGHT INCREASED,2
RU,ABDOMINAL COMPARTMENT SYNDROME,1
RU,ABDOMINAL HERNIA,1
RU,ABDOMINAL PAIN UPPER,1
RU,ANAPHYLACTIC REACTION,1
RU,AORTIC ARTERIOSCLEROSIS,1
RU,APHASIA,1
RU,APRAXIA,1
RU,ARTERIOSCLEROSIS CORONARY ARTERY,1
RU,ASCITES,1
RU,ATRIAL FIBRILLATION,1
RU,BASEDOW^S DISEASE,1
RU,BILE DUCT STONE,1
RU,BLOOD GLUCOSE INCREASED,1
RU,BLOOD PRESSURE ABNORMAL,1
RU,BLOOD PRESSURE DECREASED,1
RU,BLOOD PRESSURE FLUCTUATION,1
RU,BLOOD TRIGLYCERIDES INCREASED,1
RU,BODY TEMPERATURE INCREASED,1
RU,BRAIN HERNIATION,1
RU,BRAIN STEM INFARCTION,1
RU,BREAST NEOPLASM,1
RU,BRONCHOSPASM,1
RU,CARDIAC FAILURE ACUTE,1
RU,CATARACT,1
RU,CEREBRAL ARTERIOSCLEROSIS,1
RU,CEREBRAL INFARCTION,1
RU,CEREBROVASCULAR ACCIDENT,1
RU,CHEST DISCOMFORT,1
RU,CHOLELITHIASIS,1
RU,COLON CANCER,1
RU,CONDITION AGGRAVATED,1
RU,CORONARY ARTERY DISEASE,1
RU,CORONARY ARTERY RESTENOSIS,1
RU,CORONARY ARTERY STENOSIS,1
RU,COUGH,1
RU,CYANOSIS,1
RU,DEMYELINATING POLYNEUROPATHY,1
RU,DERMATITIS ALLERGIC,1
RU,DERMATITIS CONTACT,1
RU,DIABETIC FOOT,1
RU,DIZZINESS,1
RU,DRUG DOSE OMISSION,1
RU,DRUG-INDUCED LIVER INJURY,1
RU,DYSPEPSIA,1
RU,DYSPNOEA EXERTIONAL,1
RU,DYSURIA,1
RU,EMBOLISM,1
RU,ENDOCARDITIS,1
RU,EROSIVE DUODENITIS,1
RU,EYE IRRITATION,1
RU,EYELID OEDEMA,1
RU,FALL,1
RU,GASTRIC DISORDER,1
RU,GASTRIC POLYPS,1
RU,GASTRIC ULCER,1
RU,GASTRITIS EROSIVE,1
RU,GASTROINTESTINAL POLYP HAEMORRHAGE,1
RU,GENERAL PHYSICAL HEALTH DETERIORATION,1
RU,HAEMATURIA,1
RU,HAEMODYNAMIC INSTABILITY,1
RU,HAEMORRHAGE,1
RU,HAEMORRHAGIC STROKE,1
RU,HAEMORRHOIDAL HAEMORRHAGE,1
RU,HEART RATE DECREASED,1
RU,HEART RATE INCREASED,1
RU,HEPATIC FUNCTION ABNORMAL,1
RU,HERNIA REPAIR,1
RU,HERPES ZOSTER,1
RU,HOT FLUSH,1
RU,HYPERCHOLESTEROLAEMIA,1
RU,HYPERHIDROSIS,1
RU,HYPERHOMOCYSTEINAEMIA,1
RU,HYPOAESTHESIA,1
RU,INCREASED APPETITE,1
RU,INFARCTION,1
RU,INGUINAL HERNIA,1
RU,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
RU,LUNG INFILTRATION,1
RU,LUNG NEOPLASM MALIGNANT,1
RU,MALAISE,1
RU,MEDICATION ERROR,1
RU,METASTASES TO CENTRAL NERVOUS SYSTEM,1
RU,METASTASES TO LIVER,1
RU,METASTASES TO LUNG,1
RU,METASTASES TO LYMPH NODES,1
RU,MOUTH HAEMORRHAGE,1
RU,NAUSEA,1
RU,NERVE CONDUCTION STUDIES ABNORMAL,1
RU,NEUTROPENIA,1
RU,OEDEMA,1
RU,OEDEMA PERIPHERAL,1
RU,OSTEOLYSIS,1
RU,PAIN IN EXTREMITY,1
RU,PANCREATITIS,1
RU,PANCREATITIS ACUTE,1
RU,PANCREATITIS CHRONIC,1
RU,PARAESTHESIA,1
RU,PELVIC VENOUS THROMBOSIS,1
RU,PERIPHERAL SWELLING,1
RU,PHARYNGEAL OEDEMA,1
RU,POSTOPERATIVE HERNIA,1
RU,PRODUCTIVE COUGH,1
RU,PULMONARY TUBERCULOMA,1
RU,RECTAL CANCER,1
RU,RIB FRACTURE,1
RU,ROAD TRAFFIC ACCIDENT,1
RU,SCIATICA,1
RU,SCROTAL SWELLING,1
RU,SHOCK HAEMORRHAGIC,1
RU,SMALL INTESTINAL HAEMORRHAGE,1
RU,TACHYCARDIA PAROXYSMAL,1
RU,THROMBOPHLEBITIS,1
RU,TINNITUS,1
RU,TOXIC SKIN ERUPTION,1
RU,URTICARIA,1
RU,VASCULAR STENT STENOSIS,1
RU,VASCULITIS,1
RU,WEIGHT DECREASED,1
KN,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
KN,DRUG-INDUCED LIVER INJURY,1
KN,INTERNATIONAL NORMALISED RATIO INCREASED,1
KN,PROTHROMBIN TIME PROLONGED,1
SA,HYPERGLYCAEMIA,3
SA,CONDITION AGGRAVATED,2
SA,ANASTOMOTIC STENOSIS,1
SA,BRADYARRHYTHMIA,1
SA,CARDIAC FAILURE,1
SA,CARDIAC FAILURE CONGESTIVE,1
SA,CYTOMEGALOVIRUS TEST POSITIVE,1
SA,DYSPNOEA EXERTIONAL,1
SA,HEPATIC ARTERY STENOSIS,1
SA,HERPES ZOSTER,1
SA,NEUTROPENIA,1
SA,PRESYNCOPE,1
SA,WHITE BLOOD CELL COUNT DECREASED,1
RS,CARDIAC ARREST,12
RS,ATRIOVENTRICULAR BLOCK COMPLETE,10
RS,COMA,10
RS,TOXICITY TO VARIOUS AGENTS,8
RS,OVERDOSE,7
RS,ATRIOVENTRICULAR BLOCK SECOND DEGREE,6
RS,SHOCK,5
RS,CARDIOTOXICITY,4
RS,PULSE ABNORMAL,4
RS,INTENTIONAL OVERDOSE,3
RS,POISONING,3
RS,BLOOD GLUCOSE INCREASED,2
RS,BLOOD PRESSURE SYSTOLIC DECREASED,2
RS,IRREGULAR BREATHING,2
RS,AGEUSIA,1
RS,ANXIETY,1
RS,ASPHYXIA,1
RS,ASYMPTOMATIC BACTERIURIA,1
RS,ATRIOVENTRICULAR BLOCK,1
RS,BLOOD CREATININE INCREASED,1
RS,CHRONIC KIDNEY DISEASE,1
RS,CIRCULATORY COLLAPSE,1
RS,COAGULATION FACTOR INCREASED,1
RS,COMPLETED SUICIDE,1
RS,CUTANEOUS VASCULITIS,1
RS,DEATH,1
RS,DYSPNOEA,1
RS,EXPOSURE DURING PREGNANCY,1
RS,FATIGUE,1
RS,FIBRIN D DIMER INCREASED,1
RS,HYPOPNOEA,1
RS,LIMB INJURY,1
RS,MUSCLE ATROPHY,1
RS,NASAL CONGESTION,1
RS,OEDEMA PERIPHERAL,1
RS,PALPITATIONS,1
RS,SINUS TACHYCARDIA,1
RS,SWELLING FACE,1
RS,WEIGHT DECREASED,1
SG,SEPSIS,2
SG,ABDOMINAL DISTENSION,1
SG,CEREBRAL ARTERIOSCLEROSIS,1
SG,CEREBRAL INFARCTION,1
SG,CEREBROVASCULAR DISORDER,1
SG,CONSTIPATION,1
SG,DERMATITIS EXFOLIATIVE,1
SG,DERMATITIS EXFOLIATIVE GENERALISED,1
SG,DIABETES MELLITUS INADEQUATE CONTROL,1
SG,GASTROINTESTINAL SOUNDS ABNORMAL,1
SG,HEMIPARESIS,1
SG,ISCHAEMIC STROKE,1
SG,PERICARDIAL EFFUSION,1
SG,PERITONITIS,1
SG,VOMITING,1
SK,ACUTE MYOCARDIAL INFARCTION,2
SK,BLOOD CREATININE INCREASED,2
SK,DEATH,2
SK,DRUG INEFFECTIVE,2
SK,ABORTION INDUCED,1
SK,ABSCESS,1
SK,ANAEMIA,1
SK,AORTIC ARTERIOSCLEROSIS,1
SK,APHASIA,1
SK,ATRIAL FIBRILLATION,1
SK,ATRIAL FLUTTER,1
SK,BLOOD UREA INCREASED,1
SK,CARDIAC ANEURYSM,1
SK,CARDIAC FAILURE,1
SK,CARDIAC FAILURE CHRONIC,1
SK,CARDIOPULMONARY FAILURE,1
SK,CEREBROVASCULAR ACCIDENT,1
SK,CHILLS,1
SK,DIABETIC METABOLIC DECOMPENSATION,1
SK,EPISTAXIS,1
SK,ERYTHEMA,1
SK,EXPOSURE DURING PREGNANCY,1
SK,FACIAL NERVE DISORDER,1
SK,FEBRILE NEUTROPENIA,1
SK,HAEMOPTYSIS,1
SK,HAEMORRHAGIC STROKE,1
SK,HAEMORRHOIDAL HAEMORRHAGE,1
SK,HEMIPARESIS,1
SK,HYPOKALAEMIA,1
SK,HYPOTENSION,1
SK,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
SK,LEFT VENTRICULAR FAILURE,1
SK,MALAISE,1
SK,MALIGNANT NEOPLASM PROGRESSION,1
SK,MITRAL VALVE INCOMPETENCE,1
SK,MULTI-ORGAN FAILURE,1
SK,MYOCARDIAL INFARCTION,1
SK,MYOCARDIAL ISCHAEMIA,1
SK,OEDEMA,1
SK,PNEUMONIA,1
SK,PRE-ECLAMPSIA,1
SK,PRESCRIBED UNDERDOSE,1
SK,PRURITUS,1
SK,PULMONARY EMBOLISM,1
SK,PYREXIA,1
SK,RESPIRATORY ARREST,1
SK,SEPSIS,1
SK,SEPTIC SHOCK,1
SK,THROMBOCYTOPENIA,1
SK,TOXIC SKIN ERUPTION,1
SK,VENTRICULAR FIBRILLATION,1
SK,VENTRICULAR TACHYCARDIA,1
SI,BLOOD PRESSURE INCREASED,2
SI,GLAUCOMA,2
SI,HEADACHE,2
SI,HYPONATRAEMIA,2
SI,PRODUCT USE ISSUE,2
SI,ACUTE HEPATIC FAILURE,1
SI,CARDIAC ARREST,1
SI,CEREBROVASCULAR ACCIDENT,1
SI,CONVULSION,1
SI,GRAND MAL CONVULSION,1
SI,INFUSION RELATED REACTION,1
SI,PNEUMONIA,1
SI,POLYURIA,1
SI,PYREXIA,1
SI,RENAL FAILURE,1
SI,SEPSIS,1
ES,VENTRICULAR FIBRILLATION,6
ES,CONFUSIONAL STATE,5
ES,MEDICATION ERROR,4
ES,HYPOTENSION,3
ES,ACUTE KIDNEY INJURY,2
ES,AGITATION,2
ES,ANXIETY,2
ES,CARDIAC ARREST,2
ES,CARDIAC FAILURE,2
ES,CARDIOMYOPATHY NEONATAL,2
ES,DYSPEPSIA,2
ES,ELECTROCARDIOGRAM QT PROLONGED,2
ES,EXTRASYSTOLES,2
ES,FEBRILE NEUTROPENIA,2
ES,FOETAL EXPOSURE DURING PREGNANCY,2
ES,HYPERKALAEMIA,2
ES,MITOCHONDRIAL CYTOPATHY,2
ES,NEURALGIA,2
ES,OESOPHAGITIS,2
ES,PNEUMONIA,2
ES,TACHYCARDIA,2
ES,URINARY TRACT INFECTION,2
ES,VENTRICULAR TACHYCARDIA,2
ES,WITHDRAWAL SYNDROME,2
ES,ACUTE PSYCHOSIS,1
ES,ACUTE PULMONARY OEDEMA,1
ES,AGGRESSION,1
ES,ARTHRALGIA,1
ES,ASTHENIA,1
ES,ATRIOVENTRICULAR BLOCK,1
ES,ATRIOVENTRICULAR BLOCK COMPLETE,1
ES,BLOOD PRESSURE INCREASED,1
ES,BODY TEMPERATURE INCREASED,1
ES,CEREBRAL HAEMORRHAGE,1
ES,CHEST DISCOMFORT,1
ES,CHEST PAIN,1
ES,COGNITIVE DISORDER,1
ES,CONSCIOUSNESS FLUCTUATING,1
ES,CONSTIPATION,1
ES,DECREASED APPETITE,1
ES,DIARRHOEA,1
ES,DISORIENTATION,1
ES,DIZZINESS,1
ES,DRUG INEFFECTIVE,1
ES,HAEMATOCHEZIA,1
ES,HAEMORRHOIDAL HAEMORRHAGE,1
ES,HALLUCINATION,1
ES,HALLUCINATION_ VISUAL,1
ES,HEADACHE,1
ES,HEART RATE INCREASED,1
ES,HYPERTRANSAMINASAEMIA,1
ES,HYPOCHROMIC ANAEMIA,1
ES,IMMUNODEFICIENCY,1
ES,INCORRECT DOSAGE ADMINISTERED,1
ES,INFECTION,1
ES,MUCOSAL INFLAMMATION,1
ES,MUSCULAR WEAKNESS,1
ES,NO ADVERSE EVENT,1
ES,PAIN,1
ES,PNEUMONITIS,1
ES,PSEUDOMONAS INFECTION,1
ES,RENAL FAILURE,1
ES,RESPIRATORY TRACT INFECTION,1
ES,RHABDOMYOLYSIS,1
LK,HYPOKALAEMIA,2
LK,HYPONATRAEMIA,2
LK,MEMORY IMPAIRMENT,2
SE,NAUSEA,47
SE,FATIGUE,39
SE,DIZZINESS,38
SE,HYPOTENSION,34
SE,VOMITING,31
SE,TOXICITY TO VARIOUS AGENTS,28
SE,HEADACHE,27
SE,DYSPNOEA,26
SE,SYNCOPE,26
SE,DIARRHOEA,23
SE,FALL,23
SE,CONFUSIONAL STATE,19
SE,CHEST PAIN,18
SE,DRUG INEFFECTIVE,17
SE,ATRIAL FIBRILLATION,15
SE,RENAL FAILURE,15
SE,PNEUMONIA,14
SE,BACK PAIN,13
SE,CARDIAC FAILURE,13
SE,CEREBRAL HAEMORRHAGE,13
SE,PYREXIA,13
SE,ARRHYTHMIA,12
SE,CEREBROVASCULAR ACCIDENT,12
SE,DEPRESSED LEVEL OF CONSCIOUSNESS,12
SE,HYPONATRAEMIA,12
SE,ABDOMINAL PAIN,11
SE,ARTHRALGIA,11
SE,C-REACTIVE PROTEIN INCREASED,11
SE,DEHYDRATION,11
SE,MYOCARDIAL INFARCTION,11
SE,PARAESTHESIA,11
SE,BRADYCARDIA,10
SE,LOSS OF CONSCIOUSNESS,10
SE,MYALGIA,10
SE,PERIPHERAL SWELLING,10
SE,RASH,10
SE,ANAEMIA,9
SE,BALANCE DISORDER,9
SE,CEREBRAL INFARCTION,9
SE,CHEST DISCOMFORT,9
SE,COUGH,9
SE,HALLUCINATION,9
SE,HEPATIC FAILURE,9
SE,MUSCULAR WEAKNESS,9
SE,ORTHOSTATIC HYPOTENSION,9
SE,ALOPECIA,8
SE,BLOOD CREATININE INCREASED,8
SE,PALPITATIONS,8
SE,PERIODONTITIS,8
SE,PHARYNGEAL OEDEMA,8
SE,PRURITUS,8
SE,SLEEP DISORDER,8
SE,ACUTE KIDNEY INJURY,7
SE,CONSTIPATION,7
SE,DECREASED APPETITE,7
SE,DISORIENTATION,7
SE,DRY EYE,7
SE,GASTRIC ULCER,7
SE,MUSCULOSKELETAL STIFFNESS,7
SE,OEDEMA PERIPHERAL,7
SE,RESPIRATORY FAILURE,7
SE,SOMNOLENCE,7
SE,WEIGHT DECREASED,7
SE,AGGRESSION,6
SE,ANGINA PECTORIS,6
SE,APHASIA,6
SE,BLOOD BILIRUBIN INCREASED,6
SE,DEATH,6
SE,DRY MOUTH,6
SE,DYSPHAGIA,6
SE,DYSPHONIA,6
SE,HYPERKALAEMIA,6
SE,HYPERTENSION,6
SE,MALAISE,6
SE,OROPHARYNGEAL PAIN,6
SE,OSTEONECROSIS,6
SE,PAIN IN EXTREMITY,6
SE,RENAL IMPAIRMENT,6
SE,SINUS BRADYCARDIA,6
SE,TRANSIENT ISCHAEMIC ATTACK,6
SE,ACCIDENTAL OVERDOSE,5
SE,ANGIOEDEMA,5
SE,BLISTER,5
SE,BLOOD ALKALINE PHOSPHATASE INCREASED,5
SE,DYSSTASIA,5
SE,ELECTROCARDIOGRAM QT PROLONGED,5
SE,ERECTILE DYSFUNCTION,5
SE,ERYTHEMA,5
SE,GASTROINTESTINAL HAEMORRHAGE,5
SE,HAEMORRHAGE,5
SE,HALLUCINATION_ VISUAL,5
SE,HYPERHIDROSIS,5
SE,INFECTION,5
SE,INTERNATIONAL NORMALISED RATIO INCREASED,5
SE,PERONEAL NERVE PALSY,5
SE,TREMOR,5
SE,URINARY RETENTION,5
SE,URINARY TRACT INFECTION,5
SE,VERTIGO,5
SE,VISUAL IMPAIRMENT,5
SE,ABDOMINAL PAIN UPPER,4
SE,AGITATION,4
SE,ASPARTATE AMINOTRANSFERASE INCREASED,4
SE,ASTHENIA,4
SE,BLOOD CREATINE INCREASED,4
SE,BLOOD PRESSURE DECREASED,4
SE,CARDIAC ARREST,4
SE,CHILLS,4
SE,CHOLECYSTITIS,4
SE,CIRCULATORY COLLAPSE,4
SE,DIABETES MELLITUS,4
SE,EYE HAEMORRHAGE,4
SE,FEELING ABNORMAL,4
SE,GAIT DISTURBANCE,4
SE,GENERAL PHYSICAL HEALTH DETERIORATION,4
SE,HAEMATOMA,4
SE,HEMIPARESIS,4
SE,ISCHAEMIC STROKE,4
SE,LIVER FUNCTION TEST ABNORMAL,4
SE,METABOLIC ACIDOSIS,4
SE,NIGHTMARE,4
SE,POLYNEUROPATHY,4
SE,PRESYNCOPE,4
SE,PULMONARY EMBOLISM,4
SE,RENAL FAILURE ACUTE,4
SE,RHABDOMYOLYSIS,4
SE,SENSORY DISTURBANCE,4
SE,SEPSIS,4
SE,SPEECH DISORDER,4
SE,TACHYCARDIA,4
SE,VENTRICULAR TACHYCARDIA,4
SE,WHITE BLOOD CELL COUNT INCREASED,4
SE,ABDOMINAL DISCOMFORT,3
SE,AGEUSIA,3
SE,AGRANULOCYTOSIS,3
SE,AKATHISIA,3
SE,ALANINE AMINOTRANSFERASE INCREASED,3
SE,ATYPICAL FEMUR FRACTURE,3
SE,BLOOD GLUCOSE INCREASED,3
SE,CARDIOVERSION,3
SE,CATHETER SITE INFECTION,3
SE,CHOLELITHIASIS,3
SE,CONTUSION,3
SE,DEPRESSION,3
SE,DERMATITIS,3
SE,DEVICE RELATED INFECTION,3
SE,DRUG ERUPTION,3
SE,DUODENAL ULCER,3
SE,DYSARTHRIA,3
SE,ENCEPHALOPATHY,3
SE,HAEMOGLOBIN DECREASED,3
SE,HEAD INJURY,3
SE,HEPATIC FUNCTION ABNORMAL,3
SE,HYPOKALAEMIA,3
SE,IMMUNE SYSTEM DISORDER,3
SE,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,3
SE,INSOMNIA,3
SE,JAUNDICE,3
SE,LUNG DISORDER,3
SE,MUSCLE TWITCHING,3
SE,NEUROPSYCHIATRIC SYNDROME,3
SE,OESOPHAGITIS,3
SE,OSTEONECROSIS OF JAW,3
SE,POISONING,3
SE,PRERENAL FAILURE,3
SE,PRODUCT USE IN UNAPPROVED INDICATION,3
SE,RIB FRACTURE,3
SE,SKIN DISCOLOURATION,3
SE,SKIN REACTION,3
SE,STEVENS-JOHNSON SYNDROME,3
SE,SUICIDAL IDEATION,3
SE,SUICIDE ATTEMPT,3
SE,TRANSAMINASES INCREASED,3
SE,URTICARIA,3
SE,ABDOMINAL DISTENSION,2
SE,ACNE,2
SE,ACUTE MYOCARDIAL INFARCTION,2
SE,ADVERSE EVENT,2
SE,AMYLASE INCREASED,2
SE,ANOSMIA,2
SE,ANTIVIRAL DRUG LEVEL ABOVE THERAPEUTIC,2
SE,ANXIETY,2
SE,ATRIOVENTRICULAR BLOCK COMPLETE,2
SE,BLADDER DYSFUNCTION,2
SE,BLINDNESS,2
SE,BLOOD LACTATE DEHYDROGENASE INCREASED,2
SE,BLOOD PRESSURE INCREASED,2
SE,BLOOD URINE PRESENT,2
SE,BRAIN OEDEMA,2
SE,CARDIAC DISORDER,2
SE,CARDIAC FAILURE ACUTE,2
SE,CEREBRAL HAEMATOMA,2
SE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
SE,CHRONOTROPIC INCOMPETENCE,2
SE,CORONARY ARTERY STENOSIS,2
SE,DEEP VEIN THROMBOSIS,2
SE,DEMENTIA,2
SE,DIABETIC KETOACIDOSIS,2
SE,DISEASE PROGRESSION,2
SE,DRUG ABUSE,2
SE,DRUG LEVEL INCREASED,2
SE,DUODENITIS,2
SE,DYSGEUSIA,2
SE,DYSPHEMIA,2
SE,EMBOLIC STROKE,2
SE,EPISTAXIS,2
SE,FEELING COLD,2
SE,FEMUR FRACTURE,2
SE,FLATULENCE,2
SE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
SE,GASTRIC ULCER HAEMORRHAGE,2
SE,GASTROENTERITIS,2
SE,GENERAL PHYSICAL CONDITION ABNORMAL,2
SE,GROIN PAIN,2
SE,HAEMATOCHEZIA,2
SE,HAEMORRHAGE INTRACRANIAL,2
SE,HAEMORRHAGE SUBCUTANEOUS,2
SE,HEART RATE DECREASED,2
SE,HEART RATE IRREGULAR,2
SE,HEPATOMEGALY,2
SE,HIP FRACTURE,2
SE,HYPERSENSITIVITY,2
SE,HYPERTHYROIDISM,2
SE,HYPOAESTHESIA,2
SE,HYPOMAGNESAEMIA,2
SE,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
SE,INTENTIONAL PRODUCT MISUSE,2
SE,LEG AMPUTATION,2
SE,LIP SWELLING,2
SE,LIVER DISORDER,2
SE,MEMORY IMPAIRMENT,2
SE,MOTOR DYSFUNCTION,2
SE,MULTI-ORGAN FAILURE,2
SE,MUSCULOSKELETAL PAIN,2
SE,NASAL POLYPS,2
SE,NEPHROLITHIASIS,2
SE,NEURALGIA,2
SE,NEUROGENIC BLADDER,2
SE,NEUROLOGICAL SYMPTOM,2
SE,OEDEMA,2
SE,OVERDOSE,2
SE,PAIN,2
SE,PLEURAL EFFUSION,2
SE,PNEUMONITIS,2
SE,POLLAKIURIA,2
SE,PRODUCT QUALITY ISSUE,2
SE,PSORIASIS,2
SE,PSORIATIC ARTHROPATHY,2
SE,PULMONARY FIBROSIS,2
SE,RHEUMATOID ARTHRITIS,2
SE,SENSORY LOSS,2
SE,SHOCK,2
SE,SINUS NODE DYSFUNCTION,2
SE,SINUSITIS,2
SE,SKIN ULCER,2
SE,SUDDEN CARDIAC DEATH,2
SE,SWELLING FACE,2
SE,SWOLLEN TONGUE,2
SE,THROMBOCYTOPENIA,2
SE,TINNITUS,2
SE,TONGUE DISORDER,2
SE,TOOTH INFECTION,2
SE,TOOTH LOSS,2
SE,TOXIC SKIN ERUPTION,2
SE,TRAUMATIC HAEMORRHAGE,2
SE,VASCULAR STENT THROMBOSIS,2
SE,VENTRICULAR FIBRILLATION,2
SE,VISION BLURRED,2
SE,VISUAL ACUITY REDUCED,2
SE,WEIGHT INCREASED,2
SE,ABSCESS LIMB,1
SE,ACCIDENTAL POISONING,1
SE,ACIDOSIS,1
SE,ACTINIC KERATOSIS,1
SE,ACUTE HEPATIC FAILURE,1
SE,ACUTE MYELOID LEUKAEMIA,1
SE,ADENOCARCINOMA OF COLON,1
SE,ADVERSE DRUG REACTION,1
SE,ALCOHOL INTERACTION,1
SE,ALLERGIC OEDEMA,1
SE,ALOPECIA TOTALIS,1
SE,ALTERED STATE OF CONSCIOUSNESS,1
SE,ALVEOLITIS,1
SE,ALVEOLITIS ALLERGIC,1
SE,AMNESIA,1
SE,APATHY,1
SE,APRAXIA,1
SE,ARTERIOSCLEROSIS,1
SE,ARTHRITIS BACTERIAL,1
SE,ARTHROPATHY,1
SE,ASCITES,1
SE,ATAXIA,1
SE,AZOTAEMIA,1
SE,BACTERIAL INFECTION,1
SE,BLADDER CANCER,1
SE,BLADDER DISORDER,1
SE,BLADDER IRRITATION,1
SE,BLINDNESS TRANSIENT,1
SE,BLOOD CALCIUM INCREASED,1
SE,BLOOD CHOLESTEROL INCREASED,1
SE,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
SE,BLOOD GLUCOSE FLUCTUATION,1
SE,BLOOD PH INCREASED,1
SE,BLOOD POTASSIUM DECREASED,1
SE,BLOOD PRESSURE ORTHOSTATIC,1
SE,BLOOD SODIUM DECREASED,1
SE,BLOOD THYROID STIMULATING HORMONE INCREASED,1
SE,BODY HEIGHT DECREASED,1
SE,BONE DENSITY DECREASED,1
SE,BRAIN INJURY,1
SE,BREAST CANCER,1
SE,BRONCHOSPASM,1
SE,BURNING SENSATION,1
SE,C-REACTIVE PROTEIN DECREASED,1
SE,CARDIAC ABLATION,1
SE,CARDIAC FIBRILLATION,1
SE,CARDIAC HYPERTROPHY,1
SE,CARDIAC VALVE DISEASE,1
SE,CARDIOMYOPATHY,1
SE,CAROTID ARTERY STENOSIS,1
SE,CARPAL TUNNEL SYNDROME,1
SE,CATARACT,1
SE,CATHETER SITE HAEMORRHAGE,1
SE,CEREBELLAR HAEMORRHAGE,1
SE,CEREBRAL DISORDER,1
SE,CEREBRAL ISCHAEMIA,1
SE,CEREBRAL THROMBOSIS,1
SE,CHOLESTASIS,1
SE,CHRONIC MYELOMONOCYTIC LEUKAEMIA,1
SE,CLOSTRIDIUM DIFFICILE INFECTION,1
SE,COAGULATION TEST ABNORMAL,1
SE,COAGULOPATHY,1
SE,COGNITIVE DISORDER,1
SE,COLITIS ULCERATIVE,1
SE,COLON CANCER STAGE IV,1
SE,COMA,1
SE,COMPARTMENT SYNDROME,1
SE,CONDITION AGGRAVATED,1
SE,CONGESTIVE CARDIOMYOPATHY,1
SE,CONTRAINDICATED PRODUCT ADMINISTERED,1
SE,CYANOSIS,1
SE,DEAFNESS UNILATERAL,1
SE,DECUBITUS ULCER,1
SE,DEMYELINATING POLYNEUROPATHY,1
SE,DENTAL CARIES,1
SE,DEPRESSED MOOD,1
SE,DEVICE ALARM ISSUE,1
SE,DEVICE COMPONENT ISSUE,1
SE,DEVICE FAILURE,1
SE,DEVICE MALFUNCTION,1
SE,DEVICE OCCLUSION,1
SE,DIARRHOEA HAEMORRHAGIC,1
SE,DILATATION VENTRICULAR,1
SE,DIPLOPIA,1
SE,DISCOMFORT,1
SE,DIVERTICULITIS,1
SE,DIVERTICULUM,1
SE,DIVERTICULUM INTESTINAL,1
SE,DRUG ADMINISTRATION ERROR,1
SE,DRUG DOSE OMISSION,1
SE,DRUG EFFECT DECREASED,1
SE,DRUG EFFECT INCOMPLETE,1
SE,DRUG LEVEL FLUCTUATING,1
SE,DYSPEPSIA,1
SE,DYSPNOEA EXERTIONAL,1
SE,EATING DISORDER,1
SE,ECZEMA,1
SE,ELECTROLYTE IMBALANCE,1
SE,ENCEPHALITIS,1
SE,EPIDURAL HAEMORRHAGE,1
SE,EPILEPSY,1
SE,ERUCTATION,1
SE,ERYSIPELAS,1
SE,EXFOLIATIVE RASH,1
SE,EXOSTOSIS OF JAW,1
SE,EXTRASYSTOLES,1
SE,FACE OEDEMA,1
SE,FACIAL PAIN,1
SE,FACIAL PARALYSIS,1
SE,FAECES DISCOLOURED,1
SE,FEBRILE NEUTROPENIA,1
SE,FIBROMYALGIA,1
SE,FLANK PAIN,1
SE,FLUSHING,1
SE,FOETAL EXPOSURE DURING PREGNANCY,1
SE,FOREIGN BODY,1
SE,FUNGAL INFECTION,1
SE,GASTRIC ANTRAL VASCULAR ECTASIA,1
SE,GASTROINTESTINAL PAIN,1
SE,GASTROINTESTINAL TUBE INSERTION,1
SE,GASTROOESOPHAGEAL REFLUX DISEASE,1
SE,GENERAL SYMPTOM,1
SE,GENITAL HAEMORRHAGE,1
SE,GENITAL INFECTION FUNGAL,1
SE,GINGIVAL BLEEDING,1
SE,GINGIVAL HYPERPLASIA,1
SE,GOITRE,1
SE,GROWTH RETARDATION,1
SE,HAEMATEMESIS,1
SE,HAEMATOMA EVACUATION,1
SE,HAEMATOSPERMIA,1
SE,HAEMATURIA,1
SE,HAEMOPHILIC ARTHROPATHY,1
SE,HAEMOPTYSIS,1
SE,HAEMORRHAGIC EROSIVE GASTRITIS,1
SE,HAEMORRHOIDAL HAEMORRHAGE,1
SE,HAEMORRHOIDS,1
SE,HEART RATE INCREASED,1
SE,HEPATIC CIRRHOSIS,1
SE,HEPATIC ENZYME INCREASED,1
SE,HEPATITIS,1
SE,HEPATITIS C,1
SE,HEPATOTOXICITY,1
SE,HERPES ZOSTER,1
SE,HICCUPS,1
SE,HOSPITALISATION,1
SE,HOT FLUSH,1
SE,HYDROCEPHALUS,1
SE,HYPERCALCAEMIA,1
SE,HYPERKERATOSIS,1
SE,HYPOAESTHESIA ORAL,1
SE,HYPOGEUSIA,1
SE,HYPOGLYCAEMIA,1
SE,HYPOPHAGIA,1
SE,HYPOSMIA,1
SE,HYPOTHERMIA,1
SE,HYPOVOLAEMIA,1
SE,IDIOPATHIC PULMONARY FIBROSIS,1
SE,IGA NEPHROPATHY,1
SE,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
SE,IMPAIRED GASTRIC EMPTYING,1
SE,IMPAIRED HEALING,1
SE,INCOHERENT,1
SE,INCONTINENCE,1
SE,INFECTION SUSCEPTIBILITY INCREASED,1
SE,INFLUENZA LIKE ILLNESS,1
SE,INGUINAL HERNIA,1
SE,INJECTION SITE INDURATION,1
SE,INJECTION SITE INFECTION,1
SE,INJECTION SITE INJURY,1
SE,INJECTION SITE NECROSIS,1
SE,INTENTIONAL DRUG MISUSE,1
SE,INTERSTITIAL LUNG DISEASE,1
SE,INTERVERTEBRAL DISC COMPRESSION,1
SE,INTERVERTEBRAL DISC PROTRUSION,1
SE,INTRA-ABDOMINAL HAEMORRHAGE,1
SE,JOINT STIFFNESS,1
SE,JOINT SWELLING,1
SE,KETOACIDOSIS,1
SE,KIDNEY FIBROSIS,1
SE,LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR,1
SE,LACTIC ACIDOSIS,1
SE,LEUKAEMIA,1
SE,LEUKOPENIA,1
SE,LIPASE INCREASED,1
SE,LIVER FUNCTION TEST DECREASED,1
SE,LOW BIRTH WEIGHT BABY,1
SE,LYMPHOCELE,1
SE,LYMPHOMA,1
SE,MACULE,1
SE,MALIGNANT BREAST LUMP REMOVAL,1
SE,MALIGNANT HYPERTENSION,1
SE,MELAENA,1
SE,MENINGITIS CRYPTOCOCCAL,1
SE,MENTAL DISORDER,1
SE,MIGRAINE WITH AURA,1
SE,MONOPARESIS,1
SE,MOUTH HAEMORRHAGE,1
SE,MOUTH SWELLING,1
SE,MUCOSAL DRYNESS,1
SE,MUCOUS STOOLS,1
SE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
SE,MUSCLE HAEMORRHAGE,1
SE,MUSCLE SPASMS,1
SE,MYELODYSPLASTIC SYNDROME,1
SE,MYOGLOBIN BLOOD INCREASED,1
SE,MYOPATHY,1
SE,MYOSITIS,1
SE,NECK PAIN,1
SE,NECROSIS,1
SE,NECROTISING COLITIS,1
SE,NEPHRITIS,1
SE,NEPHROPATHY TOXIC,1
SE,NEUROENDOCRINE CARCINOMA METASTATIC,1
SE,NEUTROPENIA,1
SE,NIGHT SWEATS,1
SE,OCULAR HYPERAEMIA,1
SE,OCULAR NEOPLASM,1
SE,OESOPHAGEAL ULCER,1
SE,OPTIC ISCHAEMIC NEUROPATHY,1
SE,ORAL CANDIDIASIS,1
SE,ORAL DISCOMFORT,1
SE,ORAL FUNGAL INFECTION,1
SE,OSTEOMYELITIS,1
SE,OTOTOXICITY,1
SE,PANCREATIC CYST RUPTURE,1
SE,PANCREATITIS,1
SE,PANCYTOPENIA,1
SE,PANIC ATTACK,1
SE,PARAESTHESIA ORAL,1
SE,PARKINSONISM,1
SE,PATHOLOGICAL FRACTURE,1
SE,PCO2 ABNORMAL,1
SE,PENILE PAIN,1
SE,PERICARDIAL EFFUSION,1
SE,PERIPHERAL COLDNESS,1
SE,PERIPHERAL ISCHAEMIA,1
SE,PERITONITIS,1
SE,PERTUSSIS,1
SE,PHOTOSENSITIVITY REACTION,1
SE,PLASMA CELL MYELOMA,1
SE,PLEURISY,1
SE,PNEUMONIA ASPIRATION,1
SE,PO2 ABNORMAL,1
SE,POLYARTHRITIS,1
SE,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,1
SE,POLYP,1
SE,POLYSEROSITIS,1
SE,POST PROCEDURAL HAEMORRHAGE,1
SE,POSTERIOR CAPSULE OPACIFICATION,1
SE,PREMATURE BABY,1
SE,PRESCRIBED OVERDOSE,1
SE,PRESCRIBED UNDERDOSE,1
SE,PRODUCT USE ISSUE,1
SE,PRODUCTIVE COUGH,1
SE,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
SE,PROTHROMBIN LEVEL INCREASED,1
SE,PSYCHIATRIC SYMPTOM,1
SE,PSYCHOTIC DISORDER,1
SE,PULMONARY INFARCTION,1
SE,PULMONARY OEDEMA,1
SE,PULMONARY THROMBOSIS,1
SE,PULSE ABSENT,1
SE,PYELONEPHRITIS,1
SE,RASH GENERALISED,1
SE,RASH MACULAR,1
SE,REACTION TO DRUG EXCIPIENTS,1
SE,RECTAL HAEMORRHAGE,1
SE,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
SE,REDUCED FACIAL EXPRESSION,1
SE,REFLEXES ABNORMAL,1
SE,RENAL EMBOLISM,1
SE,RENAL FAILURE CHRONIC,1
SE,RENAL PAIN,1
SE,RESPIRATORY DISORDER,1
SE,RETCHING,1
SE,RHINITIS,1
SE,SECONDARY SYPHILIS,1
SE,SEIZURE,1
SE,SELF INJURIOUS BEHAVIOUR,1
SE,SICK SINUS SYNDROME,1
SE,SKELETAL INJURY,1
SE,SKIN CANCER,1
SE,SKIN DISORDER,1
SE,SKIN EXFOLIATION,1
SE,SKIN FRAGILITY,1
SE,SKIN LESION,1
SE,SKIN NECROSIS,1
SE,SKIN ODOUR ABNORMAL,1
SE,SMALL FOR DATES BABY,1
SE,SOFT TISSUE HAEMORRHAGE,1
SE,SOLAR DERMATITIS,1
SE,SPINAL CORD COMPRESSION,1
SE,SPINAL DEFORMITY,1
SE,SPINAL FRACTURE,1
SE,SPLENIC INFARCTION,1
SE,SPONDYLITIS,1
SE,SQUAMOUS CELL CARCINOMA OF SKIN,1
SE,STAPHYLOCOCCAL ABSCESS,1
SE,STICKY SKIN,1
SE,SUBARACHNOID HAEMORRHAGE,1
SE,SUBCUTANEOUS ABSCESS,1
SE,SUBDURAL HAEMATOMA,1
SE,SUDDEN DEATH,1
SE,SUDDEN HEARING LOSS,1
SE,SUTURE RELATED COMPLICATION,1
SE,SYSTEMIC CANDIDA,1
SE,SYSTEMIC LUPUS ERYTHEMATOSUS,1
SE,TENDON RUPTURE,1
SE,THALASSAEMIA ALPHA,1
SE,THERMAL BURN,1
SE,THIRST,1
SE,THORACIC HAEMORRHAGE,1
SE,THROAT IRRITATION,1
SE,THROMBOTIC MICROANGIOPATHY,1
SE,THYROIDITIS,1
SE,TIC,1
SE,TOOTH DISORDER,1
SE,TOOTH EROSION,1
SE,TOOTHACHE,1
SE,TOXIC EPIDERMAL NECROLYSIS,1
SE,TRANSFUSION,1
SE,TRI-IODOTHYRONINE DECREASED,1
SE,TROPONIN INCREASED,1
SE,TUMOUR FLARE,1
SE,TYPE 2 DIABETES MELLITUS,1
SE,TYPE IV HYPERSENSITIVITY REACTION,1
SE,UHTHOFF^S PHENOMENON,1
SE,UPPER GASTROINTESTINAL HAEMORRHAGE,1
SE,URETERIC OBSTRUCTION,1
SE,URETHRAL HAEMORRHAGE,1
SE,URINE OUTPUT DECREASED,1
SE,VASCULAR GRAFT,1
SE,VASCULITIS,1
SE,VASCULITIS NECROTISING,1
SE,VENTRICULAR EXTRASYSTOLES,1
SE,VIITH NERVE PARALYSIS,1
SE,WOUND INFECTION BACTERIAL,1
SE,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
CH,NAUSEA,13
CH,ACUTE KIDNEY INJURY,12
CH,TOXICITY TO VARIOUS AGENTS,12
CH,VOMITING,12
CH,DEHYDRATION,10
CH,MELAENA,10
CH,ANAEMIA,9
CH,CEREBRAL HAEMORRHAGE,9
CH,FALL,9
CH,GASTROINTESTINAL HAEMORRHAGE,9
CH,ASTHENIA,8
CH,CHOLESTATIC LIVER INJURY,8
CH,HEMIPARESIS,8
CH,CARDIAC FAILURE,7
CH,HYPERKALAEMIA,7
CH,THROMBOCYTOPENIA,7
CH,WEIGHT DECREASED,7
CH,JAUNDICE,6
CH,MESENTERIC VEIN THROMBOSIS,6
CH,PYREXIA,6
CH,RENAL FAILURE ACUTE,6
CH,ACUTE MYOCARDIAL INFARCTION,5
CH,CEREBROVASCULAR ACCIDENT,5
CH,CHROMATOPSIA,5
CH,DEATH,5
CH,DYSPHAGIA,5
CH,DYSPNOEA,5
CH,FOETAL EXPOSURE DURING PREGNANCY,5
CH,GENERAL PHYSICAL HEALTH DETERIORATION,5
CH,HAEMORRHAGIC ANAEMIA,5
CH,HALLUCINATION_ VISUAL,5
CH,HYPERTENSION,5
CH,SPEECH DISORDER,5
CH,ABDOMINAL PAIN,4
CH,ABDOMINAL PAIN UPPER,4
CH,BONE DENSITY DECREASED,4
CH,CLOSTRIDIUM DIFFICILE COLITIS,4
CH,DELIRIUM,4
CH,DIZZINESS,4
CH,DRUG INEFFECTIVE,4
CH,DRUG-INDUCED LIVER INJURY,4
CH,HYPOTENSION,4
CH,HYPOVOLAEMIC SHOCK,4
CH,MULTIPLE ORGAN DYSFUNCTION SYNDROME,4
CH,REBOUND EFFECT,4
CH,RENAL FAILURE,4
CH,RENAL IMPAIRMENT,4
CH,SEPSIS,4
CH,SEPTIC SHOCK,4
CH,SOMNOLENCE,4
CH,STAPHYLOCOCCAL INFECTION,4
CH,THERAPEUTIC RESPONSE INCREASED,4
CH,ANGINA PECTORIS,3
CH,BRADYCARDIA,3
CH,CONFUSIONAL STATE,3
CH,CONVULSION,3
CH,DIARRHOEA,3
CH,ELECTROCARDIOGRAM QT PROLONGED,3
CH,FATIGUE,3
CH,GENERALISED TONIC-CLONIC SEIZURE,3
CH,HAEMORRHAGE INTRACRANIAL,3
CH,HAEMORRHAGIC STROKE,3
CH,HYPOCHROMIC ANAEMIA,3
CH,HYPOKALAEMIA,3
CH,HYPONATRAEMIA,3
CH,INGUINAL HERNIA,3
CH,INTERNATIONAL NORMALISED RATIO INCREASED,3
CH,JAUNDICE CHOLESTATIC,3
CH,LIVER FUNCTION TEST ABNORMAL,3
CH,MEDICATION ERROR,3
CH,MUSCULAR WEAKNESS,3
CH,OVERDOSE,3
CH,OXYGEN SATURATION DECREASED,3
CH,PELVIC FRACTURE,3
CH,PNEUMONIA,3
CH,POTENTIATING DRUG INTERACTION,3
CH,PREMATURE BABY,3
CH,PRESCRIBED OVERDOSE,3
CH,SHOCK HAEMORRHAGIC,3
CH,SPINAL FRACTURE,3
CH,ACCIDENTAL OVERDOSE,2
CH,ACUTE RESPIRATORY DISTRESS SYNDROME,2
CH,AGRANULOCYTOSIS,2
CH,ANXIETY,2
CH,ARTHRALGIA,2
CH,ATRIOVENTRICULAR BLOCK FIRST DEGREE,2
CH,BASAL GANGLIA HAEMORRHAGE,2
CH,BLOOD ALKALINE PHOSPHATASE INCREASED,2
CH,BLOOD CREATININE INCREASED,2
CH,BLOOD PRESSURE DECREASED,2
CH,BREATH SOUNDS ABNORMAL,2
CH,CARDIAC DISORDER,2
CH,CARDIAC PACEMAKER INSERTION,2
CH,CARDIOACTIVE DRUG LEVEL INCREASED,2
CH,COGNITIVE DISORDER,2
CH,CONGESTIVE CARDIOMYOPATHY,2
CH,DIVERTICULITIS,2
CH,DRUG CLEARANCE DECREASED,2
CH,DRUG LEVEL INCREASED,2
CH,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,2
CH,EOSINOPHILIA,2
CH,EPISTAXIS,2
CH,EXPOSURE DURING PREGNANCY,2
CH,GAIT DISTURBANCE,2
CH,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
CH,GASTRIC ULCER,2
CH,HAEMATEMESIS,2
CH,HAEMORRHAGE,2
CH,HEART RATE INCREASED,2
CH,HEPATIC STEATOSIS,2
CH,HEPATOCELLULAR INJURY,2
CH,HYPOCALCAEMIA,2
CH,HYPOMAGNESAEMIA,2
CH,HYPOPHOSPHATAEMIA,2
CH,ILLUSION,2
CH,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,2
CH,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
CH,LEUKOPENIA,2
CH,LIVER DISORDER,2
CH,LOSS OF CONSCIOUSNESS,2
CH,LOW BIRTH WEIGHT BABY,2
CH,MITRAL VALVE INCOMPETENCE,2
CH,NEPHROSCLEROSIS,2
CH,NORMOCHROMIC NORMOCYTIC ANAEMIA,2
CH,ORTHOPNOEA,2
CH,ORTHOSTATIC HYPOTENSION,2
CH,PAIN IN EXTREMITY,2
CH,PANCREATITIS,2
CH,PEMPHIGOID,2
CH,PHOTOPSIA,2
CH,POST PROCEDURAL HAEMORRHAGE,2
CH,PRODUCT USE IN UNAPPROVED INDICATION,2
CH,PRODUCT USE ISSUE,2
CH,PSYCHOMOTOR RETARDATION,2
CH,PULMONARY EMBOLISM,2
CH,PULMONARY HYPERTENSION,2
CH,RENAL FAILURE CHRONIC,2
CH,RENAL TUBULAR DISORDER,2
CH,RETINOPATHY,2
CH,SHOCK,2
CH,SINUS ARREST,2
CH,SUDDEN CARDIAC DEATH,2
CH,SYNCOPE,2
CH,TACHYCARDIA,2
CH,TUBULOINTERSTITIAL NEPHRITIS,2
CH,UPPER GASTROINTESTINAL HAEMORRHAGE,2
CH,URINARY TRACT INFECTION,2
CH,VENOUS PRESSURE JUGULAR ABNORMAL,2
CH,VENTRICULAR TACHYCARDIA,2
CH,VISION BLURRED,2
CH,ABDOMINAL DISTENSION,1
CH,ABNORMAL BEHAVIOUR,1
CH,ACTINIC KERATOSIS,1
CH,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
CH,ACUTE HEPATIC FAILURE,1
CH,ADVERSE EVENT,1
CH,AGE-RELATED MACULAR DEGENERATION,1
CH,ANAEMIA NEONATAL,1
CH,ANTICOAGULATION DRUG LEVEL INCREASED,1
CH,ANTIDEPRESSANT DRUG LEVEL INCREASED,1
CH,ANURIA,1
CH,AORTIC ANEURYSM,1
CH,AORTIC DISSECTION,1
CH,AORTIC INTRAMURAL HAEMATOMA,1
CH,APPLICATION SITE INFLAMMATION,1
CH,APRAXIA,1
CH,ARRHYTHMIA,1
CH,ASPIRATION,1
CH,ATRIAL FIBRILLATION,1
CH,ATRIOVENTRICULAR BLOCK,1
CH,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
CH,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,1
CH,AUTOIMMUNE HEPATITIS,1
CH,BICYTOPENIA,1
CH,BLINDNESS,1
CH,BLOOD CALCIUM INCREASED,1
CH,BLOOD DISORDER,1
CH,BLOOD LACTATE DEHYDROGENASE INCREASED,1
CH,BLOOD POTASSIUM INCREASED,1
CH,BLOOD URIC ACID INCREASED,1
CH,BRADYPNOEA,1
CH,BRAIN SCAN ABNORMAL,1
CH,CARDIAC FAILURE ACUTE,1
CH,CARDIOVASCULAR DISORDER,1
CH,CARDIOVASCULAR INSUFFICIENCY,1
CH,CAROTID ARTERY THROMBOSIS,1
CH,CATARACT,1
CH,CATATONIA,1
CH,CELLULITIS PHARYNGEAL,1
CH,CEREBELLAR HAEMORRHAGE,1
CH,CEREBRAL ISCHAEMIA,1
CH,CEREBRAL MICROANGIOPATHY,1
CH,CHARLES BONNET SYNDROME,1
CH,CHEST PAIN,1
CH,CHOLESTASIS,1
CH,CHRONIC KIDNEY DISEASE,1
CH,CIRCULATORY COLLAPSE,1
CH,CONGENITAL GENITOURINARY ABNORMALITY,1
CH,CONGENITAL INGUINAL HERNIA,1
CH,CONSTIPATION,1
CH,COORDINATION ABNORMAL,1
CH,DECREASED APPETITE,1
CH,DELUSION,1
CH,DEMENTIA,1
CH,DERMATITIS BULLOUS,1
CH,DEVICE DEPENDENCE,1
CH,DEVICE RELATED INFECTION,1
CH,DIABETES MELLITUS INADEQUATE CONTROL,1
CH,DIABETIC KETOACIDOSIS,1
CH,DISEASE PROGRESSION,1
CH,DISORIENTATION,1
CH,DISSEMINATED INTRAVASCULAR COAGULATION,1
CH,DISTURBANCE IN ATTENTION,1
CH,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
CH,DRUG ADMINISTRATION ERROR,1
CH,DRUG ERUPTION,1
CH,DUODENAL ULCER,1
CH,DUODENAL ULCER HAEMORRHAGE,1
CH,DYSARTHRIA,1
CH,DYSCHROMATOPSIA,1
CH,DYSPEPSIA,1
CH,ELECTROCARDIOGRAM ABNORMAL,1
CH,ELECTROCARDIOGRAM ST SEGMENT ABNORMAL,1
CH,EMBOLIC STROKE,1
CH,EMBOLISM,1
CH,ENCEPHALOPATHY,1
CH,ENERGY INCREASED,1
CH,EOSINOPHIL COUNT INCREASED,1
CH,ERYSIPELAS,1
CH,ERYTHROBLAST COUNT DECREASED,1
CH,EXCORIATION,1
CH,FACIAL PARESIS,1
CH,FLATULENCE,1
CH,GASTRIC MUCOSA ERYTHEMA,1
CH,GASTRITIS,1
CH,GASTROENTERITIS,1
CH,GASTROINTESTINAL DISORDER,1
CH,GASTROINTESTINAL TRACT MUCOSAL PIGMENTATION,1
CH,GASTROOESOPHAGEAL SPHINCTER INSUFFICIENCY,1
CH,GRAFT LOSS,1
CH,GRAND MAL CONVULSION,1
CH,HAEMATOCHEZIA,1
CH,HAEMATOMA,1
CH,HAEMODYNAMIC INSTABILITY,1
CH,HAEMOLYTIC ANAEMIA,1
CH,HAEMORRHAGIC TRANSFORMATION STROKE,1
CH,HALLUCINATION_ AUDITORY,1
CH,HEADACHE,1
CH,HEMIPLEGIA,1
CH,HEPARIN-INDUCED THROMBOCYTOPENIA,1
CH,HEPATIC CIRRHOSIS,1
CH,HEPATIC FIBROSIS,1
CH,HEPATITIS,1
CH,HEPATITIS CHOLESTATIC,1
CH,HEPATITIS TOXIC,1
CH,HERPES SIMPLEX PHARYNGITIS,1
CH,HYPERBILIRUBINAEMIA,1
CH,HYPERTENSIVE CARDIOMYOPATHY,1
CH,HYPERTHYROIDISM,1
CH,HYPERTONIA,1
CH,HYPERTRIGLYCERIDAEMIA,1
CH,HYPNAGOGIC HALLUCINATION,1
CH,HYPOALBUMINAEMIA,1
CH,HYPOGLYCAEMIA,1
CH,HYPOGLYCAEMIA NEONATAL,1
CH,INFECTION,1
CH,INFLAMMATION,1
CH,INFLAMMATORY MARKER INCREASED,1
CH,INTENTIONAL OVERDOSE,1
CH,INTERSTITIAL LUNG DISEASE,1
CH,ISCHAEMIC STROKE,1
CH,JAUNDICE HEPATOCELLULAR,1
CH,LARGE INTESTINE POLYP,1
CH,LEFT VENTRICULAR FAILURE,1
CH,LIPOMATOSIS,1
CH,LOWER RESPIRATORY TRACT INFECTION,1
CH,LUNG DISORDER,1
CH,LYMPHADENOPATHY,1
CH,MACULAR FIBROSIS,1
CH,MALAISE,1
CH,MATERNAL EXPOSURE DURING PREGNANCY,1
CH,MEMORY IMPAIRMENT,1
CH,MENTAL STATUS CHANGES,1
CH,METABOLIC ACIDOSIS,1
CH,METABOLIC ALKALOSIS,1
CH,MOUTH HAEMORRHAGE,1
CH,MOVEMENT DISORDER,1
CH,MULTI-ORGAN FAILURE,1
CH,MUTISM,1
CH,MYELOCYTE COUNT DECREASED,1
CH,MYELODYSPLASTIC SYNDROME,1
CH,MYOCLONUS,1
CH,NECK PAIN,1
CH,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
CH,NEOPLASM,1
CH,NERVOUS SYSTEM DISORDER,1
CH,NERVOUSNESS,1
CH,NEUTROPENIA,1
CH,OCULAR TOXICITY,1
CH,OEDEMA,1
CH,OEDEMA PERIPHERAL,1
CH,OESOPHAGEAL ULCER,1
CH,PALLOR,1
CH,PANCYTOPENIA,1
CH,PARAESTHESIA,1
CH,PARAPARESIS,1
CH,PARKINSONISM,1
CH,PATENT DUCTUS ARTERIOSUS,1
CH,PEPTIC ULCER,1
CH,PERIPHERAL SWELLING,1
CH,PERITONSILLAR ABSCESS,1
CH,PHARYNGITIS BACTERIAL,1
CH,PLATELET COUNT INCREASED,1
CH,PLEURAL EFFUSION,1
CH,PNEUMONITIS,1
CH,PREMATURE LABOUR,1
CH,PROCEDURAL PNEUMOTHORAX,1
CH,PROTHROMBIN TIME SHORTENED,1
CH,PRURITUS,1
CH,PSYCHOTIC SYMPTOM,1
CH,PURPURA,1
CH,RASH PAPULAR,1
CH,RASH PRURITIC,1
CH,RENAL VEIN COMPRESSION,1
CH,RESPIRATORY DISORDER,1
CH,RESPIRATORY FAILURE,1
CH,RESUSCITATION,1
CH,RIGHT VENTRICULAR FAILURE,1
CH,SEROTONIN SYNDROME,1
CH,SKIN LESION,1
CH,SMALL INTESTINAL HAEMORRHAGE,1
CH,SOFT TISSUE NECROSIS,1
CH,SOMATIC HALLUCINATION,1
CH,SPINAL CORD ISCHAEMIA,1
CH,STOMATITIS,1
CH,SUBCUTANEOUS EMPHYSEMA,1
CH,SUBDURAL HAEMATOMA,1
CH,SUBDURAL HAEMORRHAGE,1
CH,SUICIDE ATTEMPT,1
CH,SUPRAVENTRICULAR TACHYCARDIA,1
CH,TACHYPNOEA,1
CH,TARDIVE DYSKINESIA,1
CH,THROMBOSIS,1
CH,TRACHEOMALACIA,1
CH,TRANSIENT ISCHAEMIC ATTACK,1
CH,TRANSPLANT REJECTION,1
CH,TROPONIN INCREASED,1
CH,URINARY TRACT INFECTION ENTEROCOCCAL,1
CH,URINE ANALYSIS ABNORMAL,1
CH,VISUAL IMPAIRMENT,1
CH,WEIGHT INCREASED,1
CH,WITHDRAWAL SYNDROME,1
SY,BLOOD LACTATE DEHYDROGENASE INCREASED,1
SY,CONSTIPATION,1
SY,METABOLIC ACIDOSIS,1
SY,RENAL CORTICAL NECROSIS,1
TW,ARRHYTHMIA,2
TW,ARTERIAL OCCLUSIVE DISEASE,2
TW,DYSPNOEA,2
TW,HAEMORRHAGE,2
TW,HEART RATE INCREASED,2
TW,STENT PLACEMENT,2
TW,TREMOR,2
TH,ANAPHYLACTIC SHOCK,3
TH,CARDIAC FAILURE CONGESTIVE,2
TH,CHEST PAIN,2
TH,DYSPNOEA,2
TH,RESPIRATORY DEPRESSION,2
TH,ALTERED STATE OF CONSCIOUSNESS,1
TH,ANAPHYLACTIC REACTION,1
TH,ANGINA PECTORIS,1
TH,BLOOD CHOLESTEROL INCREASED,1
TH,BLOOD PRESSURE DECREASED,1
TH,CARDIAC ARREST,1
TH,CARDIAC FAILURE CHRONIC,1
TH,CARDIOMYOPATHY,1
TH,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
TH,CONTRAINDICATED PRODUCT ADMINISTERED,1
TH,DELIRIUM,1
TH,DIZZINESS,1
TH,EPIGASTRIC DISCOMFORT,1
TH,FATIGUE,1
TH,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
TH,HYPOTENSION,1
TH,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
TH,NAUSEA,1
TH,PRURITUS,1
TH,RASH MACULO-PAPULAR,1
TH,RESPIRATORY FAILURE,1
TH,SEPSIS,1
TH,SKIN LESION,1
TH,SOMNOLENCE,1
TH,TYPE I HYPERSENSITIVITY,1
TH,VOMITING,1
TH,WRONG DRUG ADMINISTERED,1
TN,APNOEA,1
TN,BISPECTRAL INDEX DECREASED,1
TN,CARDIAC FAILURE,1
TN,GENERALISED TONIC-CLONIC SEIZURE,1
TN,LOSS OF CONSCIOUSNESS,1
TN,MYOCARDIAL INFARCTION,1
TN,SUDDEN DEATH,1
TR,TOXICITY TO VARIOUS AGENTS,15
TR,HYPOTENSION,14
TR,DYSPNOEA,12
TR,SINUS BRADYCARDIA,12
TR,MATERNAL EXPOSURE DURING PREGNANCY,11
TR,CONFUSIONAL STATE,9
TR,SUICIDE ATTEMPT,8
TR,BRADYCARDIA,7
TR,DRUG INEFFECTIVE,7
TR,FATIGUE,7
TR,HYPERTENSION,7
TR,INTENTIONAL OVERDOSE,7
TR,LACTIC ACIDOSIS,7
TR,VOMITING,7
TR,DIZZINESS,6
TR,HYPONATRAEMIA,6
TR,PALPITATIONS,6
TR,ACUTE KIDNEY INJURY,5
TR,CARDIAC FAILURE,5
TR,DYSARTHRIA,5
TR,HEADACHE,5
TR,HYPOCALCAEMIA,5
TR,HYPOKALAEMIA,5
TR,NAUSEA,5
TR,RHABDOMYOLYSIS,5
TR,ASTHENIA,4
TR,BLOOD PRESSURE INCREASED,4
TR,DIPLOPIA,4
TR,FOETAL EXPOSURE DURING PREGNANCY,4
TR,HAEMOTHORAX,4
TR,HALLUCINATION_ VISUAL,4
TR,INTERNATIONAL NORMALISED RATIO INCREASED,4
TR,ORTHOPNOEA,4
TR,PNEUMONIA,4
TR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,4
TR,SOMNOLENCE,4
TR,THROMBOCYTOPENIA,4
TR,VISUAL IMPAIRMENT,4
TR,ABDOMINAL PAIN,3
TR,ATRIOVENTRICULAR BLOCK COMPLETE,3
TR,BLOOD CREATININE INCREASED,3
TR,CARDIAC DISORDER,3
TR,DEATH,3
TR,HYPOAESTHESIA ORAL,3
TR,MULTI-ORGAN FAILURE,3
TR,MUSCLE CONTRACTIONS INVOLUNTARY,3
TR,MUSCLE SPASMS,3
TR,NEPHROTIC SYNDROME,3
TR,NEUTROPENIA,3
TR,NORMAL NEWBORN,3
TR,OEDEMA PERIPHERAL,3
TR,PANCREATITIS,3
TR,RENAL IMPAIRMENT,3
TR,SEIZURE,3
TR,SPINAL EPIDURAL HAEMATOMA,3
TR,SWOLLEN TONGUE,3
TR,URINARY TRACT INFECTION,3
TR,VENTRICULAR TACHYCARDIA,3
TR,VISION BLURRED,3
TR,ABORTION SPONTANEOUS,2
TR,ANAEMIA,2
TR,ATRIAL FIBRILLATION,2
TR,BLOOD GLUCOSE INCREASED,2
TR,BLOOD PRESSURE DECREASED,2
TR,BRADYARRHYTHMIA,2
TR,CARDIAC FAILURE ACUTE,2
TR,CHEST PAIN,2
TR,CHOLELITHIASIS,2
TR,COMA,2
TR,CONTUSION,2
TR,CORONARY ARTERY OCCLUSION,2
TR,CORONARY ARTERY STENOSIS,2
TR,FEBRILE NEUTROPENIA,2
TR,FOETAL DISTRESS SYNDROME,2
TR,HALLUCINATION,2
TR,HEART RATE INCREASED,2
TR,HEART RATE IRREGULAR,2
TR,HEPATITIS C,2
TR,HEPATITIS TOXIC,2
TR,HYPERLIPIDAEMIA,2
TR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
TR,LOSS OF CONSCIOUSNESS,2
TR,LOW BIRTH WEIGHT BABY,2
TR,MITRAL VALVE INCOMPETENCE,2
TR,MYALGIA,2
TR,MYOCARDIAL INFARCTION,2
TR,OVERDOSE,2
TR,PLEURAL EFFUSION,2
TR,PSORIASIS,2
TR,PULMONARY OEDEMA,2
TR,PYREXIA,2
TR,RASH,2
TR,STUPOR,2
TR,SUPRAVENTRICULAR TACHYCARDIA,2
TR,TACHYCARDIA,2
TR,TACHYCARDIA INDUCED CARDIOMYOPATHY,2
TR,TACHYPNOEA,2
TR,TRANSIENT ISCHAEMIC ATTACK,2
TR,TREMOR,2
TR,URINE OUTPUT DECREASED,2
TR,ABASIA,1
TR,ABDOMINAL MASS,1
TR,ABDOMINAL WALL HAEMATOMA,1
TR,ACCIDENTAL OVERDOSE,1
TR,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
TR,ACUTE MOTOR AXONAL NEUROPATHY,1
TR,ACUTE MYOCARDIAL INFARCTION,1
TR,ACUTE PROMYELOCYTIC LEUKAEMIA,1
TR,ALTERED STATE OF CONSCIOUSNESS,1
TR,AMOEBIASIS,1
TR,ANGINA PECTORIS,1
TR,ANGIODYSPLASIA,1
TR,ANTIPHOSPHOLIPID SYNDROME,1
TR,ANXIETY,1
TR,ARTERIOSPASM CORONARY,1
TR,ASPARTATE AMINOTRANSFERASE INCREASED,1
TR,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
TR,BACK PAIN,1
TR,BLOOD BILIRUBIN INCREASED,1
TR,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
TR,BLOOD PH DECREASED,1
TR,BLOOD POTASSIUM DECREASED,1
TR,BLOOD POTASSIUM INCREASED,1
TR,BLOOD SODIUM DECREASED,1
TR,BLOOD URIC ACID INCREASED,1
TR,CARDIAC VENTRICULAR THROMBOSIS,1
TR,CARDIOMYOPATHY,1
TR,CARDIOTOXICITY,1
TR,CEREBRAL HAEMORRHAGE,1
TR,CEREBRAL INFARCTION,1
TR,CEREBROVASCULAR ACCIDENT,1
TR,CEREBROVASCULAR DISORDER,1
TR,CHRONIC GASTRITIS,1
TR,CHRONIC HEPATITIS,1
TR,CHRONIC KIDNEY DISEASE,1
TR,COLON CANCER METASTATIC,1
TR,CONJUNCTIVAL HAEMORRHAGE,1
TR,CORONARY ARTERY DISEASE,1
TR,CORONARY ARTERY THROMBOSIS,1
TR,COUGH,1
TR,CREATININE RENAL CLEARANCE DECREASED,1
TR,CYSTITIS HAEMORRHAGIC,1
TR,DECREASED APPETITE,1
TR,DEPRESSED LEVEL OF CONSCIOUSNESS,1
TR,DERMATITIS BULLOUS,1
TR,DEVICE OCCLUSION,1
TR,DISEASE PROGRESSION,1
TR,DRUG ADMINISTRATION ERROR,1
TR,DRUG INTOLERANCE,1
TR,DRUG LEVEL INCREASED,1
TR,DRUG-INDUCED LIVER INJURY,1
TR,DUODENAL ULCER HAEMORRHAGE,1
TR,DYSPHAGIA,1
TR,ECCHYMOSIS,1
TR,EJECTION FRACTION DECREASED,1
TR,ELECTROCARDIOGRAM QT PROLONGED,1
TR,ELECTROCARDIOGRAM T WAVE INVERSION,1
TR,EMBOLISM ARTERIAL,1
TR,EPILEPSY,1
TR,ERYTHEMA,1
TR,EXCORIATION,1
TR,EXPOSURE DURING PREGNANCY,1
TR,EYE HAEMORRHAGE,1
TR,EYE SWELLING,1
TR,FAECES DISCOLOURED,1
TR,FALL,1
TR,FLATULENCE,1
TR,FREQUENT BOWEL MOVEMENTS,1
TR,GAIT DISTURBANCE,1
TR,GASTROENTERITIS,1
TR,GASTROINTESTINAL PROTOZOAL INFECTION,1
TR,GLOMERULAR FILTRATION RATE DECREASED,1
TR,GROIN PAIN,1
TR,HAEMATOMA,1
TR,HAEMOLYTIC ANAEMIA,1
TR,HAEMORRHAGE INTRACRANIAL,1
TR,HAEMORRHAGIC TRANSFORMATION STROKE,1
TR,HEPATIC MASS,1
TR,HEPATOMEGALY,1
TR,HEPATOTOXICITY,1
TR,HERPES ZOSTER,1
TR,HOSPITALISATION,1
TR,HYPERCAPNIA,1
TR,HYPERKALAEMIA,1
TR,HYPERTHYROIDISM,1
TR,HYPERVOLAEMIA,1
TR,HYPOALDOSTERONISM,1
TR,HYPOTHYROIDISM,1
TR,HYPOXIA,1
TR,INCORRECT DOSAGE ADMINISTERED,1
TR,INJURY,1
TR,INSOMNIA,1
TR,INTRACARDIAC THROMBUS,1
TR,ISCHAEMIC STROKE,1
TR,JOINT SWELLING,1
TR,LEFT VENTRICULAR HYPERTROPHY,1
TR,LEIOMYOSARCOMA,1
TR,LIPASE INCREASED,1
TR,MALAISE,1
TR,MEMORY IMPAIRMENT,1
TR,METABOLIC ACIDOSIS,1
TR,METABOLIC ENCEPHALOPATHY,1
TR,MYOCARDIAL DEPRESSION,1
TR,MYOCARDIAL ISCHAEMIA,1
TR,MYOCARDITIS,1
TR,MYOPATHY,1
TR,NEOPLASM,1
TR,NEOPLASM PROGRESSION,1
TR,NEPHROPATHY TOXIC,1
TR,OEDEMA,1
TR,OROPHARYNGEAL PAIN,1
TR,PAGE KIDNEY,1
TR,PAIN,1
TR,PANCREATITIS ACUTE,1
TR,PANCYTOPENIA,1
TR,PARAESTHESIA,1
TR,PARAPLEGIA,1
TR,PERITONEAL HAEMORRHAGE,1
TR,PLATELET COUNT INCREASED,1
TR,PLEURAL FISTULA,1
TR,PNEUMONIA ASPIRATION,1
TR,POSTPARTUM HAEMORRHAGE,1
TR,PREMATURE BABY,1
TR,PREMATURE LABOUR,1
TR,PRESYNCOPE,1
TR,PRODUCT USE IN UNAPPROVED INDICATION,1
TR,PRODUCT USE ISSUE,1
TR,PRURITUS,1
TR,PULMONARY EMBOLISM,1
TR,PULMONARY HAEMORRHAGE,1
TR,RASH ERYTHEMATOUS,1
TR,RENAL HAEMORRHAGE,1
TR,RENAL SALT-WASTING SYNDROME,1
TR,RENAL TUBULAR DYSFUNCTION,1
TR,RESPIRATORY DISTRESS,1
TR,RESTLESSNESS,1
TR,SEPSIS,1
TR,SINUS ARREST,1
TR,SKIN EXFOLIATION,1
TR,SPINAL CORD COMPRESSION,1
TR,SYNCOPE,1
TR,THERAPEUTIC RESPONSE DECREASED,1
TR,THERAPEUTIC RESPONSE UNEXPECTED,1
TR,THROMBOSIS,1
TR,THROMBOSIS IN DEVICE,1
TR,THYROIDITIS,1
TR,TRANSFUSION,1
TR,TROPONIN I INCREASED,1
TR,TUBERCULOSIS,1
TR,VASCULAR STENT THROMBOSIS,1
TR,VEIN DISORDER,1
TR,VERTIGO,1
UG,CAESAREAN SECTION,1
UG,DEATH,1
UG,FOETAL EXPOSURE DURING PREGNANCY,1
UG,LABILE BLOOD PRESSURE,1
UG,MATERNAL EXPOSURE DURING PREGNANCY,1
UG,PREMATURE BABY,1
UG,PREMATURE LABOUR,1
UA,DRUG-INDUCED LIVER INJURY,2
UA,VASCULAR STENT THROMBOSIS,2
UA,ACUTE MYOCARDIAL INFARCTION,1
UA,CARDIAC FAILURE ACUTE,1
UA,CARDIAC TAMPONADE,1
UA,CORONARY ARTERY DISSECTION,1
UA,DIABETIC RETINOPATHY,1
UA,DRESSLER^S SYNDROME,1
UA,DYSPNOEA,1
UA,GASTRODUODENAL HAEMORRHAGE,1
UA,HEPATOMEGALY,1
GB,ACUTE KIDNEY INJURY,40
GB,RENAL IMPAIRMENT,38
GB,FALL,36
GB,MALAISE,34
GB,CONDITION AGGRAVATED,30
GB,GENERAL PHYSICAL HEALTH DETERIORATION,26
GB,PAIN,23
GB,FEELING ABNORMAL,22
GB,PAIN IN EXTREMITY,22
GB,DIZZINESS,21
GB,DRUG INEFFECTIVE,21
GB,DYSPNOEA,21
GB,ERECTILE DYSFUNCTION,21
GB,INSOMNIA,21
GB,MYALGIA,21
GB,TOXICITY TO VARIOUS AGENTS,21
GB,ARTHRALGIA,20
GB,CONFUSIONAL STATE,20
GB,DEPRESSION,20
GB,ANXIETY,19
GB,MENTAL DISORDER,19
GB,ALCOHOL POISONING,18
GB,CARDIOMEGALY,18
GB,NAUSEA,18
GB,NEUTROPHIL COUNT INCREASED,18
GB,STRESS,18
GB,CONJUNCTIVAL HYPERAEMIA,17
GB,HEPATIC STEATOSIS,17
GB,IMPLANT SITE EXTRAVASATION,17
GB,IMPLANT SITE INFECTION,17
GB,MACROPHAGES INCREASED,17
GB,ONYCHOMYCOSIS,17
GB,PETECHIAE,17
GB,PULMONARY OEDEMA,17
GB,SCAR,17
GB,SCRATCH,17
GB,SELF INJURIOUS BEHAVIOUR,17
GB,WOUND DEHISCENCE,17
GB,FATIGUE,16
GB,PURULENT DISCHARGE,16
GB,BLOOD ETHANOL INCREASED,15
GB,BRADYCARDIA,15
GB,PULMONARY CONGESTION,15
GB,HYPERHIDROSIS,14
GB,ASTHENIA,13
GB,CARDIAC ARREST,13
GB,SEIZURE,13
GB,DEATH,12
GB,DEHYDRATION,12
GB,GASTROINTESTINAL HAEMORRHAGE,12
GB,MYOCARDIAL ISCHAEMIA,12
GB,SUDDEN DEATH,12
GB,VISION BLURRED,12
GB,ALANINE AMINOTRANSFERASE INCREASED,11
GB,BLOOD CREATINE PHOSPHOKINASE INCREASED,11
GB,BLOOD POTASSIUM INCREASED,11
GB,CONTRAINDICATED DRUG ADMINISTERED,11
GB,GLOMERULAR FILTRATION RATE DECREASED,11
GB,DIARRHOEA,10
GB,DRUG DISPENSING ERROR,10
GB,FAECES DISCOLOURED,10
GB,HAEMOGLOBIN DECREASED,10
GB,HEADACHE,10
GB,BLOOD UREA INCREASED,9
GB,CHEST DISCOMFORT,9
GB,INCORRECT DOSE ADMINISTERED,9
GB,UNEVALUABLE EVENT,9
GB,VOMITING,9
GB,BLOOD KETONE BODY INCREASED,8
GB,HOSPITALISATION,8
GB,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,8
GB,PALPITATIONS,8
GB,PNEUMONITIS,8
GB,PRURITUS,8
GB,SWELLING FACE,8
GB,ACCIDENTAL OVERDOSE,7
GB,BALANCE DISORDER,7
GB,INJURY,7
GB,LIP SWELLING,7
GB,PYREXIA,7
GB,UNRESPONSIVE TO STIMULI,7
GB,ABDOMINAL PAIN UPPER,6
GB,ACUTE PULMONARY OEDEMA,6
GB,ALVEOLITIS,6
GB,DYSPEPSIA,6
GB,HALLUCINATION_ VISUAL,6
GB,HEAD INJURY,6
GB,CARDIOGENIC SHOCK,5
GB,CHEST PAIN,5
GB,DRUG INTOLERANCE,5
GB,HEART RATE IRREGULAR,5
GB,HYPERKALAEMIA,5
GB,JOINT SWELLING,5
GB,LOWER RESPIRATORY TRACT INFECTION,5
GB,MALIGNANT ATROPHIC PAPULOSIS,5
GB,MALIGNANT NEOPLASM PROGRESSION,5
GB,PNEUMONIA,5
GB,RENAL FAILURE,5
GB,SYNCOPE,5
GB,AGITATION,4
GB,ARTHROPATHY,4
GB,C-REACTIVE PROTEIN ABNORMAL,4
GB,CARDIAC FAILURE,4
GB,CATARACT,4
GB,COLD SWEAT,4
GB,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,4
GB,DRY EYE,4
GB,DYSARTHRIA,4
GB,FOETAL EXPOSURE DURING PREGNANCY,4
GB,MUSCLE SPASTICITY,4
GB,NIGHTMARE,4
GB,ORTHOSTATIC HYPOTENSION,4
GB,PREMATURE BABY,4
GB,RASH ERYTHEMATOUS,4
GB,RASH GENERALISED,4
GB,REACTION TO DRUG EXCIPIENTS,4
GB,SKIN ULCER,4
GB,SOMNOLENCE,4
GB,SUBDURAL HAEMORRHAGE,4
GB,THERAPEUTIC RESPONSE DECREASED,4
GB,TRANSIENT ISCHAEMIC ATTACK,4
GB,TREMOR,4
GB,URTICARIA,4
GB,VIRAL UPPER RESPIRATORY TRACT INFECTION,4
GB,WOUND INFECTION,4
GB,ACCIDENTAL DEATH,3
GB,ATRIOVENTRICULAR BLOCK,3
GB,BURNING SENSATION,3
GB,CELLULITIS,3
GB,CIRCULATORY COLLAPSE,3
GB,COGNITIVE DISORDER,3
GB,EJECTION FRACTION DECREASED,3
GB,GAIT DISTURBANCE,3
GB,GAMMA-GLUTAMYLTRANSFERASE ABNORMAL,3
GB,GASTRITIS,3
GB,GASTROINTESTINAL DISORDER,3
GB,HALLUCINATIONS_ MIXED,3
GB,HEART RATE INCREASED,3
GB,HEPATITIS C,3
GB,HYPONATRAEMIA,3
GB,HYPOTENSION,3
GB,HYPOTONIA,3
GB,LACTIC ACIDOSIS,3
GB,LOSS OF CONSCIOUSNESS,3
GB,MATERNAL EXPOSURE DURING PREGNANCY,3
GB,MOBILITY DECREASED,3
GB,MUSCULAR WEAKNESS,3
GB,MYOCLONUS,3
GB,PARANOIA,3
GB,SEPSIS,3
GB,SHOCK,3
GB,TACHYCARDIA,3
GB,TARDIVE DYSKINESIA,3
GB,THERAPEUTIC RESPONSE UNEXPECTED,3
GB,TONGUE BLISTERING,3
GB,URINARY TRACT INFECTION,3
GB,VISUAL IMPAIRMENT,3
GB,WRONG TECHNIQUE IN DRUG USAGE PROCESS,3
GB,ABDOMINAL DISCOMFORT,2
GB,ACTIVITIES OF DAILY LIVING IMPAIRED,2
GB,ACUTE HEPATIC FAILURE,2
GB,ALOPECIA,2
GB,ANAEMIA,2
GB,ANAPHYLACTOID REACTION,2
GB,ARRHYTHMIA,2
GB,ATRIAL FIBRILLATION,2
GB,ATRIOVENTRICULAR BLOCK COMPLETE,2
GB,BLOOD ALKALINE PHOSPHATASE INCREASED,2
GB,BLOOD BILIRUBIN INCREASED,2
GB,BLOOD PRESSURE ABNORMAL,2
GB,BLOOD PRESSURE DECREASED,2
GB,BLOOD PRESSURE IMMEASURABLE,2
GB,BUNDLE BRANCH BLOCK LEFT,2
GB,CEREBROVASCULAR ACCIDENT,2
GB,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
GB,CONSTIPATION,2
GB,CONVULSION,2
GB,COUGH,2
GB,CYANOSIS,2
GB,DEVICE OCCLUSION,2
GB,DIABETES MELLITUS,2
GB,DRUG EFFECT DECREASED,2
GB,FEBRILE NEUTROPENIA,2
GB,FEELING COLD,2
GB,FEELING HOT,2
GB,FLUID IMBALANCE,2
GB,HEART RATE ABNORMAL,2
GB,HEMIPARESIS,2
GB,HYPERTHYROIDISM,2
GB,HYPOGLYCAEMIA,2
GB,HYPOKALAEMIA,2
GB,HYPOXIA,2
GB,IMMUNODEFICIENCY,2
GB,INFECTION,2
GB,JAUNDICE,2
GB,LEFT VENTRICULAR FAILURE,2
GB,LOCALISED INFECTION,2
GB,LOW BIRTH WEIGHT BABY,2
GB,LUNG ADENOCARCINOMA,2
GB,MOOD SWINGS,2
GB,NEUTROPENIC SEPSIS,2
GB,PALLOR,2
GB,PARAESTHESIA,2
GB,PHOTOSENSITIVITY REACTION,2
GB,PREMATURE DELIVERY,2
GB,PSORIASIS,2
GB,PULMONARY EMBOLISM,2
GB,PULSE ABNORMAL,2
GB,RECTAL HAEMORRHAGE,2
GB,RENAL CYST,2
GB,RETROPERITONEAL FIBROSIS,2
GB,THYROIDITIS ACUTE,2
GB,VENTRICULAR TACHYCARDIA,2
GB,WEIGHT DECREASED,2
GB,WHEEZING,2
GB,ABDOMINAL PAIN,1
GB,ABNORMAL FAECES,1
GB,ACTINOMYCOSIS,1
GB,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
GB,ACUTE MYOCARDIAL INFARCTION,1
GB,ADVERSE DRUG REACTION,1
GB,AGGRESSION,1
GB,ALCOHOL ABUSE,1
GB,ALCOHOLIC SEIZURE,1
GB,ALCOHOLISM,1
GB,ANAPHYLACTIC REACTION,1
GB,ANGIOGRAM ABNORMAL,1
GB,ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC,1
GB,AORTIC ANEURYSM,1
GB,AORTIC VALVE INCOMPETENCE,1
GB,APHAGIA,1
GB,APPLICATION SITE PAIN,1
GB,ARTHRITIS,1
GB,ARTHRITIS ENTEROPATHIC,1
GB,ASTHMA,1
GB,AUTOIMMUNE NEUROPATHY,1
GB,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
GB,BEDRIDDEN,1
GB,BILE DUCT OBSTRUCTION,1
GB,BILIARY SEPSIS,1
GB,BLADDER DISORDER,1
GB,BLEEDING TIME PROLONGED,1
GB,BLOOD GLUCOSE INCREASED,1
GB,BODY TEMPERATURE INCREASED,1
GB,BRAIN NATRIURETIC PEPTIDE INCREASED,1
GB,BRONCHIAL CARCINOMA,1
GB,BRUGADA SYNDROME,1
GB,BUNDLE BRANCH BLOCK RIGHT,1
GB,CANDIDA INFECTION,1
GB,CARDIOACTIVE DRUG LEVEL INCREASED,1
GB,CATHETER SITE HAEMORRHAGE,1
GB,CEREBRAL HAEMORRHAGE,1
GB,CHAPPED LIPS,1
GB,CHILLS,1
GB,CHOLECYSTITIS,1
GB,CHROMATURIA,1
GB,CLOSTRIDIUM DIFFICILE COLITIS,1
GB,CLOSTRIDIUM DIFFICILE INFECTION,1
GB,CONTRAINDICATED PRODUCT ADMINISTERED,1
GB,CROHN^S DISEASE,1
GB,CYSTITIS,1
GB,DECREASED APPETITE,1
GB,DELIRIUM,1
GB,DELUSION,1
GB,DERMATITIS EXFOLIATIVE,1
GB,DIABETIC KETOACIDOSIS,1
GB,DIVERTICULITIS,1
GB,DIVERTICULUM,1
GB,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
GB,DRUG-INDUCED LIVER INJURY,1
GB,DRY SKIN,1
GB,DUODENITIS,1
GB,DYSGEUSIA,1
GB,DYSPHAGIA,1
GB,DYSPNOEA EXERTIONAL,1
GB,ELECTROCARDIOGRAM AMBULATORY ABNORMAL,1
GB,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
GB,EMPYEMA,1
GB,EPILEPSY,1
GB,EPINEPHRINE INCREASED,1
GB,EPISTAXIS,1
GB,ERYTHEMA,1
GB,EXCORIATION,1
GB,EXPOSURE DURING PREGNANCY,1
GB,EXTRASYSTOLES,1
GB,EYE SWELLING,1
GB,EYELID OEDEMA,1
GB,FALLOT^S TETRALOGY,1
GB,FEEDING DISORDER,1
GB,FLATULENCE,1
GB,FLUSHING,1
GB,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
GB,FOETAL ACIDOSIS,1
GB,FUNCTIONAL GASTROINTESTINAL DISORDER,1
GB,GAIT INABILITY,1
GB,GASTRITIS ALCOHOLIC,1
GB,GASTROINTESTINAL CARCINOMA,1
GB,GASTROINTESTINAL STOMA COMPLICATION,1
GB,GASTROINTESTINAL VASCULAR MALFORMATION,1
GB,GASTROOESOPHAGEAL REFLUX DISEASE,1
GB,GENERALISED OEDEMA,1
GB,GINGIVAL BLEEDING,1
GB,GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE,1
GB,GLOSSODYNIA,1
GB,GLUCOSE TOLERANCE IMPAIRED,1
GB,GOUT,1
GB,HAEMATEMESIS,1
GB,HAEMATOCHEZIA,1
GB,HAEMATOMA,1
GB,HALLUCINATION,1
GB,HIATUS HERNIA,1
GB,HOT FLUSH,1
GB,HYPERCHOLESTEROLAEMIA,1
GB,HYPERTENSION,1
GB,HYPERTENSIVE EMERGENCY,1
GB,HYPOAESTHESIA,1
GB,ILL-DEFINED DISORDER,1
GB,IMMUNE SYSTEM DISORDER,1
GB,IMPAIRED HEALING,1
GB,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
GB,INTENTIONAL SELF-INJURY,1
GB,INTESTINAL HAEMORRHAGE,1
GB,INTESTINAL PERFORATION,1
GB,ISCHAEMIC STROKE,1
GB,JAW FRACTURE,1
GB,LACUNAR INFARCTION,1
GB,LEFT VENTRICULAR HYPERTROPHY,1
GB,LIMB OPERATION,1
GB,LIP BLISTER,1
GB,MASS,1
GB,MATERNAL DRUGS AFFECTING FOETUS,1
GB,MELAENA,1
GB,METASTASIS,1
GB,MIDDLE INSOMNIA,1
GB,MULTIPLE SCLEROSIS RELAPSE,1
GB,MUSCLE SPASMS,1
GB,NEOPLASM MALIGNANT,1
GB,NEPHROSTOMY,1
GB,NON-CARDIAC CHEST PAIN,1
GB,NOREPINEPHRINE INCREASED,1
GB,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,1
GB,OEDEMA,1
GB,OESOPHAGEAL RUPTURE,1
GB,OESOPHAGITIS,1
GB,ORAL PAIN,1
GB,PANCREATITIS CHRONIC,1
GB,PERIPARTUM CARDIOMYOPATHY,1
GB,PERIPHERAL SWELLING,1
GB,PHOTOPSIA,1
GB,PLATELET COUNT INCREASED,1
GB,PLEURAL EFFUSION,1
GB,PLEURAL INFECTION,1
GB,PLEURITIC PAIN,1
GB,PNEUMONIA ASPIRATION,1
GB,POLLAKIURIA,1
GB,POLYP,1
GB,POST PROCEDURAL COMPLICATION,1
GB,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
GB,PRE-EXISTING DISEASE,1
GB,PRODUCT FORMULATION ISSUE,1
GB,PRODUCT SUBSTITUTION ISSUE,1
GB,PRODUCTIVE COUGH,1
GB,PROSTATE CANCER METASTATIC,1
GB,PSORIATIC ARTHROPATHY,1
GB,RENAL FAILURE CHRONIC,1
GB,RESPIRATORY FAILURE,1
GB,RESPIRATORY RATE INCREASED,1
GB,RHEUMATOID ARTHRITIS,1
GB,SENILE DEMENTIA,1
GB,SINUS TACHYCARDIA,1
GB,SJOGREN^S SYNDROME,1
GB,SKIN HYPERTROPHY,1
GB,SKIN REACTION,1
GB,STOMAL HERNIA,1
GB,STREPTOCOCCAL SEPSIS,1
GB,SUBARACHNOID HAEMORRHAGE,1
GB,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,1
GB,SUICIDAL IDEATION,1
GB,SUICIDE ATTEMPT,1
GB,THIRST,1
GB,THROAT IRRITATION,1
GB,THROMBIN TIME PROLONGED,1
GB,UPPER GASTROINTESTINAL HAEMORRHAGE,1
GB,UPPER RESPIRATORY TRACT INFECTION,1
GB,URINARY TRACT OBSTRUCTION,1
GB,URINE ODOUR ABNORMAL,1
GB,VASCULITIS,1
GB,VENTRICULAR EXTRASYSTOLES,1
GB,VENTRICULAR FIBRILLATION,1
GB,VIRAL INFECTION,1
GB,WALKING AID USER,1
GB,WHITE BLOOD CELL COUNT INCREASED,1
GB,WITHDRAWAL SYNDROME,1
GB,WOUND INFECTION STAPHYLOCOCCAL,1
GB,WOUND SECRETION,1
GB,XANTHOMA,1
US,DRUG INEFFECTIVE,4419
US,FATIGUE,4256
US,DIARRHOEA,3928
US,DYSPNOEA,3743
US,NAUSEA,3614
US,MYOCARDIAL INFARCTION,2930
US,DIZZINESS,2846
US,ASTHENIA,2632
US,PAIN,2527
US,HEADACHE,2447
US,FALL,2415
US,DEATH,2249
US,PNEUMONIA,2136
US,GASTROINTESTINAL HAEMORRHAGE,2045
US,MALAISE,1997
US,DRUG DOSE OMISSION,1891
US,CARDIAC FAILURE CONGESTIVE,1859
US,ARTHRALGIA,1845
US,WEIGHT DECREASED,1827
US,PAIN IN EXTREMITY,1817
US,VOMITING,1792
US,ATRIAL FIBRILLATION,1654
US,RASH,1640
US,ANAEMIA,1554
US,CHEST PAIN,1523
US,COUGH,1508
US,HYPERTENSION,1484
US,CEREBROVASCULAR ACCIDENT,1464
US,DECREASED APPETITE,1462
US,BACK PAIN,1435
US,PRURITUS,1398
US,CONSTIPATION,1374
US,INSOMNIA,1367
US,HYPOTENSION,1359
US,FEELING ABNORMAL,1244
US,GAIT DISTURBANCE,1204
US,COMPLETED SUICIDE,1181
US,ANXIETY,1134
US,PERIPHERAL SWELLING,1131
US,URINARY TRACT INFECTION,1125
US,MUSCLE SPASMS,1097
US,BLOOD PRESSURE INCREASED,1081
US,PYREXIA,1042
US,WEIGHT INCREASED,1039
US,DEHYDRATION,1024
US,ABDOMINAL PAIN UPPER,1018
US,DEPRESSION,993
US,ABDOMINAL PAIN,964
US,PRODUCT USE ISSUE,953
US,CORONARY ARTERY DISEASE,952
US,CONTUSION,929
US,BLOOD GLUCOSE INCREASED,927
US,PRODUCT QUALITY ISSUE,920
US,ABDOMINAL DISCOMFORT,912
US,ALOPECIA,874
US,NASOPHARYNGITIS,861
US,ACUTE KIDNEY INJURY,848
US,INJECTION SITE PAIN,842
US,CONDITION AGGRAVATED,822
US,SOMNOLENCE,821
US,OEDEMA PERIPHERAL,816
US,EPISTAXIS,813
US,CONFUSIONAL STATE,809
US,HYPOAESTHESIA,796
US,ACUTE MYOCARDIAL INFARCTION,792
US,MYALGIA,792
US,TREMOR,788
US,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,780
US,DRUG HYPERSENSITIVITY,761
US,PARAESTHESIA,745
US,MEMORY IMPAIRMENT,743
US,MUSCULAR WEAKNESS,728
US,VISION BLURRED,716
US,INCORRECT DOSE ADMINISTERED,714
US,TOXICITY TO VARIOUS AGENTS,708
US,HEART RATE INCREASED,700
US,HAEMOGLOBIN DECREASED,660
US,RENAL FAILURE,658
US,SEPSIS,647
US,DYSPEPSIA,644
US,RECTAL HAEMORRHAGE,644
US,CARDIAC DISORDER,640
US,DYSGEUSIA,620
US,HYPERHIDROSIS,614
US,SYNCOPE,613
US,HAEMORRHAGE,606
US,ERYTHEMA,589
US,INTENTIONAL PRODUCT MISUSE,589
US,BRONCHITIS,584
US,GASTROOESOPHAGEAL REFLUX DISEASE,580
US,JOINT SWELLING,578
US,ARTHRITIS,573
US,BALANCE DISORDER,569
US,PALPITATIONS,558
US,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,553
US,LOSS OF CONSCIOUSNESS,553
US,DRY MOUTH,552
US,PLATELET COUNT DECREASED,549
US,SINUSITIS,543
US,CARDIAC ARREST,541
US,INFLUENZA,535
US,NEUROPATHY PERIPHERAL,526
US,ABDOMINAL DISTENSION,524
US,CHEST DISCOMFORT,524
US,PSORIASIS,522
US,CHILLS,514
US,FLUSHING,514
US,HYPERSENSITIVITY,511
US,VISUAL IMPAIRMENT,503
US,THROMBOSIS,501
US,PULMONARY EMBOLISM,495
US,RESPIRATORY FAILURE,495
US,DYSPHAGIA,488
US,DISEASE PROGRESSION,480
US,PLEURAL EFFUSION,476
US,OROPHARYNGEAL PAIN,474
US,WHITE BLOOD CELL COUNT DECREASED,473
US,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,473
US,DEEP VEIN THROMBOSIS,468
US,URTICARIA,448
US,DIABETES MELLITUS,444
US,INFECTION,443
US,FLUID RETENTION,439
US,DYSPHONIA,437
US,HAEMORRHAGIC ANAEMIA,433
US,CATARACT,427
US,FLATULENCE,425
US,MUSCULOSKELETAL PAIN,420
US,SWELLING,417
US,HAEMATURIA,414
US,THROMBOCYTOPENIA,408
US,DRY SKIN,402
US,OSTEOARTHRITIS,402
US,OVERDOSE,396
US,CELLULITIS,385
US,STOMATITIS,380
US,PULMONARY OEDEMA,376
US,RHEUMATOID ARTHRITIS,376
US,MUSCULOSKELETAL STIFFNESS,375
US,OEDEMA,371
US,BURNING SENSATION,370
US,UPPER GASTROINTESTINAL HAEMORRHAGE,359
US,BLOOD PRESSURE DECREASED,358
US,HAEMATOCHEZIA,358
US,RHINORRHOEA,358
US,HALLUCINATION,357
US,AMNESIA,356
US,DRUG EFFECT INCOMPLETE,356
US,BLOOD CREATININE INCREASED,346
US,HOSPITALISATION,346
US,SEIZURE,344
US,NASAL CONGESTION,340
US,RENAL FAILURE ACUTE,336
US,NECK PAIN,335
US,TRANSIENT ISCHAEMIC ATTACK,335
US,UNDERDOSE,330
US,DRUG EFFECT DECREASED,328
US,MALIGNANT NEOPLASM PROGRESSION,326
US,POLLAKIURIA,325
US,HOT FLUSH,324
US,BRADYCARDIA,323
US,UNEVALUABLE EVENT,320
US,THERAPEUTIC RESPONSE UNEXPECTED,319
US,PRODUCT USE IN UNAPPROVED INDICATION,317
US,INJURY,315
US,COAGULOPATHY,312
US,INJECTION SITE BRUISING,311
US,INJECTION SITE ERYTHEMA,311
US,TACHYCARDIA,310
US,INTERNAL HAEMORRHAGE,309
US,UPPER RESPIRATORY TRACT INFECTION,307
US,INFLUENZA LIKE ILLNESS,306
US,BLOOD GLUCOSE DECREASED,305
US,CORONARY ARTERY OCCLUSION,305
US,BONE PAIN,301
US,FEELING HOT,301
US,RENAL IMPAIRMENT,301
US,ADVERSE EVENT,300
US,CARDIAC FAILURE,300
US,CORONARY ARTERY BYPASS,299
US,HERPES ZOSTER,299
US,DYSPNOEA EXERTIONAL,298
US,MENTAL STATUS CHANGES,295
US,OSTEOPOROSIS,295
US,PLASMA CELL MYELOMA,292
US,INCORRECT DRUG ADMINISTRATION DURATION,283
US,WHEEZING,282
US,RASH PRURITIC,281
US,PRODUCTIVE COUGH,280
US,HEART RATE DECREASED,277
US,INTERNATIONAL NORMALISED RATIO INCREASED,277
US,BLOOD CHOLESTEROL INCREASED,275
US,CEREBRAL HAEMORRHAGE,274
US,NERVOUSNESS,274
US,ANGINA PECTORIS,273
US,WRONG TECHNIQUE IN DRUG USAGE PROCESS,273
US,CARDIO-RESPIRATORY ARREST,271
US,DRUG INTOLERANCE,269
US,LETHARGY,269
US,STRESS,268
US,SKIN DISCOLOURATION,267
US,ARRHYTHMIA,266
US,INJECTION SITE HAEMORRHAGE,266
US,NEPHROLITHIASIS,266
US,ARTHROPATHY,264
US,ADVERSE DRUG REACTION,263
US,RENAL DISORDER,262
US,BLISTER,261
US,LOWER GASTROINTESTINAL HAEMORRHAGE,261
US,BLOOD POTASSIUM DECREASED,260
US,LOCAL SWELLING,260
US,ORAL PAIN,258
US,SKIN EXFOLIATION,255
US,HEPATIC ENZYME INCREASED,253
US,MOBILITY DECREASED,253
US,ASTHMA,251
US,HIP FRACTURE,250
US,SWELLING FACE,250
US,HAEMOPTYSIS,249
US,PANCREATITIS,249
US,SLEEP DISORDER,249
US,DYSURIA,247
US,BLOOD URINE PRESENT,246
US,HYPOKALAEMIA,241
US,MIGRAINE,241
US,NEUTROPENIA,239
US,THERAPY CESSATION,237
US,ACUTE RESPIRATORY FAILURE,236
US,HYPOXIA,232
US,VERTIGO,231
US,PANCYTOPENIA,230
US,STAPHYLOCOCCAL INFECTION,229
US,WHITE BLOOD CELL COUNT INCREASED,228
US,OXYGEN SATURATION DECREASED,227
US,DRUG ADMINISTRATION ERROR,226
US,AGITATION,225
US,GASTROINTESTINAL DISORDER,225
US,INTENTIONAL PRODUCT USE ISSUE,225
US,HAEMATOMA,223
US,EMOTIONAL DISTRESS,222
US,HEAD INJURY,222
US,TREATMENT NONCOMPLIANCE,221
US,VISUAL ACUITY REDUCED,220
US,DIVERTICULITIS,218
US,GOUT,218
US,TYPE 2 DIABETES MELLITUS,217
US,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,216
US,HEART RATE IRREGULAR,214
US,MEDICATION ERROR,214
US,BODY HEIGHT DECREASED,212
US,CHOLELITHIASIS,211
US,CYSTITIS,210
US,RED BLOOD CELL COUNT DECREASED,210
US,GENERAL PHYSICAL HEALTH DETERIORATION,208
US,CORONARY ARTERIAL STENT INSERTION,207
US,HYPERKALAEMIA,206
US,HYPONATRAEMIA,206
US,PULMONARY HYPERTENSION,205
US,ABASIA,203
US,INJECTION SITE PRURITUS,203
US,SPEECH DISORDER,200
US,URINARY INCONTINENCE,199
US,SLEEP APNOEA SYNDROME,198
US,THROAT IRRITATION,197
US,CROHN^S DISEASE,196
US,INTERVERTEBRAL DISC PROTRUSION,195
US,ACTIVITIES OF DAILY LIVING IMPAIRED,192
US,CLOSTRIDIUM DIFFICILE INFECTION,191
US,DEVICE MALFUNCTION,190
US,EXPIRED PRODUCT ADMINISTERED,189
US,HYPERSOMNIA,189
US,PAIN IN JAW,189
US,HAEMORRHOIDS,188
US,HYPOACUSIS,187
US,MULTIPLE SCLEROSIS RELAPSE,187
US,GASTRIC DISORDER,186
US,ANGINA UNSTABLE,185
US,IMPAIRED HEALING,185
US,AGEUSIA,184
US,RIB FRACTURE,183
US,EYE PAIN,181
US,LACERATION,181
US,LUNG DISORDER,181
US,CHRONIC KIDNEY DISEASE,180
US,SEPTIC SHOCK,180
US,SUBDURAL HAEMATOMA,180
US,BONE DISORDER,179
US,FAECES DISCOLOURED,179
US,HYPOGLYCAEMIA,179
US,LOCALISED INFECTION,179
US,LIMB DISCOMFORT,178
US,PRESYNCOPE,177
US,FLUID OVERLOAD,176
US,NO ADVERSE EVENT,176
US,INTENTIONAL OVERDOSE,175
US,DRY EYE,174
US,PERICARDIAL EFFUSION,174
US,SUICIDAL IDEATION,174
US,FULL BLOOD COUNT DECREASED,173
US,DYSARTHRIA,171
US,EYE IRRITATION,171
US,NIGHT SWEATS,170
US,PRURITUS GENERALISED,170
US,HAEMORRHAGE INTRACRANIAL,169
US,HYPOTHYROIDISM,169
US,IRRITABILITY,169
US,DEVICE ISSUE,167
US,URINARY RETENTION,167
US,ROAD TRAFFIC ACCIDENT,166
US,DYSSTASIA,165
US,PULMONARY MASS,165
US,DISCOMFORT,164
US,LUNG NEOPLASM MALIGNANT,164
US,SKIN ULCER,164
US,CHROMATURIA,163
US,DISORIENTATION,163
US,TINNITUS,163
US,DRUG WITHDRAWAL SYNDROME,162
US,VENTRICULAR TACHYCARDIA,162
US,BLOOD COUNT ABNORMAL,161
US,INTESTINAL OBSTRUCTION,159
US,BLOOD PRESSURE ABNORMAL,158
US,INJECTION SITE SWELLING,158
US,VAGINAL HAEMORRHAGE,158
US,GASTRITIS,157
US,HAEMORRHAGIC STROKE,157
US,DRUG PRESCRIBING ERROR,155
US,HIATUS HERNIA,155
US,LYMPHADENOPATHY,155
US,THERAPEUTIC RESPONSE DECREASED,155
US,BLOOD POTASSIUM INCREASED,153
US,SPINAL OSTEOARTHRITIS,153
US,FEBRILE NEUTROPENIA,152
US,HYPOPHAGIA,152
US,NEURALGIA,152
US,UPPER LIMB FRACTURE,152
US,HYPERGLYCAEMIA,151
US,JOINT INJURY,151
US,LIMB INJURY,151
US,PANIC ATTACK,150
US,SURGERY,150
US,FUNGAL INFECTION,149
US,HYPERLIPIDAEMIA,149
US,OCULAR HYPERAEMIA,149
US,ATELECTASIS,148
US,ATRIAL FLUTTER,148
US,RASH GENERALISED,148
US,BLINDNESS,147
US,EYE SWELLING,147
US,FEELING COLD,147
US,DEPRESSED MOOD,146
US,FIBROMYALGIA,146
US,RASH ERYTHEMATOUS,146
US,RASH MACULAR,146
US,ASPARTATE AMINOTRANSFERASE INCREASED,145
US,GLYCOSYLATED HAEMOGLOBIN INCREASED,145
US,LACRIMATION INCREASED,145
US,INTERVERTEBRAL DISC DEGENERATION,144
US,RETCHING,144
US,SWOLLEN TONGUE,144
US,CONVULSION,143
US,DISTURBANCE IN ATTENTION,143
US,COLITIS,141
US,DEMENTIA,141
US,LIP SWELLING,141
US,FOOT FRACTURE,140
US,LIVER FUNCTION TEST ABNORMAL,140
US,WOUND,139
US,INJECTION SITE REACTION,138
US,NEOPLASM MALIGNANT,138
US,SKIN DISORDER,138
US,ANGIOEDEMA,137
US,FEMUR FRACTURE,137
US,PRODUCT SUBSTITUTION ISSUE,137
US,BLOOD PRESSURE FLUCTUATION,136
US,GLOSSODYNIA,136
US,ALANINE AMINOTRANSFERASE INCREASED,135
US,APHASIA,135
US,JOINT STIFFNESS,135
US,TOOTH DISORDER,135
US,EYE DISORDER,134
US,PROSTATIC SPECIFIC ANTIGEN INCREASED,134
US,SUICIDE ATTEMPT,134
US,VIRAL INFECTION,134
US,OSTEOPENIA,133
US,SINUS DISORDER,133
US,MUSCULOSKELETAL CHEST PAIN,132
US,INCORRECT ROUTE OF DRUG ADMINISTRATION,131
US,METABOLIC ACIDOSIS,131
US,OSTEONECROSIS OF JAW,131
US,SKIN LESION,131
US,DIVERTICULUM,130
US,GLAUCOMA,130
US,HAEMATOCRIT DECREASED,130
US,CARDIOMYOPATHY,129
US,DYSKINESIA,129
US,FREQUENT BOWEL MOVEMENTS,129
US,HERNIA,128
US,INJECTION SITE MASS,128
US,LEUKOCYTOSIS,128
US,NIGHTMARE,128
US,STENT PLACEMENT,128
US,INTENTIONAL DRUG MISUSE,127
US,BREAST CANCER,126
US,NEOPLASM PROGRESSION,126
US,OSTEOMYELITIS,126
US,ROTATOR CUFF SYNDROME,126
US,UNRESPONSIVE TO STIMULI,126
US,GINGIVAL BLEEDING,125
US,RESPIRATORY ARREST,125
US,CRYING,124
US,GASTROENTERITIS VIRAL,124
US,VITAMIN D DEFICIENCY,124
US,ACNE,123
US,MENTAL DISORDER,122
US,SUPRAVENTRICULAR TACHYCARDIA,122
US,ARTERIOSCLEROSIS CORONARY ARTERY,120
US,EYE PRURITUS,120
US,HYPOMAGNESAEMIA,120
US,MALABSORPTION,120
US,MELAENA,120
US,RESTLESSNESS,120
US,CANDIDA INFECTION,119
US,DRUG ABUSE,119
US,GASTRIC ULCER,119
US,ERUCTATION,118
US,POST PROCEDURAL HAEMORRHAGE,118
US,ABNORMAL DREAMS,117
US,GALLBLADDER DISORDER,117
US,LABORATORY TEST ABNORMAL,117
US,CARDIOMEGALY,116
US,COGNITIVE DISORDER,116
US,IRON DEFICIENCY ANAEMIA,116
US,MOVEMENT DISORDER,116
US,MYOCARDIAL ISCHAEMIA,116
US,ARTERIOSCLEROSIS,115
US,EATING DISORDER,115
US,HAIR COLOUR CHANGES,115
US,PRODUCT ADHESION ISSUE,115
US,SNEEZING,115
US,DEAFNESS,114
US,ISCHAEMIC STROKE,114
US,SPINAL COLUMN STENOSIS,114
US,MUSCULOSKELETAL DISCOMFORT,113
US,WITHDRAWAL SYNDROME,113
US,ACUTE CORONARY SYNDROME,112
US,BACK DISORDER,111
US,CLOSTRIDIUM DIFFICILE COLITIS,111
US,INCORRECT PRODUCT STORAGE,111
US,MITRAL VALVE INCOMPETENCE,111
US,PNEUMONIA ASPIRATION,111
US,RESPIRATORY DISTRESS,111
US,APPLICATION SITE ERYTHEMA,110
US,BLOOD TRIGLYCERIDES INCREASED,110
US,FEAR,110
US,ANKLE FRACTURE,109
US,ASCITES,109
US,HAIR TEXTURE ABNORMAL,109
US,PRE-EXISTING CONDITION IMPROVED,109
US,ELECTROCARDIOGRAM QT PROLONGED,108
US,SPINAL FRACTURE,108
US,LUNG INFECTION,107
US,PHARYNGEAL OEDEMA,107
US,RHABDOMYOLYSIS,107
US,SKIN BURNING SENSATION,107
US,ABNORMAL BEHAVIOUR,106
US,CHOKING,106
US,EXTRA DOSE ADMINISTERED,106
US,EYE HAEMORRHAGE,106
US,ORTHOSTATIC HYPOTENSION,106
US,SCIATICA,106
US,TOOTHACHE,106
US,RESPIRATORY TRACT CONGESTION,105
US,ENCEPHALOPATHY,104
US,PSORIATIC ARTHROPATHY,104
US,FEELING JITTERY,103
US,BLOOD SODIUM DECREASED,102
US,INFLAMMATION,102
US,ABNORMAL LOSS OF WEIGHT,101
US,DENTAL CARIES,101
US,MULTIPLE FRACTURES,101
US,ORAL DISCOMFORT,101
US,WRIST FRACTURE,101
US,AGGRESSION,100
US,ARTERIAL OCCLUSIVE DISEASE,100
US,COMA,100
US,KIDNEY INFECTION,100
US,SKIN CANCER,100
US,DIPLOPIA,99
US,EAR INFECTION,99
US,EAR PAIN,99
US,INCREASED TENDENCY TO BRUISE,99
US,MENTAL IMPAIRMENT,99
US,RESTLESS LEGS SYNDROME,98
US,SPLENOMEGALY,98
US,TRANSFUSION,98
US,MACULAR DEGENERATION,97
US,RENAL CYST,97
US,BLOOD MAGNESIUM DECREASED,96
US,DRUG DISPENSING ERROR,96
US,HAEMATEMESIS,96
US,IRRITABLE BOWEL SYNDROME,96
US,PRESCRIBED UNDERDOSE,96
US,PROSTATE CANCER,96
US,APPLICATION SITE PAIN,95
US,BASAL CELL CARCINOMA,95
US,CARDIOGENIC SHOCK,95
US,ANGER,94
US,CARDIOVASCULAR DISORDER,94
US,LIVER DISORDER,93
US,MUSCLE TIGHTNESS,93
US,RESPIRATORY DISORDER,93
US,CEREBRAL INFARCTION,92
US,ERECTILE DYSFUNCTION,92
US,METASTASES TO LIVER,92
US,SMALL INTESTINAL OBSTRUCTION,92
US,THROAT TIGHTNESS,92
US,DIABETIC KETOACIDOSIS,91
US,FEEDING DISORDER,91
US,POOR QUALITY SLEEP,91
US,SUBARACHNOID HAEMORRHAGE,91
US,THYROID DISORDER,91
US,INFUSION RELATED REACTION,90
US,LEUKOPENIA,90
US,PULMONARY ARTERIAL HYPERTENSION,90
US,PULMONARY CONGESTION,90
US,VITAMIN D DECREASED,90
US,AORTIC ANEURYSM,89
US,APPLICATION SITE PRURITUS,89
US,VENTRICULAR EXTRASYSTOLES,89
US,MASS,88
US,BLOOD TESTOSTERONE DECREASED,87
US,HAEMORRHOIDAL HAEMORRHAGE,87
US,NODULE,87
US,PNEUMOTHORAX,87
US,BLOOD GLUCOSE ABNORMAL,86
US,ECCHYMOSIS,86
US,ILL-DEFINED DISORDER,86
US,LARGE INTESTINE POLYP,86
US,MULTIPLE SCLEROSIS,86
US,NERVOUS SYSTEM DISORDER,86
US,HYPOKINESIA,85
US,MUSCLE TWITCHING,85
US,RASH PAPULAR,85
US,DELIRIUM,84
US,GINGIVAL PAIN,84
US,KNEE ARTHROPLASTY,84
US,PNEUMONITIS,84
US,BURSITIS,83
US,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,83
US,SHOCK,83
US,METASTASES TO BONE,82
US,MULTI-ORGAN FAILURE,82
US,SKIN HAEMORRHAGE,82
US,ANAPHYLACTIC REACTION,81
US,BLOOD UREA INCREASED,81
US,COLD SWEAT,81
US,COLITIS ULCERATIVE,81
US,HEAD DISCOMFORT,81
US,LOWER LIMB FRACTURE,81
US,NOCTURIA,81
US,PLATELET COUNT INCREASED,81
US,PRODUCT PHYSICAL ISSUE,81
US,SCAB,81
US,TENDERNESS,81
US,BLOOD ALKALINE PHOSPHATASE INCREASED,80
US,OESOPHAGITIS,80
US,SINUS CONGESTION,80
US,THIRST,80
US,ULCER HAEMORRHAGE,80
US,WEIGHT FLUCTUATION,80
US,ANHEDONIA,79
US,LACTIC ACIDOSIS,79
US,VASCULAR GRAFT,79
US,EJECTION FRACTION DECREASED,78
US,INCREASED APPETITE,78
US,LUNG INFILTRATION,78
US,NERVE INJURY,78
US,VENTRICULAR FIBRILLATION,78
US,ACCIDENTAL EXPOSURE TO PRODUCT,77
US,FLANK PAIN,77
US,RESPIRATORY TRACT INFECTION,77
US,CARPAL TUNNEL SYNDROME,76
US,DIABETIC NEUROPATHY,76
US,EMOTIONAL DISORDER,76
US,MOUTH ULCERATION,76
US,MUSCULOSKELETAL DISORDER,76
US,PANCREATITIS ACUTE,76
US,THINKING ABNORMAL,76
US,TROPONIN INCREASED,76
US,BACTERIAL INFECTION,75
US,DEPRESSED LEVEL OF CONSCIOUSNESS,75
US,SINUS TACHYCARDIA,75
US,EXOSTOSIS,74
US,HEPATIC STEATOSIS,74
US,MEDICATION RESIDUE PRESENT,74
US,PROCEDURAL PAIN,74
US,ULCER,74
US,HEPATIC FAILURE,73
US,JOINT RANGE OF MOTION DECREASED,73
US,PULMONARY THROMBOSIS,73
US,TOOTH INFECTION,73
US,BLOOD BILIRUBIN INCREASED,72
US,INJECTION SITE NODULE,72
US,INJECTION SITE RASH,72
US,NEUTROPHIL COUNT DECREASED,72
US,SKIN IRRITATION,72
US,HYPERCALCAEMIA,71
US,MENISCUS INJURY,71
US,MOUTH HAEMORRHAGE,71
US,RENAL FAILURE CHRONIC,71
US,SINUS BRADYCARDIA,71
US,TOOTH ABSCESS,71
US,TOOTH FRACTURE,71
US,ABDOMINAL PAIN LOWER,70
US,BLINDNESS UNILATERAL,70
US,EMPHYSEMA,70
US,HEMIPARESIS,70
US,LIGAMENT SPRAIN,70
US,MOOD SWINGS,70
US,NERVE COMPRESSION,70
US,SKIN FISSURES,70
US,BLADDER DISORDER,69
US,CARDIAC VALVE DISEASE,69
US,DISABILITY,69
US,INCONTINENCE,69
US,NEPHROGENIC SYSTEMIC FIBROSIS,69
US,PANCREATIC CARCINOMA,69
US,PERIPHERAL VASCULAR DISORDER,69
US,POST PROCEDURAL COMPLICATION,69
US,PRESCRIBED OVERDOSE,69
US,SCAR,69
US,BACTERAEMIA,68
US,BLOOD PRESSURE INADEQUATELY CONTROLLED,68
US,DEVICE USE ERROR,68
US,DIABETES MELLITUS INADEQUATE CONTROL,68
US,DIVERTICULUM INTESTINAL HAEMORRHAGIC,68
US,RENAL CANCER,68
US,TOOTH LOSS,68
US,BLOOD IRON DECREASED,67
US,CYST,67
US,DIZZINESS POSTURAL,67
US,GASTROENTERITIS,67
US,HYPOAESTHESIA ORAL,67
US,PULMONARY FIBROSIS,67
US,APHONIA,66
US,ATRIOVENTRICULAR BLOCK,66
US,COLON CANCER,66
US,DECUBITUS ULCER,66
US,DEVICE RELATED INFECTION,66
US,HEARING IMPAIRED,66
US,INJECTION SITE URTICARIA,66
US,MADAROSIS,66
US,VIRAL UPPER RESPIRATORY TRACT INFECTION,66
US,ACUTE RESPIRATORY DISTRESS SYNDROME,65
US,CARDIAC MURMUR,65
US,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,65
US,DERMATITIS,65
US,ORAL CANDIDIASIS,65
US,PAIN OF SKIN,65
US,SHOCK HAEMORRHAGIC,65
US,SPINAL COMPRESSION FRACTURE,65
US,SYSTEMIC LUPUS ERYTHEMATOSUS,65
US,TRICUSPID VALVE INCOMPETENCE,65
US,ASPIRATION,64
US,CORONARY ARTERY STENOSIS,64
US,PALLOR,64
US,PROTEINURIA,64
US,TRANSAMINASES INCREASED,64
US,TREATMENT FAILURE,64
US,BODY TEMPERATURE INCREASED,63
US,CHOLECYSTITIS,63
US,DRY THROAT,63
US,GENERALISED OEDEMA,63
US,LARYNGITIS,63
US,MICTURITION URGENCY,63
US,OBESITY,63
US,PARAESTHESIA ORAL,63
US,POLYP,63
US,SEDATION,63
US,ABDOMINAL HERNIA,62
US,DEFORMITY,62
US,GASTRIC ULCER HAEMORRHAGE,62
US,HAIR DISORDER,62
US,HAIR GROWTH ABNORMAL,62
US,LEFT VENTRICULAR HYPERTROPHY,62
US,MULTIPLE ORGAN DYSFUNCTION SYNDROME,62
US,ORAL DISORDER,62
US,PERIPHERAL COLDNESS,62
US,SPINAL DISORDER,62
US,VITREOUS FLOATERS,62
US,CATARACT OPERATION,61
US,FOREIGN BODY,61
US,GLOMERULAR FILTRATION RATE DECREASED,61
US,HYPOCALCAEMIA,61
US,LYMPHOEDEMA,61
US,LYMPHOMA,61
US,MALNUTRITION,61
US,MIDDLE INSOMNIA,61
US,PARANOIA,61
US,SEROTONIN SYNDROME,61
US,ABSCESS,60
US,BLOOD CREATINE PHOSPHOKINASE INCREASED,60
US,BLOOD TEST ABNORMAL,60
US,CARDIAC OPERATION,60
US,DIALYSIS,60
US,DRUG DEPENDENCE,60
US,EAR DISCOMFORT,60
US,END STAGE RENAL DISEASE,60
US,GROIN PAIN,60
US,URINE OUTPUT DECREASED,60
US,ACCIDENTAL OVERDOSE,59
US,DRUG ADMINISTERED AT INAPPROPRIATE SITE,59
US,ELECTROLYTE IMBALANCE,59
US,EYE INFECTION,59
US,FRACTURE,59
US,HYPERKERATOSIS,59
US,IMPAIRED GASTRIC EMPTYING,59
US,INTERSTITIAL LUNG DISEASE,59
US,MOOD ALTERED,59
US,PELVIC FRACTURE,59
US,RENAL HAEMORRHAGE,59
US,BLOOD GLUCOSE FLUCTUATION,58
US,CAROTID ARTERY OCCLUSION,58
US,HEPATIC CIRRHOSIS,58
US,IMPAIRED DRIVING ABILITY,58
US,JOINT DISLOCATION,58
US,METASTASES TO LUNG,58
US,SEASONAL ALLERGY,58
US,AORTIC STENOSIS,57
US,BLOOD CALCIUM DECREASED,57
US,CARDIAC PACEMAKER INSERTION,57
US,EXTRASYSTOLES,57
US,MYELODYSPLASTIC SYNDROME,57
US,UROSEPSIS,57
US,FOOT DEFORMITY,56
US,HALLUCINATION_ VISUAL,56
US,ILEUS,56
US,LOWER RESPIRATORY TRACT INFECTION,56
US,PERICARDIAL HAEMORRHAGE,56
US,PSYCHOTIC DISORDER,56
US,SCOLIOSIS,56
US,SPUTUM DISCOLOURED,56
US,TENDONITIS,56
US,CARDIAC FLUTTER,55
US,COMPRESSION FRACTURE,55
US,COORDINATION ABNORMAL,55
US,DEVICE FAILURE,55
US,HIP ARTHROPLASTY,55
US,HYPERCHOLESTEROLAEMIA,55
US,JAUNDICE,55
US,NO THERAPEUTIC RESPONSE,55
US,PETECHIAE,55
US,POOR QUALITY DRUG ADMINISTERED,55
US,PROSTATOMEGALY,55
US,SENSORY DISTURBANCE,55
US,IMPAIRED WORK ABILITY,54
US,ORAL MUCOSAL BLISTERING,54
US,PELVIC PAIN,54
US,PHOTOSENSITIVITY REACTION,54
US,PSYCHOLOGICAL TRAUMA,54
US,UPPER-AIRWAY COUGH SYNDROME,54
US,WOUND INFECTION,54
US,BLOOD DISORDER,53
US,BOWEL MOVEMENT IRREGULARITY,53
US,CYTOPENIA,53
US,GAIT INABILITY,53
US,HYPERTHYROIDISM,53
US,INTRAOCULAR PRESSURE INCREASED,53
US,LIVER FUNCTION TEST INCREASED,53
US,MUSCLE ATROPHY,53
US,PHOTOPHOBIA,53
US,ARTHROPOD BITE,52
US,BLADDER CANCER,52
US,BLOOD CHOLESTEROL ABNORMAL,52
US,ESSENTIAL HYPERTENSION,52
US,PANCREATIC CARCINOMA METASTATIC,52
US,PATHOLOGICAL FRACTURE,52
US,RENAL CELL CARCINOMA,52
US,WOUND HAEMORRHAGE,52
US,BACK INJURY,51
US,BONE LESION,51
US,DERMATITIS CONTACT,51
US,DIVERTICULUM INTESTINAL,51
US,GASTRIC HAEMORRHAGE,51
US,HEART VALVE INCOMPETENCE,51
US,HYPERAESTHESIA,51
US,HYPERTENSIVE CRISIS,51
US,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,51
US,SECRETION DISCHARGE,51
US,SQUAMOUS CELL CARCINOMA,51
US,TENDON RUPTURE,51
US,APPLICATION SITE RASH,50
US,BEDRIDDEN,50
US,BLOOD BLISTER,50
US,BLOOD CALCIUM INCREASED,50
US,DEVICE OCCLUSION,50
US,EYELID OEDEMA,50
US,MUSCLE STRAIN,50
US,PARKINSON^S DISEASE,50
US,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,50
US,RENAL PAIN,50
US,URINE ODOUR ABNORMAL,50
US,CATHETERISATION CARDIAC,49
US,MENORRHAGIA,49
US,MUCOSAL INFLAMMATION,49
US,NON-CARDIAC CHEST PAIN,49
US,PRODUCT TASTE ABNORMAL,49
US,TORSADE DE POINTES,49
US,ANEURYSM,48
US,BRAIN INJURY,48
US,DEVICE DISLOCATION,48
US,ECZEMA,48
US,HEART RATE ABNORMAL,48
US,HICCUPS,48
US,OSTEONECROSIS,48
US,PROTHROMBIN TIME PROLONGED,48
US,SKIN ABRASION,48
US,SQUAMOUS CELL CARCINOMA OF SKIN,48
US,TOOTH EXTRACTION,48
US,DECREASED ACTIVITY,47
US,DELUSION,47
US,FACIAL BONES FRACTURE,47
US,HAEMARTHROSIS,47
US,HUNGER,47
US,METASTATIC RENAL CELL CARCINOMA,47
US,ORAL HERPES,47
US,PRODUCT LABEL ISSUE,47
US,BREAST PAIN,46
US,CARDIAC TAMPONADE,46
US,CHOLECYSTECTOMY,46
US,FACIAL PAIN,46
US,FAILURE TO THRIVE,46
US,INJURY ASSOCIATED WITH DEVICE,46
US,NASAL DISCOMFORT,46
US,SPINAL PAIN,46
US,WALKING AID USER,46
US,CIRCULATORY COLLAPSE,45
US,COLITIS ISCHAEMIC,45
US,DIASTOLIC DYSFUNCTION,45
US,DRUG LEVEL INCREASED,45
US,EXPOSED BONE IN JAW,45
US,FAECAL INCONTINENCE,45
US,FURUNCLE,45
US,HEPATOMEGALY,45
US,INJECTION SITE EXTRAVASATION,45
US,INTERNATIONAL NORMALISED RATIO DECREASED,45
US,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,45
US,OSTEOLYSIS,45
US,PROCTALGIA,45
US,PULMONARY HAEMORRHAGE,45
US,QUALITY OF LIFE DECREASED,45
US,TEMPERATURE INTOLERANCE,45
US,CENTRAL NERVOUS SYSTEM LESION,44
US,GASTROINTESTINAL PAIN,44
US,GENERALISED TONIC-CLONIC SEIZURE,44
US,HYPOVOLAEMIA,44
US,ISCHAEMIC CARDIOMYOPATHY,44
US,JOINT EFFUSION,44
US,LIBIDO DECREASED,44
US,MALIGNANT MELANOMA,44
US,OSTEOSCLEROSIS,44
US,SKIN INFECTION,44
US,SLUGGISHNESS,44
US,TUBULOINTERSTITIAL NEPHRITIS,44
US,AORTIC ARTERIOSCLEROSIS,43
US,DECREASED INTEREST,43
US,DRUG-INDUCED LIVER INJURY,43
US,ELECTROCARDIOGRAM ABNORMAL,43
US,HAND FRACTURE,43
US,INJECTION SITE WARMTH,43
US,KYPHOSIS,43
US,LOOSE TOOTH,43
US,MUSCLE DISORDER,43
US,MUSCLE SPASTICITY,43
US,STEVENS-JOHNSON SYNDROME,43
US,THYROID FUNCTION TEST ABNORMAL,43
US,YELLOW SKIN,43
US,ABNORMAL FAECES,42
US,ANAL INCONTINENCE,42
US,AORTIC VALVE INCOMPETENCE,42
US,BIPOLAR DISORDER,42
US,CAROTID ARTERY STENOSIS,42
US,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,42
US,DYSLIPIDAEMIA,42
US,FACE OEDEMA,42
US,GLUCOSE TOLERANCE IMPAIRED,42
US,GYNAECOMASTIA,42
US,HAEMORRHAGIC ARTERIOVENOUS MALFORMATION,42
US,HYDRONEPHROSIS,42
US,HYPOTHERMIA,42
US,LEFT VENTRICULAR DYSFUNCTION,42
US,MULTIPLE INJURIES,42
US,RENAL INJURY,42
US,SINUS HEADACHE,42
US,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,42
US,ACIDOSIS,41
US,COELIAC DISEASE,41
US,CONCUSSION,41
US,CONTRAINDICATED PRODUCT ADMINISTERED,41
US,DIARRHOEA HAEMORRHAGIC,41
US,FOREIGN BODY SENSATION IN EYES,41
US,HUMERUS FRACTURE,41
US,INTERNATIONAL NORMALISED RATIO FLUCTUATION,41
US,POSTOPERATIVE WOUND INFECTION,41
US,RENAL FUNCTION TEST ABNORMAL,41
US,TONGUE DISCOLOURATION,41
US,ANORECTAL DISCOMFORT,40
US,BARRETT^S OESOPHAGUS,40
US,BLOOD PRESSURE SYSTOLIC INCREASED,40
US,BONE LOSS,40
US,CONJUNCTIVITIS,40
US,EXPOSURE DURING PREGNANCY,40
US,EYE DISCHARGE,40
US,IMMUNE SYSTEM DISORDER,40
US,INJECTION SITE DISCOLOURATION,40
US,INTERNATIONAL NORMALISED RATIO ABNORMAL,40
US,NEOPLASM,40
US,ONYCHOCLASIS,40
US,SECOND PRIMARY MALIGNANCY,40
US,THERAPY CHANGE,40
US,WOUND COMPLICATION,40
US,WOUND SECRETION,40
US,BONE DENSITY DECREASED,39
US,FORMICATION,39
US,INTENTIONAL UNDERDOSE,39
US,MULTIPLE ALLERGIES,39
US,NAIL DISORDER,39
US,PERITONITIS,39
US,POLYURIA,39
US,RETINAL DETACHMENT,39
US,SPINAL OPERATION,39
US,ADRENAL INSUFFICIENCY,38
US,AMMONIA INCREASED,38
US,DISEASE RECURRENCE,38
US,DUODENAL ULCER,38
US,GINGIVITIS,38
US,HYPOVOLAEMIC SHOCK,38
US,LUMBAR SPINAL STENOSIS,38
US,MAJOR DEPRESSION,38
US,MANIA,38
US,METASTASES TO SPINE,38
US,NEEDLE ISSUE,38
US,PRODUCT PACKAGING ISSUE,38
US,PRODUCT SOLUBILITY ABNORMAL,38
US,SCRATCH,38
US,SENSATION OF FOREIGN BODY,38
US,SKIN ATROPHY,38
US,THERAPY NON-RESPONDER,38
US,ACUTE MYELOID LEUKAEMIA,37
US,APPARENT DEATH,37
US,BENIGN PROSTATIC HYPERPLASIA,37
US,BLINDNESS TRANSIENT,37
US,BRAIN OEDEMA,37
US,DEMENTIA ALZHEIMER^S TYPE,37
US,IMMUNODEFICIENCY,37
US,NEPHROPATHY,37
US,OESOPHAGEAL PAIN,37
US,PERICARDITIS,37
US,POOR PERIPHERAL CIRCULATION,37
US,PULSELESS ELECTRICAL ACTIVITY,37
US,RASH PUSTULAR,37
US,THYROID NEOPLASM,37
US,BONE MARROW FAILURE,36
US,CARDIAC FAILURE ACUTE,36
US,EYELID PTOSIS,36
US,INCREASED UPPER AIRWAY SECRETION,36
US,INGUINAL HERNIA,36
US,LOW DENSITY LIPOPROTEIN INCREASED,36
US,PARALYSIS,36
US,PRODUCT SIZE ISSUE,36
US,PURULENT DISCHARGE,36
US,RENAL TUBULAR NECROSIS,36
US,VISUAL FIELD DEFECT,36
US,APATHY,35
US,APPETITE DISORDER,35
US,ATAXIA,35
US,BONE CANCER,35
US,BREAST MASS,35
US,CLAVICLE FRACTURE,35
US,DRUG EFFECT DELAYED,35
US,GASTROINTESTINAL INFECTION,35
US,HAEMOTHORAX,35
US,HYPERTENSIVE EMERGENCY,35
US,INJECTION SITE INDURATION,35
US,INTESTINAL PERFORATION,35
US,INTRACRANIAL ANEURYSM,35
US,LEUKAEMIA,35
US,METASTASES TO LYMPH NODES,35
US,MYOCARDITIS,35
US,ODYNOPHAGIA,35
US,SKIN REACTION,35
US,THROMBOPHLEBITIS SUPERFICIAL,35
US,TRIGGER FINGER,35
US,ACCIDENT,34
US,EMBOLISM,34
US,JAW DISORDER,34
US,MASTICATION DISORDER,34
UY,BLOOD PRESSURE FLUCTUATION,1
UY,BONE DENSITY DECREASED,1
UY,COUGH,1
UY,CUSHING^S SYNDROME,1
UY,DECREASED APPETITE,1
UY,DIARRHOEA,1
UY,DYSPEPSIA,1
UY,FEELING HOT,1
UY,GASTROENTERITIS VIRAL,1
UY,HAEMORRHAGE,1
UY,HEADACHE,1
UY,LACTOSE INTOLERANCE,1
UY,NAUSEA,1
UY,PULSE ABNORMAL,1
UY,SEPSIS,1
UY,VOMITING,1
UY,WEIGHT DECREASED,1
VE,ARTHRALGIA,2
VE,BONE FISSURE,2
VE,FALL,2
VE,FEAR,2
VE,FINGERPRINT LOSS,2
VE,HYPOACUSIS,2
VE,PNEUMONIA,2
VE,ANGINA PECTORIS,1
VE,CONCOMITANT DISEASE PROGRESSION,1
VE,CORONARY ARTERY OCCLUSION,1
VE,EXPIRED PRODUCT ADMINISTERED,1
ZW,ASTHMA,1
ZW,BRONCHOSPASM,1
